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Abstract 
 
Phosphoryl transfer is the most common class of biological reaction. Enzymes catalysing 
this type of reaction, such as kinases, mutases and small G proteins, are pharmaceutical 
targets in cancer, inflammation and infection therapy. The characterisation of the structural 
and energy framework of the enzymatic transition state is crucial for understanding enzyme 
catalysis, which is essential for successful drug design studies. In this thesis, a combination 
of 19F-NMR and X-ray crystallography was used to define the structure of phosphoryl 
transfer enzymes in complex with metallofluorides, such as AlF4- and MgF3-, which are 
analogues of the transition state of the transfer of the phosphoryl group. In this thesis three 
different biological systems have been investigated. 
 
The bacterial mutase β-Phosphoglucomutase (βPGM) catalyses the interconversion of β-D-
glucose-1-phosphate (βG1P) and D-glucose-6-phosphate (G6P). The structural experiments 
performed on this protein, have led to the characterisation of: 
• the first observed magnesium fluoride species bound in octahedral geometry in an 
enzyme active site; 
• the discrimination in binding between the G1P and G6P using a                                 
α-fluorophosphonate analogue of βG1P, which is a potential lead compound for 
combating bacterial infections.  
RhoA belongs to the Rho family of small G proteins, which cycles between an ‘on’ 
(GTP bound) and ‘off’ (GDP-bound) state. RhoGAP promotes the inactive 
conformation of RhoA by stimulating its intrinsic GTPase activity through the so called 
arginine finger. The structures solved in this thesis provide new information on this 
system by revealing: 
• the contribution to catalysis by RhoGAP binding, in the absence of the arginine 
finger; 
• the role of Tyr34RhoA, one of the most conserved residues in small G protein, in 
RhoA switch cycle. 
! vi 
p38α and MEK6 belong to one of the MAPK signalling cascades, where p38α is the MAPK 
(Mitogen activated protein kinase) and MEK6 is its activator (MAPKK). Through structural 
and biochemical studies, how MEK6 binds and activates p38α by phosphorylation, was 
investigated. The studies have led to the characterisation of: 
• structural rearrangements caused by the docking interaction of a MEK6 D-motif 
peptide to the p38α D-motif binding site; 
• the discovery that MEK6 can use ADP as phosphate donor to activate p38α.  
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Chapter 1 Introduction 
 
 
1.1 Relevance of studying phosphoryl transfer enzymes 
Phosphoryl transfer is the most common reaction catalysed by enzymes (Admiraal & 
Herschlag, 1995). Reactions at the phosphorus atom of phosphate esters and anhydrides 
form the chemical basis for many of the most fundamental processes in living systems. 
Typical phosphate monoesters are glucose or inositol phosphate, diesters are DNA and 
RNA. Common phosphoanydrides are ATP or GTP, well known enzyme substrates and 
energy suppliers (Knowles, 1980; Lassila et al., 2011; Westheimer, 1987) (Figure 1.1). 
 
 
 
Figure 1.1 Examples of phosphate esters and phosphoanhydrides. Phosphate esters can be mono-, di-  
or tri- based on the number of R groups covalently linked to the phosphate. Phosphoanydrides contain one 
or more anhydride linkages between the phosphate groups. The protonation state shown is the dominant 
form at pH 7-8 (Lassila et al., 2011).  
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One of the most relevant aspects of phosphoric acid is that phosphorous is employed by 
nature in many aspects of cell biology. For example, it is used as raw material for 
building stable molecules such as nucleic acids and lipids, or as transient element in 
post-translational modifications, such as regulatory signalling or energy production 
(Bowler et al., 2010a). Many specific phosphoryl transfer enzymes are employed in 
these processes. Enzymes are a specific class of proteins or ribozymes that are 
considered the most selective and powerful biological catalysts known (Alberts, 2008; 
Nelson et al., 2008). In phosphoryl transfer, enzymes are fundamental, because they 
catalyse a reaction which has some of the slowest non-enzymatic rates in solution and 
thus require enormous rate accelerations (Lad et al., 2003; Lassila et al., 2011; 
Schroeder et al., 2006; Wolfenden & Snider, 2001). Indeed, the understanding of how 
these biological catalysts promote and perform the phosphoryl transfer reaction has 
become a fundamental issue for investigating the relevance of phosphorus in life 
science.  
The goal of this introduction is to provide an overview of the state of the art of 
enzymatic phosphoryl transfer. First, the relevance of phosphorus and phosphoryl 
transfer enzymes in life science will be discussed. Secondly, theoretical concepts of 
enzymatic catalysis will be explored with emphasis on the investigations reported on the 
catalysed phosphoryl transfer reaction. The role that metallofluoride complexes have 
assumed in this context will be discussed. Finally, a general background will be 
reviewed for understanding the relevance of the results contained in this thesis, which 
provided new knowledge of biological systems involving phosphoryl transfer.  
 
 
1.2 The role of phosphorus and phosphoryl transfer in cell biology 
Phosphoryl transfer reactions are involved throughout cell biology. Phosphorus is a 
stable part of biological elements, it is involved in energy production and transfer, it is 
widely used in the regulation of protein activity and signal transduction. All these cell 
aspects involve enzymes, which have been classified by the specific phosphoryl 
reaction performed.  
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1.2.1 Phosphate diesters and monoesters are fundamental building blocks in 
several macromolecules 
Since the 1970s, the structural roles for phosphate diesters and monoesters have been  
well understood. Phosphate diesters, which are stable and easy to repair, are employed 
in both DNA and RNA. Monoesters, such as phospholipids, are membrane building 
blocks. Phosphorus itself is used as a mineral component of the skeletal structure. 
Several classes of enzymes are involved in the metabolism of these phosphor-elements. 
Phosphodiesterases catalyse the hydrolysis of nucleic acids, at the phosphoester 
linkage (Cleland & Hengge, 2006). Phospholipases are enzymes that hydrolyse 
phospholipids into fatty acids and other lipophilic substances (Nelson et al., 2008). 
Aspartate Transcarbamoylase, which belong to the Carbamoyl and Carboxyl 
Transferases family, catalyses carbamoyl transfer from carbamoyl-P to aspartate to 
give carbamoylaspartate, providing the raw materials for pyrimidine ring synthesis 
(Gerhart & Pardee, 1962). Part of the Kinases and Phosphatases families are also 
involved in metabolism of phosphor-elements. They catalyse, respectively, the addition 
or hydrolysis of a phosphate group onto or off small molecules, such as sugars and 
nucleotides.  
 
 
1.2.2 Phosphorus is involved in energy production and transfer 
Cell metabolism is the result of the coordination of two opposing streams of chemical 
reactions: the catabolic and anabolic pathways. Catabolic reactions break down 
foodstuffs into smaller molecules, thereby generating both a useful form of energy for 
the cell and some of the small molecules that the cell needs as building blocks. Anabolic 
reactions use the energy produced by catabolism to drive the synthesis of the many 
other molecules that form the cell. The energy released in catabolism, or driven force, is 
stored as chemical bond energy in a small set of molecules named carrier molecules. 
These molecules diffuse rapidly throughout the cell and provide energy through two 
different mechanisms: transfer of specific chemical group or transfer of 
electrons/protons. The phosphoanydrides ATP and GTP belong to the first group. In 
these molecules energy is realised by the hydrolysis of one or more phosphate groups. 
ATP is the most common currency of energy in all cells and several enzymes, such as 
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Kinases, couple reactions with ATP hydrolysis. ATPases, such as myosin in muscle 
tissue, use the energy released by ATP hydrolysis to drive motion (Smith & Rayment, 
1996).  
ATP production or glycolysis, is indeed the fundamental catabolic chain reaction, which 
occurs in both aerobic and anaerobic organisms. The pathway produces the energy 
necessary for synthesising ATP. After the breakdown of food molecules into sugars, 
glucose enters glycolysis, a sequence of reactions which produces 2 ATP molecules for 
each glucose molecule without the involvement of molecular oxygen (O2 gas). 
Phosphoryl transfer enzymes are involved in production of glucose and glycolysis itself. 
For example, Mutases catalyse the interconversion of sugar-phosphate molecules 
through a phosphor-protein intermediate. Phosphoglucomutases catalyse the 
interconversion of G1P to G6P and vice versa. βPhosphoglucomutases, one of the 
subjects of this thesis, catalyses the interconversion of β-D-glucose-1-phosphate (βG1P) 
and D-glucose-6-phosphate (G6P) in bacteria. Furthermore, the same enzyme converts 
G6P to glucose and inorganic phosphate (Golicnik et al., 2009). Finally, in oxidative 
phosphorylation energy from the Krebs cycle in mitochondria, the most remarkable 
phosphoryl transfer enzyme is ATP Synthase, which catalyses the formation of ATP 
from ADP and phosphate, using a gradient of protons, or in some cases Na+, to provide 
the energy for the synthesis (Senior et al., 2002). 
 
 
1.2.3 Phosphorus is involved in protein regulation and signal transduction 
The covalent addition of a phosphate group is a method commonly used by eukaryotic 
cells to regulate a protein’s function. It induces conformational changes that switch a 
proteins state to the active one. The removal of the phosphoryl group returns the protein 
in the original state. Furthermore, transient phosphorylation is used for changing the 
geometrical and charge properties of a specific protein region. This induces the 
formation of a “module”, a specific recognition zone for another protein. These 
processes are typically regulated by two main classes of enzymes: Kinases and 
Phosphatases. Protein kinases catalyse the transfer of a phosphate group from a 
nucleotide, such as ATP, to a protein substrate. In eukaryotic cells, protein kinases 
primarily phosphorylate serine, threonine, or tyrosine residues. In prokaryotes, histidine 
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and aspartate can also be phosphorylated by the so-called two-component mechanism, 
in which a phosphoryl group is transferred from ATP first to histidine and then to an 
aspartate (Stock et al., 2000). In contrast, protein phosphatases catalyse the hydrolysis 
of phosphate monoesters, by transferring a phosphoryl group to a water molecule, 
producing inorganic phosphate (Cleland & Hengge, 2006).  
Kinase and Phosphatase reactions are involved in cell signal transduction. A third class 
of phosphoryl transfer enzymes participate in this process, which are called Regulatory 
Proteins (Cleland & Hengge, 2006). These are, for example, small GTP proteins, in 
which the active vs inactive state is regulated by GTP hydrolysis.  
Signal transduction is the process that foresees the conversion of the “signal” 
information into a chemical change. The signal is a molecule or ligand detected by 
specific receptors. Then the interaction between the activated receptor and the cellular 
machinery produces a second signal or a change in the activity of a cellular process, 
which in turn is converted into a specific cell response. There are six basic receptor 
types, which are briefly described in figure 1.2. 
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Figure 1.2 The six general types of signal transducers. There are six basic receptor types: 
1. G protein coupled receptors (GPCR), which activate the second signal or messenger through the 
activation of heterometric G proteins, which in turn regulate an enzyme that generates the second 
messenger X. 
2.  Receptor tyrosine kinases (RTKs), which catalyse the phosphorylation of downstream effector 
proteins. Ligand binding activates the receptor by promoting dimerisation and auto-phosphorylation 
of the receptor. Typically, a small G protein, such as RAS, is activated which in turn activates a 
kinase cascade. 
3. Receptor guanylyl cyclase, which act through cyclic guanosine monophosphate (cGMP).  
4. Gated ions channels of the plasma membrane, which open and close in response to the binding of 
chemical ligands or changes of trans membrane potential. 
5. Adhesion receptors, which interact with macromolecular complex components of the extracellular 
matrix. 
6. Nuclear receptors, that bind specific ligands, which are able to pass the membrane by diffusion and 
alter gene expression.  
The representation is simplified for clarity (Nelson et al., 2008). 
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Signal transduction has several features: high specificity, high sensitivity, 
desensitisation and integration (Alberts, 2008; Nelson et al., 2008). Phosphoryl transfer 
is one of the most used reaction in the mechanisms behind these features. 
High specificity is achieved by precise molecular complementarity between the signal 
and receptor molecules. It is mediated by the same kinds of weak (non-covalent) forces 
that mediate enzyme-substrate and antigen-antibody interactions. In multicellular 
organisms further specificity is achieved by the fact that receptors or the intracellular 
targets of a given signal pathway, are present only in certain cell types. Phosphorylation 
can change the protein complementarity, by affecting the chemical and geometrical 
features of the regions involved in the binding. Examples are G proteins, which are 
proteins that cycle between a GTP or a GDP bound state. The two states are structurally 
different. Only the GTP bound state, or active state, is able to bind other enzymes, 
altering its activity. There are two distinct families of G proteins: heterotrimeric G 
proteins and small G proteins. Heterotrimeric G proteins, also called Large G proteins, 
are activated by G protein-coupled receptors and are made up of α, β, and γ subunits. 
Small G proteins are monomeric proteins homologous to the α-subunit found in the 
heterotrimers and are activated by RTK or GPCR signalling effectors (Figure 1.2). 
RhoA, one of the subjects of this thesis, is a small G protein, that belongs to the Ras 
superfamily of monomeric G proteins.  
High sensitivity is achieved through three different factors: the high affinity of 
receptors for the signal molecule (in the picomolar range), cooperativity in the ligand-
receptor interaction, and amplification of the signal by enzyme cascades. Signal 
amplification through a signal cascade results when an enzyme associated with a signal 
receptor is activated and in turn catalyses the activation of many molecules of a second 
enzyme, each of which activates many molecules of a third enzyme and so on. The 
activation process is often through a phosphorylation reaction. A typical cascade is the 
Mitogen activated protein kinase (MAPK) cascade, which is activated by both GPCR 
and RTK signalling. It comprises three kinases (MAPKKK, MAPKK and MAPK), 
which phosphorylate, in turn, each other. MEK6 and p38α, which are one of the 
subjects of this thesis, belong to one of these cascades in mammals. p38α is a MAPK, 
while MEK6 is its activator, a MAPKK. 
Desensitisation is achieved by receptor system modification. When a signal is present 
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continuously, the receptor activation triggers a feedback circuit that shuts off one of the 
receptor effectors, the receptor itself or removes the receptor from the cell surface. 
Controlled GTP hydrolysis in small G proteins or of the Gα subunits of Large G protein 
promotes the inactive conformation. In this thesis, how RhoGAP stimulates the intrinsic 
GTP hydrolysis in RhoA-GTP will be discussed. Furthermore, a receptor could be 
switched-off by de-phosphorylation of a specific site, when phosphorylation was 
responsible for an active state. Stronger desensitisation is achieved by phosphorylation 
of an intracellular domain, which will facilitate receptor sequestration from the plasma 
membrane.  
Finally, Integration, is the ability of the system to receive multiple signals and produce 
a unified response appropriate to the needs of the cell or organism. Different signalling 
pathways converse with each other at several levels, generating a wealth of interactions 
that maintains homeostasis in the cell and in the organism.  
 
 
1.3 How do enzymes work? 
Most of the chemical reactions occurring in living organisms are energetically 
favourable. However, the reactants are usually in a relatively stable state and cannot be 
changed to a lower energy state without an input of energy, this is called the activation 
energy. In a living cell, enzymes can drastically reduce this energy barrier, which 
prevents a specific reaction from occurring. By reducing the energy barrier reaction, 
times can be increased or become feasible. A remarkable example is alkaline 
phosphatase which catalyses the hydrolysis of a methyl phosphate dianion with a rate 
acceleration of more than 1027-fold (Westheimer, 1987). The investigation of this bio-
catalytic system is one of the most important and fundamental goals of life science. An 
understanding of an enzyme’s mechanism provides a critical tool for the discovery of 
new drugs, for the large-scale industrial synthesis of useful chemicals, and for the 
appreciation of the chemistry in cells and organisms (Alberts, 2008).  
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1.3.1 The enzymatic transition state 
Linus Pauling (Pauling, 1948) suggested that the incredible catalytic rate enhancement 
of enzymes could be achieved by the ability of enzymes to bind tightly to substrates 
distorted toward the highest energy state in the reaction coordinates, which is called the 
transition state (TS). 
In a potential energy diagram (Figure 1.3) where the free energy (G) is plotted against 
the progress of a reaction, the transition state (or activated complex) resides on the 
highest point of the energy surface. In an un-catalysed reaction, the starting point is the 
reactants A and B. A certain amount of free energy, named the activation energy (ΔG‡), 
is required to obtain the activated complex or TS. Then the reaction goes on to product 
at an extremely rapid rate (Lowry & Richardson, 1987). In an enzyme-catalysed 
reaction, the reactants are called substrates (S). The starting point of the reaction is the 
ground state (ES), where Substrate (S) is bound to Enzyme (E), in a specific region 
called the active site. Enzymes increase the reaction rate by decreasing the activation 
energy that would be necessary if the catalyst was absent. Then the reaction goes on to 
the Enzyme-Product (EP) complex. Afterwards, the enzyme releases the product 
(Nelson et al., 2008). 
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Figure 1.3 Reaction coordinates diagram. The reaction coordinate for an un-catalysed reaction (in 
magenta) and an enzyme-catalysed reaction (in green) are shown. The curves plot the free energy of the 
reaction complex as it progresses along the reaction coordinate from reactants to product. Reactants/ES 
and products/EP reside in energy wells on this surface, and the lowest energy course between these wells 
is travelled during the chemical transformation. ΔG‡ is the activation energy, defined as the difference in 
free energy between the reactants/ES and the transition state. G is the free energy. ΔG’° is the difference 
of energy level between reactants/ES and product/EP. When product resides in an energy well lower than 
reactants (negative ΔG’°) the reaction is favourable (Lowry & Richardson, 1987; Nelson et al., 2008). 
 
 
The rate of the reaction performed will depend on the activation energy (ΔG‡) and the 
substrate concentration, as shown by the following sequence of formulas. 
The activation energy is expressed by: 
 𝛥𝐺‡ = −𝑅𝑇𝑙𝑛𝐾 
 
where R is the gas constant, T is the temperature and K is the equilibrium constant. The 
value of K will depend on the concentrations of each component in the reaction: 
 𝐴 + 𝐵 ⇋ 𝑇𝑆⟶ 𝐶 then 𝐾‡ = 𝑇𝑆 / 𝐴 𝐵  
 
Thus, the rate for the reaction will be: 
 𝑅𝑎𝑡𝑒 = 𝑘! 𝐴 𝐵  , where 𝑘! = 𝑒!!!‡/!" 𝜅𝑘𝑇/ℎ  
 
However, due to the exponential, the main factor that determines the reaction rate will 
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be ΔG‡, implying that the proficiency of an enzyme is related to its ability to recognise 
and stabilise the transition state.  
 
 
1.3.2 Enzymes lower the activation energy through binding energy 
As suggested by Linus Pauling, enzymes preferentially stabilise the transition state 
relative to the ground state, through the formation of non-covalent interactions. Some 
weak interactions are formed in the ES complex, but the full complement of such 
interactions between substrate and enzyme is formed only when the substrate reaches 
the transition state. The formation of each interaction produces energy. The total energy 
produced is called the binding energy (ΔGB), and it is the major source of free energy 
used by enzymes to lower the activation energies of reactions (Jencks, 1987; Nelson et 
al., 2008; Pauling, 1948; Wolfenden, 1969; Wolfenden & Snider, 2001). The binding 
energy contributes to enzyme specificity, because the amount of weak interactions 
formed will depend on the ability of the enzyme to discriminate between a substrate and 
a competing molecule. 
Enzymes affect in different ways the physical and thermodynamic factor of ΔG‡: 
 
• the binding of substrate to enzyme decreases the entropy of the reaction, by 
lowering the relative motion and promoting the correct orientation. 
• The substrate-enzyme interactions cause substrate desolvation, by replacing 
most of the hydrogen bonds usually present between substrate and water; 
these weak bonds helps to compensate thermodynamically for any distortion 
that the substrate could undergo, such as electron re-distribution.   
• Binding of the substrate to enzyme causes distortion in both, which promotes 
the substrate TS structure and a new enzyme conformation. In the new 
enzyme conformation, catalytic properties are enhanced because the catalytic 
functional groups are properly aligned. 	  
	  
Some of these mechanisms are shown in figure 1.4 (Alberts, 2008; Jencks, 1972; 
Johnson, 2008; Laidler & King, 1983; Nelson et al., 2008).  
 
 12 
 
Figure 1.4 Strategies adopted by enzymes for lowering the energy barrier. Several strategies can be 
assumed by an enzyme for promoting catalysis: A) enzyme binds the substrates molecules and orients 
them precisely; B) binding of substrate to enzyme rearranges electrons in the substrate, creating partial 
negative and positive charge; C) the binding of the enzyme changes substrate shapes by bending bonds 
(modified from Alberts, 2008). 
 
 
Thus, characterising the geometry, bonding, and charge distribution of the enzymatic 
transition state is crucial for understanding catalysis. A high resolution X-ray structure 
of the Michaelis complex between an enzyme and its substrate cannot provide a full 
description of the mechanism by which an enzyme achieves enormous catalytic rate 
acceleration. This determination requires, minimally, knowledge of the structure of the 
transition state for the enzyme-catalysed reaction. This information, combined with the 
Michaelis enzyme-substrate complex, which describes the substrate recognition in the 
ES complex, will provide a better-defined picture of catalysis (Pauling L., 1946; Amyes 
TL and Richard P, 2007).  
In this thesis, a combination of solution NMR and X-ray crystallographic techniques has 
been used to investigate the requirements of specific phosphoryl transfer enzymes for 
recognising substrates and then overcoming the energy barrier. Before describing the 
questions addressed, the state of the art of how phosphoryl transfer enzymes achieve 
catalysis will be discussed. 
 
 
1.4 How do phosphoryl transfer enzymes achieve catalysis? 
The understanding of how enzymes catalyse phosphoryl transfer reactions, and in 
particular, what are the transition state features, has been studied by the comparison 
with what occurs in an un-catalysed reaction. Thus, the comprehension of enzymatic 
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phosphoryl transfer, first requires the knowledge of transition state features in un-
catalysed phosphoryl transfer (Lassila et al., 2011). 
Three main questions are raised: 
 
• Are un-catalysed phosphoryl-transfer reactions concerted, or do they proceed 
through stable intermediates?  
• Do enzymes alter transition states from those in solution? 
• How do phosphoryl-transfer enzymes achieve catalysis? 
 
The following paragraphs will go through these questions. As mentioned above, the 
enzymes studied in this thesis are kinases, mutases or small GTP proteins. Since these 
three systems involve the phosphomonoester hydrolysis reaction, reactions involving 
nucleic acids or diesters, will not be discussed.  
 
 
1.4.1 Mechanism possibilities: Associative-Concerted-Dissociative phosphoryl 
transfer transition states 
One of the most confusing issues is whether phosphoryl-transfer reactions are concerted 
or whether they proceed through stepwise processes with discrete intermediates. This 
question has largely been resolved for un-catalysed reactions.  
The transition states for phosphoryl transfer reactions are typically assigned to a 
position along a continuum between associative and dissociative extremes (Admiraal & 
Herschlag, 1995). The associative and dissociative nature of a phosphoryl transfer 
reaction is defined by the extent of bond formation between the incoming nucleophile 
and phosphorus, and the extent of bond cleavage between phosphorus and the leaving 
group in the TS. The associative transition state has a larger amount of bond formation 
to the incoming nucleophile, a small amount of bond cleavage to the outgoing leaving 
group and charge accumulation on the non-bridging phosphoryl oxygen atoms. In 
contrast, the dissociative transition state has a small amount of bond formation to the 
incoming nucleophile, a large amount of bond cleavage to the outgoing leaving group, 
and charge donation from the non-bridging phosphoryl oxygen atoms to phosphorus.  
Thus, dissociative and associative transition states are very different. In the case of a 
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dissociative TS, a stepwise elimination-addition mechanism will lead to the formation 
of a metaphosphate intermediate; in the associative TS a stepwise addition-elimination 
mechanism will produce a pentavalent phosphorane intermediate. A third scenario has 
been proposed for concerted mechanism, an SN2-type reaction proceeding through a 
single transition state with simultaneous breaking of one bond and formation of a new 
bond (Lassila et al., 2011) (Figure 1.5). 
 
 
 
Figure 1.5 Hypothetical reaction mechanisms for phosphoryl transfer. The three hypothetical 
reaction mechanisms described for phosphoryl transfer are shown. The IUPAC nomenclature is used:  
DN + AN, AN + DN , ANDN (modified from Lassila et al., 2011). 
 
 
All the possibilities are represented by two-dimensional reaction coordinate diagrams 
(Figure 1.6), also known as More-O'Ferrall-Jencks diagrams (More O'Ferrall, 1970). In 
this diagram, the two extremes are represented in the upper-left corner (a phosphorane 
intermediate) and in the lower-right corner (a metaphosphate intermediate). Around the 
perfect synchronous transition state a number of possibilities arise from how much the 
synchronisation is concerted. Thus the concerted transition state could be defined as 
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tight or loose, if it is more similar to the associative or dissociative intermediate, 
respectively. Transition states in which the phosphorus atom sees an increase in the total 
bond order to the nucleophile and the leaving group relative to that in the reactants are 
referred to as tight or associative-like transition states. Those with a decrease in total 
bond order between phosphorus and the nucleophile and leaving group are called loose 
or dissociative-like transition states.  
 
 
 
Figure 1.6 The More-O'Ferrall-Jencks diagram for phosphoryl transfer transition states. In the 
two-dimensional reaction coordinate diagram shown the reactants are depicted in the lower left corner 
and the products in the upper right. Bond breaking proceeds along the x-axis and bond formation 
proceeds along the y-axis. This two-dimensional reaction coordinate defines a three-dimensional free 
energy surface in which the free energy axis is perpendicular to the page. Starting from the reactants 
located in a free energy well at the bottom left, a reaction will proceed across this surface via the pathway 
with the lowest barrier. The range of possible concerted transition states are shown (Tight, Synchronous 
and Loose). The charge distribution for each of these three TS is shown (modified from Lassila et al., 
2011).  
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1.4.2 Un-catalysed phosphoryl transfer reactions adopt a loose transition state 
Both phosphomonoesters and phosphoanhydrides undergo phosphoryl transfer by P-O 
and P-N cleavage. Phosphate monoester hydrolysis or phosphate monoester dianion un-
catalysed hydrolysis reactions adopt a loose transition state, without the formation of a 
metaphosphate intermediate. In the two dimensional reaction diagram (Figure 1.6), the 
reaction will proceed along the lower right corner where a metaphosphate-like transition 
state will occur. Several studies are present in the literature that support this thesis. The 
experimental data were obtained through LFERs and KIEs studies, which are the typical 
tools used for defining the nature of a transition state.  
LFER or linear free energy relationship correlates the pKa values and a series of 
nucleophiles or leaving groups with a specific logK. pKa is proportional to a standard 
free energy change and it refers to the nucleophile or leaving group considered; logK is 
a linear function of the free energy of activation, where K is the rate constant for the 
reaction. The slope of the LFER, called the Brønsted value (or β value), correlates with 
the amount of bond formation or bond breaking between the phosphorus and the 
nucleophile (βnucleophile) and between the phosphorus and the leaving group (βleaving group) 
(Lowry & Richardson, 1987; Jencks 1987; Williams A, 1992). A large βnucleophile , which 
is suggestive of a substantial transition-state bond formation between the nucleophile 
and the phosphorus, together with a less negative βleaving group, which is suggestive of 
small transition-state bond cleavage between phosphorus and the leaving group, identify 
a phosphoryl transfer reaction is more associative-like, thus a tight TS. The opposite 
trend (a small  βnucleophile and a large-negative βleaving group) denotes a more dissociative-
like transition state or loose TS (Admiraal & Herschlag, 1995; Lassila et al., 2011).  
Brønsted values have been used for mapping the un-catalysed transition state of ATP, 
GTP and pyrophosphate dianion hydrolysis in solution. A series of primary alcohols of 
varying pKa were used to investigate nucleophilic participation in this transition state. 
Alcohols are chemical homologs of biological nucleophiles such as sugars, water and 
the serine and threonine residues. For all three samples, small βnucleophile values were 
obtained (0.07±0.08 for ATP; 0.05±0.08 for GTP and 0.06±0.06 for pyrophosphate 
dianion), indicating that a loose transition state is formed in all three reactions. The 
βleaving group was calculated too. The negative value obtained (-1.1±0.2) indicated a large 
amount of negative charge on the leaving group, thus bond breaking. This outcome is a 
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proof of the presence of a more dissociative-like TS in solution (Benkovic and Schray 
1978; Thatcher and Kluger, 1989; Admiraal & Herschlag, 1995). Similar results have 
been obtained in the study of other un-catalysed reactions on phosphomonoesters or 
dianion (Bourne & Williams, 1983; Bourne & Williams, 1984; Grzyska et al., 2003; 
Herschlag & Jencks, 1987; Kirby & Jencks, 1965; Kirby & Varvoglis, 1967; Skoog & 
Jencks, 1983; Skoog & Jencks, 1984).  
KIEs, or kinetic isotope effects, provide information on changes in bonding that occur 
in the transition state by measuring changes in reaction rates that occur when an atom in 
the compound of interest is substituted with a heavy isotope. The substitution can be 
made at the position of bond cleavage or formation (primary isotope effect) or at other 
positions that are not directly involved (secondary isotope effect). The substitutions 
increase the so called zero-point energy of each bond, that corresponds to its minimum 
vibrational energy state. When a bond is broken, the vibrational energy states for that 
bond are lost and there is no longer a difference in vibrational energy between the heavy 
and light isotopes. For the primary isotope effect the dominant vibration lost is the 
stretching mode, while for the secondary, significant effects are on the bending and 
torsional modes (change in geometry). Since the heavy-atom cleavage requires more 
energy, a difference in free energy can be observed at the ground state and the reaction 
is slower. This leads to a “normal” KIE (klight/kheavy > 1) (Hengge, 2002; Melander & 
Saunders, 1980). For bonds that are partially broken in the transition state, the KIE 
corresponds to the extent of bond cleavage in the transition state. In cases where 
bonding increases at the substituted position, for example as a result of protonation, an 
inverse isotope effect can be observed (klight/kheavy < 1). For monoester TS, the KIE is 
larger than for the leaving group, while it is under one for the non-bridging oxygen 
atom (Buchwald et al., 1984; Buchwald et al., 1982; Hengge et al., 1994). Thus, the 
KIE data indicate bond cleavage between the phosphorus and the leaving group and a 
small bond formation between the nucleophile and the phosphorus. This is in agreement 
with LFERs studies, which described that reactions involving monoesters or 
phosphodyesters are characterised by a loose or dissociative-like transition state. 
Eventually, in water, the bond to the incoming nucleophile starts to form before the 
bond to the leaving group has completely broken, avoiding the formation of a long-
lived, freely diffusing metaphosphate intermediate. Stereochemical studies demonstrate 
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that hydrolysis proceeds with complete inversion of configuration (Buchwald et al., 
1984; Buchwald et al., 1982), without any racemic product produced by the attacking of 
a water molecule to the metaphosphate intermediate.  
 
 
1.4.3 Enzyme challenges in accommodating the un-catalysed loose transition state 
As described above, phosphoryl transfer enzymes are involved in diverse biological 
processes. Remarkably, the reaction performed is the same (phosphoryl transfer), 
implying that the chemical basis should be similar among different enzymatic systems.  
A hallmark of the active sites of phosphoryl-transfer enzymes is the presence of 
positively charged groups, in the form either of divalent metal ions and/or positively 
charged amino acid side chains (Cleland & Hengge, 2006; Knowles, 1980). These 
elements are used by the enzyme along the reaction for transferring protons, as 
described in General Acid Base Catalysis (GABC). Many biochemical reactions, such 
as phosphoryl transfer, involve the formation of unstable charged intermediates that 
tend to break down more rapidly to their constituent reactant species instead of going to 
the product. Enzymes stabilise these intermediates by the transfer of protons to or from 
the substrate or intermediate to form a species that breaks down more readily to 
products. In GABC the proton transfer is mediated by residues and water molecules 
trapped in the active site. Water molecules and weak organic acids can supplement 
water as proton donors, while weak organic bases can serve as proton acceptors. Some 
phosphoryl-transfer enzymes use metal-catalysis in addition to GABC. A metal ion 
may serve as an electrophilic catalyst, stabilising a negative charge on a reaction 
intermediate; or it can generate a nucleophile by increasing the acidity of a nearby 
molecule. Finally, the metal ion may bind to substrate, increasing the number of 
interactions with the enzyme and thus the binding energy (Berg & Tymoczko, 2002; 
Nelson et al., 2008). 
These considerations raise the question of whether the enzymatic environment could 
accommodate the loose transition state characterised in solution.  
The dissociative transition-state charge estimates for the un-catalysed hydrolysis of 
ATP in figure 1.7, show the challenges needed to be overcome by the enzyme for 
carrying out the reaction (Admiraal & Herschlag, 1995). 
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Figure 1.7 Transition state charge estimates for the un-catalysed hydrolysis of ATP. Charges on 
oxygen atoms of the reactants, transition state and products for ATP hydrolysis estimated from LFER. 
The schematic representation shows the change in charge in going from the ground state to the transition 
state, which has a dipolar character. The transition-state geometry is depicted, with the phosphoryl group 
undergoing transfer separated from the nucleophilic water and the ADP leaving group by dashed lines. In 
blue-cyan is shown the increase in negative charge. The nonbridging γ-phosphoryl oxygen shows a 
decreasing charge (in red), while the β-γ bridging oxygen atoms undergo a large negative charge increase 
(in blue). The β-nonbridging oxygen (in cyan) atom increases in negative charge too, even though it is a 
small change (modified from Admiraal & Herschlag, 1995). 
 
 
As mentioned above, one of the effects of the binding energy is the alignment of 
enzymatic catalytic functional groups in the enzymes. This should result in: the fixing 
of the activated nucleophile with the γ-phosphate and the stabilisation of the transition 
state charge distribution.  
The positioning of the nucleophile for facilitating catalysis is one of the most important 
features for enzymes. The nucleophile must be aligned with the phosphorus atom and 
the leaving group for in-line attack at phosphorus (Admiraal & Herschlag, 1995). 
Moreover, the nucleophile is required to be activated, to act as a proton donor in GABC. 
These two aspects are relevant in both loose and tight TS. 
The change in charge from the ground state to the transition state has a dipolar character 
that leads to negative charge accumulation on the leaving group: in a loose TS the non 
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bridging γ-phosphoryl oxygen atom has a small negative charge, the β-γ bridging 
oxygen atoms undergo a negative charge increase. Moreover, the phosphorus group 
goes through substantial changes in geometry from tetrahedral coordination to a trigonal 
bipiramidal. 
 
 
1.4.4 Enzymatic TS are studied through metallofluoride complexes 
The first investigations on how loose transition states could be, or could not be, 
accommodated in a enzymatic environment, were performed through LFERs and KIEs 
calculations. However, these techniques have two limitations. First, they are applied to a 
much more complex system with regard to un-catalysed phosphorylation (Lassila et al., 
2011). Second, and more relevant, the data obtained do not provide a direct observation 
of the transition state. The transition state is a high-energy and short-lived species. This 
implies that no physical or spectroscopic method can be used to observe it directly. 
However, in the case of enzymes performing phosphoryl transfer, an alternative way has 
been found for trapping the transition state. Inorganic metallofluoride molecules, such 
as aluminium and magnesium fluoride, are used for investigating structural features of 
the phosphoryl transfer reaction. Their ability to inhibit the phosphoryl transfer reaction 
is used in X-ray crystallography and 19F-NMR for trapping the protein structure in the 
catalytically active state.  
The most known and used metallofluoride molecule is aluminium fluoride. AlFx is a 
small inorganic molecule that mimics the chemical structure of a phosphate (Bigay et 
al., 1987). Aluminium fluoride entered the scene with the accidental finding by 
Sutherland and co-workers in 1958 that adenylate cyclase is activated by fluorides (Rall 
& Sutherland, 1958). Twenty years later, Gilman and co-workers found that the target 
of the activation was a heterotrimeric G protein and that the active stimulatory agent 
was aluminium fluoride, which is present as a leached-out impurity in millimolar 
solutions of fluoride in glass (Sternweis & Gilman, 1982). Finally, in 1994, the three-
dimensional structure of heterotrimeric G proteins was solved by X-ray crystallography, 
bound to GDP and aluminium fluoride (Coleman et al., 1994; Schindelin et al., 1997; 
Sondek et al., 1994). Aluminium tetrafluoride (AlF4-) was found located in the γ-
phosphate binding site of these proteins. Aluminium was found coordinated in 
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octahedral geometry with fluoride ligands in a square-planar coordination and two 
oxygen ligands at the apical positions. One oxygen ligand is a β-phosphate oxygen 
atom, the leaving group in the transfer reaction, whereas the other is the oxygen atom 
from the attacking water molecule. Thus, surprisingly, it was mimicking the transition 
state of the phosphoryl transfer reaction rather than the ground state (Figure 1.8). AlF4− 
is square planar and carries a net negative charge. Thus, it is an isoelectronic, but not 
isosteric mimic of the phosphoryl group in transfer. 
 
 
 
Figure 1.8 Transition state analogues of GTP-hydrolysis. The transition state analogues are compared 
with the phosphorus in flight. PO3- has a TBP geometry and is negative charged. AlF4- is an isoelectronic 
mimic of PO3- , AlF3 is an isosteric mimic of PO3- , MgF3- is an isoelectronic and isosteric mimic of PO3-. 
 
 
Aluminium fluoride was also observed as an aluminium trifluoride (AlF3) species in 
other structures of small G proteins (Coleman et al., 1994). Aluminium trifluoride is an 
isosteric but not isoelectronic mimic of the phosphoryl group (Figure 1.8). It adopts a 
trigonal planar arrangement at the active site but carries no net charge. The difference in 
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species was considered to be related to pH conditions. Crystallisation below pH 7.0 
seems to favour AlF4− while higher pH results in binding of AlF3. Crystallisation of 
UMP/CMP kinase in complex with AlFx at two different pH (4.5 and 8.5) showed an 
octahedral aluminium coordinated species at the acidic pH, while a TBP aluminium as 
observed at pH 8.5 (Schlichting & Reinstein, 1999).   
In 1998, magnesium fluoride entered on the scene. In a paper by Gilman and co-
workers, a comparison was made between the RhoA-GDP-AlF4--RhoGAP-TSA 
structure and RhoA-GDP-MgF3--RhoGAP-TSA fluoride structure (Graham et al., 2002) 
(Figure 1.9).  
 
 
Figure 1.9 Aluminium and magnesium fluoride in RhoA-RhoGAP transition state structures. The 
left panel shows, in ball-and-stick representation, molecular details of the active site of RhoA-RhoGAP 
complex with AlF4− (PDB code 1TX4; Rittinger et al., 1997), while the right panel shows similare view 
for the complex with MgF3− (PDB code 1WO3; Graham et al., 2002). Arg85 from RhoGAP is colored 
green while the residues from RhoA are shown in grey. The GDP and metallofluoride moiety are shown 
in magenta while water molecules are in green (Graham et al., 2002). 
 
 
The structures showed that magnesium fluoride was coordinated in a trigonal 
bipiramidal geometry, similar both in geometry and charge to the one of the phosphorus 
group in transfer (Figure 1.8). Using proton-induced X-ray emission (PIXE) 
spectroscopy it was demonstrated that the magnesium fluoride species, rather than AlF3, 
was the correct one assigned to the electron density map. Moreover, in the 
crystallisation conditions, deferoxamine was added, which is an aluminium chelator. 
The comparison of the two structures showed that both metallofluorides are coordinated 
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in a similar way, pointing to the possibility to use magnesium as the reagent of choice 
for transition state studies. Indeed, they described for the first time the possibility to trap 
the TS using an isosteric and isoelectronic mimic of a phosphorus group. 
The use of metallofluorides in structural biology has lead to the understanding of the 
features of enzymatic transition state and, consequently, how catalysis is achieved in 
phosphoryl transfer enzymes. While X-ray crystallography describes the structural and 
geometrical features, fluoride NMR provides information on the electronic and protonic 
interactions of TSA formation in solution to the Van der Waals environment as well as 
local electrostatic fields deduced by the fluorine chemical shifts (Higashijima et al., 
1991; Hoffman et al., 1998; Graham et al., 1999; Praefcke et al., 1999). The 
combination of the two techniques is a powerful tool for distinguishing minor 
differences and obtaining complementary information. For example, it is striking that 
the structural differences between the phosphorane intermediate and a slightly 
dissociative transition state are only about 0.5 Å between the entering and leaving 
groups within a similar TBP geometry (Williams, 2004) (Figure 1.10). Due to the high 
resolution of crystallographic data combined with fluorine solution NMR the problem 
can be overcome, and the TS can be defined as more dissociative-loose one, or more 
associative-tight one.  
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Figure 1.10 Approximate distances for differing degrees of bonding to nucleophile/leaving group in 
transition states for phosphoryl transfer. The left-hand structure represents a fully dissociative 
mechanism, with zero bond order to nucleophile and leaving group; the right-hand structure a fully 
associative mechanism with a phosphorane intermediate. As the character of the central concerted 
transition state moves towards either side, its character can be described as dissociative or associative 
(modified from Williams, 2004). 
 
 
Furthermore, metallofluoride complexes provide insight into the enzyme catalysis, by 
allowing the definition of: 
• how the nucleophile is activated; 
• how the developing negative charge on the leaving group is stabilised; 
• how charge and geometry of the phosphorus group in flight are accommodated 
in the active site. 
 
 
1.4.5 Activation of the nucleophile 
Nucleophile activation can be achieved in three different ways: positioning, increasing 
nucleophilicity and overcoming electrostatic repulsion. 
 
 
1.4.5.1 Positioning 
Positioning of the nucleophile, for facilitating catalysis, is one of the important features 
for enzymes. It is important for both associative and dissociative transition states. 
However, it is doubtful how significant this would be in a dissociative transition state, 
 25 
because the transition state in the un-catalysed reaction for phosphate monoester 
hydrolysis has little nucleophile participation. The possible explanation is that even in a 
loose transition state there is some bond formation to the nucleophile, which requires 
positioning of the nucleophile with respect to the phosphoryl group (Lassila et al., 
2011). 
Both residues and metal ions can participate in nucleophile positioning. In the small 
GTP proteins of the Ras superfamily, a conserved glutamine (Gln61 in Ras, Gln 63 in 
RhoA and Gln61 in CDC42 (Nassar et al., 1998; Rittinger et al., 1997; Scheffzek et al., 
1997) is positioning the attacking water molecule in line with the γP of GTP. In kinases, 
the catalytic magnesium assists in the orientation of the γ-phosphate for “in line” with 
respect to the second substrate, creating the correct geometry to complete phosphoryl 
transfer (Lassila et al., 2011).  
 
 
1.4.5.2 Increasing the nucleophilicity 
Increasing the nucleophilicity can be achieved by a number of mechanisms, including 
removal of a proton by a general base, activation by a metal ion, or by changing the 
identity of the nucleophile (Lassila et al., 2011). Specific residues can work as general 
base: an aspartate is general base in yeast hexokinase, in glycerokinase and 
galactokinase of Piroccoccuus furiosus (Aleshin et al., 2000; Anderson et al., 1978; 
Golicnik et al., 2009; Tari et al., 1997; Tari et al., 1996); in human creatine kinase a 
glutamate is the general base (Ostanin & Van Etten, 1993). Activation by metal ion 
occurs in E. coli alkaline phosphatase, where magnesium has been suggested to be the 
general base (Cleland & Hengge, 2006) that deprotonates the Ser102. Further, it was 
described that in phosphoenolpyruvate carboxykinase, magnesium coordination orients 
the β- and γ-phosphates in a high energy eclipsed conformation resulting in increased 
electrostatic repulsion between the phosphoryl groups, which may activate ATP for 
catalysis (Stec et al., 2000). 
Interestingly, in the un-catalysed reaction, metals such as magnesium or calcium do not 
show any significant improvement in reaction rate or change in the loose TS (Smith & 
Rayment, 1996). However, from the examples described, the relevance of metal ions in 
some phosphoryl transfer enzymes is unquestionable.  
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1.4.5.3 Overcome the electrostatic repulsion 
A third way of activating the nucleophile is to overcome the electrostatic repulsion 
between the nucleophile and the negatively charged phosphoryl group. However, this 
has only small effects on un-catalysed reaction rates. For example, anionic nucleophiles 
react ~5-fold faster, whereas reactions of neutral nucleophiles are not significantly 
affected (Herschlag & Jencks, 1987; Lahiri et al., 2002). The mechanism could be 
relevant in reactions that involve highly charged phosphate esters, such as nucleoside 
triphosphates. Malarial adenylate kinase needs to overcome the charge repulsion barrier 
in order to equilibrate ATP + AMP with 2 ADPs (Figure 1.11). It achieves this 
important reaction with a turnover of kcat = 35 s-1 (Cassano et al., 2002). 
 
 
 
Figure 1.11 Electrostatic surfaces for the ATP tetra-anion (left) and the AMP dianion (right). The 
adenylate kinase reaction transfers the γP from ATP to AMP by in-line attack resulting in cleavage of γ-P 
to β-O. Negative polarity is in red; positive polarity is in blue (modified from Bowler et al., 2010a). 
 
 
1.4.6 Stabilisation of negative charge development on the leaving group  
As described in ATP hydrolysis there is a substantial negative charge that develops in 
the loose transition state relative to the ground state for phosphate monoester dianion 
reactions. Stabilisation of developing negative charge on the leaving group and on the 
other charge changes can contribute significantly to catalysis of monoester reactions. 
Adenosine(
5’+trisphosphate((
Adenosine(
monophosphate((
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Positive residues or metal co-factors can decrease the negative charge of the transition 
state dipole. Indeed, these positively charged groups are often positioned to interact 
with the non-bridging oxygen atoms such as those on the non-bridging γ-phosphate. The 
non-bridging oxygen atoms in a loose TS are characterised by a loss of negative charge 
from the ground state to the TS (Rahlfs et al., 2009). However, since there is still a 
small negative charge, stabilisation could be relevant for the catalysis.  
Possible metal co-factors that stabilise the charge development on the leaving group are 
zinc and magnesium. Alkaline phosphatase (AP) contains a three metal centre, formed 
by one magnesium atom and 2 zinc atoms. Zn1 coordinates the leaving group during the 
first reaction, in position for in line attack and it stabilises the negative charge, 
facilitating the P-O scission (O'Brien & Herschlag, 2002) (Figure 1.12). 
 
 
 
 
Figure 1.12 Model of the transition state interactions in the reaction catalysed by E. coli alkaline 
phosphatase. Zn1 coordinates the leaving group, while Zn2 coordinates the Ser102 facilitating its 
deprotonation by magnesium to form a more nucleophilic serine alkoxide. A phosphoserine is formed as 
intermediate. The roles of the two zinc ions are reversed in the subsequent hydrolysis. After ester group 
departure, water can coordinate to Zn1. The Zn1-hydroxide attacks the phosphoserine intermediate; its 
departure is stabilised by coordination with Zn2 (modified from Cleland & Hengge, 2006). 
 
 
Zn1 
Zn2 
 28 
In modelling studies for serine/threonine phosphate (PP1) it has been shown that if Mg 
coordinates the α and β phosphates instead of the β and γ phosphates of ATP; this 
results in transition state stabilisation and reaction acceleration of 3000 fold (Williams 
2000). 
A remarkable example of an amino acid that stabilises the charge development on the 
leaving group is the Arginine finger in the Ras-RasGAP system. An example is the 
RhoA-RhoGAP system, one of the subjects of this thesis. The GAP proteins enhance 
GTP hydrolysis by presenting an arginine, called the “Arginine finger”. The 
guanidinium group of this residue interacts with negative charged phosphate nucleotide 
region, decreasing the energy barrier for hydrolysis (Kim & Wyckoff, 1991; O'Brien & 
Herschlag, 2002; Reid & Wilson, 1971). 
 
 
1.4.7 Stabilisation of the charge and geometry of the phosphorus group in flight: 
the charge balance hypothesis 
The change in charge and geometry of the phosphorus group in flight needs to be 
accommodated for efficient catalysis. However, due to the difference in charge and 
geometry of the metallofluoride analogues used, it is challenging to clarify how this is 
occurring.  
Studies of the interactions between enzyme active sites and transition state analogues 
have highlighted the important consideration that charge balance for phosphoryl transfer 
enzymes rather than the native geometry is essential for TS stabilisation during 
catalysis. The proposal of a fundamental role of charge balance raises an important 
question about the possible transition state species that could be accommodated inside 
the active site. While AlF4- and MgF3- carry the same charge of a scissile phosphate, 
AlF3 only conserves a similar geometry to the phosphorus group in transfer. 
Interestingly the pH relationship between the two aluminium fluoride species is similar 
to the one between aluminium tetrafluoride and magnesium trifluoride. Most of the 
structures that contain AlF3, were crystallised in the presence of magnesium, pointing 
out the doubt that the electron density with TBP moiety were not assigned correctly. 
Moreover, no clear explanation has been provided for the switching between the two 
forms of aluminium fluoride, leaving unexplained how an enzyme such as 
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phosphoserine phosphatase could coordinate both species at the same time (Schlichting 
1999). Fluorine NMR pH tritration experiments have successfully shown that with 
increasing pH AlF4- is progressively displaced by MgF3- (Baxter et al., 2008; Jin, 2012). 
Indeed, the increased pH causes the concentration of aluminium fluoride to fall below 
that of the enzyme. This is due to the displacement of fluoride ions by hydroxide ion 
binding and the consecutive change in geometry in solution of the aluminium fluoride 
species (Mesak & Dahl, 2000; Tremblay et al., 2005; Webster, 2004). Thus, it was 
proposed that the charge on the metal fluoride species dominates its geometry in 
determining the preferred mode of binding. This hypothesis was termed the charge 
balance hypothesis. 
One of the main consequences of this hypothesis is that the enzyme’s activity ensures 
that the number of positively and negatively charged groups are exactly balanced within 
the transition state (Baxter, 2008). Thus, any charge perturbation of the TSA should be 
compensated in some way from the enzyme active site and vice versa, without any 
change in the final net-charge. A first proof of this proposal has been tested on human 
phosphoglycerate kinase (HsPGK). HsPGK catalyses the transfer of phosphate from 
1,3-bisphophoglycerate to ADP in the first energy generating step of ATP hydrolysis 
(Opperdoes, 1987). The protein has been co-crystallised with an octahedral 
tetrafluoroaluminate TSA in the active site, in agreement with the 19F NMR data (Cliff 
et al., 2010). The structure showed that Lys219 coordinates the aluminium fluoride in 
the transition state. In order to establish the role of charge balance, this positive residue 
was mutated to an alanine. The NMR data showed a change from aluminium 
tetrafluoride to trifluoride with the mutation. As expected, this caused a reduction in 
charge of the TSA species, producing a trifluoride aluminium observed in the crystal 
structure. Importantly, aluminium is still coordinated in octahedral geometry, with a 
fluoride atom replaced by a water molecule (Figure 1.13).  
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Figure 1.13 Octahedral moiety of AlF3 in the HsPGKK219A-3PG-AlF3-ADP-TSA complex. The Fo- 
Fo electron density difference Fourier map between the HsPGK-3PG-AlF4--ADP-TSA and the 
HsPGKK219A-3PG-AlF3-ADP-TSA complexes is shown as a cyan mesh contoured at 2σ, with the 3PG and 
ADP ligands and the side chains coordinating the AlF3
 moiety in the HsPGKK219A-3PG-AlF3-ADP active 
site shown as sticks. The water and magnesium are shown as red and green spheres, respectively (PDB 
code 2WZD, Cliff et al., 2010). 
 
 
Thus, no evidence of aluminium trifluoride with a TBP geometry was found, suggesting 
again that the reported AlF3 structures in the protein data bank are in fact MgF3- 
structures. Similar results have been obtained in other systems, reported in Dr. Y Jin’s 
thesis and further papers (Jin, 2012; Jin et al., 2012; Xiaoxia et al., 2011). 
Expanding the charge balance rule to the entire transition state, the roles of positive 
residues and metal-ions in stabilising the transition state charge is clearly defined. In 
transition states complexes where it has been possible to calculate the final net charge of 
the TS, it was defined as zero net for the first coordination shell of the transferring 
phosphoryl group and usually for the second shell also. This implies that beyond the 
interactions with the nucleophile and the leaving group described, further positive 
residues and metal ions are also involved in the general stabilisation of the transition 
state. In enzymes coordinating phosphoanydrides, positive protein charges are involved 
in neutralising the negative phosphoanydride charges. One example is Arg166 in 
alkaline phosphatase described above (Cleland & Hengge, 2006) (Figure 1.12); a 
second example, is the structure of the metal fluoride transition state complex of 
UMP/CMP kinase with ADP and CMP (PDB code 3UKD, Schlichting & Reinstein, 
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1997), where the six negative charges of the nucleotide are exactly neutralised by 8 
positive charges, one of which is coming from the catalytic magnesium (Bowler et al., 
2010a).  
 
 
1.4.8 Is the enzymatic transition state dissociative or associative? 
After having described how a phosphoryl transfer enzyme, which performs GABC or 
metal-catalysis accommodates the transition state, the question “Is the enzymatic 
transition state dissociative or associative?” can be addressed.  
There is no clear answer to this question. It is still not obvious how an enzymatic active 
site can stabilise a loose, metaphosphate-like transition state. Structures of kinases show 
that active site elements interact with the non-bridging oxygen atoms, which are 
negatively charged in the dissociative transition state. In contrast, positive residues 
interact with the phosphoryl group in flight, that is expected to be more negatively 
charged in the associative TS than the dissociative (Maegley et al., 1996; Rittinger et 
al., 1997). However, the phosphoryl group inverts during phosphoryl transfer, and this 
geometric change has been shown in computational studies of protein tyrosine 
phosphatases to result, by means of stronger hydrogen-bonding interactions, in 
preferential enzymatic stabilisation of a loose transition state (Cleland & Hengge, 
2006). Inverse secondary O18 isotope effects on alkaline phosphatase, nucleoside 
diphosphate kinase and hexokinase are consistent with a loose transition state 
(Alhambra et al., 1998; Asthagiri et al., 2002). 
Despite this, a pentacovalent phosphorane intermediate has been claimed to be observed 
in βPGM phosphoryl transfer in X-ray crystal structures (Lahiri et al., 2003). However, 
it was demonstrated by a combination of fluoride NMR studies and X-ray anomalous 
dispersion on the enzyme-TSA crystal that the intermediate was a magnesium fluoride, 
not a reaction intermediate (Baxter et al., 2010) which is anyway consistent with a tight 
rather then a loose TS. A tight transition state has been suggested for pyruvate kinase 
(Baxter et al., 2010) and for UMP/CMP kinase (Hassett et al., 1982). In the case of this 
enzyme, the separation of the two apical oxygen atoms in the transition state structures 
is 4.2 Å, less than required for a monomeric metaphosphate intermediate (~6.5 Å) and 
rather towards the associative reaction distance (≥3.6 Å), suggesting the formation of a 
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tight transition state. Similarly, phosphoserine phosphatase (PSP) shows an in line tight 
mechanism, by a separation of 4.24 Å between the two apical oxygen atoms (Holtz et 
al., 1999). 
Further examples could be listed for both kinds of transition state. The main conclusion 
is that while a clear dissociative-like transition state is present in un-catalysed phosphor 
mono ester reactions, the scenario becomes more complex when the reaction is 
catalysed, ruling out the possibility of a definitive identification between the two TS 
species.  
 
 
1.5 Subjects of this thesis 
Despite the fact that the enzyme transition state has not unequivocally been defined as 
loose or tight, the structural studies performed on metallofluoride transition state 
complexes has improved remarkably the understanding of the biophysical mechanism 
of enzyme catalysis (Bowler et al., 2010a). Metallofluoride complexes are considered 
the best model of phosphoryl transfer (Wittinghofer, 1997) and their used in both 
fluorine NMR and X-ray crystallography allows the study of the catalysis at a molecular 
level.  
In this thesis metallofluoride complexes have been used for investigating enzyme 
catalysis in three different systems, already described above: 
• the bacterial mutase βPhosphoglucomutase from L. lactis (βPGM); 
• the human small G protein RhoA, with its GTPase activating protein 
(RhoGAP): 
•  the human MAPK p38α, with one of its MAPKK activators (MEK6). 
While similar methods were used, different questions were addressed for each subject. 
 
 
1.5.1 β-Phosphoglucomutase from L. lactis 
The mutase protein βPhosphoglucomutase (βPGM) catalyses the interconversion of β-
D-glucose-1-phosphate (βG1P) and D-glucose-6-phosphate (G6P). Since βPGM is 
expressed only in certain bacteria and protists, it is a possible pharmaceutical target in 
infectious diseases. Therefore, our research was performed in the direction of a 
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complete dissection of the isomerisation reactions and preliminary drug design studies. 
Two main topics will be discussed in this thesis: 
• Fluorine NMR spectra of βPGM-G6P-MgF3- transition state analogue (βPGM-
G6P-MgF3--TSA) showed that βPGM can coordinate the magnesium fluoride 
molecule in two different ways: the major and the minor form, where the names 
are related to the percentage of the protein population corresponding to each 
group (Baxter et al., 2010). In Chapter 3 it will be shown how, through the 
successful combination of 19F-NMR and room temperature crystallography 
experiments, the structural details of the major and minor form have been 
revealed.  
• The absence in the literature of structural characterisation of a βPGM-βG1P-
TSA structure and the necessity to design a possible βPGM inhibitor, led to the 
design and synthesis of phosphonate and fluorophosphonate analogues of βG1P. 
In Chapter 4 it will be shown how through the successful combination of        
19F-NMR, binding assays and X-ray crystallography the best candidate in 
mimicking βG1P was selected. The resulting βPGM-TSA structures provide 
information on βG1P catalysis and a possible lead compound for combating 
bacterial infections. 
 
 
1.5.2 RhoA GTP-hydrolysis 
RhoA belongs to the Rho family of small G proteins, which cycle between an ‘on’ and 
‘off’ state that bind either GTP or GDP respectively. Rho proteins are involved in 
signalling networks that regulate actin, cell cycle progression, cell motility, cell 
behaviour and gene expression. In cancer, the Rho family is up-regulated and genetic 
mutations are involved in cardiovascular, pulmonary hypertension, neurodegenerative 
and immune disorders.  
RhoGAP (GTPase activating factor proteins) promotes the inactive conformation of 
RhoA by stimulating its intrinsic GTPase activity. It has been proposed that in small G 
proteins Rho, Ras, Cdc42 and Rab, GAPs contribute directly to the catalysis, using a 
conserved arginine residue, termed the “Arginine finger”. Despite this, there are GAPs 
(RanGAP and RapGAP) that enhance the reaction though residues other than arginine. 
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Moreover, RhoA and RhoGAPR85A conserve an intrinsic and residual activity 
respectively. In Chapter 5, through the structural characterisation of transition state of 
RhoA-GDP and RhoA-GDP-RhoGAPR85A, two unsolved questions will be investigated 
at the molecular level: 
• How does RhoGAP contribute to catalysis in the absence of an arginine finger? 
• How is charge balanced for achieving catalysis in RhoA and                          
RhoA-RhoGAPR85A? 
Finally, the results obtained show novel insight into GAP mediated RhoA-GTP 
hydrolysis, by providing complementary information to the structures already known.  
 
 
1.5.3 p38α and MEK6 
p38α and MEK6 belong to one of most well studied MAPK cascades, where p38α is the 
MAPK (Mitogen activated protein kinase) and MEK6 is its activator (MAPKK). p38α 
is one of four MAPK p38 isoforms, which has a pivotal role in stress response and 
cytokine production. p38α is under study for treatment of rheumatoid arthritis, pain 
relief, dementia and stroke. However, the drugs designed so far lack MAPK specificity. 
Therefore a better comprehension of how each MAPK interacts with upstream and 
downstream signalling protein is required.  
It was proposed that the activation of p38α by MEK6 proceeds through (Tanoue et al., 
2001) two steps: a docking interaction at a locus outside of the active site, and second, a 
transient enzyme-substrate interaction at the active site. In the second step MEK6 
promotes the active p38α conformation by double-phosphorylation at the conserved 
MAPK sequence TxY in the phosphorylation lip (P-Lip). In this thesis, structural and 
biochemical data have been produced in order to elucidate both steps: 
• in Chapter 6, the docking interaction has been investigated by solving the 
structures of apo-p38αK53R and p38αK53R in complex with a MEK6 peptide 
containing the Docking sequence (D-motif). p38αK53R is an inactive mutant of 
p38α, whose apo-structure shows the ordered conformation of the usually highly 
flexible region such as the phosphorylation lip (P-Lip) and the Glycine-rich 
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loop. For the first time it will be shown how MEK6 recognises p38α and what 
are the conformational changes induced. A model of the preliminary steps in 
p38α activation will then be proposed. 
• Unsuccessful attempts were performed to trap in the solid state the transition 
state of MEK6 phosphorylation reactions. The search for the correct approach 
for forming the TSA complex, led to the surprising discovery that MEK6 can 
use ADP as phosphate donor. Preliminary biochemical experiments, which 
suggest this non-canonical phosphorylation, will be shown. The possibility that 
MEK6 uses ADP as phosphate donor raises the question of whether ME6K 
could employ one molecule of ATP for carrying out both phosphorylation 
reactions. This scenario appears compatible with the processive or quasi-
processive phosphorylation mechanisms, where MAPKK-MAPK does not 
dissociate or dissociates quickly between the two phosphorylation steps. This 
project is still in progress and the potential of the novel findings need to be 
evaluated.  
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Chapter 2 Materials and Methods 
 
 
2.1 General materials 
All chemicals were purchased from Sigma-Aldrich Chemicals (St. Louis, MO, USA), 
Fluka Chemicals (Gillingham, UK), and Euromedex (Souffelweyersheim, Strasbourg, 
France) except for the following: Glycerol 99,5% in twice distillated water was 
purchase form VWR International (Merck House, Poole, Dorset, BH15 1TD), 2-
mercaptoethanol form MP biomedical Europe (Illkirch, France), Acrylamide/bis 
acrylamide 37.5:1 30% (w/v) stock solution was purchased from National Diagnostic 
(Atlanta, GA, USA), Luria Bertani broth from Athena enzyme system (Baltimore,MD, 
USA). Deionised water was purified using a Milli-Q academic purification system 
(Millipore Ltd, Herts, UK) by reverse osmosis and microfiltration to produce ultra-pure 
water. This water was used to prepare all aqueous solutions. 
 
 
2.2 Molecular Biology  
 
2.2.1 Materials  
Commercial kits from Qiagen were used for routine experiments, such as miniprep 
preparation or DNA gel extraction (Hombrechtikon, Switzerland).  As expression 
system for plasmid DNA, homemade DH5α cells were used. DH5α contains useful 
mutations, which allow high plasmid expression without the risk of homologous 
recombination (recA1 mutation) and possible endonuclease digestion (endA1 mutation).  
For the MEK6-p38α project, mutagenesis and DNA construct transfer from one plasmid 
to another were performed (Sections 6.3.1.1-6.3.1.2). For these mutagenesis 
experiments the following PCR machine was used: Mastercycler gradient from 
Eppendorf (Hamburg, Germany). Oligonucleotide synthesis and sequencing service 
were performed by Microgen company (London, UK). Commercial cell strains were 
used: XL1-blue (Stratagene, La Jolla, CA, USA) were used after mutagenesis 
experiments, while E. Cloni DH5α cells (Lucigen corporation, Middleton, WI, USA) 
were used for transformation after ligation in the plasmid transformation experiment.  
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2.2.2 Transformation of competent cells  
Transformation was carried out using the heat-shock method. Cells were mixed with the 
plasmid and submitted to one cycle of cold-hot-cold that allows the passage of DNA 
through the bacterial cell membrane.  
DH5α cells were regularly prepared each year by the laboratory technicians, in aliquots 
of 100 µl using the calcium chloride method. Aliquots of 100 µl of competent cells were 
thawed on ice and 1-4 µl of plasmid was added (up to 200 ng of plasmid DNA). Cells 
were incubated on ice for 30 min. Then the tubes were placed in a preheated water bath 
at 42°C for exactly 50 s and immediately put back onto ice for 5 min. LB media (500 
µl) was added to the tubes and the culture was incubated at 37°C at 250 rpm for 1 h to 
allow the bacteria to recover. Then 50-100 µl of transformed cells were plated out onto 
LB agar plates supplemented with 200 µg/ml of ampicillin. After overnight growth at 
37°C, the plate was stored for a maximum of 15 days at 4°C.  
For the transformation of commercial cell strains, the guidelines proposed by the 
manufacturer were followed carefully. In particular, the time for the heat-shock was 
reduced to 40 seconds. 
 
 
2.3 Gel electrophoresis  
Gel electrophoresis is a method for the separation and analysis of macromolecules such 
as DNA, RNA and proteins and their fragments, based on their size and charge. Three 
different kinds of electrophoresis were used in this thesis: Agarose Gel Electrophoresis, 
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and native 
PAGE. 
 
 
2.3.1 Agarose gel electrophoresis 
Electrophoresis agarose gels were used for detecting the integrity of DNA plasmids, the 
result of a specific reaction involving DNA, or for the purification of DNA through 
nucleic acid gel extraction.  
1% agarose gels (0.5 g of agarose powder) were made up to 50 mL with 1× TBE buffer 
from a 10x stock solution (108g Tris base, Boric Acid 55g, EDTA 9.3g). The solution 
 39 
was heated in a microwave until the powder was dissolved. Then, Syber safe DNA stain 
(Invitrogen, Saint Aubin, Essonne, France) was diluted one thousand times inside the 
gel solution. Finally, the agarose solution was poured into a Bio-Rad mini-sub DNA 
cell (Bio-Rad, Marnes-La-Coquette, Hauts-de-Seine, France), and left to cool for about 
30 min until the gel had set. 
Samples were prepared by mixing with a commercial agarose gel loading dye 
(Invitrogen, Saint Aubin, Ile de France, France) and centrifuged before loading. An 
appropriate DNA ladder (Euromedex, Souffelweyersheim, Strasbourg, France) was 
chosen according to the size of the sample.  
Gels were usually run in TBE buffer for 20-30 minutes at 80 V. The final result was 
visualised by exciting the syber safe with UV irradiation. Images were recorded using a 
image detector from Thermo Fisher Biolab Scientific (Illkirch, Bas Rhin, France).  
 
 
2.3.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was used to analyse the protein content of samples. SDS-PAGE uses a 
denaturing polyacrylamide gel, where the separation of proteins is based on the size of 
the macromolecules. SDS-PAGE was used for analysing the protein purity during the 
purification process.  
Mini-gels (10 cm x 10 cm) were run according to the conditions of Laemmli (Laemmli, 
1970). Running or separating gel, was prepared with an acrylamide percentage up to 
15% (w/v), while stacking gels were prepared at 4% (w/v). Gels were prepared from 
stock solutions in Milli-Q water. The SDS PAGE images reported in the thesis had an 
acrylamide percentage of 12% (w/v), for which the running (Tris HCl pH 8.8 390 mM, 
SDS 0.1%) and stacking gel (Tris HCl pH6.8 125 mM, SDS 0.1%) composition are 
indicated in Table 2.1.  
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Table 2.1 SDS PAGE 12% (w/v) composition 
 
Stock	  solutions	  
1.5	  M	  	  
Tris	  HCl	  
pH8.8	  
0.5	  M	  	  
Tris	  HCl	  
pH6.8	  
30%	  Acrilammide	  	  
	  
10%	  Ammonium	  	  
Persulfate	  (APS)	  
10%	  SDS	   TEMED	   H2O	  
RUNNING	  GEL	  	  
(12%-­‐1	  gel)	  
1.3	  ml	   -­‐	   2	  ml	   0.05	  ml	   0.05	  ml	   0.02	  ml	   1.6	  ml	  
STACKING	  GEL	  
(4%)	  
-­‐	   1.25	  ml	   0.5	  ml	   0.050	  ml	   0.050	  ml	   0.02	  ml	   3.2	  ml	  
 
 
Samples were mixed with 3X loading buffer [0.3 M Tris-HCl pH 6.8, 10% (w/v) SDS, 
25% (v/v) glycerol, 5 mM β–mercaptoethanol and 0.015% (w/v) bromophenol blue] 
and boiled for 5 minutes at 100 °C. After a quick spin, they were loaded into wells. 
Markers Broad-range and Low-range Bio-Rad were used (Bio-Rad, Marnes-La-
Coquette, Hauts-de-Seine, France). The first is a pre-stained marker, while the second 
was prepared by diluting ten fold in the loading buffer. Gels were run in running buffer 
(Solution 1L, 10X: 30.3 g Tris base, 14.4 g Glycine, 10 g SDS) in a protein gel 
electrophoresis unit (Bio-Rad, Marnes-La-Coquette, Hauts-de-Seine, France), at 
constant current of 30-45 mA. 
Proteins were visualised by soaking gels in Comassie Blue staining solution (40% (v/v) 
methanol, 10% (v/v) acetic acid and 0.25% comassie blue) for 5-15 min and by then 
transferring them into de-staining solution (75% (v/v) ethanol 25% (v/v) acetic acid).  
 
 
2.3.3 Native PAGE gel electrophoresis 
Native gels are useful for the analysis of proteins in non denaturing conditions. In this 
thesis they were used exclusively for the MEK6-p38α project, therefore, the protocol is 
reported in Chapter 7, Section 7.3.2.  
 
 
2.4 Macromolecule quantification 
Two different methods were used in this thesis for following the recovery of DNA or 
protein: UV absorption, and the Bradford assay. The first technique is used to quantify 
both macromolecules, while the second one is only for protein quantification. 
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2.4.1 UV adsorption 
The UV absorption method is based on the macromolecule’s ability to adsorb UV 
radiation at specific wavelengths. Nitrogenous bases in nucleic acids absorbed at 260 
nm, while aromatic residues in proteins absorb at 280 nm. The ratio between the two 
absorbance values is further used for characterising the amount of nucleic acid or 
nucleotide contamination in a protein sample, and vice versa.  
The concentration was calculated using the Lambert Beer Law:  
 𝐴 = 𝑙𝜀𝐶 
 
where A is the absorbance value at 260 or 280 nm, l is the path length (cm), ε is the 
molar extinction coefficient (M-1cm-1) and C is the nucleic acid or protein concentration. 
A Thermo Scientific NanoDrop 1000 was used to measure the UV absorbance of 
samples. This instrument allows the analysis of 0.5-2.0 µl samples, without the need for 
cuvettes or capillaries. Thus, l was always corresponded to 0.1 cm. 
The molecular extinction coefficient is the measure of how strongly a substance absorbs 
light at a particular wavelength. The ε of nucleic acids is automatically calculated by the 
Nano drop control software, by indicating the nature of nucleic acid in the sample (ds 
DNA, ssDNA, RNA). In the case of proteins or peptides, the value was calculated using 
the Prot Param tool, from the Expasy website (www.expasy.org), which provides two 
different numbers based on a protein’s oxidation state. Since all the buffers were 
supplied with DTT, the ε in reduced conditions were used.  
Practically, 2 µl were usually used for each experiment. Each was preceded by a blank 
measurement using buffer, and was repeated three times in order to minimize operator 
error.  
 
 
2.4.2 The Bradford assay 
The Bradford protein assay is a colorimetric protein assay used to measure the 
concentration of total protein in a solution. It is based on an absorbance shift of the dye 
Coomassie Brilliant Blue G-250, (Bio-Rad, Marnes-La-Coquette, Hauts-de-Seine, 
France), which has a maximum of absorption at 595 nm. A Biophotometer 
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spectrophotometer (Eppendorf, Hamburg, Germany) was used. 
The dye is converted from red into blue upon binding the protein being assayed. During 
the formation of this complex, two types of bond interaction take place: the red form of 
Coomassie dye first donates its free electron to the ionizable groups on the protein, 
which causes a disruption of the protein's native state, consequently exposing its 
hydrophobic pockets. These pockets on the protein's tertiary structure bind non-
covalently to the non-polar region of the dye via Van Der Waals forces and further ionic 
interactions are also formed. The binding of the protein stabilizes the blue form of the 
Coomassie dye; thus the amount of the complex present in solution is proportional to 
the protein concentration, and can be estimated by the use of an absorbance reading. 
The assay requires a standard curve, which was prepared and calculated by recording 
the 595 nm absorption of a series of protein samples with known concentration. Bovine 
albumin serum (BSA) samples were prepared in Milli-Q water in the concentration 
range 0.5-10 mg/ml and the final linear regression equation was calculated from the 
curve obtained. 
Protein concentration was determined following the guidelines provided by the 
Bradford reagent producer. The original solution was diluted 1:5 in water and 1 ml was 
used for each experiment. From 1 to 5 µl of protein sample were added in the cuvette 
containing the reagent and the concentration was calculated.  A blank was always 
performed in order to avoid that the buffer could interfere with the final result.  
 
 
2.5 Protein expression and purification 
Expression and purification of βPGM and βPGMK145A were performed in the laboratory 
of Prof. Jon Waltho in Sheffield. Protocols are described in the thesis of Dr. J Griffin  
and Dr. Y Jin  (Griffin, 2011; Jin, 2012). The following paragraphs will refer only to the 
proteins expressed and purified in our laboratory.  
The recombinant proteins purified in this thesis were inserted in two vectors: pGEX-2T 
and pET15b. Due to the similarity between the two plasmids, expression and 
purification of the recombinant proteins were performed in a similar manner. In the 
following paragraphs the general guidelines followed for expression and purification 
will be described, while greater details are reported in specific chapters.  
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2.5.1 Plasmid description 
Human RhoA and human RhoGAPR85A were expressed and purified in a recombinant 
form in the pGEX-2T vector. Human MEK6 and truncated or mutated forms of this 
protein were expressed and purified using the pET15b vector. Human p38α, and 
mutated forms of this protein were expressed and purified using the pET15b vector 
pET-BS (+). Protein expression is regulated by the lac and T7 RNA polymerase 
promoters, which confer inducible and high protein expression. Isopropyl-β-D-
thiogalactopyranoside (IPTG) is used to induce protein expression. Both expression 
vectors provide ampicillin resistance to the bacteria and add a cleavable N-terminal 
GST (glutatione-S-transferase) tag or an N-terminal His6 (6 histidine residues) tag 
respectively to the N-terminus of the protein when it is expressed. A thrombin cleavage 
site was coded in order to remove the affinity tags.  
 
 
2.5.2 Transformation of competent cells 
All the recombinant proteins, except βPGM, described in this thesis have human origin. 
Thus, they were expressed in competent Rosetta 2 BL21 (DE3) E. coli. The Rosetta 2 
host strains are BL21 derivatives designed to enhance the expression of eukaryotic 
proteins that contain codons rarely used in E. coli. These strains supply tRNAs for 7 
rare codons (AGA, AGG, AUA, CUA, GGA, CCC, and CGG) on a compatible 
chloramphenicol-resistant plasmid.  
Transformation was carried out in a similar way for E. coli strains used for amplifying 
the DNA plasmids (see Section 2.2.2). After transformation, 50-100 µl of transformed 
cells were transferred onto the LB agar plate supplemented with 200 µg/ml of ampicillin 
and 68 µg/ml of chloramphenicol in the case of Rosetta2. After overnight growth at 
37°C, the plates were store for a maximum of 15 days at 4°C.  
 
 
2.5.3 Large scale protein expression and protein harvesting 
Large scale protein expression (2-12 L) was carried out in similar conditions for all the 
proteins. To produce each protein, a pre-culture was prepared, picking one colony from 
the bacterial plate and adding it to 25-100 ml of LB supplemented with ampicillin and 
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chloramphenicol and grown at 37°C overnight. Ampicillin and chloramphenicol were 
always added in the ratio 4:1.  
Then, 12 ml of preculture was used to inoculate 750 ml LB-ampicillin-chloramphenicol. 
Cells were grown at 37 °C with shaking at 140 rpm until an optical density at 600 nm 
(OD600) of approximately 0.6 had been reached. Protein expression was then induced 
with 1mM of IPTG and the cells incubated overnight at 20°C. They were then harvested 
by centrifugation at 4°C, at 4000 g for 15 minutes. Cell pellets were directly used for 
purification or they were flash-frozen in liquid nitrogen and stored at -80°C. 
 
 
2.5.4 Cell lysis 
The purpose of the lysis step is to disrupt the cells in order to release the recombinant 
protein into an aqueous “extract” which is the first stage of protein purification.  
The cell pellet was disrupted by both enzymatic and mechanical lysis. Cell pellets were 
gently resuspended in lysis buffer (LyB). LyB was always supplied with the protease 
inhibitor cocktail COMPLETE (ROCHE, Basel, Switzerland), which reduces protein 
degradation. 10 ml of LyB was used for each flask of 750 ml of culture. Following the 
addition of deoxyribonuclease I (ROCHE, Basel, Switzerland) to break down 
contaminating DNA, cells were lysed mechanically using a sonicator (Thermo Fisher 
biolab Scientific, Illkirch, Bas Rhin, France). Sonication was performed using a 
maximum of 3 cycles of 50 sec at 60% power. During all these steps the sample was 
kept on ice. Finally, in order to remove cell debris and insoluble recombinant protein, 
the sample was centrifuged at 4°C, at 20000g for 30 minutes and the supernatant saved 
for the next purification step. 
 
 
2.5.5 Protein purification 
All the proteins contained a N-terminal tag. Resins that specifically bind GST or the His 
tags were used as the first step for purifying the recombinant proteins (affinity 
chromatography step). After tag cleavage, each protein was always further purified 
using size exclusion chromatography and occasionally ion exchange chromatography.  
The level of purification achieved was judged by a combination of different techniques. 
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SDS-PAGE was used to analyse protein purity. The elution profile recorded at two 
different wavelengths (280 and 260) provided an indication of possible nucleic acid or 
nucleotide contamination. The elution profile in combination with data produced by 
DLS analysis (dynamic light scattering), was used to assess protein poly-dispersion 
before crystallisation experiments and for comparing different protein batches. The final 
yield was calculated by using one of the methods described for quantification of protein 
concentration.  
 
 
2.5.5.1 Affinity chromatography and Thrombin cleavage  
Two pre-packed columns were used: a GST-trap column and a His-trap column (GE 
Healthcare). 
In the GST-trap column the glutathione ligand is coupled via a 10-carbon linker to 
highly crosslinked 4% agarose. The coupling is optimized to give high binding capacity 
for GST-tagged proteins and other glutathione binding proteins. The His-trap column is 
composed of Ni-NTA Sepharose. Nickel ions are coupled by NTA (tetradentate 
chelating adsorbent nitrilotriacetetic acid), which occupies four of the six ligand binding 
sites in the coordination sphere of the nickel ion, leaving two sites free to interact with 
the His6-tag. Elution of the tagged protein is performed by competition: glutathione in 
the case of GST-trap and imidazole for the His-trap. 
Columns were connected to an AKTA prime system (GE healthcare, Buc Cedex, 
France) and pre-equilibrated with Binding Buffer (BB). The soluble fraction derived 
from lysis step was applied at low flow rate (0.5-1 ml/min) and the column was washed 
extensively until UV absorbance was stable.  
Tag cleavage was performed differently for the two columns. For proteins purified on 
the GST-trap column, tag cleavage was performed on column. For the His-tag proteins, 
the cleavage was performed after elution with elution buffer. Thrombin (100U for each 
20 mg of protein) was applied to the column or added to the protein sample. Thrombin 
is a pancreatic enzyme that recognises a specific protein sequence, inserted between the 
tag sequence and the first methionine of the recombinant protein. Cleavage was 
performed overnight at 4°C, with gentle shaking. In order to separate the cleaved 
protein from the un-cleaved and from active thrombin, a Benzamidinne-FF trap column 
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was connected (GE Healthcare, Buc Cedex, France) at the bottom of the GST-trap or 
the His-trap column. The cleaved protein was then eluted and purified in one step from 
un-cleaved protein and thrombin. Further details of this step will be described in 
Chapters 5 and 6.  
 
 
2.5.5.2 Size exclusion chromatography 
The sample obtained after thrombin cleavage was further purified by size exclusion 
chromatography.  
Size exclusion chromatography separates molecules according to differences in their 
hydrodynamic size as they pass through a gel filtration medium packed in a column. 
The medium is a porous matrix in the form of spherical beads with a well-defined range 
of pore sizes. Molecules that are small enough can fit inside all the pores in the beads 
and elute in the last part of the column volume. Molecules that are larger than the pore 
size pass through the beads avoiding the pores and elute first. 
Several columns were used for this step, based on protein size and purification yield: 
HiLoad 16/60 Superdex 200 or 75 pg or a Superdex 200 or 75 10/300 GL (GE 
Healthcare, Buc Cedex, France). Columns were connected to an AKTA purifier system 
at RT or to an AKTA explorer system at 4°C (GE Healthcare, Buc Cedex, France). 
Columns were equilibrated with at least one column volume of buffer (SEC buffer). In 
order to achieve good peak separation, the sample volume never exceeded 1% of 
column bed volume. Usually, a Centricon (Millipore Ltd, Herts, UK) concentrator was 
used to concentrate the sample to the desired volume before loading. The UV 
absorbance profile was recorded during the chromatography experiment with two 
different wavelengths (280 and 260 nm). Finally, the purity of fractions collected was 
analysed on SDS-PAGE. The fractions were then pooled and, after flash freezing in 
liquid nitrogen, stored at -20° C. 
 
 
2.5.5.3 Anion exchange chromatography 
In the case of p38α and p38α mutants, the protein was further purified using a MonoQ 
anion exchange column. In these experiments, the separation of particles depends on the 
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reversible adsorption of charged molecules to immobilised ion exchange groups of the 
opposite charge. A MonoQ 5/50 GL column (GE Heathcare, Buc Cedex, France) was 
connected to the AKTA purifier and equilibrated according to manufacturer’s 
guidelines. Samples in low buffer salt were applied at low flow rate (0.3 ml/min). After 
extensive washing, a slow NaCl gradient at 0.5-1 ml/min was applied. Increasing the 
NaCl concentration changes the ionic strength, which allows the elution of the bound 
proteins at different NaCl concentrations. Analysis of the results obtained is described 
in Chapter 6, paragraph 6.3.2.  
 
 
2.5.5.4 Buffer exchange 
During the purification protocols described buffer exchange was often useful. Two 
different tools were used: a dialysis membrane and PD-10 columns. 
Dialysis was always performed at 4°C ON, with a typical ratio of 1:200 of sample to 
dialysis buffer. Dialysis membranes with a molecular cut off of 7 kDa were used 
(Spectra/Por, Breda, Netherlands).  
PD-10 columns were used when rapid RT buffer exchange was required. PD-10 
columns are Sephadex-G25 columns (GE Healthcare, Buc Cedex, France), which allow 
the separation of proteins from small molecules, such as salt, as in a SEC 
chromatography experiment. The protocol provided by the manufacturer was followed. 
 
 
2.5.6 Dynamic light scattering 
Dynamic light scattering (DLS, Zetasizer Nano, Malvern Instruments Ltd., 
Worcestershire, UK) is used to analyse the quaternary structure of a protein, to evaluate 
its aggregation state and its polydispersity. In DLS experiments, photons are scattered 
by the randomly oriented molecules in the sample analysed. The radius of these 
molecules (r) is calculated by the Stokes-Einstein relation: 
 𝑟 = 𝑘!  𝑇(6𝜋𝜂𝐷!)!! 
 
where kb is the Boltzman’s constant, T is the absolute temperature (in Kelvin), η is the 
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solvent viscosity and DT is the diffusion coefficient. The DLS measures the time 
dependent fluctuations resulting from the Brownian motions in the scattering intensity 
to determine the Dt and subsequently the hydrodynamic radius. r is the radius of a 
hypothetical hard sphere that diffuses with the same strength as the particle under 
examination.  
From the intensity, the reordered volume distribution is calculated with a polydispersity 
index (PDI). The PDI is a number between 0 and 1. A PDI value of 1 indicates that the 
sample has a very broad size distribution and may contain large particles or aggregates 
that could be slowly sedimenting. Values under 0.3 (monodisperse or low 
polydispersity) were accepted as and indication that a sample could be suitable for 
crystallisation experiments. 
Protein samples purified for crystallisation were usually analysed by DLS before being 
used. After SEC chromatography, fractions corresponding to the central elution peak 
were pooled and concentrated. 50 µl of the sample were centrifuged and used for the 
DLS analysis. 
 
 
2.6 X-ray Crystallography 
 
2.6.1 Crystallisation 
Three-dimensional protein crystals are grown by forming a super-saturated solution and 
causing precipitation sufficiently slowly, and in such a manner, that ordered arrays of 
the protein are formed. This crystallisation process consists of two major events: 
nucleation and crystal growth. Nucleation is the step where the solute molecules 
dispersed in the solvent start to gather into clusters, which can re-dissolve or become 
stable nuclei. From these nuclei, crystal growth can continue. Nucleation and growth 
occur simultaneously while the sample remains supersaturated (Figure 2.1).  
To supersaturate a protein solution there are two main possibilities: increasing the 
protein concentration, or adding a second reagent that reduces solubility. Reagents, such 
as salts or polyethylene glycols (PEGs), that ‘compete’ for the water in the solution, 
bring the protein out of solution. 
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Figure 2.1 Schematic view of solubility curve of a protein. The supersaturation state is divided into 
three zones: Clear, Nucleation and Precipitation. Only in the nucleation zone do the protein crystals 
nucleate and grow, while in the first zone the solution may not nucleate for a long time, even if preformed 
crystals growth would be sustained, and in the precipitation zone, proteins do not nucleate but precipitate 
out of solution (http://www-structmed.cimr.cam.ac.uk).  
 
 
Proteins or protein complexes described in this thesis were crystallised using the sitting 
drop vapour diffusion method. In this technique, a drop composed of a mixture of 
sample and reagent, is placed in a vapour equilibration chamber with a liquid reservoir 
composed of the reagent, so water vapour slowly leaves the drop to achieve equilibrium, 
eventually ending up in the reservoir. As water leaves the drop, the sample undergoes 
an increase in relative supersaturation. Both the sample and reagent increase in 
concentration as water leaves the drop for the reservoir. Equilibration is reached when 
the reagent concentration in the drop is approximately the same as that in the reservoir. 
In every individual experiment, the drop was prepared by mixing 1-2 µl of complex 
solution with 1-2 µl of precipitant solution. For each precipitant, 500-700 µl of buffer 
reservoir was used in each well. Sitting drop plates were covered with adhesive tape 
(Hampton Research, Aliso Viejo, CA, USA) (Figure 2.2).  
For some of the experiments described in this thesis, the microbatch technique was also 
used. The principle is that the precipitating reagent is instantaneously added to a protein 
solution, suddenly bringing the solution to a state of high supersaturation. The drop is 
then covered by oil and the superstauration is achieved by slow evaporation (Figure 
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2.2). 
 
 
 
Figure 2.2 The sitting drop and microbatch methods. The same kind of plate was adapted to both 
methods.  
 
 
In the case where crystallisation conditions are unknown, several Hampton commercial 
screens (Laguna Niguel, CA, USA) were tested at the EMBL High Throughput 
Crystallization Laboratory (HTX laboratory), EMBL, Grenoble, France.  Sitting drop 
plates for high throughput crystallisation are also used by the HTX laboratory. All the 
experiments were carried out in similar way: the drop was prepared by mixing 1nl of 
complex solution with 1 nl of precipitant solution. For each precipitant, 100 nl was used 
in each well. Experiments were run at RT, except for ΔMEK6DD, which was 
performed at 4°C.  
Optimisation of initial conditions was performed by changing the pH of the solution, 
solute concentrations or temperature. For the crystallisation of the RhoA-GDP-
MgFx/AlFx-RhoGAPR85A complex, seeding was also useful. Seeding is a technique used 
to transfer stable nuclei or micro/macro crystals in a similar or different precipitant-
protein drop where crystal nucleation is difficult but crystal growth is favourable.  
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2.6.2 Cryocooling 
Protein crystals are extremely sensitive to damage by X-rays caused by free radicals, 
which can seriously compromise the quality of the data collected. Thus, before being 
exposed to X-rays crystals required to be properly cryo-cooled.  Cooling the crystals to 
100 K dramatically reduces the damage to the crystals by preventing the chain reaction 
of radical damage (Garman, 1999). This eliminates the radical’s diffusion in the crystal. 
Typically, the cooling procedure consists of transferring a crystal from the mother 
liquor to a cryo solution; then the crystal is quickly plunged into liquid nitrogen.  
The presence of a cryoprotectant in the cryosolution is necessary to prevent the 
formation of ice crystals that can damage the crystal lattice (Garman & Schneider, 
1997).  
Common cryo-protectants are glycerol, PEG400, ethylene glycol, oil and MPD. 
Cryosolutions contained protein buffer conditions, reservoir conditions and a 
cryoprotectant at 20-25%. The preparation was carried out in two different ways. A 
quick protocol consisted of mixing all the components in an eppendorf tube. After 
equilibrating the solution obtained at the same temperature as crystal growth, the cryo-
protectant was ready to use. A longer, but more efficient protocol, was then formulated. 
Cryo-protectant was prepared by repeating the protein crystallisation experiment by 
using the protein buffer supplied with the cryo-protectant instead of the protein. After 
24 hours equilibration the cryo-solution was ready to use. MicroMount (MiTeGen, 
Ithaca, NY, USA) loops were then used for mounting the crystals in the cryo-cooling 
procedure. 
During this thesis, a new cryo-protectant protocol was developed. In this protocol, 
crystals are cryo-cooled without adding any cryo-protectant. Instead, crystals are 
mounted using a MicroMesh loop (MiTeGen., Ithaca, NY, USA) and mother liquor is 
removed by touching the reverse of the mesh to laboratory tissue paper (Kimtech 
KimWipes, Kimberly Clark, Irving, Texas, USA) or by leaving them to dry out for a 
few seconds. The removal of the mother liquor limits the formation of ice by reducing 
the amount of liquid surrounding the crystal. In these conditions the protein itself is 
probably acting as the cryo-protectant by inhibiting the formation of crystalline ice 
within the solvent channel. Details of this protocol had been published (Pellegrini et al., 
2011). 
 52 
2.6.3 X-ray crystallography analysis 
 
2.6.3.1 Brief description of the beamlines used  
Crystals were taken to the European Synchrotron Radiation Facility (ESRF, 6 Rue Jules 
Horowitz, Grenoble, France), where the structural biology Beamlines ID14-1, ID14-2, 
ID14-4, ID29, ID23-1 and ID23-2 were used. The choice of beamline was based on 
crystal size or on the experimental requirements. ID14-1, 14-2 and 14-4 were mostly 
used for screening or data collection from well ordered crystals. ID29 equipped with a 
Pilatus 6M detector was used when collection of several datasets with high quality was 
required. ID23-1 and 23-2 were chosen when a 5-10 µm beam was necessary. The 
essential features of these beam lines are shown in Table 2.2. The sample environment 
is comprised of a cryostream to maintain the sample at 100K, a diffractometer and a 
sample changer, which is an automatic crystal mounting tool. All the beamlines are 
controlled using the same software system, MxCuBE, which allows users to interact 
with beamline hardware and provides an intuitive interface for managing the entire     
X-ray experiment from sample loading and detection, to on-line data collection and X-
ray emission spectra (Gabadinho et al., 2010). 
Long wavelength data collection on RhoA-GDP-MgFx/AlFx-RhoGAPR85A crystals was 
performed at the BESSY Synchrotron (Berliner Elektronenspeicherring-Gesellschaft für 
Synchrotronstrahlung, Berlin, Germany), at MX beamline 14.2. The beamline has an 
energy range of 5-15.5 KeV, and a beam  size of 180×70 µm2 (H×V).  
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Table 2.2 Essential features of the ESRF beam lines 
 
	   ID14-­‐1	   ID14-­‐2	   ID14-­‐4	   ID23-­‐1	   ID23-­‐2	   ID29	  
Energy	  range	   13.27	  KeV	   13.294	  KeV	   9-­‐15	  KeV	   5-­‐20	  KeV	   14.2	  KeV	   6-­‐20	  KeV	  
Beam	  size	  
(H×V)	  
100	  ×	  100	  μm2	   100	  ×	  100	  μm2	   50	  ×	  50	  μm2	  
20	  x	  30	  to	  10	  ×	  
10	  μm2	  
8	  ×	  5	  μm2	  
50	  x	  50	  to	  10	  ×	  
10	  μm2	  
X-­‐ray	  Detector	  
	  
ADSC	  
Q210CCD	  
ADSC	  
Q4R	  
ADSC	  
Q315r	  CCD	  
ADSC	  
Q315R	  
Mar/Rayonix	  
3×3	  Mosaic	  
225	  
Pilatus	  6M	  
(Dectris)	  
Flux	  
1	  x	  1011	  
ph/sec	  
1	  x	  1011	  
ph/sec	  
1	  x	  1012	  
ph/sec	  
5	  x	  1012	  
ph/sec	  
5	  x	  1011	  
ph/sec	  
1	  x	  1013	  
ph/sec	  
 
 
2.6.3.2 Data collection 
Collecting two images 90 degrees away from each other in ω orientation was used to 
assess the quality of the diffraction for each crystal. These images are named reference 
images; they provide information about the quality of the diffraction in different 
orientations, the resolution limit and the level of order in the crystal. At the ESRF, the 
collection of the two images is included in the EDNA flow process (Enhanced 
automateD collectioN of datA). EDNA is a software program implemented in 
MxCuBE, which provides diffraction characterisation and data collection strategy 
calculation (Incardona et al., 2009). After collection of the reference images, 
autoindexing is performed by EDNA through the program Mosflm (Leslie, 2006), 
which calculates crystal orientation, probable space group and unit cell parameters. 
Once the orientation of the crystal is determined, a strategy function is used to calculate 
the starting angle and minimum φ range needed to collect a complete data set. The tool 
used in this case is BEST (Popov & Bourenkov, 2003), which takes into account 
radiation damage effect using the program Raddose (Paithankar & Garman, 2010).  
Usually, when a strategy at a reasonable resolution was proposed, datasets were 
collected using the suggested strategy. Searching for better diffracting volume within 
the crystal was performed by changing crystal orientation using the MiniKappa 
goniometer or by evaluating sample diffraction properties through diffraction 
cartography (Bowler et al., 2010b). This automatic scan with micro beam has been used 
successfully in this thesis as tool for finding the best diffracting point of small p38α 
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crystals. 
 At the BESSY synchrotron both indexing of reference images and strategy calculation 
were performed using iMosfilm. iMosflm is the graphical interface of Mosflm (Battye 
et al., 2011)  Searching for the better diffracting positions was performed manually.  
 
 
2.6.3.3 Data processing 
The goal of the data processing step is to produce from a set of diffraction images a set 
of indices (hkl) with their associated intensities. Data processing was performed with 
two programs: iMosfilm and XDS. Both programs go through fundamental steps: spot 
finding and determination of the most probable space group (indexing), cell refinement 
and intensity measurement (integration).  
Mosflm has been used from the graphical interface iMOSFLM (Battye et al., 2011). In 
this program, Indexing is performed as default on two images 90 degrees apart. It then 
produces a list of possible space groups and unit cell parameters; generally, the option 
with the lowest penalty and highest symmetry space group is correct. The accuracy of 
the choice of unit cell is verified by placing boxes where spots are predicted from the 
selected space group: if the boxes overlay all observed reflections, the unit cell is 
correct. After space group solution choice, mosaic spread can be estimated (see 
Appendix A). Refinement of the unit cell and the mosaic spread is then performed, by 
measuring observed reflection in a certain number of images.  Finally, images are 
integrated in blocks of 5-10 images. The integration is a two-step procedure: first the 
position in the image for each Bragg peak is predicted; second the intensity for each hkl 
is measured. In Mosflm, mosaicity is continuously refined during integration. The final 
intensities are written to an mtz file. 
XDS is a command line program, which run 8 different programs in sequence from the 
input file XDS.INP, which contains information about the experimental details 
(detector, beam position etc) and Jobs to run. First, image correction, background 
calculation and spot finding are run (programs: XYCORR, INIT and COLSPOT). Then 
the IDXREF program calculates the orientation, matrix and symmetry of the crystal 
lattice and refines all or a specified subset of parameters contained in the XDS.INP file. 
The job continues until 70% of the given spots can be accurately explained. If the 
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program fails further programs are required for better spot prediction. Finally, 
INTEGRATE and CORRECT are run. The first is the integration function, which 
follows the same principles described above for Mosflm. However, the method used is 
different. While Mosflm uses a two-dimensional integration, XDS uses a three-
dimensional integration (Leslie, 2006). Thus, while in Mosflm the intensities of the 
different components of a partially recorded reflection are evaluated independently by 
two-dimensional profile fitting, in XDS they are assembled and a three-dimensional 
profile is used to evaluate the total intensity. CORRECT applies correction factors to 
the intensities and standard deviations of all reflections found, it determines the space 
group if unknown and refines the unit-cell parameters, it reports the quality and 
completeness of the data set and saves the final integrated intensities in the file 
XDS_ASCII.HKL (Kabsch, 2010). The file is converted to mtz format using the 
program Pointless (Evans, 2006). 
 
 
2.6.3.4 Data reduction 
In data reduction Structure Factors (Fs) are estimated from the intensities. Theoretically, 
the measured intensity Ih of a reflection h is proportional to the square of the underlying 
Structure Factor, with an associated measurement error, but systematic effects of the 
diffraction experiment break this proportionality. Such systematic effects include 
changes in the beam intensity, changes in the exposed volume of the crystal, radiation 
damage, bad areas of the detector and physical obstruction of the detector, such as the 
cryo-stream (Evans, 2011). Thus, before data reduction, the data are required to be on 
the same scale. First, Pointless was run to define the most probable Laue group after 
images integration. Intensity scaling and merging were performed though the program 
Scala. Finally, Structure Factors were calculated through CTruncate.  
Indexing of the lattice in mosflm and XDS is based on lattice geometry, with no regard 
for the symmetry of the diffraction pattern, which can only be determined after 
integration. Thus Pointless (Evans, 2006) was used for scoring potential symmetry 
operators, looking at systematic absences and  ranking the possible Laue group. Usually 
the Pointless solution was used for run a second time the integration step, by inserting 
the most probable space group in the XDS.INP file. 
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Then the data were scaled and merged. The program Scala tries to make symmetry-
related and duplicate measurements of a reflection equal by modelling the diffraction 
experiment, principally as the function of the incident and diffracted beam directions in 
the crystal (Evans, 2011). Moreover, this step provides the best measure of the quality 
of the data. Several data-quality indicators are obtained, such as resolution limit, data 
completeness, multiplicity, Wilson B factor, Rmerge and I/σ(I) values. Rmerge represents 
the discrepancy between the intensities of independently-measured symmetry related 
reflections, while I/σ(I) represents the ratio between signal (I) and noise in the data. 
From these statistics decisions were made about elimination of problematic data or 
outliers, setting a new resolution cut off and possible third integration run with different 
parameters. The integrated and scaled data were then merged to form a single mtz 
containing the intensities for a complete data set. 
The scaled and merged intensities were converted to structure amplitudes or (Structure 
Factors, Fs) by CTruncate (French & Wilson, 1978), which was run along with the 
Scala process.  For perfect data, the module of Fs is the square root of the intensity. 
However, in presence of errors small intensities are wrongly estimated with this 
formula, with the final result that the negative intensities are set to zero and the 
contribution from weak reflections is underestimated. CTruncate estimates the “best” Fs 
based on the probability distribution of I. It outputs an mtz file containing the observed 
Fs and a Wilson B factor. The Wilson B factor plot should give a straight line which 
above 4 Å reflects how temperature factors and absolute scale of the intensities fall off 
with resolution. Deviation from the line indicates possible unreliable data. Moreover 
CTruncate provides statistical information about possible crystal problems, such as 
twinning, which indicates the presence of more than one lattice in the crystal (Evans, 
2011).   
At this stage a random 5% of the data were ‘flagged’ to be used in the Free Rfactor 
calculation (see Appendix A).  
 
 
2.6.3.5 Molecular replacement 
For all the proteins described in this thesis a homologous structure is already known, the 
method for solving the phase problem was molecular replacement (MR) (see Appendix 
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A). The program MolRep from the CCP4i suite was used. The program requires as 
input the structure factors produced by CTruncate and a search model in the form of a 
PDB coordinate file. The goal of the molecular replacement program is to find the 
combination of rotation and translation functions, which allow the overlap of the 
Patterson map calculated from the model with the one derived form the reflection 
dataset (see Appendix A). MolRep goes through all the MR stages automatically. The 
rotation search is calculated for three orthogonal orientations of the model and averaged 
over them. Instead of the Rossman method, the more elegant fast rotation function from 
Crowther (Crowther, 1972) is used. The translation function (TF) is calculated by using 
the Patterson map and all the symmetry operators (Murshudov et al., 1997) (see 
Appendix A). Structure factors are calculated for each orientation/position of the model 
by back calculation from the model coordinates. The TF is supported by a packing 
function, which eliminates the translation that allows the molecule to clash with each 
other. The TF concludes with a multi-domain rigid body refinement in space group P1 
and provides as an output the position of the model in the unit cell. During the process a 
soft resolution cut off is applied to all calculation, which prevents the presence of 
systematic errors in the electron density, particularly at the surface of the molecule 
(Murshudov et al., 1997). The output of the program is a list of translation function 
solutions together with the particular rotation function solution. The program outputs a 
contrast, which is the ratio of the top score to the mean score. At reasonable contrast 
(>2.5), the program provides a file of the model already incorporated in the unit cell. 
 
 
2.6.3.6 Model refinement 
In the final step in the process of solving a macromolecular crystal structure, refinement 
is carried out to maximise the agreement between the model and the X-ray data. There 
are several programs available that are either designed to perform refinement or offer 
refinement as an option. In this thesis Refmac5 from the ccp4i suite and Phenix.refine 
from the Phenix suite were used (Adams et al., 2010; Murshudov et al., 1997). 
Moreover, programs such as Buccaneer, Arp/wARP and AutoSol were used for 
improving partial models by re-building or automatically adding water molecules 
(Cowtan, 2006; Perrakis et al., 1999; Terwilliger et al., 2009). The results of each 
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refinement cycle were validated visually using the graphical program COOT. COOT 
was also used for manual refinement (Emsley & Cowtan, 2004). 
 
 
2.6.3.6.1 Refinement using Refmac5 and phenix.refine 
The model produced by MolRep is refined against the observed data using the program 
Refmac5 (Murshudov et al., 1997) and the program phenix.refine, which are likelihood 
based macromolecular refinement programs.  Refinement programs differ in the target 
functions and optimisation techniques used to derive model parameters.  The target 
function minimised in Refmac5 (ftotal) comprises two components: a component 
utilising geometry (or prior geometry) and a component utilising experimental 
knowledge: 
 𝑓!"!#$ = 𝑓!"#$ + 𝑤𝑓!"#$ 
 
Thus, refinement works through likelihood function which transfers optimal 
information from the data to the derived model. In this process fgeom ensures that the 
derived model is consistent with the presumed chemical and structural knowledge. In 
the target formula w is a weight between the relative contributions of the two 
components. In the refinement cycles with Refmac5 the value is varied in order to 
obtained the one that gives the lowest Free Rfactor and best stereochemistry (Murshudov 
et al., 2011) (see Appendix A).  
The target function in phenix.refine is slightly different. Fgeom is indicated as Fmodel, and 
it contains geometric and non geometric parameters such as bulk solvent contributions, 
twinning, crystal anisotropy and other parameters. Refinement goes through three main 
steps: model parameterisation, refinement of the target and optimisation method. The 
program optimises the target weight value automatically in each refinement cycle 
(Afonine et al., 2012). Phenix.refine provides sophisticated algorithms, which are not 
present in Refmac5. In this thesis rotamer optimisation and simulating annealing (see 
Appendix A) were used for improving the final model.  
Both programs have a dictionary of bond angles, lengths and other restraints for 
polypeptides and ligands to maintain correct stereochemistry within the model during 
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refinement. These dictionaries can be implemented by providing to the program cif files 
about the molecule of interest. Dictionaries for un-recognised molecules, such has 
magnesium fluoride, aluminium fluoride and fluorinated compounds were built using 
eLBOW or PRODRG (Moriarty et al., 2009; Schuttelkopf & van Aalten, 2004). 
The quality of the refinement was assessed by the Rfactor values and root mean square 
deviations (RMS deviations) in bond angle and chirality (see Appendix A). In this 
thesis, Refmac5 was run in the early stages, while Phenix.refine was used later and 
during the validation step. Non-crystallographic symmetry (NCS) and Translation 
Libration Screw-motion (TLS) were refined with Phenix.refine (see Appendix A).  
 
 
2.6.3.6.2 Manual rebuilding 
After each refinement round, the result was assessed with COOT, a molecular 
modelling program (Emsley & Cowtan, 2004; Emsley et al., 2010), which requires as 
input files the model and phases calculated with Refmac5 or phenix.refine. From the 
model and phases, COOT calculates two maps, the Fourier map and the difference 
Fourier map (see Appendix A). The program allows the maps and model to be displayed 
in three-dimensions and the rebuilding of the model to match the observed electron 
density. The maps were inspected initially for their quality and for novel features. Then 
manual rebuilding was carried out by searching for the highest peak in the difference 
Fourier map (either positive or negative) and interpreted by eye. This procedure was 
performed from the command ‘Difference map Peaks’, which shows the differences 
between the model and the observed data. The largest features in the difference maps 
were due to missing ligands, missing residues and missing ordered solvent. Additional 
positive and negative peaks were derived from non-fitting side-chain positions and 
disordered loop regions.  Ligands (for example the magnesium fluoride) were not 
included in the model until further refinement had been performed, so as not to bias the 
maps. Real-space refinement, regularisation and rotate/translate zone from the 
‘Model/Fit/Refine’ toolset were used for regularising the coordinates of the model and 
increasing the fitting to the map. Ramachandran restraints were added at resolution < 2 
Å. After manual rebuilding, the coordinates were written out and refined against the 
observed X-ray data. This process was repeated until the difference density peaks 
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remaining could not be interpreted. 
 
 
2.6.3.7 Structure validation 
The final model was validated (see Appendix A), through the comparison against the 
electron density and by performing geometrical checks of protein structures. First 
validation was performed in COOT. COOT has a validate toolset which allows 
geometrical checks such as deviation form Ramachandran plot and Kleywegt plot, water 
geometry and rotamer analysis. Moreover, the ‘density fit analysis’ tool was used to 
validate the fit of the model to the map (Emsley et al., 2010).  
Further validation was performed using external tools, usually run within the 
phenix.refine cycle. Molprobity is a structure validation tool, which provides at the end 
of each cycle a list of geometrical errors and a summary of the observed and target 
values for assorted validation criteria such as, percentage of outliers in the 
Ramachandran plot, percentage of rotamer outliers and percentage of C-beta outliers 
(Chen et al., 2010). The list of geometrical errors indicates deviations in bond length, 
bond angle, dihedral (torsion) angles, chiral centers and planar groups (such as aromatic 
rings). All-atom contact analysis is also run after adding hydorgen atoms to the model 
using the program phenix.reduce. Reduce will flag residues whose sidechains require 
flipping based on hydrogen-bonding geometry and clashes caused by newly added 
hydrogen atoms. These include asparagines, glutamines, and histidines, which are easily 
poorly fit, due to the apparent symmetry of the sidechain without hydrogen atoms 
(Adams et al., 2010). Finally Molprobity performs a real-space correlation analysis, 
which provides similar results to the density fit analysis run with COOT (Chen et al., 
2010). 
Polygon is a program used to compare model quality indicators to similar structures in 
the PDB databank. Pre-computed values for a selection of 1000 structures determined at 
similar resolution are plotted radially as one-dimensional histograms and the lines 
connecting these points form a complete polygon. For a high-quality, well-refined 
structure, the shape should be approximately symmetric and small (Urzhumtseva et al., 
2009). 
Improving geometrical properties was judged by running phenix.refine. Small decreases 
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of Free Rfactor and a decreased gap between Rfactor and Free Rfactor were positive 
indicators. Moreover, improvements in the Molprobity validation statistics and Polygon 
geometry after phenix.refine cycles were considered positive.  
 
 
2.7 Figure preparation 
All images of models, electron density maps and other structures were produced using 
the molecular graphics program PyMOL developed by DeLano, WL 2002 
(www.pymol.org). The coordinates for solved structures, used to prepare figures, were 
downloaded from the Protein Data Bank [http://www.pdb.org/, (Berman et al., 2000)]. 
Maps were calculated using the program FFT from ccp4i (Ten Eyck, 1985).  
Structures of small molecules and schematic views of protein structures were prepared 
with CS Bio Draw Ultra, (Cambridge soft).  
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Chapter 3 The Major and the Minor conformers in  
βPGM-G6P-MgF3--TSA  
 
 
3.1 Introduction 
 
3.1.1 βPGM is a pharmacological target 
Phosphoglucomutases catalyse the interconversion of D-glucose-1-phosphate (G1P) and 
D-glucose-6-phosphate (G6P) (Bailey et al., 1970). This reaction is central to energy 
metabolism in all cells (Lahiri et al., 2002). Operating in the forward, G6P-forming 
direction, this reaction links polysaccharide phosphorolysis to glycolysis. In the reverse 
direction, the reaction provides G1P for the biosynthesis of cell wall polysaccharides in 
bacteria, in particular, exo-polysaccharides (Qian et al., 1997; Qian et al., 1994; Ramos 
et al., 2001). 
There are two classes of phosphoglucomutases, the α-phosphoglucomutases (αPGM), 
ubiquitous among eukaryotes and prokaryotes, and the β-phosphoglucomutases 
(βPGM,), present only in certain bacteria and protists. Both carry out the same reaction, 
employing Mg2+ and a bisphosphate glucose intermediate as cofactors (Qian et al., 
1997; Qian et al., 1994). In addition, both mutases are monomeric proteins.  However, 
the two protein families are quite different in terms of structure and reaction specificity. 
Indeed, the two classes of mutases are distinguished by their protein-fold and their 
specificity for α- or β-D-glucose phosphates. These differences make βPGM an 
interesting pharmacological target. Therefore, a complete dissection of the isomerisation 
reaction it catalyses is a relevant goal in order to better understand its functional role. 
Bacterial βPGM from Lactococcus lactis was the first βPGM crystallised and many of 
the studies on this family have been performed using this bacterium as a protein source. 
Following this path, a recombinant form of βPGM from L. lactis was used in this thesis 
as a model of the reaction. First, the role of this protein in L. lactis will be described, 
followed by structural features and the state of the art of the reaction. Differences 
between the α- and β-phosphoglucomutase will be also elucidated.  
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3.1.2 In L. lactis βPGM belongs to maltose and trehalose metabolic pathways  
L. lactis is a Gram positive bacterium; it does not produce spores and is not mobile. It is 
used extensively in the production of buttermilk, yogurt and cheese due to its ability to 
produce lactic acid from lactose sources. The lactic acid produced by the bacterium 
curdles milk, which then separates to form curds, which are used to produce cheese and 
whey (Madigan et al., 2006). 
In L. lactis, βPGM is involved into two pathways: the maltose and trehalose catabolic 
pathways, which are linked through their metabolite, β-D-glucose-1-phosphate (βG1P). 
In other bacteria, βPGM is only involved in maltose degradation. Maltose is degraded 
by the concerted action of maltose phosphorylase and βPGM, whereas trehalose is 
assimilated by a novel pathway, including trehalose-6-phosphate phosphorylase, and 
βPGM (Andersson & Radstrom, 2002a) (Figure 3.1). Maltose is split into glucose and 
βG1P by a Pi-dependent reaction catalysed by maltose phosphorylase (Nilsson & 
Radstrom, 2001). The glucose formed then enters glycolysis via glucokinase while 
βG1P is converted to D-glucose-6-phosphate (G6P) by βPGM before entering 
glycolysis (Qian et al., 1997). The maltose pathway is controlled by a transcriptional 
regulator, MalR, that regulates the expression of maltose transporters. Indeed, it 
regulates the maltose degradation pathway without affecting the main enzymes involved 
(Andersson & Radstrom, 2002b). In a similar way, trehalose is split into G6P and βG1P 
with same aims (Andersson & Radstrom, 2002a). 
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Figure 3.1 The closely connected maltose and trehalose metabolic pathways in L. lactis. Schematic 
view of the two pathways in L. lactis. Mal, maltose; Tre, trehalose; PTS, phosphotransferase system; MP, 
maltose phosphorylase; TrePP, trehalose 6-phosphate phosphorylase; β-PGM, β-phosphoglucomutase; 
GK, glucokinase; Glu, glucose; T6P, trehalose 6-phosphate; β-G1P, β-glucose 1-phosphate; G6P, glucose 
6-phosphate (Andersson & Radstrom, 2002a). 
 
 
3.1.3 Structural characterisation of βPGM 
βPGM is a member of the haloacid dehalogenase (HAD) superfamily, which includes 
the sarcoplasmatic Ca2+-ATPase, phosphomannomutase and phosphoserine 
phosphatase. Indeed, the X-ray structure of βPGM shows a 2 domain α/β protein, the 
common fold shared with the entire HAD family. This fold is different from the α-
phosphoglucomutase family, where αPGM (65KDa) is approximately twice the size of 
the βPGM (25 KDa) (Dai et al., 1992) and the X-ray structure of αPGM reveals a 4-
domain α/β protein. All four domains contribute residues to form a large active-site 
crevice (Lahiri et al., 2002).  
The first structure of βPGM was solved in the open conformation (with no sugar bound) 
at 2.3 Å resolution (PDB code 1LVH; Lahiri et al., 2002). The protein was crystallised 
in its phosphorylated form (P-Asp8, βPGMP). βPGM (221 residues in total) is a 
monomer that is composed of two distinct domains, a helical cap domain (residues 1-14 
and 93-221) and the α/β domain (residues 15-92). Together, the core and the cap 
domain give rise to a kidney-bean shaped monomer, this suggested that the reaction is 
performed by conformational changes via cap domain closure (Figure 3.2). The 
 	  
66 
CAP$domain$
CORE$domain$
movement of the cap domain was visualised when the first closed structure was solved. 
βPGM has been crystallised in the closed conformation by two different groups. Karen 
Allen and co-workers crystallised it with bound a phosphorane intermediate (PDB code 
1O03; Lahiri et al., 2003). The second group demonstrated that the phosphorane group 
was in fact magnesium trifluoride, mimicking the transfer of the phosphate from the 
protein to the sugar molecule (Baxter et al., 2010). Since the arguments reported in this 
and further papers (Webster, 2004), in this thesis only the closed structure with 
magnesium fluoride will be considered (PDB code 2WF5; Baxter et al., 2010). 
 
 
Figure 3.2 Ribbon representation of the cap domain movement. βPGMP is in grey, with 
phosphorylated Asp8 represented in sticks (PDB code 1LVH; Lahiri et al., 2002). βPGM-G6P-MgF3--
TSA is in green (PDB code 2WF5; Baxter et al., 2010). The arrow indicates the hypothetical movement 
direction. 
 
 
The two structures showed that the active site of βPGM is located at the domain-domain 
interface. The exact location is identified by the phosphorylated side chain of Asp8 and 
by the Mg2+ cofactor. The active site is comprised of the cap domain side chains of 
Lys45 and the Thr16, and the side chains of Asp8, Asp10, Val12, Ser114, Lys145, 
Asp169 and Asp170 contributed by the core domain. Of these, Asp8 and Asp10, 
Ser114, Lys145, Asp169 and Asp170 are conserved among the HAD 
phosphotransferases. As further described in the closed conformation these residues are 
involved in magnesium coordination or in sugar binding. The magnesium is coordinated 
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in octahedral geometry by the side chains of Asp8, Glu169, Asp170, by the backbone of 
Asp10 and by a water molecule. In the closed conformation, Asp8, Asp10, Ser114, 
Ala115 and Lys145 interact with the magnesium fluoride molecule (Figure 3.3), 
indicating a role in phosphoryl transfer. 
 
 
 
Figure 3.3 Schematic view of the βPGM-G6P-MgF3--TSA complex active site. Interactions between 
the active site residues and the magnesium fluoride are shown (Baxter et al., 2010). 
 
 
3.1.4 The reaction catalysed by βPGM  
β-phosphoglucomutase performs a multi-step reaction, that goes through a bisphosphate 
sugar intermediate, β-D-glucose-1,6-bisphosphate (βG16BP). The reaction is anomeric 
specific: βPGM catalyses the reaction of the β-C(1), while αPGM acts on the α-C(1) 
anomer of G1P. The reaction requires magnesium as co-factor and initial activation of 
the protein by phosphorylation at the active site residue Asp8. The reaction proceeds 
through a ping-pong mechanism involving an aspartyl-phosphoenzyme (βPGMP) and 
βG16BP intermediate (Zhang et al., 2005). In particular, the βPGMP initiates the ping-
pong mechanism: βG1P is converted to βG16BP, which is dephosphorylated either to 
G6P or back to βG1P. Furthermore, βPGM can also catalyse the hydrolysis of G6P, the 
major species under equilibrium conditions, yielding glucose and inorganic phosphate 
(Figure 3.4).  
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Figure 3.4 Reactions catalysed by βPGM. A) The mutase activity of βPGM catalyses the transfer of 
phosphate between the 1 and 6 positions of glucose. B) βPGM also catalyses the hydrolysis of G6P, the 
major species under equilibrium conditions, yielding glucose (Golicnik et al., 2009).  
 
 
The reaction proceeds through a general base catalysis system, which is comprised of 
two aspartates: Asp10 and Asp8. As shown by the structure of the transition state, Asp8 
offers the nucleophile oxygen atom, while Asp10 is the proton acceptor or general base 
in the catalysis. The distances between the magnesium fluoride and the apical oxygen 
atoms are 2.09 and 2.18 Å, which defines the transition state as a tight one (Figure 3.5).  
 
 
 
Figure 3.5 Residues involved in the General acid base catalysis of βPGM. The main characters of the 
reaction are shown, as described in the main text. The two aspartates involved are represented as stick. 
Magnesium is represented as green sphere. 
Asp10&
Asp8&
G6P& 2.09Å&2.18Å&
MgF33&
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3.1.4.1 βPGM activation 
Presteady-state and steady-state kinetic analysis has shown that the amplitude of the 
initial burst is proportional to the concentration of βPGMP. Depending on the cofactor 
that activates the protein, a lag period can be observed before a linear steady-state 
reaction is observed. This time is defined by the βPGM phosphorylation sources, such 
as βG16BP, αG16BP and αG1P.  
βG16BP is the most efficient molecule in activating βPGM. Most phosphomutases 
require a sugar bisphosphate for optimal activity and in 1974 it was demonstrated that 
βG16BP is the one required for activating and maintaining the βPGM reaction 
(Marechal & Belocopitow, 1974). Indeed, no lag phase is observed when this molecule 
is used (Golicnik et al., 2009). Furthermore, it was observed that a transient 
accumulation of [14C]βG16BP (12% at 0.1 s) occurs in a single turnover reaction 
performed with an excess of βPGM (40 µM) and limiting [14C]βG1P (5 µM) and 
βG16BP (5 µM). This experiment supported the role of βG16BP as a reaction 
intermediate in the conversion of the βG1P to G6P (Dai et al., 2006). In experimental 
conditions, a constant amount of this molecule remains in solution in order to generate 
new βPGMP and any remaining after complete consumption of βG1P is slowly 
converted to G6P (Golicnik et al., 2009).  
Due to its general availability, αG16BP is used experimentally as enzyme activator. 
αG16BP requires further isomerisation or hydrolysation to be able to activate the 
protein. Thus, in this case where a lag period is required for starting properly the 
reaction, βPGM can isomerise the α anomer to the β, producing an amount of βG16BP 
necessary for maintaining the βPGMP pool (Golicnik et al., 2009). 
Eventually, in a less efficient way, the protein can hydrolyse αG16BP to αG1P; αG1P as 
a further phosphate donor for βPGM (Golicnik et al., 2009). 
Due to the ability of water to hydrolyse P-Asp8, βPGMP produced in this way has a      
half-life of 12 s. In this βPGM differs from αPGM, where a phospho-serine is involved 
in the reaction and the phosphoprotein is stable in water (Dai et al., 2006; Zhang et al., 
2005). 
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3.1.4.2 Isomerisation induces through an intermediate 
The ability of βPGM to convert both the monophosphosugars is related to the fact that 
βG16BP binds to the active site in two different orientations with roughly the same 
efficiency (Dai et al., 2006). This means that βG16BP needs to be reoriented to produce 
either G6P or βG1P. For βPGM catalysis in the βG1P-forming direction, the βG16BP 
must be bound with the C(1)phosphate interacting with the cap domain and the 
C(6)phosphate with the Asp8. This orientation is termed E(βG16BP)-1. For βPGM 
catalysis in the G6P-forming direction, the βG16BP must be bound with the 
C(6)phosphate interacting with the cap domain and the C(1)phosphate with the Asp8. 
This orientation is termed E(βG16BP)-2. The reorientation of the bisphosphate has 
historically been studied in αPGM, where the αG16BP is reoriented by rotating 180° 
while still associated with the enzyme (Naught & Tipton, 2005). In the case of βPGM 
the same mechanism has been explored by kinetic methods and interpreted through the 
structure of the open and closed conformations. It has been postulated that the 
reorientation in the active site is achieved by dissociation into solvent and then binding 
in the opposite reorientation (Dai et al., 2006). This is supported by the X-ray structure 
of the enzyme: in its catalytically active, fully closed conformation little room exists for 
ligand reorientation, while the apo-phosphorylated enzyme (Lahiri et al., 2002) 
illustrates the open conformation in which the cap domain and core domain are 
dissociated and the active site is open to solvent (Baxter et al., 2010; Lahiri et al., 
2002). 
 
 
3.1.4.3 Possible inhibition of the βPGM reaction 
In the pre-steady state the reaction can be inhibited in several ways. βG1P in either low 
or high concentrations decreases the reaction rate. Over a longer time scale, when the 
βG1P concentration is lower, water can compete with the glucose monophosphate 
species present to dephosphorylate βPGMP and deplete the active components of the 
system. In the opposite direction, when βG1P is at high concentrations, substrate 
inhibition is observed. βG1P can bind to βPGM with the phosphate group in the distal 
binding site, presenting the 6-OH into the active site, thereby inhibiting the enzyme. 
Alternatively, if βG1P is bound with the phosphate group in the active site, it still 
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effectively forms an unproductive complex, as it only transfers the phosphoryl group to 
the enzyme very slowly relative to the other processes under these conditions (Golicnik 
et al., 2009). Moreover, αG16BP can slow down the reaction rate, when the phosphate 
in position 1 is close to the βPGM active site.  
 
All the steps described are summarised in figure 3.6. For each reaction kcat and Km are 
reported (Table 3.1). Eventually the limiting step of the reaction, is βPGM 
phosphorylation or activation.  
 
 
 
 
Figure 3.6-Table 3.1 Simplified reaction scheme of the reaction catalysed by βPGM in the presence 
of αG16BP as a cofactor. When the βG16BP intermediate binds to βPGM, either the 6-phosphate 
(βG16BP·βPGM) or the 1-phosphate (βG16BP*·βPGM) is placed at the phosphoryl transfer site. 
αG16BP can either bind productively (αG16BP·βPGM, with the 6-phosphate at the transfer site) or 
unproductively (αG16BP*·βPGM, with the 1-phosphate at the transfer site). The hydrolase activity is 
slow in comparison with the isomerase activity when α or βG16BP are present in the reaction solution as 
a cofactor. However, the removal of G6P by the coupled assay, used for measuring reaction parameters, is 
fast and irreversible (Golicnik et al., 2009). 
 
 
1.5 Challenges in studying the βPGM reaction  
As described above, βPGM carries out a multistep reaction, making it a challenge to 
study. Of particular interest is how one active site can effectively catalyse a phosphoryl 
transfer reaction to two different substrates – this is notably the case with βPGM. X-ray 
crystallography is the most eligible technique that increases the reaction knowledge by 
providing reaction snapshots. Ideally, structures of βPGM in complex with each 
substrate (βG1P, βG6P and βG16BP) will provide a complete scenario for the whole 
Parameters	   	  
Ki(βG1P)	   122	  ±	  8	  μM	  
k1	   253	  ±	  22	  s-­‐1	  
K1(βG1P)	   51	  ±	  5	  μM	  
k2	   105	  ±	  3	  s-­‐1	  
K2(βG16BP)	   1.1	  ±	  0.1	  μM	  
k5	   2.9	  ±	  0.3	  s-­‐1	  
K5(αG16BP)	   91	  ±	  6	  μM	  
Kiα(αG16BP)	   21	  ±	  2	  μM	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reaction. However, growing crystals of βPGM in complex with mono-phosphor sugar 
failed. This was because βG1P can be converted to G6P by activating βPGM, and G6P 
can slowly be converted to glucose and inorganic phosphate (Baxter et al., 2006; Lahiri 
et al., 2003). As described in the introduction of this thesis, the mechanism of 
phosphoryl transfer has been successfully studied by using metal fluoride compounds 
such as magnesium or aluminium fluoride. Fluoride inhibits phosphoryl transfer by 
blocking the reaction studied in the transition state, providing a chance to obtain a 
relevant reaction snapshot for understanding the transition state scenario. In the case of 
βPGM it has been demonstrated that increasing amounts of magnesium fluoride inhibit 
the hydrolase activity (kcat = 70 nM) and G6P is more tightly bound to βPGM (Golicnik 
et al., 2009). Indeed, as described in Section 3.1.3, βPGM was successfully crystallised 
in complex with G6P and magnesium fluoride (Baxter et al., 2010). Furthermore, 19F-
NMR has been demonstrated to be a tool for analysing the transition state formation and 
describing its energy environment in solution.  
In this chapter and chapter 4, further details of this reaction will be analysed by the 
combination of 19F-NMR and X-ray crystallography. Two main unsolved questions will 
be discussed. The first investigates the so called “major-minor form” of magnesium 
trifluoride. The second focus on the study of the first reaction step: the phosphorylation 
of βG1P. This second topic will be discussed in Chapter 4. 
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3.2 Aim of this project 
The major-minor form refers to the particular NMR spectra recorded in the case of the 
βPGM-G6P-MgF3--TSA complex (PDB code 2WF5; Baxter et al., 2010). The spectra 
showed that apparently βPGM could coordinate the magnesium fluoride molecule in 
two different ways: the major and the minor form, the names are related to the 
percentage of the protein population corresponding to each group. However, no 
evidence was observed for the minor conformation in the crystal structure, showing that 
the structure in solution could be different from the one in the solid state.  
βPGM was mutated to remove one of the positivly charged residues coordinating the 
transition state to a neutral one (βPGMK145A). As expected from the charge balance 
hypothesis, the spectra collected on the βPGMK145A-G6P-MgF2-TSA recorded two 
peaks, instead of the usual three. Surprisingly, the chemical shifts of the two peaks were 
very similar to two of the minor form pattern. Thus, in order to characterise structurally 
both major and minor populations, it was decided to combine the new structural 
knowledge from the mutant with further methods that will allow the convergence of X-
ray crystallographic with NMR data.  
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3.3 Experimental procedures 
 
3.3.1 Cloning, protein expression and purification 
Cloning, expression and purification experiments are described in the thesis of Dr. 
Joanna Griffin (Griffin, 2011). 
 
 
3.3.2 Crystallisation of βPGM-G6P-MgF3--TSA and βPGMK145A-G6P-MgFx-TSA 
complexes 
For crystallisation experiments, proteins were received purified in 50 mM HEPES pH 
7.2, DTT 0.1 mM and MgCl2 5 mM and concentrated to 30 mg/ml. For crystallisation, 
the solution was adjusted to 15 mg/ml. 10 mM NH4F and 6 mM G6P were added and 
the sample left for a few minutes on ice in order to promote complex formation. For 
crystallisation, the solution was mixed 1:1 with precipitant and placed in sitting drop at 
room temperature (RT), with a final volume of 4 µl. Crystallisation conditions were 
slightly different for the complexes. In the case of the WT large plate crystals were 
obtained after one to two days in 27-32% (w/v) PEG 4000, 50-125 mM NaAc. In the 
case of the mutant, higher concentrations of PEG were required (30-36% (w/v)). As in 
the case of the mutant both closed (needles) and open conformation (plates) grew in the 
same conditions it was necessary to harvest the plate crystals in three days, before they 
were surrounded by needles (Figure 3.7).  
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Figure 3.7 Crystal of βPGMK145A-G6P-MgFx-TSA 
 
 
3.3.3 Data collection at 100 K, structure solution and refinement 
All crystals were cryocooled as previously described (Pellegrini et al., 2011). In the case 
of βPGM-G6P-MgF3--TSA, all data collection was performed at 100K. For structure 
analysis the structure deposited in the PDB as 2WF5 was used (Baxter et al., 2010). 
Data from βPGMK145A-G6P-MgFx-TSA crystals were collected to 1.6 - 1.4 Å resolution 
on an ADSC Q210 CCD detector on beamline ID14-2 at the European Synchrotron 
Radiation Facility, Grenoble, France (ESRF). Data were processed using XDS (Kabsch, 
2010) and structures were solved by molecular replacement using MolRep (Vagin & 
Teplyakov, 2010). 2WF5 without ligands or water molecules was used as a search 
model. Refinement was carried out using REFMAC5 (Murshudov et al., 1997) in 
combination with manual refinement in COOT (Emsley & Cowtan, 2004). Ligands 
were added in the last refinement cycles. Validation was performed with Phenix as 
described in Chapter 2 (Adams et al., 2011). 
 
 
3.3.4 Data collection at room temperature, structure solution and refinement 
Data collection was performed at room temperature using the EMBL HC1b humidity 
control device. The HC1b allows dehydration experiments to be performed at 
synchrotron beam lines with minimal perturbation to the experiment configuration 
(Sanchez-Weatherby et al., 2009). The experiment is thoroughly described in Russi et 
al., 2011. Briefly, a typical dehydration experiment starts from the determination of the 
50#μm#100	  µm	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relative humidity (RH) of the crystal mother liquor. This can be achieved by placing a 
drop of the mother liquor in a loop at a chosen RH and monitoring the changes in the 
defined region using a specific image processing software. No changes in size of the 
point of interest indicate the start RH. Then the crystal is mounted and images taken to 
evaluate the crystal quality.  
To alleviate the problems of radiation damage a helical data collection protocol was 
used (Flot et al., 2010). This allowed continues exposure of fresh crystal volumes 
during data collection. Eventually, a data set at 1.47 Å resolution was collected with 
excellent data processing as statistics. Data processing was carrying out as described in 
section 3.3.3 and Chapter 2. 
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3.4 Results and Discussion 
 
3.4.1 19F-NMR spectra revealed an alternative way of coordinating magnesium 
fluoride in the βPGM-G6P-MgF3--TSA complex 
In the case of the βPGM-G6P-MgF3--TSA complex (Baxter et al., 2010), it has been 
demonstrated that the combination of solution NMR and high resolution X-ray 
crystallography can provide an independent validation of MgF-TSA complex formation. 
Indeed, it was shown that there is a remarkable relationship between NMR chemical 
shifts, primary isotope shifts, NOEs, hydrogen bond F···H-X scalar couplings, and the 
atomic positions determined from the high-resolution crystal structure. These data 
provided proof in solid and solution states of the ability of magnesium fluoride, rather 
than a pentacovalent phosphorane intermediate, to trap the transition state and to be a 
sensitive probe of the electrostatic and hydrogen bonding distributions in a near-TS 
conformation. The first key probe of the interactions within the TSA was provided by 
19F-NMR. The spectra recorded in water and D2O show three distinct peaks, each one 
corresponding to a different fluoride atom coordinating the Mg atom (FA, FB and FC). 
The high resolution crystal structure of βPGM-G6P-MgF3--TSA (1.3 Å) showed that the 
magnesium is pentacoordinated in trigonal bipiramidal geometry with two oxygen 
atoms (protein D8-O and sugar C1-O) at the apical positions; while on the equatorial 
plane, the magnesium atom is coordinated by the three fluorides (bond lengths: Mg-FA= 
1.8 Å, Mg-FB= 1.8 Å Mg-FC= 1.9 Å) (PDB code 2WF5; Baxter et al., 2010). 
Furthermore, isotope shifts combined with the structure characterisation provide 
information about the proton coordination of each atom. The three fluorine atoms in 
each of the MgF3- moieties are hydrogen bonded to multiple exchangeable donors of the 
protein, and a comparison of the spectra recorded in H2O buffer and D2O buffer allows 
the sum of the individual isotope shifts to be measured. Three protons, Leu9HN, 
Asp10HN, and Ser114HO coordinate FA, in a distorted tetrahedral arrangement, giving a 
sum isotope shift of 1.6 ppm. FB and FC have trigonal coordination involving two 
protons (Ala115HN and Lys145HN) and one proton (G6P-2’HO), respectively, and have 
correspondingly smaller sum isotope shifts (1.4 ppm and 0.9 ppm, respectively) (Figure 
3.8).  
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Figure 3.8 19F-NMR spectra of βPGM-G6P-MgF3--TSA complex. Spectra were recorded at 20°C in 50 
mM K HEPES buffer at pH 7.2, in 100% H2O or in 100% D2O. Chemical shifts are given in ppm for each 
19F resonance in the complex. A) βPGM-MgF3--G6P-TSA in 100% H2O buffer (FA= -147.0, FB=-151.8, 
FC=-159.0). B) βPGM-MgF3--G6P-TSA in 100% D2O buffer (FA= -148.6, FB=-153.3, FC=-159.8). C-F) 
Not of interest for the topic discussed. The peaks indicated by green letters are part of the minor form 
pattern (Baxter et al., 2010).	  
 
 
X-ray crystallography experiments failed in the assignment of all the peaks show in the 
NMR data. In the panels A-B further small peaks are present. Surprisingly, there are 
three of them and they are always present in βPGM-G6P-MgF3--TSA solution. The 
respective ppm are: Fa=133.8, Fb=134.8, Fc=153.6 (in green in figure 3.8). Previous 
experiments have shown that the three peaks are related to each other. Indeed, repeating 
the same experiment in different conditions, such as different temperatures, the three 
peaks increased or decreased simultaneously.	   It was also reported that this minor 
conformer most likely exchanges with the major conformer more rapidly than the 
complex dissociates because the resonances were found to correlate via saturation 
Fa	  Fb	   Fc	  
Fa	  Fb	   Fc	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transfer with specific resonances of the major conformer (Baxter et al., 2006; Griffin, 
2011). These experiments, described in Dr. J Griffin’s thesis, clearly show that in the 
sample two populations are present and each one is related to different pattern of peaks. 
Since in the first experiment the Fa, Fb, Fc peaks were observed at a low percentage of 
the entire population, they were termed the minor form; the FA, FB, FC peaks were 
defined as the major form.  
As the two populations should be different in terms of structure, two hypotheses were 
formulated. First, it was hypothesised that the protein was able to coordinate the 
magnesium fluoride using different residues from those described previously. No 
signals in the difference electron density map suggest a possible alternative 
conformation of the active site, which could accommodate the magnesium trifluoride 
differently in TBP geometry. 
Second, it was hypothesised that these three peaks could indicate an alternative 
geometry of the coordinated magnesium, even if no proof supporting this hypothesis has 
been found in the literature. In vacuum and gas phase, the magnesium fluoride geometry 
depends on the number of fluoride atoms coordinating it or by the presence of solvent. 
Mg-F bonds are weakened and lengthened as the number of coordinating fluorine atoms 
is increased (Shibata et al., 2011). All fluoride atoms tend to keep away from each other 
to reduce strong F-F Coulomb repulsion, and the bond angle is thus understandable in 
terms of the VSEPR model (Valence Shell Electron Pair Repulsion). In the case of 
magnesium trifluoride the averaged Mg-F bond lengths and F-Mg-F angles are 
respectively 1.845 ± 0.04 Å and 119.90 ± 0.1 (intermediate values between the gas 
phase and aqueous solution) conferring trigonal planar geometry. In the case where 
solvent is present, the bond angles are significantly bent, without affecting the trigonal 
geometry (Shibata et al., 2011) (Figure 3.9).  
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Figure 3.9 Optimised geometry of MgF3- in the gas phase (A) and in aqueous solution (B). Angles 
and bond lengths are given in degrees and Å (Shibata et al., 2011).  	  
 
Similarly, in crystal structures the bond lengths are 1.880 ± 0.15 Å and 108.80 ± 0.6, 
which are much closer to the values in the gas phase (Shibata et al., 2011). Furthermore, 
in the electron density of βPGM-G6P-MgF3--TSA there was no clear evidence 
supporting an alternative geometry. Thus further investigations were required. 
 
 
3.4.2 The βPGMK145A-G6P-MgFx-TSA structure is related to the minor form 
βPGM was mutated to remove one of the positivly charged residues coordinating the 
transition state to a neutral one. Lys145 was mutated to an alanine, and the protein 
mixed with G6P and magnesium fluoride in order to observe any changes in the 
transition state analogue. Based on the charge balance hypothesis, the loss of a positive 
charge should bring the loss of a negative charge in the bound substrate in order to 
satisfy the zero charge required in the active site (Baxter et al., 2008; Cliff et al., 2010). 
In the case of PGK, it has been found that one of the fluoride atoms of ALF4- was 
substituted by a water molecule, without any change in the protein structure or in the 
metal fluoride features (Cliff et al., 2010). The 19F-NMR experiment on the K145A 
mutant of βPGM recorded two peaks, instead of the usual three. This indicated that the 
complex is still formed and that the magnesium atom is coordinated by two fluoride 
atoms instead of three, satisfying the charge balance in the active site. Surprisingly, the 
chemical shifts of the two peaks were very similar to two of the minor form pattern (Fb 
and Fc in figure 3.10, table 3.2), suggesting a structural relationship between the mutant 
and the minor form structure. Therefore crystallisation attempts of the mutant complex 
were performed. 
A)	   B)	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Fa	  Fb	   	  	  	  Fc	  
Fb	   	  	  	  Fc	  
A	  
B	  
 
Figure 3.10-Table 3.2 19F-NMR spectra of βPGM-G6P-MgF3--TSA and βPGMK145A-G6P-MgF2-TSA 
complexes. Spectra were recorded at 20°C in 50 mM K HEPES buffer at pH 7.2 in 100% H2O. In green 
the peaks/values of chemical shift of the minor form are shown. In pink the ones about the mutant 
complex are shown.  
	  
 
The mutant complex was crystallised successfully, in the same space group as the 
published wild type structure (P212121). The asymmetric unit contained one molecule 
and the structure was solved to 1.4 Å resolution (Table 3.3). Macroscopically, the 
structure is very similar to βPGM-G6P-MgF3--TSA structure with an rmsd between Cα 
atoms of 0.26 Å (calculated with Superpose, Krissinel & Henrick, 2004). The difference 
Fourier map showed clear peaks for the expected ligands and the absence of electron 
density for Lys145, confirming that the protein crystallised was indeed the mutant.  
	   Minor	  form	  
Fa	   133.8	  ppm	  
Fb	   134.8	  ppm	  
Fc	   153.8	  ppm	  
	   βPGMK145A-­‐MgF2-­‐G6P-­‐TSA	  
Fa	   -­‐	  
Fb	   136.3	  ppm	  
Fc	   153.8	  ppm	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Table 3.3 Data collection and refinement statistics 
 
	  
PGMK145A-­‐MgF2(H2O)-­‐G6P-­‐TSA	  
Space	  group	   P212121	  
Wavelength	  (Å)	   0.933	  Å	  
Unit	  cell	  dimension	  (Å)	  a,b,c	   37.41,54.17,104.48	  
Resolution	  range	  (Å)1	   20(1.48-­‐1.4)	  
Number	  of	  unique	  reflections	   42,671	  
Multiplicity	   6.4(6.4)	  
Completeness	  (%)	   99.9	  (100)	  
Rmerge	   0.075	  (0.631)	  
<I/σ(I)>	   19.0	  (3.0)	  
Wilson	  B	  factor	  (Å2)	   7.76	  	  
Water	  molecules	   306	  
Rfactor	  (%)	   15.75	  
Free	  Rfactor	  (%)	   19.23	  
RMS	  deviations:	   	  
Bonds	  (Å)	   0.019	  
Angles	  (°)	   1.785	  
 
1Values	  for	  the	  higher	  resolution	  shell	  are	  in	  brackets 
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The most striking difference between the WT and the mutant was in the coordination of 
the magnesium ion in the metal fluoride. The density of mutant clearly showed 
octahedral coordination of the metal. This confirmed the NMR data, indicating that the 
mutation causes a change in the magnesium fluoride molecule. Due to the high 
resolution, it was possible to distinguish between peaks related to fluorine atoms and 
water molecules. The coordination distances between water and magnesium and that of 
fluoride are different (2.0 vs 1.8 Å); electron density peaks that can be assigned to 
fluorine atoms are usually continuous with density for the metal ion. In the case of 
water coordination this continuity is abolished; this difference can only be discerned at 
high resolution. As shown in Figure 3.11 the electron density corresponding to the 
magnesium fluoride was easily assigned to a magnesium difluoride, coordinated by an 
additional water molecule (W). 
 
 
 
Figure 3.11-Table 3.4 Difference Fourier map of the magnesium fluoride molecule. The magnesium 
fluoride molecule is shown in sticks. The difference map, contoured at 5σ, is shown as green mesh. The 
table shows bond lengths and angles. 
 
 
 
While the apical coordination has been conserved, the magnesium is now coordinated in 
octahedral geometry with the water molecule and two fluoride atoms symmetrically 
arranged around it. The other two vertices of the octahedron are occupied by the second 
fluoride molecule and by the carboxyl oxygen of Ser114 (Figure 3.12).  
The fact that a protein can coordinate a magnesium fluoride species in octahedral 
geometry is a novelty. The fluoride-magnesium bonds are longer with regard to the 
	   Bond	  lengths	  (Å)	   	   Angles	  (°)	  
Mg-­‐Fa	   1.99	   Fa-­‐Mg-­‐W	   167.67	  
Mg-­‐W	   2.1	   W-­‐Mg-­‐Fc	   92.4	  
Mg-­‐Fc	   1.93	   Fc-­‐Mg-­‐	  Fa	   99.51	  
Fc	  
Fa	  W	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trifluoride magnesate. This has also been described for MgF4- in an aqueous solution, 
where the average bond length is 1.93 Å (Shibata et al., 2011).  
 
 
 
Figure 3.12 Magnesium is coordinated in octahedral geometry. Stereo-views of the molecules and 
residues in βPGMK145A involved in the octahedral coordination. On the bottom panel the overlay of 
βPGMK145A-G6P-MgF2(H2O)-TSA (in green) with βPGM-G6P-MgF3--TSA (in cyan) highlight the 
conformational change of Ser114 backbone for accommodating the octahedral specie.  
	  
 
The ability of the protein to accommodate this new species depends on the plasticity of 
the active site. This is clearly shown by the overlay between βPGM and βPGMK145A 
(Figure 3.12). The Ser114 backbone has flipped in order to coordinate the magnesium 
fluoride species to compensate for the loss of a fluoride due to the lack of Lys145. The 
Ser114 backbone is not only the 4th vertex of the octahedron, but is also coordinated to 
the water molecule coordinating the magnesium difluoride. Moreover, the interaction 
between the fluoride magnesium and the amine group of Ala115 has been substituted by 
two hydrogen bonds with further water molecules. These waters are absent in the 
βPGM-G6P-MgF3--TSA structure (Figure 3.13). 
Ser114&
Ala145&
G6P&
Asp8&
Ser114&
Ala145&
G6P&
Asp8&
Ser114&
Ala145&
G6P&
Asp8&
Ser114&
Ala145&
G6P&
Asp8&
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Figure 3.13 Stereo-view of the coordination of W-FB. The hydrogen bonds are represented in black 
dashed lines. On the top panel βPGMK145A-G6P-MgF2(H2O)-TSA is in green, in the bottom panel βPGM-
G6P-MgF3--TSA is in cyan. 
	  
 
In conclusion, the substitution of Lys145 with an alanine had three main consequences: 
a loss in charge of the magnesium fluoride, a rearrangement of the TSA species from 
TBP to octahedral geometry and protein conformational changes useful in the 
accommodation the new species.  
Due to the correlation between the NMR spectrum of the minor form and mutant 
complex, it was proposed that the structural features observed could give structural 
information on the minor form. It was hypothesised that the minor form was related to 
the ability of βPGM to coordinate a magnesium fluoride molecule in octahedral 
geometry instead of the usual TBP. 
First, the difference Fourier map of the βPGM-G6P-MgF3--TSA structure was inspected 
for features indicating alternative coordination. An overlay of the two magnesium 
fluoride molecules with the electron density map, highlights that the electron density 
corresponding to FB or the water molecule has an elongated form, in which both 
molecules could be accommodated (Figure 3.14). Since the high resolution of the 
Ser114&
Ala145&
G6P&
Asp8&
Ser114&
Ala145&
G6P&
Asp8&
Ser114&
Lys&145&
G6P&
Asp8&
Ser114&
Lys&145&
G6P&
Asp8&
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structure, this detail had been assumed to be an indication of the minor form presence in 
the solid state. However, further X-ray data were required. 
 
	  
Figure 3.14 Overlay of the two magnesium fluoride structures on βPGM-G6P-MgF3- -TSA Fourier 
map. The two magnesium fluoride molecules MgF3- from βPGM-G6P-MgF3--TSA and MgF2(H2O) from 
βPGMK145A-G6P-MgF2(H2O)-TSA are represented in sticks. The Fourier map from βPGM-G6P-MgF3--
TSA contoured at 3σ is shown as grey mesh.	  
	  
 
3.4.3 Structure solved from room temperature data collection reveals the structure 
features of the minor form conformer 
One of the main differences between the solid state and solution state is the amount of 
conformations a protein can assume. In solution, the mobility of protein regions is quite 
high, while in a crystal the protein is in an almost unique conformation due to crystal 
packing interactions. One of the factors affecting this phenomenon is the temperature. 
NMR experiments were run at 298K, while X-ray data collection was performed at 
100K. The absence of alternative conformations, such as the minor form, could be 
caused by this difference. 
Therefore it was decided to perform room temperature data collection, using the 
humidity control device HC1b on ID14-1, at the ESRF (Russi et al., 2011). This system 
provides the possibility to collect a full dataset at a temperature around 293K, a 
temperature more similar to the NMR conditions. Combining dehydration with helical 
data collection (Flot et al., 2010), a full dataset has been acquired.  
The structure was successfully solved at 1.47 Å using as model the βPGM -G6P-MgF3--
TSA structure. The rmsd of the Cα atoms was 0.18 Å, indicating that the RT data 
collection did not	  affect the protein macro-conformation. The electron density for the 
FB-­‐W	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FB#
FA%Fa#
FC%c#
Ser114#
Fb#
FB#
FA#
FC#
Ser114#
magnesium fluoride in TBP geometry was clearly evident. Surprisingly, in the 
difference Fourier map a positive peak of 3σ was present close to the Ser114 backbone 
and one more to the FB electron density. This was a clear indication that the room 
temperature data collection affected the active site conformation by allowing a low 
percentage of the protein population to assume a conformation similar to the mutant 
complex (Figure 3.15).  
 
 
Figure 3.15 View of βPGM-TSA structure collected at room temperature. Overlay of the room 
temperature structure on the Fourier (grey mesh, countered level 2σ) and difference Fourier map (green 
mesh, countered at 3σ). On the left panel, the room temperature structure is shown before modelling the 
minor form. On the right panel, the final model is shown.   
 
 
Thus, using the coordination of the octahedral magnesium fluoride molecule for the 
mutant and the Ala113-Ser114-Ala115 coordinates, an alternative conformer was 
modelled in the room temperature structure. As it was proposed that this alternative 
conformer was the minor form of the magnesium fluoride, instead of the water molecule 
a third fluoride atom was modelled in this position. The refinement statistics increased 
in quality, supporting the hypothesis that the peaks found were not noise, but a real 
signal coming from an alternative conformation (Table 3.5). 
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Table 3.5 Data collection and refinement statistics 
 
 
1Values	  for	  higher	  resolution	  shell	  are	  in	  brackets 
 
 
The alternative conformer or minor form was modelled at 20% occupancy, with a 
trifluoride magnesium molecule coordinated octahedrally. The final geometry 
characterisation of the octahedral magnesium fluoride and trigonal bipiramidal species 
	  
βPGM-­‐G6P-­‐MgF3
-­‐-­‐
TSA100K	  	  
(Baxter	  et	  al.,	  2010)	  
βPGMK145A-­‐G6P-­‐
MgF2(H2O)-­‐TSA	  
βPGM-­‐G6P-­‐MgF3
-­‐-­‐
TSART	  
Space	  group	   P212121	   P212121	   P212121	  
Wavelength	  (Å)	  
Temperature	  (K)	  
0.933	  	  
100	  
0.933	  	  
100	  
0.933	  	  
295	  
Unit	  cell	  dimension	  (Å)	  
a,b,c	  
37.6,	  54.6,	  105.2	   37.41,	  54.17,	  104.48	   38.0,	  54.6,	  105.5	  
Resolution	  range	  (Å)1	   20(1.37-­‐1.3)	   20	  (1.47-­‐1.4)	   24.3	  (1.55-­‐1.47)	  
Number	  of	  unique	  
reflections	  
45,520	   42,671	   36,783	  
Multiplicity	   2.5	  (1.8)	   6.4(6.4)	   2.3	  (2.2)	  
Completeness	  (%)	   84.8	  (47.2)	   99.9	  (100)	   95.1	  (94.3)	  
Rmerge	   0.06	  (0.24)	   0.075	  (0.631)	   0.052	  (0.198)	  
<I/σ(I)>	   8.5	  (2.7)	   19	  (3)	   12.1	  (4.9)	  
Wilson	  B	  factor	  (Å2)	   11.7	  	   7.76	  	   12.55	  	  
Water	  molecules	   202	   306	   159	  
Rfactor	  (%)	   17.3	   15.75	   11.34	  
Free	  Rfactor	  (%)	   19.2	   19.23	   14.78	  
RMS	  deviations:	   	   	   	  
Bonds	  (Å)	   0.011	   0.019	   0.01	  
Angles	  (°)	   1.501	   1.785	   1.39	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are listed in table 3.6. In the case of the octahedral molecule, the bond lengths are 
shorter than those in βPGMK145A. This was depending on the fact the magnesium 
fluoride molecule has been considered one entire molecule and it has been refined 
against dictionary containing specific restraints. Mg-Fa and Mg-Fb are shorter with 
regard to the βPGM-G6P-MgF3--TSA structure, while Fc has conserved the same 
position as FC. However, the differences can be dependent on the fact that at 100K we 
cannot distinguish clearly between the two forms.  
 
 
 
 
 
  
Figure 3.16-Table 3.6 Geometric details of the Major and Minor form. The minor and major form 
geometric features obtained from the RT structure, are shown. 
	  
Bond	  lengths	  	  
(Å)	  
	  
Angles	  	  
(°)	  
	  
	  
Bond	  lengths	  	  
(Å)	  
	  
Angles	  	  
(°)	  
Mg-­‐FA	   1.91	   FA-­‐Mg-­‐	  FB	   124.57	   	   Mg-­‐Fa	   1.87	   Fa-­‐Mg-­‐	  Fb	   167.67	  
Mg-­‐FB	   1.88	   FB-­‐Mg-­‐	  FC	   124.88	   	   Mg-­‐Fb	   1.84	   Fb-­‐Mg-­‐	  Fc	   92.40	  
Mg-­‐FC	   1.89	   FC-­‐Mg-­‐	  FA	   110.30	   	   Mg-­‐Fc	   1.89	   Fc-­‐Mg-­‐	  Fa	   99.51	  
Major&form&
FB& FA&
FC&
Ser114& Ser114
&
Fb&
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3.5 Conclusions 
The structures presented here define the structure of the minor form of MgF3- observed 
by 19F-NMR in solution. In the minor conformer, the magnesium is still coordinated by 
three fluoride ions, but the coordination changes from TBP to octahedral and the 
backbone of Ser114 contributes to this coordination. The major/minor conformation 
data provide us with two major insights into the βPGM active site. The first is the 
novelty of the possibility for an active site to coordinate magnesium trifluoride in 
octahedral geometry. This opens the intriguing question of whether phosphorus could 
be similarly coordinated. The second is the plasticity of the A113-A115 protein region. 
Further experiments are required in order to understand the extent of this plasticity and 
how it is related to environment conditions. For example, it could be investigated 
whether such protein dynamicity is involved on the reorientation of βG16BP, a 
mechanism still not understood. The backbone flipping could be stabilised in one 
conformation by further mutations. Mutation of Ser114 or closer residues (such as Ala 
115) to proline could decrease the backbone flexibility and lead to mutants, which bind 
preferentially βG16BP in one specific orientation. For future drug design projects, the 
results of these investigations will affect the design of a molecule. A practical example 
is discussed in the next chapter.  
In conclusion, through the successful combination of 19F-NMR and room temperature 
crystallographic experiments, new features of the βPGM active site have been 
determined. Moreover, this work is an excellent example of how two important 
structural biology techniques, in this case solution NMR and X-ray crystallography, are 
complementary to each other. The combined methods applied in this study could offer 
the possibility to study similar cases, in which alternative protein conformations are not 
visible at the usual 100K data collection (Lang et al., 2010).  
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Chapter 4 Discrete analysis of both steps of the βPGM reaction using 
phosphonate analogues of Glucose 1-β-Phosphate 
 
 
4.1 Introduction 
 
4.1.1 Challenges in trapping βPGM-βG1P-TSA complex 
Solid state attempts to trap a βPGM-βG1P-TSA complex failed when βG1P was used. 
This is due to the ability of βG1P to phosphorylate the protein, leading to the conversion 
of βG1P into G6P and resulting in the formation of a βPGM-G6P-TSA complex.  
Searching for a method to successfully trap the βG1P complex is relevant for two 
reasons. First, the structure of βPGM-βG1P-TSA will provide a more complete 
understanding of the mutase enzyme mechanism. βPGM in a closed conformation 
bound to βG1P was only observed as a component of the dual occupancy βPGM-G6P-
BeF3 complex, where the complex is in a near attack conformation (Griffin et al., 2012). 
However, this structure did not provide novel information into the catalysis in the 
phosphoryl transfer reaction on βG1P, as neither of the two βG1P conformers observed 
presents the 6-OH in line with the beryllium surrogate for the phosphorus centre of the 
Asp8 phosphate (Figure 4.1). 
Secondly, a βPGM-βG1P-TSA complex will provide structural and chemical 
information, which are required for successful drug design. 
To achieve both goals, it was decided to generate non-hydrolysable βG1P analogues by 
chemical synthesis. Since the design of these molecules called on the principle 
chemistry of α-fluorophosphonates, the following section will provide an overview of 
the use of phosphonates and α-fluorophosphonates, and the role of fluorine in medicinal 
chemistry.  
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Figure 4.1 Structure of G1P in the βPGM-G6P-BeF3- active site. Structural details of the two βG1P 
conformers are shown. A) βG1P bound with the 6-OH close to the BeF3- complex. B) βG1P bound with 
the 3-OH close to the BeF3- complex. The donor-acceptor distance shown in round dots is 5.1 Å in each 
figure. βG1P was not added when the protein sample was prepared for these crystallization trials. In fact, 
the βG1P molecule observed results from significant mutase activity that persisted in the βPGM-G6P-
BeF3 complex (Griffin et al., 2012). 
 
 
4.1.2 α-fluorophosphonates and fluorine in medicinal chemistry 
As in the case of βPGM, several enzymes catalyse the hydrolysis or the transfer of a 
phosphate group from a metabolite. Aside from prodrug applications, the production of 
non-hydrolysable metabolite, which has the same, or a higher, binding affinity as the 
natural substrate for the enzyme of interest, has became a key step in drug design and 
development. In the field of synthesis of phosphate ester analogues, the potential of 
phosphonates as phosphate mimics has been recognised for many years in drug 
development (Engel, 1977). Unlike a phosphate group, the phosphonate linkage is not 
readily hydrolysed in a biological environment, and this unique property has made these 
phosphate compounds attractive as phosphate analogues in numerous applications. 
Moreover, C-C-P and C-O-P bonds conserve a structural correspondence, which does 
not affect protein binding. However C-C-P and C-O-P, are significantly dissimilar in 
their chemical characteristics. Much more similar chemical characteristics have been 
achieved with the arrival of α-fluorophosphonate compounds, where the CH2 group is 
substituted by CHF and CF2 groups. CHF and CF2 groups can both sterically and 
electronically mimic an oxygen atom, because the second dissociation protonation 
constant pKa is much more similar to the natural phosphate. Indeed fluorine substitution 
on the phosphonate methylene group has been proved to lower the pKa of phosphonate 
(Blackburn, 1981). This is particularly true for CHF, in which the second protonation 
A	   B	  
βG1P	   βG1P	  
BeF3-­‐Asp8	   BeF3-­‐Asp8	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constant pKa is 6.5, while the one for the corresponding phosphate is 6.4 (Romanenko 
& Kukhar, 2006). Moreover, since fluorine is a small atom (Van der Waals radius of 
1.47 Å versus hydrogen atom Van der Waals radius of 1.2 Å, Bondi, 1964) the 
replacement of an oxidisable C-H group by a C-F group doesn’t usually affect the 
binding affinity to the target (Barnette, 1984; Clader, 2004; Penning et al., 1997; Van 
Heek et al., 1997). However, fluorine has high electronegativity (Pauling, 1960), which 
could change the chemical properties of the molecule.  
These fluorine features (size and electronegativity) are considered an advantage in 
medicinal chemistry. Fluorinated compounds are synthesised on a routine basis in 
pharmaceutical research (OHagan & Rzepa, 1997; Park et al., 2001; Smart, 2001), with 
the remarkable result that 20 to 30% of all drugs on the market have fluorine in them 
(Muller et al., 2007). 
Usually, a carbon-bound fluorine, such as in the α-fluorophosphonates, is selected for 
introduction into a designed small molecule. This modification will alter the potential 
potency of the drug by altering pharmaceutical properties such as bioavailability and 
chemical biochemical properties such as protein target binding affinity.  
 
 
4.1.2.1 How does a fluorine atom affect bioavailability? 
Bioavailability is the percentage of the dose reaching the circulatory system and is 
denoted F. A drug’s potency is directly proportional to its bioavailability, which 
depends on several factors such as metabolic stability and compound lipophilicity.  
Metabolic stability is one of the key factors in determining the bioavailability of a 
compound. The introduction of a fluorine atom can block the rapid oxidative 
metabolism by liver enzymes (in particular the P450 cytochromes) (Figure 4.2). This is 
due in part to the high electronegativity of the atom, which increases the molecule’s 
polarity.  
 
	   94 
 
Figure 4.2 Development of Ezetimibe by optimization of a lead compound. An example of 
replacement of an oxidisable C-H group by a C-F group is the discovery of the cholesterol-absorption 
inhibitor Ezetimibe. The original compound contained two methoxy groups, which usually undergo 
metabolic demethylation The introduction of a fluorine atom to replace one methoxy group and 
fluorination of the unsubstituted benzene ring prevented oxidation of the benzene rings to phenols. These 
changes increased the drug potency 400 fold, and enabled the use of lower doses due to improved 
metabolic stability in vivo (Clader, 2004; Van Heek et al., 1997).  
 
 
Bioavaliability of orally administrated drugs is also negatively affected by first-pass 
metabolism, poor absorption and inefficiency resulting from passage through the cell 
membrane (Purser et al., 2008). Higher F values can be achieved by modifying the pKa 
of the molecule of interest. As an electronegative atom, fluorine can change the 
physiochemical properties of a compound and a pKa shift of several log units can be 
observed (Bohm et al., 2004) (Table 4.1). This can affect both absorption, such as the 
stomach level (Figure 4.3), and lipophilicity (Bœhm & Schneider, 2003).  
 
 
Table 4.1 Effect of fluorine substitution on pKa and pKb values 
 
Carboxylic	  acid	   pKa	   Alcohol	   pKa	   Amine	   pKb	  
CH3CO2H	   4.76	   CH3CH2OH	   15.9	   CH3CH2NH2	   10.6	  
CH2FCO2H	   2.59	   CF3CH2OH	   12.4	   CF3CH2NH2	   5.7	  
CHF2CO2H	   1.34	   (CH3)3COH	   19.2	   C6H5NH2	   4.6	  
CF3CO2H	   0.52	   (CF3)3COH	   5.1	   C6F5NH2	   –0.36	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Figure 4.3 Structure of Flurithromicyn. The introduction of a fluorine atom in the original drug 
Erythromycin, increased the stability of the compound under acid conditions. The resulting new drug, 
which is called Flurithromycin, has higher biological half-life than the original molecule, particularly in 
the stomach. For this reason it still has macrolide antibiotic activity like Erythromycin, but it can also be 
used against Helicobacter pylori infection and in the treatment of gastritis (Fera et al., 2001; Mabe et al., 
2004). 
 
4.1.2.2 How does introduction of a fluorine atom affect protein binding affinity? 
The introduction of a fluorine atom can have significant and positive effects on the 
binding affinity in protein–ligand complexes. This effect can be directed by increased 
polarity of the bridging group, increased hydrolytic stability and the possibility of 
formation of new bonds. These can include H-bonds or dipolar contacts, non-polar and 
hydrophobic interactions between the fluorine atom and protein atoms (Bissantz et al., 
2010; Bohm et al., 2004; Muller et al., 2007; Paulini et al., 2005; Zhou et al., 2009) 
(Figures 4.4-4.5).  
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2.85Å''
2.85Å''
Met109'
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Figure 4.4 Structure of UDP-galactose-4’-epimerase from Trypanosoma brucei in complex with the 
substrate analogue UDP-4’-deoxy-4’-fluoro-α-D-galactose (UFG). Probable H-bonds between the 
ligand and with Tyr173 and Ser142 side chains are indicated as black dashed lines. The ligand and 
residues Ser142 and Tyr173 of the protein are drawn in sticks (PDB code 2CNB; Alphey et al., 2006). 
 
 
 
Figure 4.5 Binding of a fluorinated inhibitor to p38 kinase. Polar interactions have been observed in 
many fluorinated inhibitors of p38 kinase (Boehm et al., 1996). One example is shown in this figure 
(PDB code 1AU9). The introduction of a fluorine atom forms two more polar interactions with the 
protein, increasing the binding affinity. Atoms involved and interactions are represented in orange balls. 
H-bonds are in black dashed lines. (Wang et al., 1998). 
 
 
It has been demonstrated that the kind of bond formed usually correlates with the 
electron density surrounding the fluorine atom. In this sense, Dalvit and Vulpetti (Dalvit 
& Vulpetti, 2011) proposed the “rule of shielding”, which is an empirical correlation 
between the fluorine isotropic chemical shift, measured by 19F-NMR spectroscopy, and 
the type of fluorine–protein interactions observed in crystal structures in the Protein 
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Data Bank (PDB; Berman et al., 2000).  
Chemical shifts are a measure of the fluorine atom environment, which define how 
much the atom is shielded. In 19F-NMR spectra, fluorine atoms rich in electron density 
are upfield, while the de-shielded atoms are downfield. Thus the shielding nature of the 
fluorine atom increases from the left to right along the chemical shift scale. The 
isotropic chemical shifts of compounds with groups CF3, CF2 and CF were correlated 
with fluorine–protein interactions observed in crystal structures in the PDB. The results 
show that shielded fluorine atoms are observed primarily in close contact to hydrogen 
bond donors within the protein structure, suggesting the possibility of intermolecular 
hydrogen bond formation with the side chain nitrogen of histidine (78 % NE2 and 22 % 
ND1), tryptophan (NE1), glutamine (NE2), asparagine (ND2), lysine (NZ), arginine 
(NE, NH1, NH2), the oxygen atom of serine (OG), threonine (OG1), and tyrosine (OH). 
De-shielded fluorine atoms are predominantly found in close contact with hydrophobic 
side chains and with the carbon of carbonyl groups of the protein backbone.  
Importantly, not all of the fluorine atoms in close contact with hydrogen bond donor 
nitrogen or oxygen atoms form hydrogen bonds. Investigations of the X-ray crystal 
structures of small molecules and fluorinated natural products listed in the Cambridge 
Structural Database (CSD; Allen, 2002) and available in the PDB reveal a general 
description of the F···H-X (where X=N, O) bond (Dalvit & Vulpetti, 2012; Vulpetti & 
Dalvit, 2012). As shown in figure 4.6, three measurements are considered: F···H 
distance (d), F···H-X angle (α1) and C-F···H angle (α2). The angle α1 shows a linear 
correlation with distance d. For short contacts (d < 2.13 Å), the angle α1 is restricted to 
values between 140° and 180°, whereas with larger distances the allowed range of 
angles becomes increasingly wide (110°–180°). The difference in range is due to the 
repulsive electrostatic interaction between fluorine and oxygen, which has to be 
accommodated.  Angle α2 does not correlate with the distance d, and its range is 
between 100° and 170°. 
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Figure 4.6 Schematic representation of C-F···H-X bond. d, α1 and α2 are represented in a C-F···H-X 
(where X=N, O) bond. 
 
 
Short contacts C-F···H-X (where X = O, N), are also called dipolar interactions (Zhou et 
al., 2009). The fluorine atom has three electron lone pairs that are held tightly by the 
nucleus, resulting in only weak hydrogen bond-accepting capability. Therefore, C-F···H-
X looks much more like a dipolar interaction rather than a H-bond. Even if this 
observation appears to be a semantic discussion, it is important to remember that 
hydrogen bonding has a covalent component, whereas dipolar interactions by definition 
are purely electrostatic. The covalent component is anisotropic and provides distinct 
local geometric control whereas electrostatics do not. 
In conclusion, the rule of shielding is a general guideline that will aid in the rational 
drug design process, providing guidance in the selection of fluorinated moieties for 
judicious incorporation into molecules in order to create favourable interactions with the 
protein target.  
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4.2 Aim of this project 
The knowledge of the chemistry of fluorinated phosphonates has lead to the synthesis of 
α-fluorinated phosphonocarbohydrates as a new class of phosphate mimics of natural 
metabolites that retain high affinity for targeted enzymatic phosphate binding pockets 
but are themselves resistant to phosphatase-mediated cleavage. In the last decade, 
several α-fluorinated phosphonate analogue compounds were synthesised: G6P, D-
galactofuranosylphosphonate, difluoromethylphosphonate azasugars and fluorinated 
phosphonodithioacetate. All these compounds are potential inhibitors against specific 
proteins: D-galactofuranosylphosphonate could inhibit enzymes involved in D-Gal 
metabolism, difluoromethylphosphonate azasugars and fluorinated-
phosphonodithioacetate are potential inhibitors for glycosyl transferase; finally the 
possibility to synthesise phosphatase resistance analogues as potential inhibitors of 
phosphatidylinositol 3-phosphate (PtdIns(3)P) has been also exploited (Alphey et al., 
2006; Behr, 1997; Berkowitz et al., 2000; Kovensky et al., 1999; Xu et al., 2006). 
The aim of this work is to apply this knowledge to the design of phosphonates and 
fluoro-phosphonate analogues of βG1P. Two phosphonates and four fluorine 
phosphonate analogues were produced. The evaluation of the best of these six 
candidates was performed through a combination of biochemical binding assay,         
19F-NMR and X-ray crystallographic structural studies. Since this work has been done 
in collaboration with Professor Dr. Jakeman (Dalhousie University, Nova Scotia, 
Canada), Prof. G.M. Blackburn and Dr. Jin Yi (University of Sheffield, UK), the non-
crystallographic data is attributed to them.  
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4.3 Experimental procedures 
 
4.3.1 Design and synthesis of the phosphonate analogues and 19F-NMR 
experiments  
βG1P analogues were designed by Prof. G.M. Blackburn (Sheffield University, UK) 
and synthesised by Dr. Debabrata Bhattasali and Professor D. Jakeman (Dalhousie 
University, Nova Scotia, Canada). The six phosphonates obtained were evaluated by 
fluorescence binding (section 4.3.2) and 19F-NMR studies for the formation of metal 
fluoride TSAs with aluminium and magnesium fluoride. NMR experimental details are 
described in Dr Jin Yi’s thesis (Jin, 2012).  
 
 
4.3.2 Fluorescent titration binding assay 
The binding assay experiments were performed by Dr. Y Jin (Sheffield University, 
UK). Dissociation constants (Kd) for the compounds prioritised by 19F-NMR 
experiments were measured using a fluorescence based binding assay. This technique is 
based on the concept that the intrinsic fluorescent spectra of a protein changes when it 
binds a ligand. Fluorescence spectra were measured using a Varian Cary Eclipse 
Fluorescence Spectrophotometer. The excitation wavelength was 285 nm, which in turn 
gave an emission spectrum with a maximum at 450 nm. 
A cuvette containing 0.5 mL of 20 µmol βPGM solution in a buffer of 50 mM HEPES 
pH 7.2, 5 mM MgCl2, 1 mM EDTA, 10 mM NH4F was prepared and a fluorescence 
spectrum was run, giving a value for the apo-protein fluorescence. Trial compounds in 
stock solution were prepared at high concentration in the same protein buffer. For 
ligand titration, the compound solution was added to the protein, mixed by pipetting for 
30 sec and a fluorescence spectrum determined. This gave a value for the fluorescence 
maximum at 336 nm, corresponding to the state where compound is fully bound to the 
protein in a TSA complex under the experimental conditions. This was repeated for a 
total of 25 aliquot additions. Data analysis was performed with Origin8 software 
(www.OriginLab.com). 
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4.3.3 Crystallisation of, βPGM-YO5-MgF3--TSA, βPGM-GRX-MgF3--TSA and 
βPGM-GRX-AlF4--TSA  
Crystallisation of methylenephosphonate analogue (CH2βG1P, also described as YO5) 
bound to βPGM-MgF3-, and of the monofluoromethylenephosphonate analogue ((S)-
βCHFG1P, also described as GRX) bound to βPGM as MgF3- or AlF4- TSAs, was 
carried out in a similar manner to that previously described (Baxter et al., 2010). βPGM 
was expressed and purified as detailed previously, in the laboratory of Prof Jon Waltho 
in Sheffield university (Baxter et al., 2006; Griffin, 2011). Buffer was freshly 
exchanged to 50 mM HEPES pH 7.2, 5 mM MgCl2 and 0.1 mM DTT prior to 
crystallisation experiments. For each complex, 10 mM NH4F and 5 mM βG1P analogue 
were added at a protein concentration of 15 mg/mL. For the βPGM-GRX-AlF4--TSA, a 
further 2 mM AlCl3 was added to form the aluminium complex. For crystallisation, 2 µL 
of the complex solution defined above was mixed 1:1 with the precipitant (27-32% PEG 
4000, 50-75 mM magnesium acetate) and placed in sitting drop crystallisation plates. 
Large plate crystals appeared between 1-4 days. They were mounted directly from the 
mother liquor using a mesh loop and cryo-cooled as described in Pellegrini et al., 2011.  
 
 
4.3.4 Data collection, structure solution and refinement 
Diffraction data were collected from cryo-cooled crystals between 1.5 Å and 1.1 Å 
resolution on a PILATUS 6M detector on beamline ID29 or on a ADSC Q210 CCD 
detector on beamline ID14-2 at the ESRF, Grenoble, France. Data were processed with 
XDS (Kabsch, 2010). The βPGM-G6P-MgF3--TSA complex structure was used as a 
search model with Molrep (PDB code 2WF5; Baxter et al., 2010) with all ligands and 
water molecules removed. Due to the high resolution, in the refinement protocol          
B-factors values were refined as anisotropic. Solvent molecules were built with the 
ARP/Waters function of ARP/wARP (Lamzin & Wilson, 1993). A refinement 
dictionary for each molecule was generated using ProDRG (Schuttelkopf & van Aalten, 
2004). Refinement and validation were performed as described in Chapter 2. 
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4.4 Results and Discussion 
 
4.4.1 Design and synthesis of βG1P phosphonate analogues 
Three βG1P analogues, one phosphonate and two fluorinated phosphonates were 
designed and synthesised. The major modification was the replacement of the C(1)-O 
by a CH2 or CHF group. The CH2 phosphonate was synthesised in order to analyse the 
effects of the C-F group (a1 in Figure 4.7, CH2βG1P). The fluorinated phosphonate 
compounds were separately prepared in both configurations R and S: (R)-βCHFG1P b1 
and (S)-βCHFG1P c1 respectively (Figure 4.7). Analysis of both isomers of the CHFP 
function has been found to be important. In studies on fluorinated phosphonate 
analogues of G6P by Berkowitz and co-workers, titration binding experiments showed 
that the R stereoisomer was a better-binding analogue than the S isomer. However, this 
difference did not correlate with the results of steady-state enzyme kinetic analysis, 
where the two CHF isomers showed a similar kcat/Km values. These data clearly 
indicate that it is a challenge to identify the best substrate analogue a priori, without 
considering the protein environment (Berkowitz et al., 2000). 
 
 
 
Figure 4.7 Chemical structures of βG1P phosphonate analogues.  
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In addition, the three compounds, a2, b2, and c2 (Figure 4.7) were also produced.  
These compounds have an α-hydroxyl group on C(1) as they were intermediates in the 
synthetic pathway prior to reduction to the 1-deoxy counterparts a1, b1, and c1. Being 
readily available, they were employed to extend testing of the substrate steric 
discrimination of βPGM. 
After synthesis, a combination of several techniques was used to judge the compound 
that best formed a transition state analogue complex. Without an activity test in vivo, the 
most powerful compound was defined as the one able to bind to the protein with the 
highest affinity. First the ability of each compound to form a βPGM-βG1P-TSA in 
presence of AlF4- or MgF3-, and thus inhibit the enzyme, was tested. Following 
successful TSA complex identification by 19F-NMR, analogues giving the best results 
were used in crystallisation trials. Two crystal structures were used to analyse the 
transition state of phosphorylation of βG1P and to rationalise the relative differences in 
binding affinity, determined by the fluorescence assay for TSA complex formation.  
 
 
4.4.2 19F-NMR, binding studies and X-ray crystallography identified two viable 
candidates 
 
4.4.2.1 19F-NMR experiments and binding studies 
All six compounds were tested by 19F-NMR for their potential to form a 
trifluoromagnesate or tetrafluoroaluminate TSA complex with βPGM (Figure 4.8). The 
β-1-phosphonomethylene-D-glucopyranose (a2) and (R)-1-β-
phosphonofluoromethylene-D-glucopyranose (b2) compounds showed no sign of TSA 
complex formation. (S)-1-β-Phosphonofluoromethylene-D-glucopyranose (c2) forms a 
very weak complex with aluminium fluoride but not with magnesium fluoride. The 
fluoromethylenephosphonate compound (R)-βCHFG1P (b1) did not form a complex 
with either magnesium or aluminium fluoride. On the other hand, βCH2G1P (a1 or 
YO5) and (S)-βCHFG1P (c1 or GRX) formed very stable TSA complexes with both 
magnesium and aluminium fluorides (Jin, 2012). This contrasts with the Berkowitz 
results where both diastereoisomeric fluorophosphonates bind, albeit to different 
degrees. 
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Figure 4.8 19F-NMR spectra of (a) βPGM-βCH2G1P-MgF3--TSA complex and (b) βPGM-(S)-
βCHFG1P- MgF3--TSA complex. The spectra were recorded at the same concentrations of fluoride, 
magnesium, and βG1P analogue, showing (S)-βCHFG1P binding stronger than βCH2G1P. Both samples 
contain 1 mM βPGM, 5 mM MgCl2, 10 mM NH4F, 5 mM (S)-βCHFG1P or CH2G1P at pH 7.3. The free 
and bound (S)-βCHFG1P in (b) show peaks at -214.0 and -217.0 ppm, labelled in blue (Jin, 2012). 
	  
	  
The strength of interaction between the protein and βCH2G1P or (S)-βCHFG1P was 
calculated through a fluorescence based binding assay, performed by Dr. Y Jin.  Results 
are shown in figure 4.9. (S)-βCHFG1P binds twice as strongly as the corresponding 
non-fluorinated compound, showing that the S-fluorine atom has created favourable 
features to TSA binding.  
 
 
Figure 4.9 Fluorescence titration curve from a plot of binding fraction versus [ligand]. 
-­‐214	  
-­‐217	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4.4.2.2 X-ray crystallography  
Taken together, the NMR and binding studies clearly prioritised using compounds 
βCH2G1P and (S)-βCHFG1P for crystallisation trials, with very good results. The 
following three TSA complexes were crystallised successfully: βPGM-YO5-MgF3--
TSA, βPGM-GRX-MgF3--TSA, and βPGM-GRX-AlF4--TSA, where YO5 is βCH2G1P 
and GRX is (S)-βCHFG1P. All complexes crystallised in the orthorhombic space group 
P212121 with one molecule in the asymmetric unit. The structure of βPGM-MgF3-YO5 
was solved at the highest resolution achieved for this protein (1.1 Å). It provided for the 
first time the features of the fully resolved βPGM-YO5-MgF3--TSA complex. The 
structures for the second and third complex were solved at 1.5 Å resolution. Because of 
the high resolution, the difference Fourier maps show the geometry of the ligands very 
clearly. In particular, the electron density for the sugar analogues is well defined, by 
contrast to that observed for G6P (PDB code 2WF5; Baxter et al., 2010), implying 
tighter binding in the active site. The statistics are summarised in table 4.2.  
In the following discussion, the terminology βCH2G1P and (S)-βCHFG1P will be used 
instead of YO5 and GRX.  
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Table 4.2 Data collection and refinement statistics 
 
Structures	   βPGM-­‐YO5-­‐MgF3
-­‐-­‐TSA	  -­‐	   βPGM-­‐GRX-­‐MgF3
-­‐-­‐TSA	  -­‐	   βPGM-­‐GRX-­‐AlF4
-­‐-­‐TSA	  
Space	  group	   P212121	   P212121	   P212121	  
Wavelength	  (Å)	   0.976	   0.933	  	   0.933	  	  
Unit	  cell	  dimension	  (Å)	  	  
a,b,c	  
38.01,	  54.20,	  105.41	   37.54,	  54.34,	  104.35	   37.19,	  54.28,	  104.5	  
Resolution	  range	  (Å)1	   20	  (1.16-­‐1.1)	   20	  (1.58-­‐1.5)	   20	  (1.58-­‐1.5)	  
Number	  of	  	  
unique	  reflections	  
82900	   33872	   34022	  
Multiplicity	   4.7	  (4.7)	   3.4	  (2.9)	   4.2	  (3.4)	  
Completeness	  (%)	   93.1	  (85.7)	   97.1	  (88.1)	   98.1	  (92.1)	  
Rmerge	   0.052	  (0.352)	   0.042	  (0.338)	   0.085	  (0.595)	  
<I/σ	  (I)>	   12.7	  (4.9)	   19.8	  	  (3.2)	   12.5	  (2.1)	  
Wilson	  B	  factor	  (Å2)	   5.37	   11.56	   11.11	  
Water	  molecules	   566	   296	   456	  
Rfactor	  (%)	   14.92	   17.25	   15.91	  
Free	  Rfactor	  (%)	   17.26	   19.84	   19.94	  
RMS	  deviations:	  
	   	   	  
Bonds	  (Å)	   0.01	   0.03	   0.015	  
Angles	  (°)	   1.36	   1.42	   1.39	  	  
1Values	  for	  the	  higher	  resolution	  shell	  are	  in	  brackets 
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4.4.2.2.1 Structure characterisation of βPGM-βCH2G1P-MgF3--TSA  
Using βCH2G1P in combination with aluminium or magnesium fluoride, a snapshot of 
the βG1P phosphorylation reaction was obtained with high precision for the first time. 
Experimentally, crystallisation trials were successful only for the magnesium fluoride 
sample. In the βPGM-βCH2G1P-MgF3--TSA structure the nucleophilic OH (6-OH) is 
perfectly in line with the magnesium fluoride atom and the side-chain Oδ from Asp8. 
The pentacoordinate magnesium fluoride is in the typical TBP geometry. Due to the 
high resolution of the data, the magnesium fluoride was refined without any restraints 
allowing the bond lengths to be determined with high precision. The resulting equatorial 
Mg-F bonds are 1.83 ±	  0.02 Å, in accord with those previously described (Baxter et al., 
2010) (Figure 4.10). 
 
 
 
Figure 4.10 Active site of the βPGM-βCH2G1P-MgF3--TSA complex. Difference Fourier electron 
density for βCH2G1P and MgF3- is shown as green mesh contoured at 3σ. Hydrogen bonds are shown as 
black dashed lines. Interactions in red dashed lines of TSA are shown. The two aspartates involved in 
covalent and general base catalysis are shown as sticks. 
 
 
The magnesium of the metal fluoride complex is almost equidistant from the two 
oxygen atoms (6OH-Mg = 2.11 Å; Mg-OAsp8 = 2.07Å), which suggest a tight 
transition state. As in the case of βPGM-G6P-MgF3--TSA structure, one of the Oδ 
atoms of Asp10 forms a hydrogen bond to the nucleophilic 6-OH group and it is so 
positioned for general base catalysis of the nucleophile by accepting its proton. Due to 
the high resolution, all the Asp10 hydrogen atoms were easily modelled by the 
phenix.refine program (Afonine et al., 2012). The hydrogen of the amide Asp10 
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backbone (Asp10HN) is pointing to one of the equatorial fluorine atoms, which 
contributes to TSA stabilisation (Figure 4.11). 
 
 
Figure 4.11 Asp10 in the βPGM- βCH2G1P-MgF3--TSA complex. Difference Fourier electron density 
map and electron density map for the βPGM active site are represented in green mesh (contoured at 3σ) 
and grey mesh (contoured at 3σ) respectively. Hydrogen bonds are in black dashed lines. Interactions in 
red dashed lines of TSA are shown. The bonding between Asp10 and MgF3- is shown in light blue. The 
two aspartates involved in catalysis are shown as sticks.  
 
 
4.4.2.2.2 Specificity for the recognition of βCH2G1P and G6P  
As in the βPGM-G6P-MgF3--TSA structure, residues from both the cap and the core 
domain contribute to the active site.  
 
 
Figure 4.12 G6P and βCH2G1P in βPGM active site. G6P (in grey) and βCH2G1P (in magenta) are 
shown in the active site of βPGM of structure βPGM- βCH2G1P-MgF3--TSA. Arg49 coordinates the 
phosphorus group of the sugar, while Asp10 and Asp8 interact with the 6-(OH) of βCH2G1P or the 1-
(OH) of G6P. 
Asp10&
Asp8&
βCH2G1P&
Asp10&
Asp8&
βCH2G1P&
G6P&Arg49&
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Despite the fact the two structures do not show any large differences in conformation 
(rmsd between Cα atoms of 0.3 Å), the sugar ring is coordinated differently (Figure 
4.12).  
 
 
Figure 4.13 Schematic view  of the βPGM- βCH2G1P -MgF3--TSA  and βPGM-G6P-MgF3--TSA 
active site. The overlay of hydrogen bonds are shown as grey dashed lines. “W” are water molecules. 
Oxygen atoms belong to the carboxylic backbone group and backbone amide are shown between two V 
shape lines. Groups belong to side chains are shown with a straight line.  
 
In the case of βCH2G1P, residues Trp24, Ser52 and Leu44 and Lys76 coordinate 
directly to the sugar ring. In contrast in G6P coordination Trp24 does not participate 
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while Val47 becomes involved. Moreover, the other residues (Leu44, Ser52, and Lys76) 
coordinate indirectly G6P, using water molecules as intermediates (Figures 4.12-4.13).  
Surprisingly, the structural conformation of βPGM region 136-144 is also different in 
the two TSA complexes. In βPGM-G6P-MgF3--TSA, Ser144 assumes two alternative 
conformations. In the structure with βCH2G1P, the Ser144 side chain shows a third 
conformation that allows the residue to interact with the Ser48 backbone. Ser48 is part 
of a clamp loop that terminates with Arg49, a key residue in the coordination of the 
“static” sugar phosphate (Figure 4.14). 
Overall, the βCH2G1P TSA complex is more tightly bound than the corresponding    
G6P-TSA complex, because of the absence of water molecules coordinating the sugar 
hydroxyl groups and better stabilisation of the phosphate clamp region that traps the 
sugar inside the active site. 
 
 
Figure 4.14 Structural details of the interaction between the region of residues 136-144 and the 
clamp loop. A black arrow indicates the protein region 136-144 and the clamp loop position in the 
overlay of βPGM-βCH2G1P-MgF3--TSA (in magenta) onto βPGM-G6P-MgF3--TSA (in grey). The panel 
arrow represents the locus of maximum spatial difference between the two structures. Residues involved 
in the phosphate clamp stabilisation are represented as sticks. Hydrogen bonds are in black dashed lines. 	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4.4.2.2.3 Structural characterisation of βPGM-(S)-βCHFG1P-TSA structures  
The βPGM-(S)-βCHFG1P-TSA complex was crystallised successfully with both AlF4- 
and MgF3-. The two structures are very similar (0.165 rmsd of Cα). Further comparisons 
in rmsd on Cα atoms are reported in table 4.3. As in the case of the βPGM- βCH2G1P -
MgF3--TSA complex no large conformational differences were observed (Figure 4.15).  
 
 
Table 4.3 Rmsd of Cα displacement among (S)-βCHFG1P, βCH2G1P and G6P structures 
 
	   βPGM-­‐	  βCH2G1P	  -­‐MgF3
-­‐-­‐TSA	   βPGM-­‐G6P-­‐MgF3
-­‐-­‐TSA	  
βPGM-­‐(S)-­‐βCHFG1P	  -­‐MgF3
-­‐-­‐TSA	   0.274	   0.216	  
βPGM-­‐(S)-­‐	  βCHFG1P	  -­‐AlF4
-­‐-­‐TSA	   0.292	   0.224	  
 
 
 
Figure 4.15 Active sites of the βPGM-(S)-βCHFG1P-MgF3--TSA active site and βPGM-(S)-
βCHFG1P -AlF4--TSA complex. Difference Fourier density map for (S)-βCHFG1P and MgF3- is shown 
as green mesh, contoured at 4σ.  
 
	  
	  Comparing βPGM-(S)-βCHFG1P-MgF3--TSA with βPGM-βCH2G1P-MgF3--TSA, 
differences can be seen in sugar coordination and in the structure of the clamp loop and 
βPGM region 136-144. The introduction of fluorine appears to result in a possible 
additional interaction between the fluorine and the side chain amide of Arg49 at a 
distance of 2.96 Å. This amide group is coordinated by a water molecule (W2) in 
βPGM-βCH2G1P-MgF3--TSA, which is absent when the fluorophosphonate is bound 
(Figure 4.16). 
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Figure 4.16 Schematic view of the βPGM- (S)-βCHFG1P -MgF3-. The figure legend is the same as  
figure 4.13. The distance between the fluorine and the Arg49 amine is shown as blue dashed line. 
 
 
In addition, a new pattern of water molecules is observed in the region, located close to 
Arg49, the α-fluorine, and the sugar phosphate. Loop 136-144 is in a similar 
conformation to that in the βPGM-G6P-MgF3--TSA, apart from the fact that the 
interaction with the clamp region is maintained as in βPGM-βCH2G1P-MgF3--TSA. 
This is due to water molecules coordinated by Ser49, Asp51 and Ser144 (Figure 4.17). 
Thus, it appears that a third conformation of this loop exists in addition to the ones 
described for βPGM-G6P-MgF3--TSA and βPGM-βCH2G1P-MgF3--TSA. It is unclear 
whether this interaction is caused by the fluorophosphonate.  
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Figure 4.17 Structural details of the βPGM-βCH2G1P-MgF3--TSA active site and βPGM region 
136-144. Hydrogen bonds are in black dashed lines, water molecules are red spheres. Distances of C-
fluorine to Arg49 and C-fluorine to a water molecule are shown in light blue dashed lines. The right panel 
is a magnification of the fluorine and Arg49 coordination. 
 
 
4.4.3 (S)-βCHFG1P is the best ligand for TSA formation 
From 19F-NMR, the binding affinity assay, and the structures solved, βCH2G1P and (S)-
βCHFG1P appear to be the best candidates for forming TSA complexes with the 
mutase. Moreover, the affinity assay showed a higher Kd for the (S)-fluoro-phosphonate, 
which appears to make a novel interaction with Arg49 in the structure.  
Thus, these data provide answers to three specific questions: 
• Why do phosphonates with 1-α-hydroxyl on D-glucopyranose not bind? 
• Why does (S)-βCHFG1P bind stronger than βCH2G1P to βPGM? 
• Why is there specificity for the (S)-stereochemistry of the α-fluorine? 
 
 
4.4.3.1 Why do phosphonates with a 1-α-hydroxyl phosphonate not bind? 
19F-NMR has shown that 1-α-hydroxyl analogues 1b, 2b and 3c (Figure 4.7) do not 
form a TSA complex. The crystal structures show clearly that the 1-α-hydroxyl on D-
glucopyranose is a negative factor for complex formation, as the distance between C(1) 
on (S)-βCHFG1P and the imidazole ring of His20 is too short to allow an α-hydroxyl 
substituent on C(1) (Figure 4.18).  
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Figure 4.18 Surface representation of His20 and βCHFG1P in βPGM-(S)-βCHFG1P-MgF3--TSA 
structure. The distance between the His20 ring and the sugar ring is 3.7 Å. The insertion of an α-C1-
hydroxyl group would clearly disrupt the hydrophobic interaction between the imidazole and the pyranose 
ring and it will prevent binding. 	  
 
 
4.4.3.2 Why does (S)-βCHFG1P bind more strongly than βCH2G1P to βPGM? 
In section 4.2.3.3 it was shown that the α-fluorine is in close proximity to the amide 
backbone of Arg49. The shielding rules described in section 4.1.2.2 can now be applied 
to determine whether a favourable interaction exists. 
NMR experiments have determined that the 19F chemical shift for the fluoro-sugar 
analogue is in the range of -214/-217 ppm, which suggests a shielded fluorine atom. 
Following the rule of shielding, if the atom is close to a H-bond donor, a H-bond or a 
dipolar interaction should be observed.  
The program phenix.reduce was used to calculate the probable position of protons 
(Afonine et al., 2012) (Figure 4.19). Fluorine is at short distance from the two protons 
of Arg49: HN of the amide backbone (2.63 Å), and HCβ of Arg49 (2.68 Å). The first 
group is a H-bond donor, while the second one could make a polar interaction. Since the 
chemical shift is strongly negative, that rules out the possibility of a polar interaction.  
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Figure 4.19 Protons in βPGM-(S)-βCHFG1P-MgF3--TSA structure. The electron density map 
contoured at 2σ is shown for (S)-βCHFG1P and Arg49. Distances between fluorine and protons of amide 
backbone and Cβ of Arg49 are shown in light blue and yellow respectively.  
 
 
For defining if a dipolar interaction or a H-bond is present, the shielding rules consider 
three measurements: F···H distance (d), F···H-X angles (α1) and C-F···H angle (α2). 
F···H is 2.63 Å, while α1 and α2 are respectively 104.36° and 172.3° (Figure 4.20). The 
long d should correlate with a α1 in the range 110°–180°, therefore the measured α1 is 
outside this range and should not support H-bond assignment. Similarly, angle α2 is near 
the limit. However, because the two angles are close to the limits, the presence of a H-
bond cannot be excluded. Unfortunately, even at this resolution, an X-ray structure 
cannot define the real position of protons. Thus, in conclusion, (S)-βCHFG1P binds 
tighter than CH2G1P in the TSA complex because of a probable interaction between the 
fluorine and the backbone amide proton of Arg49. Since the fluorine atom is a poor      
H-bond acceptor, the bond is considered a dipolar interaction.  
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Figure 4.20 The C-F···H-N bond in βPGM-(S)-βCHFG1P-MgF3--TSA structure. The electron density 
map countered at 2σ is shown in grey for (S)-βCHFG1P and Arg49.  
 
 
4.4.3.3 Why is there specificity for the fluorine (S)-stereochemistry? 
19F-NMR data has shown that the stereoisomer (R)-βCHFG1P does not bind in a 
trifluoromagnesate complex and binds only weakly in a tetrafluoroaluminate complex. 
At first sight, there is no evident steric hindrance to explain this result. The reason has 
to be found in the possible protein interaction. Thus, using Pymol tools, the fluorine in 
R configuration was modelled and possible residues involved in adverse interactions 
defined. The model revealed that fluorine in the R configuration will be close to 
potential hydrogen bond donors, such as the amide groups of Ser116 or Lys117. 
Importantly, the R configuration will be too close to the pyranose oxygen, which 
implies that an unfavourable dipole-dipole interaction will be formed. Such interactions 
can drive rotation of both C1 and phosphate group, which will change the small 
molecule structure to a non-binding mode. Furthermore the R conformer is close to 
Ser114, whose backbone has the ability to flip inside out (see Chapter 3) making that 
region unstable and a poor candidate for binding (Figure 4.21).  
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Figure 4.21 VdW clash in (R)-βCHFG1P. Distances between the fluorine and possible H-bond donors 
are shown in light blue dashed lines. Surface representation of fluorine and pyranose oxygen atom show 
where VdW spheres overlap. Clearly the (R)-fluorine eclipses the pyranose oxygen in the bound 
conformation of the βG1P. The VdW clash between F and O5 is at a distance of 2.44 Å shown as grey 
dashed line, while the sum should be 2.67 Å. 
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4.5 Conclusions 
Several goals have been achieved in this study. First, two analogues of βG1P able to 
form TSA complexes with β-phosphoglucose mutase have been identified by analysis of 
transition state complex formation. Combinations of complementary techniques were 
essential for achieving this goal. 
 Second, high resolution analysis of these TSA complex structures for phosphorylation 
of βG1P has enabled the first direct comparison of the features of catalysis of both steps 
of a mutase reaction that bind a common hexose moiety in two different orientations. 
The overlay of structures reveals that the sugars are coordinated differently and also that 
βPGM region 136-144 is a flexible protein region, possibly involved in sugar 
binding/recognition, and which adopts different conformations based on which sugar 
mono-phosphate is bound. It appears that βPGM has developed to recognise both 
sugars: interacting more specifically with βG1P and adapting the same binding site for 
G6P. As expected, the more specific binding concerns the sugar that defines the α/β 
anomer specificity.  
Third, the advantage of fluorination of a phosphonate analogue has been demonstrated 
to improve the physical properties relative to βG1P, and the dependence of strong 
binding identified with specific stereochemistry at the chiral C-CHF-P centre: the order 
being (S)-CHFP > CH2P >> (R)-CFHP for the trifluoromagnesate transition state 
analogue complex. The higher affinity of the (S)-configuration CHF- over the CH2-
analogue may be due to an additional dipole interaction. A higher resolution structure or 
a neutron structure will be useful for better evaluating the nature of fluorine. The strong 
reduction of binding of the (R)-analogue depends on the fact that the VdW contacts 
between the fluorine in R-conformer and the pyranose oxygen will clash, which 
probably induces a non-binding conformational change in the sugar phosphate. 
Although the details of hydrogen bonding cannot be determined directly, the 
crystallographic results are in full accord with 19F-NMR and fluorescence binding 
studies, which suggests the (S)-CHFPβG1P analogue to be a possible lead compound 
for combating bacterial infections.  
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Chapter 5 Novel insight into RhoA GTP-hydrolysis  
 
 
5.1 Introduction 
 
5.1.1 RhoA is a small G protein  
There are two distinct families of G proteins: heterotrimeric G proteins and small G 
proteins. Heterotrimeric G proteins, also called Large G proteins, are activated by G 
protein-coupled receptors and are made up of α, β, and γ subunits. Small G proteins are 
monomeric proteins homologous to the α-subunit found in the heterotrimers. Small G 
proteins (20 ~ 25kDa) belong to the Ras superfamily of small GTPases. As the             
α-subunits, most of them are localised to membranes. This is due to modified C-
terminus containing prenyl groups (such as farnesyl and geranylgeranyl), which act as 
lipid anchors (Bos et al., 2007).	  
All small G proteins are inefficient GTPases. The rate of spontaneous GTP-hydrolysis 
in water (10-9 s-1) is accelerated to 10-4 s-1 by small G proteins. However, this is 
insufficient for biological signalling. A protein called GAP (GTPase Activating Protein) 
is required to enhance the reaction up to 105-fold (Lamarche & Hall, 1994; Lancaster et 
al., 1994). How GAPs stimulate the intrinsic GTPase activity of G proteins, is an 
intriguing question that has been largely investigated through biochemical and structural 
approaches. Structures of small G proteins in complex with GAP and aluminium 
fluoride transition state analogues have elucidated this mechanism and  magnesium 
fluoride has been first used in this context (Graham et al., 2002). However, some 
questions remain unanswered, which have been addressed in this thesis. Before 
introducing the aim of this work, the structure and functional role of the Ras 
superfamily proteins will be summarised. In particular, the state of the art of the Rho 
proteins family, to which RhoA belongs, will be discussed.  
 
 
5.1.1.1 The Ras superfamily of monomeric G proteins 
The Ras superfamily is divided into five major families: the Ras, Rho, Arf/Sar, Ran, and 
Rab families. Recent phylogenetic analysis has identified 167 proteins in the human Ras 
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superfamily: 39 Ras proteins, 30 Arfs, 22 Rhos, 65 Rabs, and 1 Ran family (Rojas et al., 
2012). All the members function as signalling nodes in eukaryotes that are activated by 
diverse extracellular stimuli and that regulate intracellular signalling. This signalling 
ultimately controls gene transcription, which in turn influences fundamental processes 
such as cell growth and differentiation. The Ras family is involved in transmitting 
signals from the cell surface to other parts of the cell, in particular the nucleus. The 
genes expressed regulate cell proliferation, differentiation, morphology, and apoptosis 
(Karnoub & Weinberg, 2008). The Rab family is involved in regulating the traffic of 
intracellular transport vesicles and the trafficking of proteins between different 
organelles via endocytotic and secretory pathways (Zerial & McBride, 2001). The Rho 
family is involved in signalling networks that regulate actin, cell cycle progression, cell 
motility, cell behaviour and gene expression (Heasman & Ridley, 2008; Mulloy et al., 
2010; Park & Bi, 2007; Schlessinger et al., 2009). The Ran proteins are the most 
abundant in the cell and they are involved in nuclear transport. Finally, the Arf family 
of proteins comprises the most divergent proteins, which, like Rab family proteins, are 
involved in vesicle trafficking (Wennerberg et al., 2005). These are referred to as 
‘‘atypical’’ Rho/Rac GTPases because they are very different from the other GTPase 
subfamilies according to structural, regulatory and functional criteria (Bustelo et al., 
2007).  
 
 
5.1.1.2 The Small G protein switching cycle and structure correlation 
Despite the divergence in function, all Ras proteins have a conserved mechanism. They 
act as molecular switches, moving between an active GTP-bound state and an inactive 
GDP-bound state (Mackay & Hall, 1998). The interconversion between the two forms 
allows Ras proteins to act as molecular switches that regulate the intracellular signalling 
pathways described above (Ihara et al., 1998). The entire cycle is highly regulated by 
two protein families: the Guanine nucleotide-exchange factors (GEFs) and the GTPase-
activating proteins (GAPs). The GEFs reset the Ras switch, promoting the exchange of 
the nucleotide from GDP to GTP (Bourne et al., 1990). The GAPs promote the inactive 
conformation by stimulating the intrinsic GTPase activity of the G protein (Boguski M. 
S. and McCormick F., 1993) (Figure 5.1). For a subset of small G proteins (mainly the 
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Rab and Rho proteins) guanine nucleotide-dissociation inhibitors (GDIs) provide an 
additional level of control. These proteins remove small G proteins from membranes by 
sequestration of their lipid tails (Bos et al., 2007) .  
 
 
 
Figure 5.1 The Ras superfamily G protein cycle. The diagram shows the regulation of Ras proteins in 
the cell. On receiving an upstream signal, the GEF activates Ras by stimulating it to release its GDP; as 
the cellular GTP concentration is greater than the GDP concentration, Ras rapidly binds GTP once GDP 
has been ejected. The GAP stimulates GTP-hydrolysis, inactivating Ras. GAP maintains most of the Ras 
protein in unstimulated cells in an inactive GDP-bound form (modified from Alberts, 2008). 
 
 
The Ras superfamily of small GTP-binding proteins maintains a structurally and 
mechanistically preserved GTP-binding core (Colicelli, 2004; Wennerberg et al., 2005). 
Crystallographic and NMR analyses of some small G proteins, including Ha-Ras, N-
Ras, Rap2A, RhoA, Rac1, Rab3A, Rab7, Arf1, and Ran, have revealed that all 
GDP/GTP-binding domains have a common topology (Geyer & Wittinghofer, 1997). 
By comparison of the structure in the GTP-bound conformation and the GDP-bound 
conformation, two highly flexible regions surrounding the γ-phosphate of GTP have 
been established: the Switch I region within loop L2 and β2 (the effector region) and the 
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Switch II region within loop L4 and helix α2. Switch I (28-38 residues in RhoA) and II 
(61-78 residues in RhoA) regions are the small G protein regions mostly involved in the 
GTP-GDP transition (Figure 5.2).  
 
 
 
Figure 5.2 Structure of Switch I and II regions in RhoAG14V-GTPγS and RhoA-GDP structures. 
RhoA consists of a single domain with six stranded β-sheets, surrounded by α-helixes connected with 
loops. In this ribbon representation of RhoAG14V-GTPγS on the left (PDB code 1A2B; Ihara et al., 1998) 
and RhoA-GDP on the right (PDB code 1FTN; Wei et al., 1997), Switch regions and other relevant 
regions are highlighted: Switch I (residues 27-36) and Switch II (residues 61-78) are in red, the catalytic 
magnesium ion is shown as a green sphere, GDP is in cyan sticks and the P-loop is in brown. The P-loop 
or phosphate binding loop (residues 13-20) wraps around the nucleotide so strongly that GTP and GDP 
bind to RhoA with dissociation constants in the nanomolar range. Tyr34, Thr37 from Switch I and Gly62, 
Gln63 from Switch II are in sticks. Black dashed lines represent hydrogen bonds. 	  	  
 
 
The Ras superfamily proteins generally undergo an enzymatic cycle that involves the 
so-called loaded-spring mechanism, where release of the γ-phosphate after               
GTP-hydrolysis allows the two switch regions to relax into the GDP-specific 
Insert'helix'
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Insert'helix'
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Switch'II' Switch'II'
Ploop'Ploop'
RhoA4GTP' RhoA4GDP'
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conformation (Ihara et al., 1998; Milburn et al., 1990; Vetter & Wittinghofer, 2001). In 
the GTP-bound state there are two hydrogen bonds from GTP γ-phosphate oxygen 
atoms to the main chain amine groups of the invariant Thr37 and Gly62 residues, in 
Switch I and II respectively. In the GDP-bound state, where the GTP γ-phosphate is 
already hydrolysed, these interactions are broken (Figure 5.2). Both GEFs and GAPs act 
on small GTP proteins by interacting with the Switch regions.  
 
 
5.1.1.3 Physiological roles of mammalian Rho family 
In the mammalian Rho GTPases family, twenty protein isoforms have been described: 
Rho (A, B and  C), Cdc42, Rac (1, 2 and 3), TC10; TCL, Chp (1 and 2), RhoG, Rnd (1, 
2 and 3), RhoBTB (1 and 2), RhoD, Rif and TTF (Etienne-Manneville & Hall, 2002). 
The human genome contains over 82 Rho family GEFs, over 67 Rho family GAPs, and 
only three Rho family GDIs (Hall, 2012; Meller et al., 2005).  
The three best characterised Rho family members are: Cdc42, Rho and Rac (Hall, 1998; 
Madaule & Axel, 1985). Historically, they have been described by their effects on actin 
polymerisation on serum-starved Swiss 3T3 fibroblast cells in vitro. Activation of the 
three proteins promotes fibroblast movement by formation of filipodias, lamellipodias, 
membrane ruffles, focal adhesion and stress fiber formation (Figure 5.3). 
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Figure 5.3 The effects of Rac, Rho, and Cdc42 on actin organisation in fibroblasts. In each case, the 
actin filaments have been labelled with fluorescent phalloidin and the focal contacts have been located 
with an antibody against vinculin. A-B) Quiescent, serum-starved Swiss 3T3 fibroblasts (-) contain very 
few organised actin filaments or vinculin containing integrin adhesion complexes. C-D) Addition of the 
growth factor lysophosphatidic acid activates Rho, which leads to stress fibres and focal adhesion 
formation. E-F) Microinjection of constitutively active Rac induces lamellipodia and associated adhesion 
complexes. G-H) Microinjection of FGD1, an exchange factor for Cdc42, leads to formation of filopodia 
and the associated adhesion complexes. Cdc42 activates Rac; hence, filopodias are intimately associated 
with lamellipodias, as shown in (G). Scale: 1 cm = 25 µm (modified from Hall, 1998).  
 
 
In vivo, the regulation of the actin cytoskeleton and further functions, mediated by the 
Rho family, contributes to different aspect of cell biology, such as morphology, 
movement and behaviour of the cell.  
All three proteins are involved in the morphogenesis of epithelial and neuronal cells, by 
contributing to cell polarity determination. In epithelial cells, the Rho GTPase pathway 
is involved in the formation of cell-cell interactions such as adherent junction, tight 
junction and cell-ECM (extra cellular matrix) interactions; these contacts contribute to 
the apical/basal polarity of epithelial cells (Ebnet et al., 2001; Jacinto et al., 2001; 
O'Brien et al., 2001; Raich et al., 1999; Vasioukhin et al., 2000). In neurons, Rho 
proteins are determinants for axon or dendrite development. While Cdc42 and Rac 
promote the neurite outgrowth, Rho inhibits the extension (Lee et al., 2000; Li et al., 
2000; Luo, 2000; Ozdinler & Erzurumlu, 2001; Wong et al., 2000). Furthermore, the 
Cdc42 pathway is one of the main determinants in establishing cell polarity in yeast 
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budding and cell asymmetry in mammalian zygotes (Gotta et al., 2001; Kay & Hunter, 
2001; Pruyne & Bretscher, 2000). 
In single-cell migration, Rho GTPases act on both actin and the microtubule 
cytoskeleton. Rac promotes the protrusive activity, by actin polymerisation and integrin 
adhesion complex assembly at the cell periphery (Condeelis, 2001; Kraynov et al., 
2000; Small et al., 2002), while Rho is involved in the contraction and retraction of the 
rest of cell body by promoting the formation of stress fibers (Worthylake et al., 2001). 
The isoform RhoA is particularly involved in this process (Ridley et al., 1992). Cdc42 
pathway stabilises the direction of the movement (Allen et al., 1998). Recent studies 
suggest that Rho is also active at the leading edge protrusion, where, together with Rac, 
it promotes the protrusion (Machacek et al., 2009) Moreover, the Rho proteins are 
involved in cell migration and cell stretching involved in the dorsure closure during 
morphogenesis (Brock et al., 1996; Knust, 1997; Lu & Settleman, 1999; Stronach & 
Perrimon, 1999).  
Rho, Rac and Cdc42 contribute to cell behavior, where contractile actin and myosin 
filaments are used by many cell types to induce rapid, reversible changes in shape. The 
Rho pathway promotes actin and myosin contraction in aortic smooth muscle cells for 
the regulation of blood pressure (Fukata et al., 2001; Sakurada et al., 2001). It also 
promotes destabilisation in endothelial cell-cell junctions to regulate extravasion of 
lymphocytes from circulating blood into surrounding tissues (Wojciak-Stothard et al., 
2001). All three GTPases are involved in several behaviour processes, such as 
phagocytosis (Bokoch, 2000; Caron & Hall, 1998), G1 cell cycle procession (Cantrell, 
1998; Olson et al., 1995; Olson et al., 1998; Welsh et al., 2001) and in regulating 
secretion of histamine and serotonin from mast cells (Pinxteren et al., 2000). 
Rho GTPases mediate their signalling by activating a huge number of effectors. 100 
targets have been reported until now, which include 30 kinases and a large number of 
scaffold-adaptor-like proteins (Bishop & Hall, 2000; Hall, 2012). Well known effectors 
are ROCK and mDIA, which are both activated by Rho (RhoA for ROCK) and they 
lead to polymerisation of actin in linear filaments and activation of myosin II 
respectively (Kimura et al., 1996; Watanabe et al., 1999; Watanabe et al., 1997) (Figure 
5.4).  
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Figure 5.4 Rho family signalling in cell motility. The steps required in cell motility are shown with 
details of signalling molecules involved. Arp2/3 effectors are activated by Rac (Etienne-Manneville & 
Hall, 2002), while ROCK is activated by Rho. In step 3 MMPs, which are surface protein proteases, are 
produced. It has been suggested that Rho signalling is required for the activation of these proteases (Parri 
& Chiarugi, 2010).  
 
 
5.1.1.4 The Rho family role in cancer and further diseases 
Ras, the founder member of the Ras superfamily was intensely studied in the 1980s as it 
was found to be an oncogene in 30% of all human cancers (Hall, 2012). Further analysis 
revealed a single amino acid substitution resulting in a protein that was insensitive to 
GAPs and therefore constitutively active. Similar mutations have been reproduced in 
vitro in Rho family proteins. The Rho oncogenes are dominant active mutants 
(Cdc42V12, RacV12, and RhoV14), which corresponds to a permanently GTP-bound 
state, insensitive to GAP (Feig, 1999). Constitutively active forms of Rho family 
proteins in cancer cells were thought to promote the acquisition of migratory and 
invasive properties, a key event in the oncogenic progression of cells (Hanahan & 
Weinberg, 2000; Schmitz et al., 2000). However, the enormous amount of sequencing 
information derived from human cancers has uncovered none of the mutations 
hypothesised in vitro in Rho GTPases. Further studies have shown that the role of the 
Rho family proteins in cancer is due to up-regulation of almost all the family, which 
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affect all the cancer steps, within the transformation step.  The up-regulation induces 
uncontrolled proliferation, which increases survival signals and permits the tumour cells 
to escape from apoptosis (Vega & Ridley, 2008). For example, in the case of the Rho 
proteins, RhoA and RhoC are up-regulated, while RhoB is down-regulated. In vitro and 
in vivo studies have shown that RhoA has transforming activity, while RhoC up-
regulation correlates to the metastasis step (Gomez del Pulgar et al., 2005; Hakem et al., 
2005). RhoB down-regulation correlates with increasing tumour aggressiveness (Huang 
& Prendergast, 2006). 
The possibility that the Rho family GEFs and GAPs might act as tumour suppressors 
has also been explored. Many of the Rho GEFs were originally identified as oncogenes 
in experimental tissue culture transformation assays. Despite this, there are just a few 
sporadic examples of genetic alterations in Rho GEFs in human cancer (Hall, 2012).  
For GAPs, there is strong evidence supporting an oncogenic function for DLC1 (deleted 
in liver cancer 1), a GAP active on Rho (Xue et al., 2008; Yuan et al., 2003). 
Heterozygous deletions are found in approximately 50% of human cancers, and loss of 
DLC1 can promote tumorogenesis in mouse cancer models. However, homozygous 
deletions of DLC1 are not found in human cancer, whereas expression from the 
remaining allele appears to be attenuated in some cancers, definitive proof for a tumour-
suppressor role has yet to be obtained (Yuan et al., 2003). 
Rho signalling is also involved in cardiovascular, pulmonary hypertension, 
neurodegenerative and immune disorders (Hall, 2012; Lu et al., 2009; Nossaman & 
Kadowitz, 2009; Shimokawa, 2002; Shimokawa et al., 2002). In these diseases genetic 
mutations of Rho signalling proteins have been found. Mutations in GAPs, GEFs and 
targets are found in a variety of mental retardation syndromes and it has been proposed 
that these lead to defects in spine morphogenesis and an alteration in the size and shape 
of dendritic spines associated with memory and learning (Nadif Kasri & Van Aelst, 
2008). Genetic alterations are also associated with immunological disorders: Rac2 is 
mutated in LAD (leucocyte adhesion deficiency), while Cdc42 and cdc42 GEF FGD1 
are respectively mutated in WASP (Wiskott–Aldrich syndrome), and developmental 
disorders such as faciogenital dysplasia syndrome (Kirchhausen & Rosen, 1996; Olson 
et al., 1996; Pai et al., 2010).  
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Finally, there is a great deal of interest in ROCK, one of the major Kinase effectors of 
Rho, as a pharmaceutical target. Aberrant actomyosin contraction has been implicated 
in a variety of human diseases, including hypertension, atherosclerosis and ischemia. A 
ROCK inhibitor is already in clinical use in Japan for cerebral ischemia and Phase II 
trials are underway in the US for treatment of glaucoma (Zhou et al., 2011). 
 
 
5.1.2 How do GAPs stimulate GTP-hydrolysis? 
The role that the Rho family proteins have has led to the idea of Rho GTP-hydrolysis as 
a natural way to inhibit activity, in particular in cancer, where genetic alterations are not 
present and a much more efficient hydrolysis system is required. Thus, several 
biophysical and structural studies have revealed the mechanism by which GAPs 
stimulate the intrinsic GTP-hydrolysis of small GTP proteins. Effective catalysis of 
phosphoryl transfer by GAPs comprises several elements: the proper orientation of the 
attacking water molecule and its polarisation, occlusion of water from the active site, 
stabilisation of the leaving group and stabilisation of the transition state. 
In the case of the Ras superfamily, it has been proposed that GAPs act either through 
residues that participate directly in the catalysis or through an allosteric mechanism 
(Wittinghofer, 1993). RhoGAP uses a conserved arginine residue, termed the “Arginine 
finger”, to stabilise the transition state and to promote the cleavage of the γ-phosphate 
(γP) (Barrett et al., 1997). Details of this reaction have been explored in the structures of 
the RhoA-GDP-AlF4--RhoGAP-TSA and RhoA-GDP-MgF3--RhoGAP-TSA complexes 
(Graham et al., 2002; Rittinger et al., 1997). These structures show how residues that 
participate directly in catalysis, such as Arg85RhoGAP, are responsible for the hydrolysis 
of GTP. The Arginine finger acts by stabilising the negative charge on the GTP 
phosphate groups, as well as by coordinating Gln63RhoA, a vital residue that properly 
positions a water molecule for nucleophilic attack (Rittinger et al., 1997). Similar 
conclusions have been made for Ras and Cdc42 proteins (Nassar et al., 1998; Scheffzek 
et al., 1997). In Rab, both residues are supplied by the GAP, while Rab Gln92 is 
pointing away from the active site (Pan et al., 2006). In ArfGAP/Sar system the Gap 
contributes to the reaction with the Arginine finger, while the glutamine is substituted 
by a histidine (Bi et al., 2002). Thus, it has been proposed that GAPs promote           
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GTP-hydrolysis by contributing directly to catalysis. However, there is evidence, which 
suggest that an allosteric function upon protein binding is also relevant. For example, 
RhoGAPR85A is an active mutant and it is able to increase the hydrolysis rate of Rho-
GTP by 160-fold, without affecting protein binding (Graham et al., 1999). Similarly, the 
mutant Cdc42GAPR305A conserves 20% of its activity (Nassar et al., 1998). 
Furthermore, it is known that small GTP proteins have an intrinsic GTPase activity, 
which is independent of the contribution from the Arginine finger. This implies that 
further contributions to activation are involved in catalysis.  
Interestingly, there are GAP proteins, such as RapGAP and RanGAP, which lack an 
Arginine finger. In the case of RanGap-Ran, RanGAP supplies an asparagine to 
stabilise the orientation of the Gln69 of Ran. A tyrosine (Tyr39Ran) belonging to Ran, 
well conserved in all Ras proteins, interacts with the GTP-γP instead of the Arginine 
finger (Seewald et al., 2002).  In the case of RapGAP-Rap the GAP contributes an 
asparagine, referred to as the “Asparagine thumb”, into the active site to substitute the 
missing glutamine (Scrima et al., 2008). The same tyrosine described for Ran 
(Tyr32Rap) also interacts with the γP instead of the Arginine finger.  This tyrosine is 
conserved in Rho, Ras, Cdc42, Ran and Rap: Tyr34Rho, Tyr32Ras, Tyr32Cdc42 Tyr39Ran 
and Tyr32Rap respectively. As shown in figure 5.5, Tyr34Rho and Tyr32Ras are in the so 
called open conformation, while Tyr32Cdc42 Tyr39Ran and Tyr32Rap, are in a close 
conformation, which correspond to the one coordinating the γP. The closed 
conformation appears to clash with a potential Arginine side chain. Surprisingly, in the 
structure of Cdc42-GDP-AlF3-Cdc42GAPR305A-TSA, in which the Arginine finger has 
been mutated to an alanine, the side chain of the conserved Tyr32Cdc42 is in the same 
position as the Arginine finger, coordinating the γP, in a closed conformation (Nassar et 
al., 1998) (Figure 5.5). As no Cdc42-GTP structure is available, which is the 
physiological role of Tyr34Rho,Tyr32Ras, Tyr32Cdc42 in the Rho family switch cycle has 
not been yet defined.  
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Figure 5.5 Structure conformation of conserved tyrosine. The superimposition of the active sites from 
various structures shows the two possible conformations assumed by the conserved tyrosine during 
catalysis. The tyrosine is in closed conformation in Ran-GPPNHP-RanBP1-RanGAP (PDB code 1K5D; 
Seewald et al., 2002), in Rap-GDP-BeF3--RapGAP (PDB code 3BRW; Scrima et al., 2008), and in 
Cdc42-GDP-AlF3-Ccd42GAPR305A-TSA (PDB code 2NRG; Nassar et al., 1998). The tyrosine is in an 
open conformation in RhoA-GDP-MgF3--RhoGAP-TSA (PDB code 1OW3; Graham et al., 2002), Cdc42-
GDP-AlF3-Ccd42GAP-TSA (PDB code 1NGR; Nassar et al., 1998) and Ras-GDP-AlF3-RasGAP-TSA 
(PDB code 1WQ1; Scheffzek et al., 1997). 
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5.2 Aim of this project 
The question of how GAPs stimulate the intrinsic GTPase activity of G-proteins is still 
open. The aim of this work is to investigate the structural and the catalytic consequences 
caused by the absence of the Arginine finger in the Rho-RhoGAP system, in order to 
define the relevant characteristics in the active site of Arg85RhoGAP and Gln63Rho. 
Among the three isoforms of Rho, RhoA was chosen as a model system. RhoA, RhoB 
and RhoC are highly homologous (83%), but appear to have divergent biological 
functions (Wennerberg & Der, 2004).  
Two systems were studied: RhoA-GDP-AlFx-TSA, through which the intrinsic RhoA 
activity will be investigated, and RhoA-GDP-AlFx-RhoGAPR85A-TSA or RhoA-GDP-
MgFx-RhoGAPR85A-TSA, through which the Arginine finger independent events will be 
described. Since both RhoA and RhoA-RhoGAPR85A have an intrinsic and residual 
activity respectively, the question of how charge balance in these catalytic systems is 
achieved will be discussed.  
Finally the results obtained bring novel insight into GAP mediated RhoA                 
GTP-hydrolysis by providing complementary information to the structures already 
known.
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5.3 Experimental procedures 
 
5.3.1 RhoA-GDP-AlFx-TSA and RhoA-GDP 
 
5.3.1.1 RhoA expression and purification 
Human RhoA was expressed and purified recombinantly from pGEX-2T vector, which 
encodes a cleavable N-terminal GST-tag. The plasmid carrying human RhoAF25N gene 
was kindly provided by Dr. Katrin Rittinger (MRC, National Institute for Medical 
Research, London). In this thesis RhoA will refer to this mutant. Expression after IPTG 
induction was carried out ON, at 20°C in Rosetta 2 cells. A GST-trap column was used 
for the first purification step. Tag cleavage was performed with thrombin on the 
column. As a final purification step, size exclusion chromatography was performed (see 
Chapter 2). Table 5.1 shows details of the purification procedure.  
The protein eluted as monomer at an elution volume of 66 ml from the size exclusion 
column, with a 260/280 ratio close to 1 (Figure 5.6). The ratio is high due to the GDP 
bound to the protein that co-purified from the cells. The purity was determined by SDS-
PAGE. The yield was typically 14mg/L of culture. 
 
 
 
Figure 5.6 Size exclusion chromatography profile of RhoA. From purification of 1.5 L of culture, 20 
mg of protein was eluted. The absorbance at 260 nm is shown in red and 280 nm in blue. The 
chromatogram was run with a HiLoad 16/60 Superdex 75 pg column. 
66	  ml	  
Void	  volume	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Table 5.1 Protein purification steps 
 
Purification	  steps	   	   Solutions 
1. Cell	  Lysis	   Bacteria	  were	   resuspended	   in	   Lysis	   Buffer	   or	   LyB	   (10ml	   LB	   for	  
750	  ml	  of	  bacteria)	  with	  addition	  of	  a	  protease	  inhibitor	  cocktail	  
tablet	   (EDTA	  free)	  and	  DNase	   I	   (trace).	  The	  cells	  were	   lysed	  by	  
sonication	  on	   ice	   for	   2	   *	   50	   s	  with	   1	  minute	   gap,	   60%	  power;	  
then	  centrifuged	  for	  20	  min	  at	  20,000	  g,	  4	  °C.	  
Lysis	  buffer	  
(LyB)=	  50	  mM	  
Tris	  pH	  7.5,	  
150	  mM	  NaCl,	  
5	  mM	  MgCl2	  ,	  
5	  mM	  DTT	  
2. Affinity	  
Chromato-­‐
graphy	  
A	  GST-­‐trap	  column	  was	  used	  (GST	  column-­‐5	  ml,	  GH),	  connected	  
to	   an	  AKTA	  prime	   system.	  After	   equilibrating	   the	   column	  with	  
the	  BB,	  the	  Crude	  Extract	  (CE)	  or	  soluble	  phase	  was	  applied.	  The	  
binding	   step	   was	   performed	   at	   0.5	   ml/min	   until	   the	   UV	   line	  
started	   to	  decrease.	   Then	   the	   column	  was	  extensively	  washed	  
with	  BB	  until	  the	  UV	  lines	  become	  flat.	  	  
Binding	  Buffer	  
(BB)=	  50	  mM	  
Tris	  pH	  7.5,	  
150	  mM	  NaCl,	  
5	  mM	  MgCl2	  ,	  
1	  mM	  DTT	   
	  
3. GST-­‐tag	  
cleavage	  
The	  column	  was	  extensively	  washed	  with	  the	  TCB	  until	   the	  UV	  
lines	  become	  flat	  again.	  Thrombin	  sample	  dissolve	  in	  the	  TB	  was	  
applied	  to	  the	  column.	  After	  ON	  incubation	  with	  at	  4°C,	  gently	  
shaking	  (100U/20	  mg	  of	  protein),	  the	  column	  was	  connected	  to	  
Benzamidine-­‐trap	   column	   and	   the	   cleaved	   protein	   was	   eluted	  
using	  the	  CB.	  This	  step	  was	  performed	  at	  1	  ml/min.	  	  	  
	  
	  
Figure	  5.7	  12%	  SDS-­‐PAGE	  of	  RhoA	  purification	  –	   initial	   tests.	   Samples	   loaded	  
show	  details	  of	  RhoA	  purification	  while	  the	  optimisation	  of	  the	  procedure	  was	  
in	  progress.	  Due	  to	  its	  high	  solubility,	  the	  protein	  was	  purified	  from	  the	  soluble	  
phase	   (see	   CE=crude	   extract)	   and	   an	   additional	   column	   was	   required	   to	  
recuperate	  the	  Protein	  remaining	  in	  the	  unbound	  fraction	  (Ub)	  from	  the	  affinity	  
column.	   The	   further	   lanes	   show	   the	   uncleaved	   (Un)	   and	   cleaved	   species	   (Cl).	  
The	   column	   Un/CL	   is	   an	   example	   of	   the	   test	   run	   for	   checking	   the	   thrombin	  
amount	  required.	  2	  ug	  of	  protein	  were	  loaded	  in	  each	  lane.	  (M=Marker). 
	  
Thrombin	  
Cleavage	  
Buffer	  (TCB)=	  
50	  mM	  Tris	  pH	  
8,	  150	  mM	  
NaCl,	  5	  mM	  
MgCl2	  ,	  1	  mM	  
DTT	   
	  
4. Size	  exclusion	  
chromato-­‐
graphy	  (SEC)	  
A	  Hi	  load	  16/60	  Superdex	  75	  pg	  gel	  filtration	  column	  was	  run	  a	  
flow	  rate	  1	  ml/min	  with	  SEC	  buffer.	  	  
SEC	  buffer=	  50	  
mM	  Bis/Tris	  
pH	  6,	  150	  mM	  
NaCl,	  5	  mM	  
MgCl2	  ,	  1	  mM	  
DTT	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RhoA was then concentrated or mixed with RhoGAP (see sections 5.3.2.3-5.3.2.4) in 
order to prepare a stock solution for crystallisation of the single protein RhoA or for the 
crystallisation of the complex. RhoA was concentrated to 12 mg/ml and setup for 
crystallisation experiments immediately. The protein was conserved at -20°C for 
maximum of one week. After this time, crystals were not obtained. 
  
 
5.3.1.2 RhoA-GDP-AlFx-TSA and RhoA-GDP crystallisation 
Several crystallisation experiments were performed. The RhoA-GDP-AlFx sample was 
prepared by adding 10 mM NH4F and 2 mM AlCl3 from concentrated stock solution 
(0.5 M) to the concentrated RhoA stock solution, without adjusting the final protein 
concentration. For establishing crystallisation conditions, several commercial screens 
were tested at the EMBL High Throughput Crystallisation Laboratory (HTX 
Laboratory), EMBL, Grenoble (Figure 5.8; Table5.2; see Chapter 2). 	  	  
	  
	  
Buffer	   Salt	   Precipitant	  
0.1	  M	  Tris	  pH8.5	   0.2	  M	  NaCl	   25%	  (w/v)PEG	  3350	  	  
0.1	  M	  Tris	  pH8.5	   0.2	  M	  Li2SO4	   25%	  (w/v)	  PEG	  3350	  	  
0.1	  M	  Hepes	  pH7.5	   0.2	  M	  Li2SO4	   25%	  (w/v)	  PEG	  3350	  	  
0.1	  M	  Hepes	  pH7.5	   0.2	  M	  MgCl2	   25%	  (w/v)	  PEG	  3350	  	  
	   0.2	  M	  KF	   25%	  (w/v)	  PEG	  3350	  	  
	  
Figure 5.8-Table 5.2 Crystals obtained from initial robot conditions. The table shows the robot 
conditions in which crystals were observed. The picture shows crystals that diffracted to 2.5 Å in the best 
direction. 
 
 
In order to determine the best conditions obtained, the diffraction properties of the 
plate-like crystals obtained in each condition were tested for their diffraction properties 
at beamline ID23-1 at the ESRF. All the crystals were thin and diffracting at reasonable 
resolution only in one direction. The crystals grown from 0.1 M Tris HCl pH 8.5, 0.2 M 
NaCl and 25%PEG 3350, displayed the best diffraction quality (2.5 Å in the best 
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direction). Further optimisation was then performed in order to obtain larger and thicker 
crystals. Several tests were also performed to promote the accommodation of an 
aluminium fluoride molecule inside the active site. Optimisation of the salt and PEG 
concentration was necessary to scale up the crystals obtained from the HTX Laboratory 
from nano-drops to micro-drops. The replacement of NH4F with NaF increased the 
crystal quality. Crystals were also obtained at lower pH values (5-7), necessary for 
maintaining aluminium in solution. Further aluminium and sodium fluoride in the 
sample and in the reservoir solution were added to improve the probability of 
aluminium fluoride binding. Crystals were grow at 4°C and RT. Eventually, RhoA-
GDP-AlFx-TSA crystals were obtained at RT by the sitting-drop method from solutions 
containing 10 mg/ml RhoA, 50 mM Bis/tris pH 6.5, 150 mM NaCl, 5 mM MgCl2, 1mM 
DTT, 2 mM AlCl3, 10mM NaF equilibrated against 24% (w/v) PEG 3350 and 0.3 M 
NaCl. Plate crystals appeared overnight and were mounted directly from the mother 
liquor using a mesh loop and cryo-cooling as described in E. Pellegrini et al., 2010 (see 
Chapter 2). 
 
5.3.1.3 Data collection, structure solution and refinement 
The structure of RhoA in complex with GDP was solved using molecular replacement 
with X-ray diffraction data collected at 100 K from a single crystal. All diffraction data 
were collected on beamline ID29 at the ESRF, Grenoble, France. The diffraction images 
were then integrated with XDS (Kabsch, 2010). The previously published structure of 
RhoA-GDP (PDB code 1FTN; Wei et al., 1997) without bound ligand and water 
molecules was used as a search model for MolRep (Vagin & Teplyakov, 2010). 
Refinement and validation have been performed as described in Chapter 2. 
 
 
5.3.2 RhoA-GDP-AlFx-RhoGAPR85A-TSA and RhoA-GDP-MgFx-RhoGAPR85A-
TSA 
 
5.3.2.1 Site-directed mutagenesis of RhoGAP to generate the R85A mutant 
The Arginine finger residue of RhoGAP, arginine 85, was mutated to an alanine. The 
pGEX-2T expression vectors carrying human p29RhoGAP were provided by Dr. Katrin 
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Rittinger (MRC, National Institute for Medical Research, London). p29RhoGAP 
comprised the carboxyl terminal fragment of p50 RhoGAP (Lancaster et al., 1994). The 
mutagenesis experiment was performed by Dr. Y Jin. Details are described in her PhD 
thesis (Jin, 2012). In this thesis, RhoGAPR85A will refer to this mutant. 
 
 
5.3.2.2 RhoA and RhoGAPR85A expression and purification 
The two recombinant proteins were cloned into the same vector. Thus, the expression 
and purification were carried out as described for RhoA. Expression after IPTG 
induction was carried out ON, at 20°C in Rosetta 2 cells. A GST-trap column was used 
for the first purification step. Tag cleavage was performed with thrombin on the 
column. As a final purification step, size exclusion chromatography was performed (see 
Chapter 2), with SEC buffer was prepared with Bis/Tris pH 7. This did not affect the 
size exclusion chromatography profile of RhoA. In the case of RhoGAPR85A, the protein 
eluted as monomer at an elution volume of 56 ml, with a 260/280 ratio of 0.6 (Figure 
5.9). The yield of the entire process was typically 1.6 mg/L culture. 
 
 
Figure 5.9 Size exclusion chromatography profile of RhoGAP. From 6 L culture, 10 mg of protein 
was eluted in a unique peak. The absorbance at 260 nm is shown in red and 280 nm in blue. The 
chromatogram was run with a HiLoad 16/60 Superdex 75 pg column. 
56	  ml	  
Void	  volume	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5.3.2.3 Generation and crystallisation of the RhoA-GDP-AlFx-RhoGAPR85A-TSA 
complex 
A unique stock of the metallofluoride protein complex was prepared every time 
immediately after the size exclusion chromatography experiments. The two proteins 
were mixed in equimolar amounts and 20 mM NaF and 2 mM AlCl3 from concentrated 
stock solutions (0.5 M) were added to the mix. Usually, the initial complex 
concentration was around 11 µM. The complex was incubated overnight at 4°C and then 
concentrated to 230 µM for crystallisation experiments. The complex concentration was 
monitored by Bradford assay. After the first successful crystallisation experiments it 
was established that 230 µM corresponds to a concentration of 8 mg/ml. 
At first, published conditions were tested (Rittinger et al., 1997). Sea urchins and thin 
plates in unique clusters were obtained. Since separation of the plates from the sea 
urchins was challenging it was decided to find new crystallisation conditions by using 
the service provided by the HTX Laboratory. Three samples were prepared for this 
experiment: the metallofluoride complex and the single proteins mixed with aluminium 
fluoride and concentrated as in the heterodimer sample. The last two samples act as 
control experiments, which allowed the definition of whether crystals were of the 
complex or of individual components. Several efforts were made to reproduce all the 
hits obtained. Eventually, showers of microcrystals and plate clusters were obtained 
from sitting drop experiments over a reservoir containing 100 mM Bis/Tris pH 5.8 or 
pH 6 and PEG 3350 23-26% (w/v).  
Optimisation was required to produce crystals useful for data collection. The 
combination of the microbatch method and seeding techniques proved successful.  
Microbatch experiments were set up using sitting drop plates (D'Arcy et al., 2004; Del 
Campo & Lambowitz, 2009). The protein sample was mixed at different ratios and at 
different concentrations with the reservoir solution described for the sitting drop 
experiments. In this way, the optimal microbatch conditions were established: 2µl of 
sample plus 2µl reservoir, covered by 25 µl of paraffin oil. The protein concentration 
used was the same as for the sitting drop. In this way thicker crystals were obtained, but 
they still formed in clusters or were very thin. Three generations of seeding were 
required to obtain good crystals. Microseeding was carried out through the preparation 
of a stock seeding solution prepared by crushing a few crystals (often a cluster) and 
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diluting them in 50 µl of reservoir solution. Drops were prepared in two different ways: 
Seed crystals were transferred to the microbatch drop with an otter whisker or by 
substituting partial reservoir volumes with the seed stock (typically 0.5-0.25 µl) 
(Bergfors, 2003; Patrick D. Shaw Stewart 2011). The progression of these experiments 
was monitored in two ways: by eye using a microscope with polarised lens and by 
diffraction quality. Diffraction experiments were carried out at the microfocus beamline 
ID23-2, ID14-4 or at ID29, according to the crystal size. Each time data collection was 
performed in order to check for any resolution improvement. In the end, single and well 
diffracting crystals were obtained (Figure 5.10). The final crystals obtained were in 
different conditions from those published for the WT complex (RhoA-GDP-AlFx-
RhoGAP-TSA, Rittinger et al., 1997). 
 
 
 
Figure 5.10 RhoA-GDP-AlFx-RhoGAPR85A-TSA crystal optimisation. Images of the crystals and the 
diffraction patterns show the main steps in the optimisation progress. A) Sea urchins and clusters obtained 
from the robot screening in 100 mM Bis/Tris pH 5.5-6.5, 20-25% (w/v) PEG 3350; similar initial hits 
were obtained by repeating in sitting drop plate the same conditions. B) Improvements obtained after one 
round of microseeding experiments in microbatch. Diffraction data to 3Å resolution were collected at 
ID23-2, on a MAR 225 CCD detector. At this step the crystals were thin and up to 30 um in the largest 
dimension. C) Single crystals that diffracted to higher resolution were obtained after further seeding 
experiments. The data were collected at ID29, with a Pilatus 6M detector. 
A	  
3Å	   2.2Å
ÅÅ	  
B	   C	  
50	  μm	   50	  μm	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5.3.2.4 Generation and crystallisation of RhoA-GDP-MgFx-RhoGAPR85A-TSA 
complex 
The generation and the crystallisation of the magnesium fluoride complex was carried 
out in similar manner to that described for the aluminium fluoride complex. The 
complex was prepared by adding 20 mM MgCl2 and concentrating to 30 mg/ml as 
indicated by a Bradford assay. Sitting drop experiments were carried out in the 
conditions described for the aluminium fluoride complex. As before, no good crystals 
were obtained. Thus, microbatch and microseeding experiments were also used in this 
case. Conditions were screened and eventually the complex was crystallised at 15mg/ml 
with 2 µl of the sample were added to 4 µl of the reservoir. Paraffin oil (20 µl) was used 
to cover the drop. Again, at least three microseeding generations were necessary for 
growing useful crystals.  
 
 
5.3.2.5 Data collection, structure solution and refinement 
The crystals obtained from microbatch experiments were prepared for flash cooling by 
immersion in the mother liquor made up with 25% PEG 400. Diffraction data from 
RhoA-GDP-AlFx-RhoGAPR85A-TSA crystals at 2.2 Å resolution were collected at 
100K, at beamline ID29. Diffraction data from RhoA-GDP-MgFx-RhoGAPR85A-TSA 
crystals at 2.1 Å resolution were collected at 100K, at beamline ID14-4. Reflections 
were integrated with iMOSFLM and XDS (Battye et al., 2011; Kabsch, 2010). The 
structure of the complex was solved by molecular replacement using the previous 
structure (PDB code 1TX4 or 1OW3; Rittinger et al., 1997; Graham et al., 2002) as a 
search model with the bound ligands and water molecules removed. Ligands were 
included after a few refinement cycles. Refinement and validation were performed as 
described in Chapter 2. 
 
 
5.3.2.6 Sulphur-SAD data collection 
In order to determine the identity of ions, a long wavelength experiment was performed 
at 14.2 beamline at the BESSY Synchrotron, in Berlin. The experiment was run at a 
remote wavelength from the adsorption edge of Sulphur or Phosphorus (see Appendix 
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A). At this wavelength, the observation of the anomalous scattering of light elements 
becomes possible, such as chloride and potassium, because the adsorption edge is much 
closer with regard to the usual data collection wavelength of 0.97Å. 
Since the anomalous scattering signal of light elements is low at the wavelengths 
achievable at MX synchrotron beamlines, the success of the experiment depends on the 
combination of several factors. Conditions for cryocooling crystals should be optimised 
in order to avoid excess liquid around the crystal and on the loop. This is important to 
reduce the X-ray absorption effects, which will increase the background scattering 
(Kitago et al., 2005; Teng, 1990). The correct or ‘best’ wavelength for the experiment 
should be considered carefully. For protein structure determination, it has been 
suggested to be in the range of 1.5 - 3 Å (Chayen et al., 2000; Weiss et al., 2001). 
Finally, the redundancy of the data required should be considered. High redundancy 
allows more accurate determination of the anomalous differences, which in the end will 
allow a better location of anomalous scatters (Dauter et al., 2002; Harrop et al., 1996; 
Weiss et al., 2001). 
The long wavelength experiment was performed on the same crystals used for data 
collection described previously. The wavelength was set to 2Å (E = 6.2 keV) and two 
collections of 360 degrees were performed in order to have high redundancy. The 
anomalous map was calculated after the first and the second collection. For the second 
map the two data collection datasets were merged together and the possible benefit from 
using more data was judged. The diffraction images were integrated with XDS (Kabsch, 
2010). After scaling, Fs and phases were calculated using SFALL from the ccp4 suite 
(Brunger, 1992). The program required as input the mtz files with separated Fhkl and       
F-h-k-l, and the pdb file of the native protein. A final map was generated using a fast 
Fourier transform, through FFT in the ccp4 suite (Read, 1988). Inspection of the peaks 
in the resulting map was performed by eye using the molecular modelling program Coot 
(Emsley & Cowtan, 2004; Emsley et al., 2010).  
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5.4 Results and Discussion 
 
 
5.4.1 RhoA-GDP-AlF3-TSA crystallisation 
RhoA-GDP-AlFx--TSA has primarily been studied in our laboratory for investigating 
the role of the charge balance hypothesis in small G proteins. As described in the 
general introduction, the removal of a positive charge inside the active site of a protein, 
which is relevant in transition state stabilisation, should be compensated by a 
corresponding decrease in charge of the transition state analogue. Since Arg85RhoGAP is a 
positively charged residue involved in the stabilisation of the transition state in RhoA-
GDP-AlF4--RhoGAP-TSA and RhoA-GDP-MgF3--RhoGAP-TSA, the charge balance 
principle was investigating by studying the RhoA-GDP-AlFx-TSA, where the 
Arg85RhoGAP is absent. This complex is also of interest, because it is not a dead mutant. 
RhoA has an intrinsic GTPase activity and the RhoA elements that perform this reaction 
and stabilise the transition state when RhoGAP is absent have not been defined (see 
Chapter 1). 
Structural studies of the RhoA-GDP-AlFx-TSA complex proved difficult. 19F-NMR data 
showed the formation of an aluminium trifluoride complex in solution. NMR spectra, 
recorded by Dr Jin Yi, showed three peaks, corresponding to an aluminium trifluoride 
species with no net charge (Jin, 2012) (Figure 5.11). This confirmed that the expected 
RhoA-GDP-AlF3 complex is formed in solution. As demonstrated for PGK, it is 
proposed that an aluminium atom coordinated in octahedral geometry by three fluorides 
and one water molecule is the bound species (Cliff et al., 2010). However, only a crystal 
structure could define the bound aluminium fluoride species.  
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Figure 5.11 19F-NMR spectra of RhoA-GDP-AlF3-TSA complex. Spectra of a) RhoA-GDP-AlF3 
complex in 50 mM Tris at pH 7.5, containing 0.5 mM RhoA (with 1 eq. GDP bound), 5 mM MgCl2, 1 
mM DTT, 10 mM NH4F, 1 mM AlCl3 using pulse program zg. b) The same sample using presaturation 
pulse program, zgpr to saturate the free F– signal at –119 ppm to remove the problem of non-protein 
bound free F and AlFx resonances in fast exchange. FA = –137.9 ppm, FB = –149.9 ppm, and FC = –166.9 
ppm (Jin, 2012). 
	  
	  
 Referring to the RhoAG14V-GTPγS structure (PDB code 1A2B; Ihara et al., 1998), the 
aluminium fluoride was expected to be in the position of the γP, coordinated by the 
Tyr34 and Gln63 residues belonging to the Switch I and Switch II regions respectively. 
The Switch regions were then expected to be in the Rho-GTP bound state. However, the 
crystallisation of RhoA-GDP-AlF3-TSA resulted in a RhoA-GDP structure that 
crystallised in the orthorhombic space group P212121, with one molecule in the 
asymmetric unit (Table 5.3). Thus, the Switch regions crystallised in Rho-GDP 
conformation (Figure 5.12). None of the peaks in the difference map around the active 
site could be assigned to an aluminium trifluoride moiety. Inspection of the electron 
density maps showed no peaks corresponding to bound aluminium fluoride in other 
locations in the protein. Further efforts to reproduce the NMR results in the solid state 
were unsuccessful. 
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Table 5.3 Data collection and refinement statistics 
 
	   RhoA-­‐GDP	  
Space	  group	   P212121	  	  
Wavelength	  (Å)	   0.976	  
Unit	  cell	  dimensions	  (Å)	  a,b,c	   31.80,	  66.27,	  83.68	  
Resolution	  range	  (Å)1	   35.38	  (1.37-­‐1.3)	  
Number	  of	  unique	  reflections	   44107	  
Multiplicity	   4.6	  (4.5)	  
Completeness	  (%)	   99.5	  (99.3)	  
Rmerge	   0.037	  (0.265)	  
<I/σ(I)>	   20.3	  (5.1)	  
Wilson	  B	  factor	  (Å2)	   15.5	  	  
Water	  molecules	   207	  
Rfactor	  (%)	   15.56	  	  
Free	  Rfactor	  (%)	   18.43	  	  
RMS	  deviations:	   	  
Bonds	  (Å)	   0.013	  
Angles	  (°)	   1.636	  
 
1Values	  for	  higher	  resolution	  shell	  are	  in	  brackets	  
 
 
The absence of bound aluminium fluoride was probably due to dynamic properties of 
the RhoA-GDP-AlF3-TSA sample. This makes a scenario likely in which the Switch 
regions involved in aluminium fluoride coordination and the aluminium fluoride itself 
are continually in motion in solution. In the solid state, where one of the two states 
should be fixed, the Rho-GDP conformation was stabilised by crystal packing. Each 
RhoA molecule interacts through hydrophobic interactions with the symmetry related 
molecules in the crystal. The benzene group of Tyr34 from the Switch I of one molecule 
is indeed packed between the benzene group of Phe134 and the Met157 side chain of 
another molecule (Figure 5.13). 
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Figure 5.12-Table 5.4 The structure of RhoA-GDP at 1.3Å resolution. In this ribbon representation of 
RhoA-GDP, Switch regions and further relevant regions are highlighted as in figure 5.2: Switch I 
(residues 27-36) and Switch II (residues 61-78) are in red, the catalytic magnesium is shown as a green 
sphere, GDP is in cyan sticks and the P-loop is in brown. In the table Cα rmsd valued are shown between 
RhoAG14V-GTPγS (PDB code 1A2B; Ihara et al., 1998) and RhoA-GDP (PDB code 1FTN; Wei et al., 
1997). Rmsd xyz displacement was calculated with the program Superpose, from CCP4 suite (Krissinel & 
Henrick, 2004). 
Insert'helix'
Switch'I'
Switch'II'
Ploop'
	   Overall	   P	  loop	   SwitchI	   SwitchII	  
1A2B	   1.31	   0.25	   1.91	   1.65	  
1FTN	   0.24	   0.07	   0.13	   0.23	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Figure 5.13 Crystal packing contacts between RhoA molecules. The relationship between two 
molecules in the crystal is shown (A). Details of the interaction are shown in the panel (B). Residues 
involved in symmetry related molecules interactions that stabilise the switch in the ADP bound state, are 
shown in sticks. 
 
 
Nevertheless, we obtained a further structure of RhoA-GDP at higher resolution (1.3 Å) 
than previously obtained 1FTN, 2.1 Å (Wei et al., 1997) . Surprisingly, electron density 
was visible for key catalytic residues that have occupancy zero in the published 
structure. Differences in the Switch II region are particularly interesting. While in 1FTN 
Gln63 is still inside the active site, RhoA-GDP shows that Gln63 no longer interacts 
Tyr34&
Phe134&
Met157&
A	  
B	  
 146 
with the active site when the nucleotide is hydrolyzed (Figure 5.14). Thus the RhoA-
GDP structure solved in this thesis, provides a complete and detailed snapshot of the 
RhoA conformation in the GDP-bound state. In the next paragraphs the name RhoA-
GDP will refer to the structure solved in this thesis. 
 
 
 
Figure 5.14 Structure of Switch II region in RhoA-GDP and RhoA-GDP-1FTN. In the overlay the 
structure of the Switch II region in Rho-GDP is in red, while Rho-GDP-1FTN is in light blue. The panel 
magnifies the difference in conformation of Gln63 in both structures. Gln63 is shown in sticks. Gln63 has 
occupancy zero in 1FTN structure. The overlay is on the Switch I region. 
 
 
5.4.2 The structures of RhoA-GDP-AlF4--RhoGAPR85A-TSA and RhoA-GDP-MgF3-
-RhoGAPR85A-TSA 
Since the crystallisation of RhoA-GDP-AlF3	  failed, it was decided to study the charge 
balance theory in a small G protein, by crystallising RhoA-GDP-AlFx/MgFx-TSA in 
complex with RhoGAPR85A, where Arg85 has been mutated to an alanine. As in the case 
of RhoA-GDP, this complex is still active and it was also of interest to investigate 
which are the transition state features of GTP-hydrolysis performed by this complex. 
The RhoA-GDP-AlF4--RhoGAPR85A-TSA and the RhoA-GDP-MgF3--RhoGAPR85A-
TSA complexes crystallised in the monoclinic space group P21 with 2 molecules per 
Insert'helix'
Switch'I'
Switch'II'
Ploop'
Gln631FTN'
Gln63RhoA;GDP'
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asymmetric unit. The structures were solved to 2.2 and 2.1 Å resolution respectively 
(Table 5.5).  
The two proteins assumed the same relative orientation as in the WT complex RhoA-
GDP-AlF4--RhoGAP-TSA structure (PDB code 1TX4; Rittinger et al., 1997) or in the 
RhoA-GDP-MgF3--RhoGAP-TSA structure (PDB code 1OW3; Graham et al., 2002) 
with an rmsd between Cα atoms of 0.5 and 0.7 Å respectively. The difference Fourier 
maps showed clear peaks for the expected ligands (GDP and aluminium fluoride) and 
the absence of electron density for the Arg85RhoGap side chain (Figure 5.15). 
Surprisingly, density for the backbone of residues 31-33 in the RhoA effector loop was 
clearly visible in both structures. These residues are disordered in RhoA-GDP-AlF4--
RhoGAP-TSA structure. Both aluminium and magnesium are coordinated by the same 
number of fluorides atoms as in the WT structures: aluminium is coordinated by four 
fluorides in octahedral geometry, while magnesium is coordinated by three fluorides in 
trigonal bypiramidal geometry, despite the removal of a charged residue from the active 
site.  
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Table 5.5 Data collection and refinement statistics 
 
	   RhoA-­‐GDP-­‐AlF4
-­‐-­‐RhoGAPR85A-­‐TSA	   RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAPR85A-­‐TSA	  
Space	  group	   P21	   P21	  
Wavelength	  (Å)	   0.976	  	   0.939	  	  
Unit	  cell	  dimensions	  	   	   	  
a,b,c	  (Å)	   72.55	  ,	  66.06,	  76.76	   70.53,	  68.24,	  74.37	  
α,	  β,	  γ	  (°)	   90.00,	  96.00,	  90.00	   90.00,	  93.24,	  90.00	  
Resolution	  range	  (Å)1	   48.72	  (2.32-­‐2.2)	   50.24	  (2.21-­‐2.1)	  
Number	  of	  unique	  
reflections	  
36,197	   41,361	  
Multiplicity	   3.0	  (3.0)	   2.4	  (239)	  
Completeness	  (%)	   98.5(98.6)	   91(90.9)	  
Rmerge	   0.082	  (0.529)	   0.153	  (0.507)	  
<I/σ(I)>	   8.5	  (2.1)	   4.7	  (2.1)	  
Wilson	  B	  factor	  (Å2)	   33.1	   27.45	  	  
Water	  molecules	   159	   273	  
Rfactor	  (%)	   21.76	   21.6	  	  
Free	  Rfactor	  (%)	   26.63	   27.55	  
RMS	  deviations:	   	   	  
Bonds	  (Å)	   0.01	   0.017	  
Angles	  (°)	   1.395	   1.692	  
 
1Values	  for	  higher	  resolution	  shell	  are	  in	  brackets	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Figure 5.15 Difference electron density in the active site of the	   structures of RhoA-GDP-AlF4--
RhoGAPR85A-TSA and RhoA-GDP-MgF3--RhoGAPR85A-TSA. The difference Fourier map for each 
fluoride species (in green) at a counter level of 3σ is shown  (Fourier map in grey contoured at 1σ). At 
this resolution the catalytic water molecule (Wc) is included in the same continuous electron density. A-
B) RhoA-GDP-MgF3--RhoGAPR85A-TSA .C-D) RhoA-GDP-AlF4--RhoGAPR85A-TSA. Details about 
residues, dashed lines and colours are explained later in the chapter.  
 
 
At first sight this is in contrast with the charge balance hypothesis, in which the loss of a 
positive charge should cause a concomitant reduction of negative charge in the bound 
ligand. This result was confirmed by 19F-NMR, in which the AlF4- is an average peak, 
the integration of which shows four atoms are present, and the MgF3- species show three 
peaks (Figure 5.16).   
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Figure 5.16 19F-NMR spectra of the RhoA-GDP-AlF4--RhoGAPR85A-TSA and RhoA-GDP-MgF3--
RhoGAPR85A-TSA complexes. Spectra of a) RhoA-GDP-AlF4--RhoGAPR85A-TSA complex in 50 mM 
Tris at pH 7.5: 0.5 mM RhoA (with 1 eq. GDP bound), 5 mM MgCl2, 1 mM DTT, 10 mM NH4F, 1 mM 
AlCl3. The rotationally averaged peak has a chemical shift at –142.0 ppm and its integration shows there 
are 4 fluorines in the complex. b) RhoA-GDP-MgF3--RhoGAPR85A-TSA complex which shows three 
peaks at FA = –143.4 ppm, FB = –154.3 ppm, and FC = –173.4 ppm (Jin, 2012). 
 
 
The next section will discuss the importance of these structures in the understanding of 
catalysis and will try to investigate how the charge balance hypothesis can be applied to 
this particular system. Since RhoA-GDP-AlF4--RhoGAPR85A-TSA and RhoA-GDP-
MgF3--RhoGAPR85A-TSA show similar features, RhoA-GDP-MgF3--RhoGAPR85A-TSA 
will be used as model in the following paragraphs. This because MgF3- is a better 
transition state analogue (see Chapter 1) and the structure was determined at higher 
resolution. 
 
 
5.4.3 RhoA-GDP-MgF3--RhoGAPR85A-TSA and Rho-GDP structures provide novel 
insight into the GTP-hydrolysis reaction 
Through the comparison of the RhoA-GDP-MgF3--RhoGAPR85A structure with the 
RhoAG14V-GTPγS (PDB code 1A2B; Ihara et al., 1998) and RhoA-GDP-MgF3--
RhoGAP (PDB code 1OW3; Graham et al., 2002) structures, the GTP-hydrolysis 
transition state is clearly defined by two consecutive steps: a stabilisation step and a 
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catalytic step. In the first step, the binding of RhoGAP to RhoA induces the 
conformational changes necessary for the reaction start. In the second, the Arginine 
finger stimulates RhoA activity. The hydrolysis reaction can be carried out using either 
step one or step two, this asks the question: what are the necessary components for 
catalysis and how is charge balanced? Further dramatic changes occur at the Switch 
regions when RhoGAP releases RhoA, which moves out from the active site residues 
involved in catalysis.  
 
 
5.4.3.1 The stabilisation step 
The stabilisation step will be described by comparing the RhoAG14V-GTPγS, RhoA-
GDP-MgF3--RhoGAPR85A-TSA and RhoA-GDP-MgF3--RhoGAP-TSA structures.  
In order to carry out the reaction, RhoA requires the binding of RhoGAP to stabilise the 
Switch I (residues 28-38) and Switch II (residues 61-78) regions.  
The Switch regions are the protein segments mainly involved in this step. As described, 
they contain several key residues for the coordination of the transition state and are 
involved in the interaction between the proteins. The binding of RhoGAP causes 
conformational changes in the Switch regions that induce fundamental changes in the 
coordination of the γP or transition state analogue. In RhoAG14V-GTPγS, the 
triphosphate moiety is coordinated by the side chains of Tyr34RhoA, Lys18RhoA, 
Gly62RhoA, Thr37RhoA and by the Mg2+ ion. The catalytic water molecule is located at a 
position 10° away from the hypothetical line for nucleophilic attack, at 3.6 Å from the 
phosphorous atom (Ihara et al., 1998) (Figure 5.17). 
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Figure 5.17 GTPγS bound to RhoA in the RhoAG14V-GTPγS structure. The GTPγS and the predicted 
catalytic water molecule coordination are shown. Potential H-bonds are shown as black dashed lines. 
Black lines represent the proposed line for the nucleophilic attack and the distance between the 
phosphorous atom and the predicted catalytic water molecule. 
 
 
It has been proposed that the formation of the complex occurs through the interaction of 
the GAP protein with the Switch regions. In particular, the Switch II region seems to act 
as a pivot point around which rigid-body motions occur on the progression from the 
ground state to the transition state (Rittinger et al., 1997). This causes conformational 
changes in the Switch I region, where the Tyr34RhoA is in an open conformation. This is 
clearly shown by the overly of the two structures (Figure 5.18). However, the analysis 
of the superimposition of RhoAG14V-GTPγS protein with RhoA-GDP-MgF3--
RhoGAPR85A-TSA, leads to different conclusions. RhoGAP stabilises the Switch I and 
II regions through several hydrogen bonds. The Switch I region is stabilised by the 
interaction between Asn194RhoGAP and Tyr34RhoA. The binding causes a slight rotation 
of the phenol ring and maintains the closed conformation rather then the open one. 
Indeed, the side chain of Asn194RhoGAP interacts with the backbone of Tyr34, stabilising 
the OH---O bond with the tri-phosphate (Figure 5.18). The importance of this 
interaction has already been described in previous work. In the Cdc42-GDP-AlF3-
Cdc42R305A-TSA structure this binding has already been described (Nassar et al., 1998).  
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Figure 5.18 Stabilisation and conformational changes of Tyr34RhoA in the Switch I region. The 
Switch I region in RhoA-GDP-MgF3--RhoGAP-TSA and RhoA-GDP-MgF3--RhoGAPR85A-TSA is shown 
in red. A) Overlay of RhoAG14V-GTPγS (in grey) and RhoA-GDP-MgF3--RhoGAP-TSA (RhoGAP is in 
green and RhoA in cyan). The Tyr34RhoA progresses from the closed conformation to the open one. B) 
Overlay of RhoAG14V-GTPγS (in grey) and RhoA-GDP-MgF3--RhoGAPR85A-TSA (RhoGAP is in green 
and RhoA in cyan). Tyr34RhoA is stabilised in the closed conformation. The H-bonds are represented with 
a black dashed line. In both RhoA-RhoGAP structures the amine group of Asn194RhoGAP side chain 
interacts with the carbonyl of Tyr34RhoA backbone. Residues 35-38 from the Switch I region have been 
deleted for clarity. 
 
 
In the case of the Switch II region, GAP binding causes a shift of a segment comprised 
of residues 61-69 through the formation of hydrogen bonds between the two proteins. 
As previously described, Lys122RhoGAP, and Asn202RhoGAP interact with Asp65RhoA while 
Val197RhoGAP and Asn220RhoGAP interact with Tyr66RhoA. As a result of this shift, the 
side chain of Gln63RhoA moves in a way that aligns the catalytic water molecule in line 
with the magnesium atom (analogous to the phosphorus it is a surrogate for) and it 
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coordinates the transition state. Ala85RhoA backbone is hydrogen bonded with Gln63RhoA 
side chain. Furthermore both Asp65RhoA and Tyr66RhoA stabilise this position by 
interacting with the backbone carbonyl oxygen atom of Gln63RhoA (Figure 5.19). 
 
 
  
Figure 5.19 Stabilisation and conformational changes in the Switch II region. A cartoon 
representation of the Switch II region (in red) conformational changes induces in RhoA (in cyan) by 
RhoGAP (in green), in the structure of RhoA-GDP-MgF3--RhoGAPR85A-TSA. RhoA is overlaid with 
RhoAG14V-GTPγS (in grey) for comparison. Black dashed lines represent hydrogen bonds. Red dashed 
lines represent the interactions between βP-O, MgF3- and the catalytic water molecule. Lys122RhoGAP, 
Asn202RhoGAP, Val197RhoGAP, Asn220RhoGAP, Ala85RhoGAP, Asp65RhoA, Tyr66RhoA and Gln63RhoA are 
represented in sticks. The same view is shown from two different orientations, 180° apart. Residues 35-38 
from Switch I region have been deleted for clarity. Wc is the catalytic water molecule. 
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This scenario appears to be in contrast with previous theories. As shown in figure 5.20, 
it has been proposed that in the RhoA-RhoGAP system there is an active role of the 
Arginine finger in positioning Gln63RhoA and the catalytic water for the nucleophilic 
attack (Rittinger et al., 1997). The RhoA-GDP-MgF3--RhoGAPR85A-TSA structure 
shows that this event is independent of the presence of the Arginine finger and that after 
binding the catalytic water molecule is in line with the magnesium atom. We observe an 
H-bond between the Gln63RhoA side chain and the Ala85RhoGAP backbone, but even if 
there is a connection between the two residues, this stabilisation interaction is 
independent from the nature of Arg85.  
It is not possible to describe precisely the starting position of this residue, due to a bulky 
Val14 side-chain in RhoAG14V-GTPγS. RhoAG14V has been described as a dominant 
mutant and the Val maintains the Gln63RhoA too far from here to be able to start the 
reaction. Moreover, the bulky sulphur atom sterically shields the phosphorus atom from 
the close approach of the nucleophile water molecule and interfere with the stabilisation 
of the transition state by Gln63RhoA (Ihara et al., 1998). This observation does not 
conflict with the evidence for the absence of an active role of the Arg85RhoGAP side 
chain in the positioning of the Gln63RhoA/catalytic water molecule.  
Thus, the stabilisation step is the first event required for activation of intrinsic RhoA 
GTPase activity. The GAP protein performs an allosteric function, leading to the 
reaction starting through hydrogen bond formation in the Switch I and the Switch II 
regions. After binding, Gln63RhoA and the catalytic water molecule are correctly 
positioned for nucleophilic attack.  
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Figure 5.20 Allosteric effects of RhoGAP binding.  The contribution of the binding effect of RhoGAP 
are shown by comparing the previous structures, and the one proposed with the RhoA-GDP-MgF3--
RhoGAP-TSA structure. A) The stick representation of the overlay between the active site of RhoAG14V-
GTPγS (in grey) structure and RhoA-GDP-MgF3--RhoGAP-TSA (RhoGAP is in green and RhoA in 
cyan) structures shows the effect on the Switch regions (in red) and the catalytically water molecule 
caused by the entrance of the Arginine finger. B) The stick representation of the overlay between the 
active site of RhoAG14V-GTPγS (in grey) structure and RhoA-GDP-MgF3--RhoGAPR85A-TSA (RhoGAP is 
in green and RhoA in cyan) structures show the events independent of the Arginine finger. Colours and 
dashed lines are similar to previous figures. Grey dashed lines represent the magnesium coordination. Wc 
is the catalytic water molecule.  
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5.4.3.2 The catalytic step 
This section describes the catalytic steps through the comparison of RhoA-GDP-MgF3--
RhoGAPR85A-TSA and RhoA-GDP-MgF3--RhoGAP-TSA. Once the stabilisation event 
has occurred, the Arginine finger displaces Tyr34RhoA and stabilises it in an open 
conformation (Figure 5.21). As previously described, the Arginine finger interacts with 
the nucleotide phosphates (αP and γP/MgF3-), stabilising the leaving group by 
decreasing the negative charge around the γP. Both Lys18RhoA and Gly62RhoA maintain 
the interactions with the γP (or MgF3-), as described in the RhoAG14V-GTPγS structure. 
No further residue movements occur, except for Switch I region displacement caused by 
the conformational change of Tyr34RhoA.  
 
 
 
Figure 5.21 The Arginine finger flips out the Tyr34RhoA. A stick representation of the overlay between 
RhoA active site (in cyan) from RhoA-GDP-MgF3--RhoGAPR85A-TSA (in grey) and RhoA-GDP-MgF3--
RhoGAP-TSA (RhoA in cyan and RhoGAP in green) structures. Residues from Switch regions are in red.  
 
 
5.4.3.3 The releasing step 
Once the reaction has occurred, RhoGAP releases RhoA in a GDP-bound state. In order 
to analyse the final conformational changes, the structure of RhoA-GDP solved in this 
thesis to higher resolution (1.3 Å), is used. The overlay between the RhoA-GDP-MgF3--
 158 
RhoGAP and the RhoA-GDP shows a large conformational change in the Switch 
regions (Figure 5.22). In particular, after catalysis, both the Tyr34RhoA and Gln63RhoA 
residues no longer form part of the active site. This conformation is stabilised by a 
rotation of the Thr37RhoA in the Switch I region. Indeed, Thr37RhoA still coordinates the 
magnesium atom, but through the main chain instead of the side chain.    
 
 
 
Figure 5.22 Dramatic changes of the Switch regions in RhoA-GDP. A cartoon representation of the 
Switch regions (in red) with RhoA-GDP (in cyan) and RhoA from RhoA-GDP-MgF3--RhoGAP-TSA (in 
grey). Tyr34RhoA, Thr37RhoA and Gln63RhoA are shown in sticks. The left panel magnifies the rotation of 
Thr37RhoA. Colours and dashed lines are similar to previous figures.  
 
 
5.4.4 Residual activity in RhoA and RhoA-RhoGAPR85A 
The previous section has provided a complete and detailed scenario of the 
conformational changes that occur from the ground state to the transition state that 
enhance the hydrolysis of GTP in RhoA. Interestingly, as well as the Arginine finger 
and Gln63RhoA, a third relevant residue has been described: Tyr34RhoA, which is the same 
tyrosine that in other Ras proteins such as Ran and Rap is known to be involved in 
catalysis. In RhoA-GTP and RhoA-GDP-MgF3--RhoGAPR85A-TSA Tyr34RhoA is in a 
closed conformation, coordinating one of the oxygen atoms of the GTP-γP. Since RhoA 
has an intrinsic GTPase activity and RhoGAPR85A is still active, it was decided to 
investigate how these systems could hydrolyse the nucleotide and how Tyr34RhoA is 
involved in the reaction.  
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5.4.4.1 The intrinsic activity of RhoA 
Despite the formation in solution of the RhoA-GDP-AlF3-TSA complex, no structural 
data are available. Thus, only a hypothesis can be proposed on how this basal hydrolysis 
works. The RhoAG14V-GTPγS structure shows that the sulphur atom in the γP interacts 
with the hydroxyl group of Tyr34RhoA (in the closed conformation) and the amine group 
of Lys18RhoA, while both Gln63RhoA and the catalytic water molecule are too far from 
the γP to allow nucleophilic attack. Similar O3-γP coordination has been found in two 
other structures: the RhoAQ63L-GMPPNP structure (PDB code 1KMQ; Longenecker et 
al., 2003), which is another permanently GTP-bound state RhoA protein, and in the 
RhoA of the 3KZ1 structure, where RhoA is in complex with a GEF domain (Chen et 
al., 2010). Thus, the RhoA-GTP active site is likely the one described by these three 
structures. In this scenario Gln63RhoA could move occasionally in a way to place the 
water molecule in line with the γP, at distances that allows associative or dissociative 
phosphoryl transfer. In this catalysis Tyr34RhoA is likely stabilising the transition state, 
by working as a pseudo-arginine: it makes an H-bond interaction with the γP group and 
positive charge is localized in a way that would increase the electronegative interaction 
with it. This could be enough for stabilising the negative charge around the leaving 
group in a reaction that happens occasionally.  
 
 
5.4.4.1 The RhoGAPR85A residual activity 
RhoGAPR85A is still able to accelerate RhoA GTP-hydrolysis 160-fold (Graham et al., 
1999). As the structures of RhoA-GDP-MgF3--RhoGAPR85A-TSA and RhoA-GDP-AlF4-
-RhoGAPR85A-TSA show, the catalysis is independent of the Arginine finger and no 
other residues are provided by the GAP. The charge balance theory suggests that the 
mutant system should compensate the loss of the positive charge with a corresponding 
unit reduction in negative charge through the loss of one ﬂuoride from the magnesium 
or aluminium ﬂuoride moiety in the mutant complex (see Chapter 1). However, both 
fluoride species maintain their charge and the Arginine finger is replaced by a tyrosine. 
As said above, tyrosine could work as pseudo-arginine. However, this is not enough to 
stabilise the negative charge around the leaving group and thus allow efficient catalysis.  
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Two main hypotheses are proposed for explaining how the RhoGAPR85A accelerates the 
reaction. The first proposes the presence of a counter ion, which decreases the 
nucleotide negative charge, by interacting with the phosphate nucleotide region. The 
second proposes a tightening effect achieved in the RhoA active site upon RhoGAPR85A 
binding. 
 
 
5.4.4.1.1 Potential counter ions around α-phosphate 
Looking at the sequence of structures RhoAG14V-GTPγS, RhoA-GDP-MgF3--
RhoGAPR85A-TSA and RhoA-GDP-MgF3--RhoGAP-TSA, it is evident that the water 
molecules around the nucleotide increase in number and change in position and residue 
coordination (Figure 5.23), with the exception of the ones coordinating the magnesium 
ion. The same observation could be made on the sequence of structures of RhoAG14V-
GTPγS, RhoA-GDP-AlF4--RhoGAPR85A-TSA and RhoA-GDP-AlF4--RhoGAP-TSA. 
However, for the aluminium fluoride structures the difference in resolution is too large 
to make them comparable.  
The displacement of the water molecules is relevant because they change the charge 
environment around the nucleotide in the progression from the ground state to the 
transition state. Two water molecules characterise GTPγS solvation in RhoAG14V: one is 
involved in the base coordination and the other is associated with the 2’-hydroxyl group 
of the ribose.  
Upon RhoGAP binding, further water molecules interact with the nucleotide phosphate 
region. The major difference between the WT and the R85A mutant structure is the 
interaction between the α- and β-phosphates with the Arg85RhoGAP and surrounding 
water molecules. The Arg→Tyr mutation changes the solvation subtly around the 
oxygen of α-phosphate on the side of the mutated area. This introduces the possibility 
that the water molecule coordinating one of the oxygen atoms of the α-phosphate is a 
counter ion instead of a water molecule. The presence of a counter positive charged ion 
in RhoA-GDP-MgF3--RhoGAPR85A-TSA structure would re-establish charge balance. A 
water molecule in the same position is also present in the corresponding aluminium 
fluoride structure. However, due to the limited resolution of the mutant structure, it is 
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difficult to identify the nature of the atoms or their protonation state according to the 
electron density. 
An attempt was made to identify any potential ions by collecting a further dataset of 
RhoA-GDP-MgF3--RhoGAPR85A-TSA crystal at an energy of 6 keV (2 Å wavelength). 2 
Å is a long wavelength, which allows observation of the anomalous scattering of light 
elements, such as sulphur or phosphorous. Moreover, as the adsorption edge of lighter 
elements such as chloride and potassium is much closer with regard to the usual data 
collection wavelength of 0.97Å, it is possible to define whether the assigned water 
molecules are ions. The long wavelength data collection experiment was performed at 
the BESSY II Synchrotron in Berlin, at a beamline dedicated to these experiments 
(14.2). However, the anomalous map obtained was too noisy to identify sulphur or 
phosphorus atoms in the anomalous difference Fourier maps. This may have been due 
to the crystal conditions, where crystals were cryo-cooled in a large amount of paraffin 
oil belonging to the microbatch experiment. The oil may have disturbed the experiment, 
by increasing X-ray adsorption and thus preventing the correct measurement of the 
anomalous differences, which is a critical point in a long wavelength collection 
experiment.  
Thus, no conclusions could be made about the presence of a counter ion in the RhoA 
active site. However, the change in solvation is a clear event, which is affecting in some 
way the reaction.  
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Figure 5.23 GTP solvation. The three panels represent the nucleotide solvation in RhoA-GTPγS (A), 
RhoA-GDP-MgF3--RhoGAPR85A-TSA (B) and RhoA-GDP-MgF3--RhoGAP-TSA (C). Colours and 
dashed lines are similar to previous figures. 
 
 163 
5.4.4.1.2 The tightening effect around γ-phosphate during catalysis 
As described above, the binding of RhoGAP causes the correct positioning of Gln63RhoA 
in order to align the catalytic water molecule for nucleophilic attack. New hydrogen 
bonds are created around the γP-MgF3-. Upon binding FC (equivalent to the S atom in 
the RhoAG14V-GTPγS structure) is coordinated by the catalytic water molecule and the 
amino group of Gln63RhoA. The catalytic water molecule is in line at 2.12 Å distance 
from the MgTSA and the new interaction restricts its freedom. All the hydrogen bonds 
present in RhoAG14V-GTPγS structure are still present. Surprisingly, hydrogen bonds in 
RhoA-GDP-MgF3--RhoGAPR85A-TSA are shorter and much more similar to the ones in 
RhoA-GDP-MgF3--RhoGAP-TSA (Table 5.6). This tightening effect is induced upon 
RhoGAP binding; it induces stability in the RhoA active site and probably decreases the 
energy barrier as described by enzyme definition. This effect could be enough for 
accelerating the GTP-hydrolysis of 160-fold, without further leaving group stabilisation. 
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Table 5.6 Tightening effects. The table shows the hydrogen bonds coordinating the oxygen or fluorine 
atoms of the γP or MgTSA (magnesium belong to the TSA). Red distances represent the distances between 
the catalytic water molecule and γP/MgF3-. SC (side chain) or BB (back bone) indicate where the 
chemical group is place in the residue. WM are the waters coordinating the magnesium. WC is the catalytic 
water molecule.  
 
O1/FA	   Lys18RhoA	   Gly62RhoA	   	   	  
RhoAG14V-­‐GTPγS	   NH-­‐2.9	  Å	  (SC)	   NH-­‐3.31	  Å	  (BB)	   	   	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAPR85A-­‐TSA	   NH-­‐2.66	  Å	  (SC)	   NH-­‐2.68	  Å	  (BB)	   	   	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAP-­‐TSA	   NH-­‐2.63	  Å	  (SC)	   NH-­‐2.69	  Å	  (BB)	   	   	  	  	  	  
	   	   	   	   	  
O2/FB	   Mg	   WM1	   WM2	   T37	  RhoA	  
RhoAG14V-­‐GTPγS	   2.92	  Å	   3.1	  Å	   2.9	  Å	  
O-­‐3.1	  	  Å	  	  (SC)	  	  
NH-­‐3.15	  Å	  
(BB)	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAPR85A-­‐TSA	   1.83	  Å	   3.1	  Å	   2.76	  Å	  
O-­‐2.95	  	  Å	  (SC)	  	  
NH-­‐2.9	  Å	  (BB)	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAP-­‐TSA	   1.94	  Å	   2.95	  Å	   2.92	  Å	  
O-­‐2.84	  	  Å	  	  (SC)	  	  
NH-­‐2.69	  Å	  
(BB)	  
	   	   	   	   	  
S/Fc	   Y34RhoA	   Wc	   Q63RhoA	   R85	  RhoGAP	  
RhoAG14V-­‐GTPγS	   0H-­‐2.92	  Å	  (SC)	   -­‐	   -­‐	   -­‐	  
RhoA-­‐GDP-­‐MgF3
—RhoGAPR85A-­‐TSA	   OH-­‐2.48	  Å	  (SC)	   2.82	  Å	   NH-­‐2.81	  Å	  (SC)	   -­‐	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAP-­‐TSA	   -­‐	   2.85	  Å	   NH-­‐2.73	  Å	  (SC)	   NH-­‐2.6	  Å	  (SC)	  
	   	   	   	   	  
Wc	   Q63	   T37	   	   γP/MgTSA	  
RhoA-­‐GTPγS	   -­‐	   O-­‐2.8	  	  Å	  	  (SC)	  	  	   	   3.55	  Å	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAPR85A-­‐TSA	   O-­‐2.61	  	  Å	  	  (SC)	  	  	   O-­‐3.1	  	  Å	  	  (SC)	   	   2.13	  Å	  
RhoA-­‐GDP-­‐MgF3
-­‐-­‐RhoGAP-­‐TSA	   O-­‐2.73	  	  Å	  	  (SC)	  	  	   O-­‐2.89	  	  Å	  	  (SC)	   	   2.11	  Å	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5.5 Conclusions 
The structures solved here have brought novel insights into the RhoGAP mediated 
RhoA GTP-hydrolysis. In particular, through the overlay of four different structures, 
representing four different steps in the reaction, how RhoGAP contributes to the 
reaction has been analysed. Figure 5.24 shows a sequence of four snapshots that 
summarize the main changes occurring in the entire reaction around the γP/MgF3-. 
Similar snapshots can be created using the corresponding aluminium fluoride structure.  
First, RhoGAP binds RhoA through the recognition of the Switch regions. The binding 
stabilises the Switch I region in the RhoA-GTP conformation, while inducing a shift in 
the Switch II region. Thus, it appears that Switch I region, rather than Switch II, acts as 
a pivot point around which RhoGAP induces conformational changes in RhoA on 
progression from the ground state to the transition state. As result of this, the catalytic 
water molecule is moved close enough to the gamma phosphate for nucleophilic attack 
to occur. This event is independent of the Arginine finger and it is caused by an 
allosteric effect from GAP binding. Only after this step does the RhoGAP enter in an 
active role, by displacing Tyr34RhoA with the Arg85RhoGAP. Finally, upon RhoGAP 
release, both Switch regions no longer interact with the active site. The RhoA-GDP 
conformation is stabilised by the rotation of Thr37RhoA. Thus, the Gap protein acts 
actively only in the catalytic step, stimulating the intrinsic RhoA activity, while it 
performs an allosteric function during the stabilisation step.  
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In this scenario, a new role has been described for Tyr34RhoA. As has already been 
observed by Scrima A. et al., Tyr34 in RhoA is highly conserved across the main Ras 
proteins: Ras (Tyr32), RhoA (Tyr34), Ccd42 (Tyr32), Rap (Tyr32) and Ran (Tyr39). 
Upon GAP binding, the tyrosine assumes either an open or closed conformation, based 
on which further residues will be involved in the GTP-hydrolysis reaction. In the case of 
RhoA and Cdc42 it has been demonstrated that when the Arginine finger is missing, 
RhoGAPR85A is still able to increase the hydrolysis rate of Rho-GTP by 160-fold, 
(Graham et al., 1999), while the similar mutant Cdc42GAPR305A conserves 20% of its 
activity (Nassar et al., 1998). In these cases tyrosine remains in the closed 
conformation, assuming a possible role in catalysis. Indeed, taking into account the 
pseudo-arginine role that the tightening effect upon RhoGAP binding, the reaction 
could still work. Whether a counter ion is present is still an open question. Further long 
wavelength data collection experiments with better cryocooled crystals will be 
performed for answering this question.  
However, in the case of the small GTP proteins from the Rho family, the Arginine 
finger is required in order to obtain maximum reaction efficiency, leaving doubtful a 
role for the tyrosine in catalysis under physiological conditions. Considering the cycle 
described in figure 5.24, it appears that Tyr34RhoA is more involved in regulation of the 
switching cycle rather than transition state stabilisation.  Indeed, Tyr34RhoA together 
with Arg85RhoGAP and Thr37RhoA perform the RhoA RhoGAP mediated GTP-hydrolysis. 
Tyr34RhoA side chain is the hallmark, which defines where the Arginine finger should 
enter. When Tyr34RhoA coordinates the γP, the Switch I region is in closed 
conformation. The entry of the Arginine finger moves the Switch I region in the 
direction of the GDP bound conformation (semi-open conformation). Finally the 
rotation of Thr37RhoA prevents Tyr34RhoA from coming back in the active site (open 
conformation). Thus while the catalysis is working, the switch cycle is progressing from 
the GTP bound state to the GDP bound state (Figure 5.25).  
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Figure 5.25 Switch I conformational changes from the GTP-bound state to the GDP-bound state. 
The conformational changes assumed by the Switch I loop are shown. In RhoAG14V-GTPγS and RhoA-
GDP-MgF3--RhoGAPR85A-TSA Switch I is in closed conformation; in the RhoA-GDP-MgF3--RhoGAP-
TSA structure is in semi-open conformation, while it is in open conformation in the RhoA-GDP structure.   
 
 
The relevance of Tyr34RhoA and Thr37RhoA in this cycle is highlighted by the fact that 
both residues are targets of bacterial toxins and virus enzymes. In case of infection by 
the viruses H. somnus and V. parahaemolyticus, enzymes mediate AMPylation at 
Tyr34RhoA and Thr37RhoA, respectively (Worby et al., 2009; Yarbrough et al., 2009). 
AMPylation leads to the inactivation of the GTPase activity by preventing the 
interaction with downstream effectors, thereby inhibiting actin assembly in infected 
cells. Thr37RhoA in the Rho family proteins is the target of Clostridium difficile toxins A 
and B, which monogluosylate it and maintained the small G protein in off-state (Just et 
al., 1996).  
In conclusion, through the structures presented here, evidence has been provided that 
define how RhoGAP stimulates RhoA GTP-hydrolysis. Firstly a structural proof has 
been provided for the fundamental allosteric role of RhoGAP, which induces the proper 
orientation and polarisation of the catalytic water molecule. Secondly, the possible 
elements involved in RhoA intrinsic GTP-hydrolysis and the residual activity of 
RhoGAP were found. Thirdly it was defined the fundamental role in the switching cycle 
of the conserve Tyrosine in RhoA-RhoGAP system, rather than a possible role in 
catalysis. This series of events is probably also occurring in the similar proteins Ras and 
Cdc42. 
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Chapter 6 The effect of the MEK6 docking interaction on p38α 
 
 
6.1 Introduction 
 
6.1.1 MAPKs belong to the MAPKs cascade, a druggable pathway 
Mitogen activated protein kinases (MAPKs) are ubiquitous signalling molecules, which 
belong to the so called MAPK cascades. MAPK signalling confers switch-like 
responses to a wide variety of extracellular stimuli that lead to cell fate decisions such 
as differentiation, proliferation, apoptosis and senescence (Chen et al., 2001; Deng et 
al., 2004; Johnson & Lapadat, 2002).  
MAPK signalling is characterised by a cascade of multiple kinases, through which the 
signal is transduced in the form of phosphorylation events from the upstream kinase to 
the downstream one. MAPK kinase kinases (MAPKKKs) activate MAPK kinases 
(MAPKKs), which in turn phosphorylate the MAPK (Figure 6.1). This last 
phosphorylation event is a dual phosphorylation, which occurs on a conserved threonine 
and a conserved tyrosine residue in the phosphorylation lip (P-Lip) or activation loop 
(Anderson et al., 1990). The same sites are the targets of dual specificity tyrosine and 
serine/threonine phosphatases that will switch off the activated kinase via 
dephosphorylation (Dickinson & Keyse, 2006; Saxena & Mustelin, 2000). The 
activated MAPK will activate downstream proteins, such as transcription factors or 
others protein kinases (Tanoue et al., 2001).  
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Figure 6.2 MAPK cascades in mammals. The cartoon shows how the MAPK cascade is activated upon 
ligand binding to a G-protein-coupled receptor (GPCR). Activation of mitogen activated protein kinase 
(MAPK) cascades proceeds by the sequential activation of a MAPK kinase kinase (MAPKKK), a MAPK 
kinase (MAPKK) and a MAPK. The cascade for ERK, JNK and p38 is then shown. ERK is activated 
mainly by growth factors and phorbol esters, while JNK/SAPK and p38 are activated by extracellular 
stresses, such as UV irradiation and osmotic stress, and by inflammatory cytokines (Garai et al., 2012; Ip 
& Davis, 1998; Kyriakis & Avruch, 1996; Laughlin et al., 2012; Nishida & Gotoh, 1993) (modified from 
Pierce & Lefkowitz, 2001).  
 
 
There are three major MAPK subgroups described in vertebrates: ERK, p38 and 
JNK/SAPK (Tanoue et al., 2001). The three families have 40 to 50% sequence identity 
(Caffrey et al., 1999) and each one contains several isoforms (Figures 6.1-6.2).  
Each MAPK is activated by a specific upstream MAPKK, through the common 
mechanism described above (Figure 6.1). The conserved threonine and tyrosine are 
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within a Thr-X-Tyr motif, where X is proline, glutamate, and glycine for ERK, JNK, 
and p38, respectively (Cobb & Goldsmith, 1995; Davis, 1995). The phosphorylation 
activates MAPK by 100- to 1000-fold, and is necessary to achieve maximum enzymatic 
activity (Johnson et al., 1996; Payne et al., 1991; Robbins & Cobb, 1992; Robbins et 
al., 1993).  
 
 
 
Figure 6.2 The Human MAPK family tree. The family tree of human MAPKs was built through local 
alignment on the EXPASY web site using ClustalW (www.expasy.org; Thompson et al., 1994). Isoforms 
highlighted in yellow are structurally characterised.  
 
 
MAPK cascades are involved in several human pathologies and many drugs are already 
in development. ERK2 pathway components are drug targets for cancer (Roberts & Der, 
2007; Sebolt-Leopold & Herrera, 2004). JNKs are drug targets for apoptosis related 
diseases such as Alzheimer’s disease, Parkinson’s disease, type II diabetes, hearing loss, 
and also for autoimmune diseases (Manning & Davis, 2003; Resnick & Fennell, 2004). 
The p38 MAP kinase pathway is a therapeutic target for inflammatory diseases such as 
psoriasis, rheumatoid arthritis and chronic obstructive pulmonary disease (Kaminska, 
2005; Kumar et al., 1995). Currently, p38α, one of the four isoforms of p38, is under 
study for the treatment of rheumatoid arthritis, pain relief, dementia and stroke (Adams 
et al., 2001; Poornam et al., 2009; Schindler et al., 2007).  
In the case of p38α, most of these drugs bind competitively with the nucleotide in the 
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ATP binding site (Adams et al., 2001; Kaminska, 2005). Only a few bind to a region 
adjacent to the ATP binding site, which is termed the DFG-out site. The term “out”, 
indicates the conformational changes in this motif induced by drug binding (Regan et 
al., 2003; Wrobleski & Doweyko, 2005). 
However, all these drugs appear to have broad specificity: ATP is used by all kinases, 
and DFG is highly conserved across all the protein kinase family.  
 
 
6.1.2 Docking interactions are relevant in MAPK-specific drug design 
The understanding of how MAPKs interact specifically with upstream and downstream 
signalling proteins has highlighted a possible specific MAPK target.  
Through mutagenic analysis (Bardwell et al., 2001; Barsyte-Lovejoy et al., 2002; Gum 
& Young, 1999; Tanoue et al., 2000; Tanoue et al., 2001; Zuniga et al., 1999) and 
crystallographic studies (Chang et al., 2002; Heo et al., 2004; Liu et al., 2006; Remenyi 
et al., 2005; Zhou et al., 2006) it has been defined that MAPK interacting proteins, 
recruit MAPKs by binding at loci outside the active site, through an almost linear 
peptide docking motif called the D-motif (Enslen et al., 2000; Kallunki et al., 1996; 
Zuniga et al., 1999). The longest D-motifs characterised have the consensus sequences 
X-ϕH-X2-(Arg/Lys)1-2-(X)2-6-ϕA-X-ϕB (where ϕA, ϕB and ϕH are hydrophobic residues 
(Leu, Ile, or Val) (Gavin & Nebreda, 1999; Smith et al., 1999), while shorter motifs can 
lack the first four residues (Sharrocks et al., 2000) (Table 6.1).  
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Table 6.1 Structure-based sequence alignment of the D-motifs. The basic residues and ϕ residues are 
shown in blue and orange letters, respectively (modified from Chang et al., 2002).  
 
 
Docking	  protein	   Docking	  site	   MAPK	  
 
MEK1  
MEK2 
LIN-1  
SAP-1  
ELK-1  
MEK6  
MEK3b  
MEF2A  
MEF2C  
MEK7                
NFAT4  
C-JUN  
JIP-1  
ATF-2  
PTP-SL  
HePTP 
STEP   
      
     KKKPTP-IQL-NPNP  
    RKPVLPA-LTI-NP   
     GMKPNP-LNL-TATS 
    RSKKPKG-LGL-APT  
    KGRKPRD-LEL-PLSPS  
  SKGKKRNPG-LKI-PKEA  
   GKSKRKKD-LRI-SCNS  
       RKPD-LRV-VIPPSS  
       RKPD-LRV-LIPPGS  
     ARRRID-LNL-DISP 
   LERPSRDH-LYL-PLEP  
   KILKQSMT-LNL-AD  
    RPKRPTT-LNL-FPQVP  
    VHKHKHE-MTL-KFGPA  
  GLQERRGSN-VSL-TLDM  
  RLQERRGSN-VAL-MLDV 
GLQERRGSNVS-LTL-DM 
 
ERK 
ERK 
ERK 
ERK 
p38 
p38 
p38 
p38 
JNK 
JNK 
JNK 
JNK 
JNK,p38 
ERK,p38 
ERK,p38 
ERK,p38 
 R/K1-2-(X)2-6-ϕAXϕB  
 
 
The binding site of this motif on MAPKs is named the D-motif binding site. This site is 
formed by an acidic patch known as the CD domain (for Common Docking) (Tanoue et 
al., 2000) and a hydrophobic docking groove (Chang et al., 2002; Gum & Young, 
1999). The CD domain accommodates the ϕH and basic residues, while the hydrophobic 
docking groove is supposed to bind ϕA and ϕB (Akella et al., 2010; Heo et al., 2004; Lee 
et al., 2006). 
Structures of ERK2, JNK1 and p38α in complex with docking peptides, show a similar 
mechanism of binding among proteins that interact with the same MAPK, but 
substantial differences between the three families (Garai et al., 2012; Heo et al., 2004; 
Laughlin et al., 2012; Zhang et al., 2011; Zhou et al., 2006). Indeed, D-motifs are 
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selective and pathway specific despite relatively weak (micro molar) binding constants 
(Bardwell et al., 2009; Bardwell, 2006; Smith et al., 2000). 
Therefore, D-motifs (also known as D-domains, DEJL motifs, or kinase interaction 
motifs) are probably the main specificity determinants that distinguish different MAP 
kinases (Bardwell, 2006; Garai et al., 2012), which make the D-motif binding site a 
possible target for designing substrate based inhibitors specific for each MAPK. This 
idea is well established for protein kinases, but new for MAPKs (Akella et al., 2008).  
 
 
6.1.3 The docking interaction by MAPKK promotes MAPK activation  
MAPKK binds MAPK by the N-terminal tail, which the D-motif belongs. This 
interaction is followed by the formation of transient enzyme-substrate complex at the 
active site (Tanoue et al., 2001), where the double-phosphorylation occurs. 
Therefore, the structural and biochemical studies, which investigate the docking 
interaction between MAPKK docking peptide and MAPKs, are not only useful for drug 
design studies, but also provide information about the preliminary structural 
rearrangements that occur during MAPK activation. So far, four structures have been 
solved showing MAPKK-MAPK interactions: ERK2 in complex with a MEK2 and 
MEK1 peptide and p38α in complex with MKK3b (Chang et al., 2002; Garai et al., 
2012; Zhou et al., 2006). Recently, a structure of p38α in complex with a MEK6 
peptide was also solved (Garai et al., 2012). In this last structure p38α is mutated in the 
D-motif binding site, which makes the model proposed questionable. 
The subject of this chapter is the structural characterisation of the docking interaction 
between p38α and MEK6. In the p38α construct used no mutated residues are in the    
D-motif binding site. In order to understand the results of this chapter, knowledge of 
how kinases, and in particular p38, becomes activated is required. Therefore, in the next 
sections a general overview about conserved kinase motifs within their role in the active 
kinase state, will be presented. Successively, the structures of the inactive and active 
conformations of p38 will be described with the goal of highlighting the molecular 
processes necessary for activating a kinase in general and p38 specifically. Eventually 
the p38α D-motif binding site will be described and the known effects induced by the 
MAPKK docking interaction on p38α discussed.  
 175 
6.1.3.1 Structural features of activate state of protein kinases  
Despite the diversity of input signals that kinases receive, the result is always the 
reorganisation of catalytic active site, which then becomes suitable for carrying out 
phosphorylation reaction. The catalytic site is located between the two lobes of protein 
kinases, termed the N- and C-terminal lobes. It is characterised by a set of highly 
conserved structural features, which define the so called “active state” of a protein 
kinase (Jura et al., 2011).  
Based on the structure of the active state of c-AMP-dependent protein kinase A (PKA; 
PDB code 1ATP), the relevant features of the internal active site architecture are the 
following (Kornev & Taylor, 2010):  
• ATP is properly accommodated in the active site; this is due to the 
phosphorylation of the P-Lip (or activation loop) at specific sites, which induces 
a hinge motion of the two lobes and changes the relative orientation from a more 
open in the inactive state to a closer one in the active state.   
• The P-Lip is involved in both nucleotide and substrate binding. The N-terminal 
region of the P-Lip contains the DFG motif, with the aspartate pointing towards 
the nucleotide phosphate group and playing a critical role in coordinating one of 
the two magnesium ions. The C-terminal region acts as platform for docking the 
substrate peptide. 
• The secondmagnesium ion is coordinated by the catalytic base, which is the 
aspartate belonging to the HRD motif. 
• ATP αP-βP are coordinated by a conserved lysine residue, which belongs to the 
strand β3 in the N-lobe; the same lysine forms a salt bridge with a well 
conserved glutamate in helix αC. 
• ATP βP-γP interact with Glycine-rich loop, within the consensus Gly-X-Gly-X-
X-Gly sequence. This region is also called the phosphate anchor, due to its role 
in recruiting the nucleotide (Hemmer et al., 1997). 
 
 
6.1.3.2 Structural conformational changes from the inactive to the active form of 
p38 
The structure of the apo, un-phosphorylated form of p38α is available both for the 
 176 
murine (2.1 Å, PDB code 1P38) and human species (2.3 Å, PDB code 1WFC), which 
are 99% identical (Wang et al., 1997; Wilson et al., 1996a). For the description of the 
probable p38α active conformation, the structure of bis-phosphorylated p38γ (PDB code 
1CM8; Bellon et al., 1999) will be analysed. 
 Crystal structures have shown that p38α has a typical protein kinase conformation: it is 
a small protein composed of the typical N- and C-terminal lobes. The N-terminal lobe is 
composed largely of a β-sheet, whereas the C-terminal lobe is largely α-helical (Figure 
6.3). The catalytic site is at the junction between the two domains (Knighton et al., 
1991).  
 
 
 
Figure 6.3 Secondary structure of p38α. The secondary structure of human p38α is represented as a 
ribbon representation (PDB code 1WFC; Wilson et al., 1996a). The nomenclature is the common one for 
kinases. The surface representations show the two proteins lobes. The N-terminal lobe (in grey) contains 
both N and C-terminus of the protein, denoted by the black arrows.  
 
 
Based on comparisons with PKA, the N-terminal domain (residues 1-109 and 320-
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Asp168'
Thr180,Tyr182'
Tyr35'
Glycine,rich'
loop'
P,Lip'
DFG'
352) creates a binding pocket for the purine base of ATP (Walker et al., 1982). Further, 
it contains the so called Glycine-rich loop (residues 31–36) (Figure 6.4). The Glycine-
rich loop is poorly defined in both structures of un-phosphorylated p38α. In the murine  
kinase it is partially disordered, while in the human structure it is highly mobile, with 
average B-factor of 61 Å2 (total molecule B-factor is 24.5 Å2). 
The C-terminal domain (residues 110-318) contains the HDR motif with the base 
catalyst, the magnesium binding sites and the phosphorylation lip (P-lip) within the 
DFG motif (residues 168-185) (Wilson et al., 1996b) (Figure 6.4). The P-Lip contains 
the phosphorylation sites. MAPKKs activate p38α by phosphorylating residues Tyr182 
and Thr180 (Mansour et al., 1994). These residues are well defined in the electron 
density in both structures. Thr180 is on the surface, while Tyr182 interacts through a 
water molecule with the side chain hydroxyl group of Thr221. The rest of the P-Lip is 
partially disordered in both structures: residues 171-178 are poorly defined in the 
electron density for the murine, while 171-174 are not visible in the human structure.  
 
 
Figure 6.4 Functional motifs in p38α. Ribbon and surface representation of functional motifs in the 
human p38α structure (PDB code 1WFC; Wilson et al, 1996a). The Glycine-rich loop is in orange, with 
Tyr35 in sticks. This tyrosine has occupancy zero in the structure. DFG motif is in magenta with Asp168, 
in sticks. The glycine of DGF motif is not visible in the electron density of human p38α structure. The P-
Lip is in red, with the phosphorylation sites in sticks. Part of it is disordered.  
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In the structure of the p38 active state, an ATP analogue is bound in the active site. As 
expected, Asp171p38γ (Asp168p38α) belonging to the DFG motif interacts with a 
magnesium ion that coordinates the nucleotide analogue. The base catalyst Asp153p38γ 
(Asp150p38α) belonging to the HDR motif points toward the active site. Lys56p38γ 
(Lys53p38α) from strand β3 and Glu74p38γ (Glu71p38α) from helix αC form a salt bridge 
which is involved in ATP coordination (Figure 6.5; Bellon et al., 1999).  
 
 
 
Figure 6.5 p38 active site. The panels magnify the active site of both inactive (left) and active (right) 
state of p38, where residues involved in catalysis are shown in sticks. Colours are similar to previous 
figures. H-bonds are represented with black dashed lines.  
 
 
The comparison of the structures of the inactive p38α and active p38γ shows that 
phosphorylation causes a reconfiguration of the P-Lip and of the protein active site.  
Phosphorylation is supposed to cause the alignment of two fundamental intramolecular 
networks between the N-lobe and C-lobe, which are defined as the “regulatory spine” 
and the “catalytic spine” (Kornev et al., 2006; Kornev et al., 2008). Both networks 
contain hydrophobic residues, which become assembled upon kinase phosphorylation. 
The comparison of inactive and active state of CDK and Src kinases suggested that the 
DFG motif has a different orientation in the two states (Jura et al., 2011). In particular, 
the aspartate and the phenyalanine side chains exchange positions due to a crankshaft-
like motion of the peptide backbone. In the active state conformation, DFG is in the “in” 
conformation with the aspartate pointing toward the active site and the phenylalanine is 
assembled in the core of the regulatory spine. In the inactive conformation the DFG is 
in the “out” conformation, with the phenyalanine pointing toward the active site. The 
Glu71p38α*
*
Lys53p38α*
Asp168p38α*
*
Asp150p38α*
*
Glu74p38γ*Lys56p38γ*
Asp171p38γ*
Asp153p38γ*
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inactive phenyalanine conformation prevents both the ATP binding and the assembling 
of the catalytic spine. As discussed, the DFG-out conformation is also induced by 
certain drug molecules.  
Upon kinase phosphorylation, a change in the helix α3 orientation is also expected, 
which promotes the formation of the lysine-glutamate salt bridge and ATP binding. 
Structures of inactive and active kinase show that the helix α3 goes from an “outward” 
conformation associated to DGF-out state, to “inward” conformation associated to the 
DGF-in state.  
In summary, phosphorylation at the P-Lip cause relevant structural rearrangements, 
which lead to the DGF-in conformation and consequently to proper orientation of helix 
α3. Indeed in the p38 active state, the DFG is in the “in” conformation and helix α3 is in 
inward state, which defines p38 being in the active state (Figure 6.6). 
 
 
 
Figure 6.6 DFG-in conformation in the active state of p38γ. The active site of the bis-phosphorylated 
p38γ with bound AMP-PNP is shown (PDB code 1CM8; Bellon et al., 1999), with a zoom on the DGF 
motif. Colours are similar to previous figures. H-bonds are represented with black dashed lines.  
 
 
The comparison between the inactive p38α and active p38γ shows that this 
rearrangement is guided by the phosphorylation of the TxY motif and consequently, by 
Glu74p38γ*
(*from*helix*α3)*
Lys56p38γ*
Asp171p38γ*
Phe172p38γ*
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the formation of two specific phosphate-residue binding grooves. These basic patches 
are composed by a series of highly conserved arginine resedues (Figure 6.5; Bellon et 
al., 1999; Canagarajah et al., 1997). The same arginine resedues are indeed too far from 
each other in the inactive p38α.  
 
 
 
 
Figure 6.7 Activation of p38. The structural changes caused by phosphorylation are shown through the 
comparison of the un-phosphorylated structure of p38α (PDB code 1WFC; Wilson et al., 1996a) and the 
bis-phosphorylated structure of p38γ with bound AMP-PNP (PDB code 1CM8; Bellon et al., 1999). The 
surface representations show how the YPO (P-Tyr182) binding site and the TPO (P-Thr180) binding site 
are formed. In the sequence alignment of the two proteins the functional motifs are represented in colours 
described in previous figures. The arginines involved in phosphorylated residue binding are highlighted 
in cyan. Residues involved in catalysis are highlighted in green.      
 
 
p38α ---MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 57  
p38γ MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60 
     *  *****:.** ***   *::*.********:**:*.* :** :**:*** *   
p38α PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117  
p38γ PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM 120 
     **** :.***:**********:************* .:*::*.*.***  :**:** :::   
p38α KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177  
p38γ KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180  
     * :** :*::***:**:*:**:***:* ********.*******************::*.   
p38α EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237  
p38γ EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240  
     ******.********::****:*.**************::**:*** *:**:**** *::   
p38α LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 297  
p38γ VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300 
     :.*** **:::::.*:.*:**::.* :: * :**.::  *.****:*********:::*:   
p38α TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEE 357  
p38γ TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGAR 360  
     **.:**** ** . ** :*** .: **:**:. *  :**** :**.**:** **     .   
p38α MES---- 360  
p38γ VSKETPL 367                                     
     :..     
 
Arg70p38α*
*
Arg149p38α*
*
YPO*binding*site*
(Arg186,189*in*p38γ)*
*
TPO*binding*site*
*(Arg73,*176,*152*
in*p38γ)*
*
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In particular, the formation of the P-Thr180 binding site (TPO) brings together three 
arginine resedues, which belong to three different protein regions relevant in catalysis: 
Arg73p38γ (Arg70p38α) from helix α3, Arg152p38γ (Arg149p38α) from the catalytic motif 
HDR and Arg176p38γ (Arg174p38α) from the P-Lip (Figure 6.7). 
Surprisingly, the Phenyalanine in both human and murine structure of inactive p38 is 
outward of the active site, suggesting for a DFG-in conformation. However, since the 
Phenyalanine is the last visible residue before the disordered region, its orientation is 
doubtful. 
 
 
6.1.3.3 D-motif binding site in the inactive p38α 
As described above, the D-motif binding site on MAP kinases is formed by an acidic 
patch in the C-terminal extension of the kinase core known as the CD domain (Tanoue 
et al., 2000) and a hydrophobic docking groove (Chang et al., 2002; Gum & Young, 
1999). The CD domain is an electrostatic surface depression (Zhou et al., 2006). It 
comprises acidic residues, which are Asp313, Asp315 and Asp316 in p38α. Moreover, 
it is part of a long loop (Loop16 or L16), which connects the C-terminal lobe with the N-
terminal lobe. Residues belonging to this loop can also participate in the interaction. 
The hydrophobic docking groove is located near helices αd and αe and in the β7-β8 
reverse turn (Akella et al., 2010; Heo et al., 2004; Lee et al., 2006), which contains a 
sub-domain named ED, characterised by mutagenic analysis (Tanoue et al., 2001) 
(Figure 6.8). 
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Figure 6.8 D-motif binding domain in p38α. The secondary structure elements involved in the D-motif 
binding domain are shown for human p38α (PDB code 1WFC; Wilson et al., 1996b). The ED domain 
belongs to the β7-β8 reverse turn. The CD domain is part of Loop16, which is shown in pink. 
 
 
6.1.3.4 How does the MAPKK docking interaction promote p38 activation?  
 
Structures of MAPKs in complex with peptides containing the MAPKK D-motif have 
shown that docking interactions cause long-range conformational changes, particularly 
in the activation loop. This is a preliminary event which prepares the MAPK for 
activation by phosphorylation.  
Murine p38α has been co-crystallised with docking peptides from MKK3b 
(pepMKK3b-p38α), a MAPK kinase, and with MEF2A (pepMEF2A-p38α), one of the 
transcription factors activated by p38α (Chang et al., 2002). Peptide sequences are 
reported in table 6.1. Since the structural changes induced by both peptides are equal, 
both structures were used for building a model of p38α activation (Akella et al., 2010). 
Both peptides bind in an elongated manner, without showing any binding to the CD 
domain. The selective interactions are in the hydrophobic pocket built around residue 
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Ile116. The peptide-protein interaction is stabilised by sidechain-backbone hydrogen 
bonds between sidechains of Gln120p38α, Gln160p38α and His126p38α and the peptide 
backbone. Gln160p38α had been previously characterised by mutagenic analysis and it is 
part of the so called ED domain. Despite these experiments, no interaction with 
aspartate 161 has been observed. For this reason, the ED domain will not be referred to 
in this chapter. A similar peptide-protein interaction is present in the recently published 
structure of p38α in complex with MEK6 peptide (pepMEK6-p38αC126S, Garai et al., 
2012), where only the peptide residues interacting with the hydrophobic groove are 
visible in the electron density. 
The binding of the peptide trough the hydrophobic region induces disorder in the P-Lip, 
which should facilitate its binding to the MAPKK active site. Further conformational 
changes also occur in the ATP binding loop. Indeed, it has been proposed that the 
docking interaction promotes the nucleotide binding, through conformational changes at 
the inactive p38 active site (Figure 6.9). 
 
Figure 6.9 Conformational changes induced by docking interaction in inactive p38α. The cartoon 
shows conformational changes occurring upon docking interaction. The peptide is shown in orange.  The 
interaction with the hydrophobic groove (helix αd in purple) induces disorder in the P-Lip. New water 
molecules appear after peptide binding (red sphere). This last observation has been described in the 
structure of double-phosphorylated p38α in complex with MKK3b peptide, but not in pepMKK3b-p38α 
structure (modified from Akella et al., 2010). 
 
 
Similar hydrophobic and electrostatic interactions between MAPKK peptide and 
MAPK D-motif binding site have been found in the structures of ERK2 complexes with 
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docking peptides (Zhou et al., 2006). However, the structural rearrangements induced 
are different in ERK from p38.  
The model of ERK2 activation has been built through two peptide-MAPK structures. 
ERK2 has been co-crystallised with a peptide (pepMEK2) derived from the activating 
kinase MEK2 and also with a docking peptide derived from hematopoietic protein 
tyrosine phosphatase (pepHePTP), which dephosphorylates and retains the enzyme in 
the cytoplasm (Pulido et al., 1998; Saxena & Mustelin, 2000; Zuniga et al., 1999). 
Peptide sequences are shown in table 6.1. The two complexes are very similar (rmsd 0.4 
Å) therefore, equivalent observations have been made on both (Zhou et al., 2006). 
There are several features specific for ERK2-activation model, which appear to be 
absent in the p38α-activation model. The D-motif peptide adopts a helical conformation 
at the N-terminus, which promotes the binding to the CD domain. This binding causes 
long-range conformational changes in Loop16, which finally induce conformational 
changes in the P-lip. The un-phosphorylated ERK2 structure shows that only one of the 
two phosphorylation sites is exposed to the solvent. Upon the docking interaction, both 
phosphorylation sites are exposed to the solvent (Figure 6.10). 
 
 
 
Figure 6.10 Conformational changes induced by docking interaction in inactive ERK2. The cartoon 
shows which conformational changes are required for exposing the ERK2 phosphorylation sites to the 
solvent. The two arginines of pepHePTP (RLQERRGSNVALMLDV) in yellow, interact whit the CD 
domain in Loop16 (in purple). Following the formation of a new contact between the Loop16 and the P-
Lip, both phosphorylation sites are exposed. N- and C- terminal lobes are represented by small and large 
blues eggs. P-Lip is in red (modified from Zhou et al., 2006). 
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Thus, despite the fact that p38 and ERK are both MAPKs and a common 
phosphorylation- activation mechanism has been described, the structures solved so far 
reveal that MAPK activation can be achieved in different ways. D-motif peptides bind 
differently and different conformational changes are observed in the P-Lip. While in 
ERK2 the docking interaction is mainly through the CD domain, and it causes a change 
in P-Lip conformation, in p38α the loop becomes completely disordered upon binding 
of MAPKK at the hydrophobic groove.  
However, there are still some open questions about the p38α-activation model proposed.  
No interactions with the CD domain have been detected in the crystallographic 
structures of p38α in complex with a docking peptide. However, mutagenesis analysis 
has shown that peptide binding is decreased or absent when aspartate residues of the CD 
domain are mutated to alanines (Tanoue et al., 2000). Modelling of pepMKK3b-p38α 
and pepMEF2A-p38α, has shown that basic residues from the peptide, not visible in the 
electron density, could interact with the CD domain (Chang et al., 2002). Furthermore,  
15N-1H TROSY spectra on pepMKK3b-p38α complex (Akella et al., 2010) revealed 
that Asp313, 315, 316 from p38α and surrounding residues move in response to peptide 
binding. Thus, the role of peptide binding to p38α CD domain remains unclear. 
The second open question relates to the disorder induced in the p38α P-Lip, which 
could be a crystal artefact. The 15N-1H TROSY data on pepMKK3b-p38α has shown 
that long-range conformational changes occur when the peptide is bound. However, due 
to a problem of assignment, no observation was made for the P-lip, leaving open the 
question of the solution state of the loop in the docking complex. The assignment 
problems are likely due to the absence of defined structure in the P-Lip. Thus, a better 
and more stable reference model of the apo-p38α is needed for investigating the 
veracity of the p38α-activation model proposed. 
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6.2 Aim of this project 
The aim of this project was to investigate the interaction between MEK6 and p38α 
through the structure of p38α in complex with a MEK6 D-motif peptide. As explained 
in the introduction, the structural characterisation of this complex will provide useful 
information for drug design and possibly, novel insight into p38α activation. 
 For these crystallisation experiments a mutant of p38α was used, in which the apo-
structure showed a completely ordered P-Lip and, furthermore, a more stable Glycine-
rich loop. The comparison between the apo-structure and the pepMEK6-p38α structure 
shows the molecular basis of initial MEK6 binding and the conformational changes 
induced in p38α. Despite the already published structure of pepMEK6-p38α, in the 
structure solved here the C-terminus of the peptide is partially visible in the electron 
density, which allows the definition of possible secondary elements and possible 
interactions with the CD domain. Moreover, the published structure contains a mutation 
in the hydrophobic groove (C162S), whereas the structure determined here does not 
have this mutation.  
Thus, the structures solved in this thesis (p38αK53R and pepMEK6- p38αK53R) provide 
answers to the open questions presented in section 6.1.3.3. Therefore, a model of p38α-
activation will be shown at the end of this chapter. 
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6.3 Experimental procedures  
 
6.3.1 Plasmids 
Several constructs were used in the study. Some for crystallisation purposes, others for 
kinetic studies (see Chapter 7). Two plasmids pET-BS(+) and pET15b were employed 
for protein expression. The first encodes a non-cleavable N-terminal His6-tag, the 
second is cleavable. Cloning was performed partially in Sheffield (in the NMR group of 
Prof. Jon Waltho) and partially in our laboratory.  
 
For MEK6, three constructs were used: 
 
• pET-BS(+)-MEK6: full length form of human MEK6; the construct had been 
retro-mutated from MEK6DD, in order to have an inactive form. This form 
requires phosphorylation by an upstream kinase to be activated. The 
mutagenesis experiment was performed in Sheffield; 
• pET-BS(+)-MEK6DD: the full length, constitutively active form of human 
MEK6; this plasmid was donated by Vertex pharmaceuticals, Cambridge, MA, 
USA. The original construct was transferred into pET15b in order to have a 
cleavable His6-tag (see below for details);  
• pET15b-ΔMEK6DD: MEK6DD truncated at residue 46, a constitutively active  
form of human MEK6 ; the truncation eliminates the flexible region, supposed 
to be responsible for p38α recruitment; 
 
For p38α, three constructs were used: 
 
• pET-BS(+)-p38α: the full length, inactive (non-phosphorylated) form of human 
p38α.  
• p38αK53R: full length, inactive and mutated form of human p38α. The protein 
is supposed to be unable to bind ATP. The mutagenesis experiment was 
performed in our laboratory (see below for details); 
• p38αT180A: full length, inactive and mutated form of human p38α. The 
protein can be phosphorylated only at one site (Tyr182). The mutagenesis 
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experiments and protein purification were performed in Sheffield (Xiaoxia et 
al., 2011).  
 
 
6.3.1.1 MEK6DD cloning in pET15b 
The MEK6DD DNA fragment was transferred from pET-BS(+) to pET15b in order to 
obtain an N-terminal cleavable His6-tag. Both plasmids were cleaved overnight at 37°C 
by the restriction enzyme NdeI (New England Biolabs, Ipswich, MA, USA). The 
recognition site of the restriction enzyme is CA^TATG and it was chosen for its ability 
to cut at the first ATG codon, after the His6-tag DNA sequence. The cleavage was 
verified by electrophoresis and both the MEK6DD fragment and pET15b plasmid were 
purified using the gel extraction kit from Qiagen (Hombrechtikon, Switzerland). Since 
only one restriction enzyme was used, the cutting plasmid was incubated with alkaline 
phosphatase (Sigma, St. Louis, MO, USA) in order to dephosphorylate the DNA 
plasmid to prevent recircularisation. Finally, the dephosphorylated plasmid was mixed 
with the MEK6DD fragment in different ratios (1:3, 1:6, 1:9, 1:12, named T-samples) 
and incubated for one hour at room temperature with T4 DNA Ligase (Rapid DNA 
ligation kit, Fermentas). As a control, equivalent samples were prepared without the 
MEK6DD fragment (named C-samples). All eight ligation products were transformed 
into E. Cloni DH5α cells (Lucigen corporation, Middleton, WI, USA). Evaluation of the 
experiment was performed by comparing for each ratio the number of colonies between 
the T-sample plate and its respective C-sample plate. Eventually, a few colonies were 
selected and the correct incorporation of the gene verified by sequencing.  
 
 
6.3.1.2 Mutagenesis of p38α in p38αK53R 
Mutagenesis of p38α was performed on His6-tagged human p38α in pET-BS(+). 
p38αK53R was constructed by PCR-based mutagenesis, using Pfu polymerase 
(Fermentas, Vilnius, Lithuania) in magnesium supplemented buffer. The following 
primers were used:  5’tacgtgtggcagtgaggaagctctccagacc-3’, with antisense 5’-
ggtctggagagcttcctcactgccacaagta-3’. The melting temperature of both oligonucleotides 
was 72°C. The following PCR program was run: 
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1. first denaturation: 3’ 95°C 
2. cycle (repeated 18 times): 1’ 95°C, 1’ 65°C 1’,  8’ 68°C 
3. 10’ 68°C 
PCR product was treated with DpnI restriction enzyme (Stratagene, La Jolla, CA, 
USA), which eliminates the original templates by recognising methylated DNA. Treated 
PCR product was transformed into XL1-Blue Competent cells (Stratagene, La Jolla, 
CA, USA). Positive clones were picked and mutagenesis was verified by sequencing.  
 
 
6.3.2 Protein expression and purification 
All proteins were expressed and purified in a similar way. Due to the human origins, 
Rosetta2 cells were used for expression. Expression was carried out ON, at 20°C.  
As all the constructs have an N-terminal His6-tag, a nickel column was used for the first 
purification step. Thrombin was employed to cleave the His6-tag for the cleavable 
constructs. Size exclusion chromatography was then performed. Details of purification 
are reported in Table 6.2. 
ΔMEK6DD protein eluted as dimers at an elution volume of 78 ml from the size 
exclusion column of 130 ml bed volume, with a 260/280 ratio of 0.64 (Figure 6.11). 
The yield of the entire process was around 10 mg/L culture.  
MEK6 and MEK6DD were purified using a smaller column (24 ml bed volume). The 
full length proteins were used in kinetic experiments (see Chapter 7), which required 
lower protein amounts than the crystallisation experiments. For this volume, elution was 
typically around 15 ml, with a 260/280 ratio in the range of to 0.65. The final yield was 
6 mg/L culture for MEK6 and 10 mg/L culture for MEK6DD. 
In all MEK6 purifications, the correspondence between the highly purified protein and 
the peak described was confirmed by SDS PAGE The protein was then concentrated 
and stored at -20°C.  
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Figure 6.11 Size exclusion chromatography profile of ΔMEK6DD, MEK6 and MEK6DD. The 
absorbance at 280 nm is shown in blue, while the absorbance at 260 nm is shown in red. The ΔMEK6DD 
chromatogram was run with a HiLoad 16/60 Superdex 200 pg, while the MEK6 or MEK6DD 
chromatogram was run with Superdex 200 10/300 GL. Both chromatograms are the results of purification 
from 3L of culture.  
 
 
For p38α constructs, a further anion exchange chromatography step was necessary for 
separating the phosphorylated form from the un-phosphorylated form. Phosphorylation 
is probably due to endogenous bacterial kinases. A NaCl gradient was used to separate 
the two forms. The success of the experiment was verified on native PAGE gels, where 
the two species are clearly separated (Figure 6.12). The protocol for native PAGE gel 
will be described in the next chapter. Un-phosphorylated p38α was then collected and 
Void	  volume	  
78	  ml	  
15	  ml	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concentrated before storage at -20°C. The final yield for both p38α and p38αK53R was 
20 mg/L culture. 
 
 
 
 
Figure 6.12 Anion exchange chromatography of p38αK53R. The elution profile from 15 to 30% of 
buffer B is shown. 10 mg of protein were used for the experiment. In the native PAGE gel below, one or 
two fractions are run for each peak (pK). The distinction between un-phosphorylated p38α and mono-
phosphorylated p38α will be elucidated in the next chapter. The absorbance at 280 nm is shown in blue , 
the absorbance at 260 nm is shown in red, %B is in purple. Conductance, expressed in %, is in green.  
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Table 6.2 Protein purification steps 
 
Purification	  steps	   	   Solutions	  for	  
MEK6	  
constructs	  
Solutions	  for	  
p38α	  
constructs	  
1. Cell	  Lysis	   Bacteria	   were	   resuspended	   in	   the	  
Lysis	   Buffer	   or	   LyB	   (10ml	   LyB	   for	   750	  
ml	   of	   bacteria)	   with	   addition	   of	   a	  
protease	   inhibitor	   cocktail	   tablet	  
(EDTA	   free)	   and	   DNase	   (trace).	   The	  
cells	   were	   lysed	   by	   sonication	   on	   ice	  
for	   3	   *	   50	   s	   with	   1	   min	   gap,	   60%	  
power;	  then	  centrifuged	  for	  20	  min	  at	  
20,000	  g,	  4	  °C.	  
	  
Lysis buffer (LyB)= 
50 mM Tris pH 7.5, 
500 mM NaCl, 10 
mM MgCl2 , 2 mM 
DTT, 10 mM 
Imidazole (40 mM 
only for ΔMKK6) 
 
Lysis buffer 
(LyB)= 50 mM Tris 
pH 7.4, 500 mM 
NaCl, 10 mM 
MgCl2 , 1 mM DTT, 
10 mM Imidazole , 
5% Glycerol 
 
2. Affinity	  
Chromatograpy	  
A	  Ni-­‐NTA	  prepacked	  column	  was	  used	  
(His-­‐trap	   column-­‐5	   ml,	   GH),	  
connected	   to	   an	   AKTA	   prime	   system.	  
After	   equilibrating	   the	   column	   with	  
the	   Binding	   Buffer,	   the	   binding	   step	  
was	  performed	  at	  0.5	  ml/min	  until	  UV	  
absorbance	  started	  to	  decrease.	  Then	  
the	   column	   was	   washed	   extensively	  
with	   BB	   until	   the	   UV	   absorbace	   was	  
constant.	  The	  protein	  was	  eluted	  with	  
a	  linear	  gradient	  at	  1ml/min.	  
Binding	  Buffer	  (BB)=	  
50	  mM	  Tris	  pH	  7.5,	  
500	  mM	  NaCl,	  10	  
mM	  MgCl2	  ,	  0.5	  mM	  
DTT,	  10	  mM	  
Imidazole	  (40	  mM	  
only	  for	  ΔMKK6)	  
	  
Elution	  Buffer	  (EB)=	  	  
50	  mM	  Tris	  pH	  7.5,	  
500	  mM	  NaCl,	  10	  
mM	  MgCl2	  ,	  0.5	  mM	  
DTT,	  500	  mM	  
Imidazole	  
	  
Binding	  Buffer	  
(BB)=	  50	  mM	  Tris	  
pH	  7.4,	  500	  mM	  
NaCl,	  10	  mM	  MgCl2,	  
10	  mM	  Imidazole	  
5%	  Glycerol	  
	  
Elution	  Buffer	  (EB)=	  	  
50	  mM	  Tris	  pH	  7.4,	  
500	  mM	  NaCl,	  10	  
mM	  MgCl2	  ,	  500	  
mM	  Imidazole,	  5%	  
Glycerol	  
	  
3. His6-­‐tag	  
cleavage	  
The	  protein	  buffer	  was	  exchange	  with	  
a	   p10	   column	   in	   the	   Thrombin	  
cleavage	   buffer.	   After	   ON	   incubation	  
with	   Thrombin	   at	   4°C,	   gently	   shaking	  
(100U/20	  mg	   of	   protein),	   the	   affinity	  
chromatography	  step	  was	  repeated	  in	  
order	  to	  separate	  the	  cleaved	  protein	  
from	   the	   un-­‐cleave.	   A	   Hitrap	  
benzamidine	   column	   was	   connected	  
to	   His	   trap	   column	   to	   purify	   the	  
cleaved	   protein	   from	   Thrombin.	   This	  
step	  was	  performed	  at	  1	  ml/min.	  
Thrombin	  cleavage	  
buffer	  (TCB)=	  50	  mM	  
Tris	  pH	  7.5,	  500	  mM	  
NaCl,	  10	  mM	  MgCl2	  ,	  
0.5	  mM	  DTT,	  2mM	  
CaCl2	  
Thrombin	  cleavage	  
buffer	  (TCB)=	  50	  
mM	  Tris	  pH	  7.4,	  500	  
mM	  NaCl,	  10	  mM	  
MgCl2,	  2mM	  CaCl2,	  
5%	  Glycerol	  
4. Size	  exclusion	  
chromato-­‐
graphy	  (SEC)	  
A	  HiLoad	  16/60	  Superdex	  200	  pg	  or	  a	  
Superdex	  200	  10/300	  GL	  was	  run	  at	  a	  
flow	  rate	  of	  1	  mL/min	  with	  SEC	  buffer.	  
MEK6	   constructs	   require	   this	   step	   at	  
4°C.	  	  
SEC	  buffer=	  50	  mM	  
HEPES	  pH	  7.5,	  250	  
mM	  NaCl,	  10	  mM	  
MgCl2	  ,	  5	  mM	  DTT,	  
5%	  Glycerol	  
	  
SEC	  buffer	  =	  
50	  mM	  Tris	  pH	  7.4,	  
50	  mM	  NaCl,	  10	  
mM	  MgCl2,	  1mM	  
DTT,	  5%	  Glycerol	  
	  
5. Mono	  Q	   A	  MonoQ	  5/50	  GL	  column	  was	  run	  for	  
p38α	   constructs.	   Loading	   was	  
performed	   at	   0.3	   ml/min	   in	   50	   mM	  
salt.	  A	  slow	  gradient	  from	  150	  mM	  to	  
500	   mM	   salt	   was	   selected	   after	  
several	  trials	  (1ml/min).	  
	   Buffer	  A	  =	  
50	  mM	  Tris	  pH	  7.4,	  
50	  mM	  NaCl,	  10	  
mM	  MgCl2,	  1mM	  
DTT,	  5%	  Glycerol	  
	  
Buffer	  B	  =	  
50	  mM	  Tris	  pH	  7.4,	  
1	  M	  NaCl,	  10	  mM	  
MgCl2,	  1mM	  DTT,	  
5%	  Glycerol	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6.3.3 Crystallisation experiments 
After a MonoQ purification step, un-phosphorylated p38αK53R was concentrated to 10 
mg/ml and stored at -20°C. For crystallisation trials, p38αK53R was prepared by adding 
NH4F (10 mM) and AlCl3 (2mM) as additives.  For p38αK53R in complex with the 
MEK6 peptide (pepMEK6-p38αK53R), p38αK53R was incubated ON at 4°C with a        
3-fold molar excess of peptide. The peptide SKGKKRNPGLKIPKA was purchased 
from Eurogentec (Angers, France). 
p38αK53R and pepMEK6-p38αK53R crystallised in different conditions. Crystallisation 
conditions were established by testing several commercial screens at the EMBL High 
Throughput Crystallisation Laboratory (Grenoble, France). Crystals of p38αK53R were 
obtained at 20°C by the sitting drop method from solutions containing 10 mg/ml 
p38αK53R in 20 mM Tris HCl pH 7.5, 150 mM NaCl, 10mM MgCl2, 1mM DTT, 5% 
(v/v) glycerol, 10 mM NH4F and 2 mM AlCl3 equilibrated against 3.5 M Na Formate 
pH 7.0 (Figure 6.13). Crystals were transferred to a cryoprotection buffer prepared by 
equilibrating protein buffer solution against reservoir solution supplemented with 20% 
(v/v) glycerol in a sitting drop plate and harvested using a micromesh loop (MiteGen, 
Ithica, NY, USA), plunged into liquid nitrogen and stored at 70K.   
Crystals of pepMEK6-p38αK53R were obtained as above but equilibrated against a buffer 
containing 25% (w/v) PEG 3350 and 0.1 mM Bis/Tris pH6.5 (Figure 6.13). Crystals 
were transferred to a cryoprotection buffer, prepared as described above (reservoir 
supplemented with 20% (v/v) PEG400) and harvested using a micromesh loop 
(MiteGen, Ithica, NY, USA), plunged into liquid nitrogen and stored at 70 K.  
 
 
6.3.4 Data collection, structure solution and refinement 
Diffraction data were collected at beamlines ID23-1 and ID23-2 at the ESRF (Grenoble, 
France) on an ADSC Q315 CCD detector (ID23-1) or a MAR225 CCD detector (ID23-
2) to between 2.2 and 2.8 Å resolution. Crystals of p38αK53R contained multiple leaves 
of crystals and the combination of a micro-focussed or micro-beam in combination with 
automated mesh scans was essential. Crystals of pepMEK6-p38αK53R formed long 
needles (100 x 20 x 20 µm3) in clusters that were difficult to visualise (Figure 6.13). 
Crystals were visualised and the best diffraction volumes were defined by diffraction 
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cartography as implemented in the beamline GUI MxCuBE (Bowler et al., 2010; 
Gabadinho et al., 2010).  
Data were processed with XDS (Kabsch, 2010). The structures were solved by 
molecular replacement with MolRep (Vagin & Teplyakov, 2010). For p38αK53R, the 
PDB accession code 1WFC (Kamps & Sefton, 1986) was used as search model. For 
pepMEK6-p38αK53R, p38αK53R structure was used as search model. Refinement was 
carried out alternately using Phenix.refine (Afonine et al., 2012) and by manual 
rebuilding with the program COOT (Emsley & Cowtan, 2004), as described in Chapter 
2. Single peptide residue occupancy was refined using Phenix.refine (Afonine et al., 
2012) .  
 
 
 
Figure 6.13 Crystals of p38αK53R and pepMEK6-p38αK53R. 
 
 
 
 
p38αK53R( pepMEK6-p38αK53R(
500(μm( 500(μm(
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6.4 Results and Discussion 
 
6. 4.1 The structure of p38αK53R  
 
6.4.1.1 p38αK53R is an inactive mutant 
Structures of both murine and human recombinant p38α have been solved to high 
resolution. Both structures show disorder in a few regions, such as the Glycine-rich loop 
and the phosphorylation lip region. The structure of p38αK53R was solved at 2.8 Å 
resolution. Surprisingly, the structure of the mutant is much more ordered in the P-Lip 
and in the Glycine-rich loop than WT p38α. This mutant was used for further 
crystallographic (in this Chapter) and kinetic experiments (see Chapter 7).  
Lys53 in subdomain II of p38α is fully conserved among the protein kinase family 
members (Hanks et al., 1988). This lysine has been described to be essential in the 
phosphoryl transfer reaction (Gibbs & Zoller, 1991; Kamps & Sefton, 1986). In the 
structure of double-phosphorylated p38γ, Lys56, which corresponds to Lys53 in p38α, 
is coordinating the αP of AMP-PNP (Bellon et al., 1999). Mutation of this conserved 
lysine in several protein kinases has resulted in loss of kinase activity, or kinases with 
low residual activity (Gibbs & Zoller, 1991; Kamps & Sefton, 1986; Robbins et al., 
1993; Snyder et al., 1985). Mutation of this lysine in ERK2 (K52A and K52R), 
drastically lowered the kinase activity by reducing kcat, conserving 5% of activity of the 
wild type protein. Structural analysis of ERK2K52R with ATP has revealed that the 
substitution of a lysine with an arginine altered the way that the ATP β-phosphate group 
is bound due to an interaction with the guanidinium group. Furthermore, the 
coordination sphere of Mg2+ is altered. Thus, the mutation creates a non-productive 
binding mode for ATP. This suggests a relevant role of Lys52 in orienting ATP binding 
in ERK2 (PDB code 1GOL; Robinson et al., 1996). Interestingly, the ERK2K52R 
structure revealed an ordered Glycine-rich loop with regard the WT, due to a hydrogen 
bond between the Tyr35 backbone and the guanidinum group of Arg52. Similar 
mutagenesis experiments have been performed on the human form of p38α.	  
Biochemical data show an elimination of kinase activity (Kumar et al., 1995).  
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 p38αK53R crystallised in the orthorhombic space group P212121 with one molecule in 
the asymmetric unit (Table 6.3). General features, such as lobe orientation, are similar 
to the human and murine p38α structures. 
 
 
Table 6.3 Data collection and refinement statistics 
 
	  
p38αK53R	  
Space	  group	   P212121	  
Wavelength	  (Å)	   1.07	  	  
Unit	  cell	  dimension	  (Å)	  a,b,c	   45.42,	  87.02,	  122.92	  
Resolution	  range	  (Å)1	   20	  (2.95-­‐2.8)	  
Number	  of	  unique	  reflections	   10748	  (1584)	  
Multiplicity	   3.9	  (3.9)	  
Completeness	  (%)	   87.9	  (90.8)	  
Rmerge	   0.174	  (0.582)	  
<I/σ(I)>	   8.3	  (3.1)	  
Wilson	  B	  factor	  (Å2)	   28.05	  
Water	  molecules	   64	  
Rfactor	  (%)	   16.73	  
Free	  Rfactor	  (%)	   22.6	  
RMS	  deviations:	   	  
Bonds	  (Å)	   0.008	  
Angles	  (°)	   1.225	  
 
1Values for higher resolution shell are in brackets 
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The structure provides evidence for the inability of the protein to bind nucleotide. 
Arg53 is extended in the active site cleft in a similar way to Lys53 in the WT structure. 
However, the replacement of the lysine with an arginine causes the formation of a new 
hydrogen bond network among the Arg53 side chain, the Glu71 side chain and the 
Tyr35 backbone (Figure 6.14). This interaction, absent in the wild type structure, is 
close to the hypothetical nucleotide phosphate binding site and it is comprised of 
residues involved in the catalysis and the Glycine-rich loop. Unexpectedly, the DFG 
motif is in “in” conformation. 
 
 
 
6.14 Effects of mutation K53R on the Glycine-rich loop. Details of p38α phosphate anchor or Glycine-
rich loop are shown in human p38α structure (PDB code 1WFC; Wilson et al., 1996a) and in p38αK53R. 
Tyr35 has occupancy zero in the WT structure (represented in lines). New hydrogen bonds introduced by 
the mutation are shown in black dashed lines. The Glycine-rich loop is in orange, the P-Lip in red. 
 
 
The mutation has two likely effects. Firstly, it stabilises the Glycine-rich loop or 
phosphate anchor in one conformation, which decreases the flexibility of this region, 
required for recruiting the nucleotide. Tyr35p38αK53R, which has low occupancy in the 
human and murine structure of p38α structure, is now interacting with Arg53p38αK53R 
through the backbone as described in the ERK2K52R structure. The conformation 
assumed by Tyr35p38αK53R and the orientation assumed by Arg53p38αK53R are identical to 
the one in the ERK2 structure, even if the two structures are not similar in the hydrogen 
bond network caused by the mutation. Secondly, the arginine impedes ATP binding due 
Glu71p38α*
*
Lys53p38α*
Tyr35p38α*
Glu71p38αK53R*
*
Arg53p38αK53R*
Tyr35p38αK53R*
Asp174p38αK53R*
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to steric hindrance. This is shown in figure 6.15, where an arginine has been modelled 
instead of Lys56 in the structure of active p38γ. The dot surface representation of the 
VdW sphere shows clearly that a conformational change is require for accommodating 
both the charge and size of the guanidinium group. It is probable that the larger amino 
acid sidechain cannot be accommodated with productive ATP binding.  
 
 
 
Figure 6.15 Possible effects of mutation K53R in the active site of active p38. The active site of bis- 
phosphorylated p38γ is shown (PDB code 1CM8; Bellon et al., 1999). VdW sphere of Lys56 (A) and 
Arg56 (B) are shown in dots. Glu74 and one of the water molecules coordinating magnesium are too 
close to the guanidinium group of Arg56. The mutation has been performed with Pymol. 
 
 
6.4.1.2 The functional motifs of p38α are well ordered in p38αK53R structure 
The mutation K53R leads to a better ordered structure, in comparison with the human 
and murine structure of p38α. As in ERK2K52R, all the Glycine-rich region is well 
ordered in the electron density with acceptable B-factors for the resolution achieved 
(43.7 Å2 vs 25.6 Å2 of the entire structure). Importantly, the P-Lip (Gly170-Thr185) is 
almost completely ordered. The structure of un-phosphorylated p38α P-lip has never 
been observed before. Clear density is visible for all the residues. The hydroxyl group 
of the Tyr35 is oriented toward the phosphorylation lip and it appears to coordinate the 
Asp176 side chain. Thr180 and Tyr182 maintain the same conformation and 
interactions described in p38α structure. Furthermore, more residues are visible in the 
N- and C-terminal regions. An additional interaction not present in WT p38α was 
Glu74p38γ*
Lys56p38γ*
A*
Glu74p38γ*
Arg56p38γ*
B*
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observed in the N-terminal lobe, where a hydrogen bond between the side chain of Gln3 
and the Ile346 backbone, stabilises the interaction between the protein termini. In this 
thesis the name N-terminal hinge will refer to this interaction (Figures 6.16-6.18). 
 
 
 
Figure 6.16 Electron density map of functional motifs in p38αK53R. Electron density countered at 1σ 
is shown for N- and C-terminus (in blue), Glycine-rich loop (in orange), DFG motif (in magenta) and P-
Lip (in red). The motifs are shown as sticks.  
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Figure 6.17 Functional motifs in the structure of p38αK53R. The structure of p38αK53R is shown. 
Functional motifs are shown in different colours, as described in figure 6.4. Gln3, Ile346, Tyr35, Thr180 
and Tyr182 are shown as sticks. Hydrogen bonds are represented by black dashed lines. 
 
 
 
 
Figure 6.18 The N-terminal hinge. The N-terminal hinge is represented in blue on the surface 
representation. The panel is a magnification of the H-bond (3.2Å) connecting Gln3 to Ile346. 
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6.4.1.3 Is auto-inhibition in the p38αK53R a crystal artefact? 
Further stabilisation of the structure is achieved by crystal contacts. Interestingly, 
residues from the N-terminus occupy the docking groove of a symmetry related 
molecule. Similar interactions have been described for several Ser/Thr kinases, such as 
c-AMP-dependent protein kinase (cAPK), casein kinase-1, and cyclin-dependent kinase 
2 (CDK2) (De Bondt et al., 1993; Knighton et al., 1991; Xu et al., 1999). A C-terminal 
groove interaction is also present in WT human p38α. As further structural details are 
visible in the p38K53R structure, such as a complete N-terminus, the interaction can be 
further described. The structure shows that the interaction is not only hydrophobic, as 
described previously, but Gln120, which belongs to the D-motif binding grove, is 
hydrogen bonded to the N-terminus. However, this interaction goes to a residue 
remaining from the cleavage of the His6-tag (Figure 6.19). Thus, the tail-groove 
interaction observed is partially an artefact of the construct used. 
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Figure 6.21 Docking interactions in symmetry related molecules of p38K53R. The docking 
interaction between two symmetry related molecules is shown in the D-motif binding site. This region is 
coloured in red and yellow as described in figure 6.6. The panel is a magnification of the interaction. 
Residues belong to different molecules are shown with labels in different colours (purple instead of 
black). Hydrogen bonds are in black dashed lines.  
 
 
6.4.2 The structure of p38αK53R bound to the docking peptide of MEK6 
 
6.4.2.1 The MEK6 peptide binds in the D-motif binding site of p38αK53R 
p38αK53R has been successfully crystallised in complex with a 16 residue synthetic 
peptide containing the MEK6 docking sequence. The structure was solved at 2.4 Å 
resolution, a similar resolution to other p38-peptide complexes reported in  the literature 
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(1.9-2.3 Å). The complex crystallised in space group P3121, with one molecule per 
asymmetric unit (Table 6.4).  
 
 
Table 6.4 Data collection and refinement statistics 
 
	  
pepMek6-­‐p38αK53R	  
Space	  group	   P3121	  
Wavelength	  (Å)	   0.87	  	  
Unit	  cell	  dimensions	  	  
	  
a,b,c	  (Å)	   82.38,	  82.38,	  123.33	  
α,	  β,	  γ	  (°)	   90.00,	  90.00,	  120.00	  
Resolution	  range	  (Å)	  1	   20	  (2.52-­‐2.4)	  
Number	  of	  unique	  reflections	   17587	  (1638)	  
Multiplicity	   3.9	  (3.2)	  
Completeness	  (%)	   90.3	  (59)	  
Rmerge	   0.093	  (0.524)	  
<I/σ(I)>	   13.3	  (2.1)	  
Wilson	  B	  factor	  (Å2)	   29.18	  
Water	  molecules	   253	  
Rfactor	  (%)	   16.18	  
Free	  Rfactor	  (%)	   22.7	  
RMS	  deviations:	  
	  
Bonds	  (Å)	   0.008	  
Angles	  (°)	   1.25	  
 
1Values for higher resolution shell are in brackets 
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!9#!8#!7##!6#!5#!4#!3#!2#!1###φAX#φB#+1+2+3+4#
pepMEK6:##S#K#G#K#K#R#N#P#G##L#K#I##P#K#E#A##
The choice of the sequence used was based on the alignment proposed in table 6.1 
(Chang et al., 2002). The peptide contains the D-motif region, preceded by several 
lysine residues: SKGKKRNPGLKIPKEA. Previous experiments defined that the 
binding constant for a similar peptide (SKGKKRNPGLKIPK) is 7µM (Garai et al., 
2012). S is residue number four in the MEK6 sequence, while it is residue -9 based on 
the D-motif-peptide nomenclature (Figure 6.20). In this sequence the D-motif-basic 
residue is an arginine, while a lysine is in between the two hydrophobic residues.  
 
 
 
Figure 6.20 Peptide sequence nomenclature. Residues number zero are ϕA and ϕB, (in orange). Basic 
residues are in blue. The nomenclature reported is the one used in Chang et al., 2002. 
 
 
Residues PGLKIP (inter-Pro) are well defined in the electron density, (Figure 6.21; 
Table 6.5). The N-terminus of the peptide is partially visible in the electron density, in 
particular around the three lysine residues. The C-terminal residues K, E and A are not 
visible in the electron density.  
It was possible to build the main chain from Ser-9 to Pro+1 and to determine whether 
possible secondary structure elements were present. In total, 12 of the 16 peptide 
residues were built. Residues KEA (+2 - +4) and residue -6 are not visible. Side chains 
have been successfully built for the intra-Pro residues, while in the N-terminus only side 
chains of S-9, K-8 and the guanidinium group of R-4 are visible in the electron density 
contoured at 1σ (Figure 6.21).  
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   B-­‐factors	  (Å2)	   	   B-­‐factors	  (Å2)	  
S	  -­‐9	   49.3	   P	  -­‐2	   59.6	  
K	  -­‐8	   51.6	   G	  -­‐1	   40.9	  
G	  -­‐7	   45.2	   L	  φA	   28.5	  
K	  -­‐6	   48.3	   K	   26	  
K	  -­‐5	   52.2	   I	  φB	   41	  
R	  -­‐4	   46.3	   P	  +1	   45.5	  
N	  -­‐3	   57.4	   	   	  
 
Figure 6.21-Table 6.5 B-factor analysis of MEK6 peptide. The MEK6 peptide is coloured based on the 
atomic B-factors (scaled blue to red via white, mimimum = 20 Å2, maximum = 70 Å2). B-factors 
correlate with the electron density distribution, shown in green mesh at 0.8 σ. Low B-factors and well-
defined electron density correspond to the hydrophobic region, while high B-factors and less defined 
electron density, belong to the basic-residues zone. 
 
 
Indeed the peptide was found to bind in an extended conformation in the hydrophobic 
groove between αd and αe and the reverse turn between β7 and β8 in the C-terminal lobe 
of the kinase (Figure 6.22), as described in pepMKK3b-p38α, pepMEF2-p38α and 
pepMEK6-p38αC162S (PDB codes 1LEZ, 1LEW, 2Y8O; Chang et al., 2002; Garai et al., 
2012).  
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Figure 6.22 MEK6 peptide bounds to the p38α D-motif binding groove. The ribbon and surface 
representation of pepMEK6-p38αK53R structure show that the peptide binds in the groove formed by the 
CD domain, α-helixes αe and αd, and β7-β8 turn. The MEK6 peptide is in purple. The D-motif binding 
groove is coloured as in figure 6.8. 
 
 
Among the structures solved of proteins that use the N-terminal tail for recruiting p38α, 
this is the longest ordered peptide characterised so far. Analysis of the B-factors shows 
that the peptide N-terminus is highly flexible, which explains why it is difficult to see in 
the crystal structures. It is likely that the well-ordered peptide is due to the K53R 
mutation which locks the protein into a single and much more stable conformation. 
Surprisingly, the peptide residues modelled in pepMEK6-p38αK53R have a different 
position in the recently solved pepMEK6-p38αC162S structure (PDB code 2Y8O; Garai et 
al., 2012). In this structure, p38α carries the mutation C162S. p38αC162S has been 
described to increase protein stability, to facilitate the crystallisation process and 
crystals of p38αC162S show better diffraction than crystals of WT (Patel et al., 2004). The 
different peptide conformation is probably due to the mutation C162S, which stabilises 
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the position of P-2 in the position of R-4 of the MEK6 peptide used in this thesis. As 
shown in the figure 6.23, S162 is hydrogen bonded to the peptide backbone. 
 
 
 
Figure 6.23 Differences in MEK6 peptide conformations. The electron density map of MEK6 peptide 
from pepMEK6-p38αK53R is shown overlaid into the structure of pepMEK6-p38αC162S (PDB code 2Y8O; 
Garai et al., 2012). Mutated residue is in yellow. The H-bond between the Ser162p38αC162S  side chain and 
the peptide backbone (2.8Å) is shown in black dashed line. The electron density map, countered at 1σ, 
clearly shows that the conformation proposed does not correspond with the one built in pepMEK6-
p38αK53R. 
 
 
 
6.4.2.2 How does the peptide bind specifically to the protein? 
 
6.4.2.2.1 MEK6 binds differently from MKK3b and MEF2A in the hydrophobic 
docking groove 
Three structures of p38α in complex with docking peptides are reported in literature: 
pepMKK3b-p38α, pepMEF2-p38α and pepMEK6-p38αC162S (Table 6.6). The mutation 
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C162S is present only in the pepMEK6-p38αC162S structure. The description of how the 
MEK6 peptide, used in this thesis, interacts with p38αK53R will be performed through 
the comparison with these published structures. 
 
 
Table 6.6 Alignment of MEK6, MKK3b and MEF2A peptides. The residues visible in the electron 
density of each structure are highlighted in yellow. 
 
Docking	  protein	   Docking	  site	   Structure	  
	  
MEK6	  	  
MEK6	  
MKK3b	  	  
MEF2A	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
  SKGKKRNPG-LKI-PKEA 
  SKGKKRNPG-LKI-PK 
   GKSKRKKD-LRI-SCNS  
     RKPDLR-VVI-PPSS 
  
  
 
  
pepMEK6-­‐p38αK53R	  
pepMEK6-­‐p38αC162S	  
pepMKK3b-­‐p38α	  
pepMEF2-­‐p38α	  
 R/K1-2-(X)2-6-ϕAXϕB 	  
 
 
As B-factor analysis and electron density distribution suggested, the docking interaction 
in pepMEK6-p38αK53R is mainly through the hydrophobic pocket. Predominance of a 
hydrophobic anchor has been described in pepMKK3b-p38α, pepMEF2-p38α and 
pepMEK6-p38αC162S. Surprisingly, the MEK6 peptide does not conserve all the 
hydrogen bond interactions characterised in these three structures and it assumes a 
different linear conformation in comparison to MEF2A and MKK3b (Figure 6.24). 
Indeed, the four peptides are quite different to each other, both in the number and 
position of the basic residues (Table 6.6). 
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Figure 6.24 Differences in MEK6, MEF2A and MKK3b peptide conformation. The electron density 
map of MEK6 peptide from pepMEK6-p38αK53R is shown on the structure of pepMEF2A-p38α (PDB 
code 1LEZ; Chang et al., 2002) and pepMKK3b-p38α (PDB code 1LEZ; Chang et al., 2002). MEF2A 
peptide is in cyan, while MEK3b peptide is in magenta. The electron density map, countered at 1σ, shows 
that the MEK6 peptide use in this thesis assumes a different conformation form MKK3b and MEF2A 
peptides.   
 
 
The interaction between p38α and the peptide MEK6 backbone is made by two 
sequence-independent hydrogen-bonding interactions, involving ϕA and the X residue of 
the motif ϕA-X- ϕB (K), Gln120 in the αd helix and Glu160 in the β7-β8 reverse turn of 
p38α. The backbone amide of K forms a hydrogen bond with the side chain oxygen of 
Gln120-Oε2 (2.7 Å). The backbone amide of the ϕA hydrogen bonds to the backbone 
carbonyl of Glu160 (2.88 Å). In the pepMKK3b-p38α and pepMEF2-p38α structures 
further H-bonds are described, in particular with His126, which in pepMEK6-p38αK53R 
is too far from the peptide (Figure 6.25). In the pepMEK6-p38αC162S, the interaction with 
His126 is also conserved. However, since His126 is part of the same binding pocket of 
C162S, it is unclear whether the presence of the interaction is caused by the mutation.  
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Figure 6.25 Hydrogen bonds in the inter-Pro peptide sequence. The hydrogen bonds between the C-
terminal portion of the peptide and the protein are shown as black dashed lines. The distance between 
His126 and the peptide backbone is shown as a grey dashed line.  
 
 
The hydrogen bonds observed are in the inter-Pro peptide sequence, where further 
stabilisation is achieved by hydrophobic contacts in a similar way to the complexes 
already described. The side chains of ϕA and ϕB residues bind to a continuous groove, 
making extensive contact with Ile116. The side chain of the ϕA makes VdW contacts 
with the side chains of Ile116, Leu122 in αd, Val158 in β7, and Cys162 in β8. The ϕB 
residue contacts the side chains of Ala111 and Ile116 in αd and Val158 in β7. Other 
hydrophobic residues, such as Leu113, Thr123, Val127, Phe129, Leu130, Ile131, Ile 
134 and Ala157, contribute to enlarge the hydrophobic interactions. 
All the interactions are stabilised by further electrostatic interactions. The side chain of 
the X residue (K) interacts with several water molecules with low B-factors (17-22 Å2), 
which are hydrogen bonded to the Cys119 backbone oxygen atom. Since this residue 
interacts with Ile116, the final result is a better stabilisation of the hydrophobic 
interactions (Figure 6.26).  
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Figure 6.26 Hydrophobic interactions of the inter-Pro peptide sequence. The surface representation 
shows in yellow the residues involved in hydrophobic binding. Only residues that interact directly with ϕA 
or ϕB are indicated, for clarity. The bottom panel shows how through the water molecules pattern stabilises 
the peptide interaction with Ile116. MEK6 peptide is shown in purple. Water molecules are in red 
spheres. Dashed black lines represent hydrogen bonds.  
 
 
Such a network of ordered water molecules is also present in the pepMEK6-p38αC162S 
structure. In the pepMKK3b-p38α structure, the X residue is an arginine, whose 
guanidinium group interacts directly with the Cys119 backbone. In the pepMEF2-p38α 
the X residue is a valine, a short hydrophobic residue, which cannot interact directly or 
indirectly with Cys119. 
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6.4.2.2.2 MEK6 shows unique binding with Loop16 
Further electrostatic interactions are made through the N-terminal portion of the 
peptide, where 5 basic residues are present. Since the side chain of residues -9, -8 and -4 
only are visible in the electron density, the interactions among these residues and the 
protein will be discussed.  
It has been proposed that this basic region should bind to the CD domain. Modelling 
studies and NMR studies suggest that in solution this is possible for MEF2A and 
MKK3b peptides (Akella et al., 2010; Chang et al., 2002). However, no interaction is 
observed between the peptide and the aspartates of the CD domain in pepMEK6-
p38αK53R. The K-8 side chain is too far (6Å) from Asp313. The structure of ERK2 in 
complex with a docking peptide shows that the concerted binding to the hydrophobic 
groove and CD domain is allowed by secondary structure elements such as a short α-
helix. The electron density map of MEK6 peptide leaves no doubt about the absence of 
a similar conformation, which is in agreement with model of p38α activation, elucidated 
in the introduction.  
Interestingly R-4 interacts with residues belonging to Loop16, close to the protein acidic 
patch. The guanidinium group of R-4 is hydrogen bonded to the hydroxyl group of 
Tyr311, to the side chain of Gln310 and one of the alternative conformations of Asp125 
of helix αe (Figure 6.27). This binding is further tightened through H-bonds between 
Gln310 and Ala309 to S-9. The side chain of R-4 has been modelled in a small 
hydrophobic pocket, where Phe129, Cys162 and His126 are present. Surprisingly, a 
different residue is modelled inside this pocket for MEF2A or MEK6 in pepMEK6-
p38αS162 (a leucine and a proline respectively). The conformation of Asp125 is highly 
variable in the three structures. In pepMEK6-p38αS162 two conformations are present, 
while in pepMEF2A-p38α the conformation binding the R-4 in pepMEK6-p38αC162S is 
predominant. An exception is pepMEK3b-p38α, where a lysine backbone has been 
modelled inside this pocket and Asp125 conserves the conformation of the apo-protein.  
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Figure 6.27 Electrostatic interactions of MEK6 N-terminus peptide. Protein residues involved in the 
interaction with MEK6 peptide are shown in sticks. The distance between K-8 and Asp313 is shown by 
grey dashed line. MEK6 peptide is shown in purple. Hydrogen bonds are in black dashed lines. 
 
 
6.4.3 Peptide-induced conformational changes in p38αK53R 
Peptide binding cause several conformational changes, which are expected to prepare 
the protein for activation. These conformational changes induced by the peptide will be 
described through the comparison of the apo-structure (p38αK53R) and the peptide-
protein structure (pepMEk6-p38αK53R) solved in this thesis. 
The overlay is based on the C-terminal lobe, as described in the characterisation of the 
conformational changes induce by MKK3b and MEF2A peptide binding (Chang et al., 
2002). 
 
 
6.4.3.1 Conformational changes at the D-motif binding site 
No dramatic conformational changes occur at the D-motif binding site, where the 
MEK6 peptide is accommodated with the exception of the rearrangement of hydrogen 
bonds that occurs between L16 and helix αe. As described above, R-4 enters in a small 
pocket formed by Tyr311, Gln310 and Asp125. As result of these new interactions, 
Asp125 is in multiple conformations. Furthermore, the side chain of Asp124 rotates in a 
way that interacts with Tyr307, from the L16, and Gln128 from αe (Figure 6.28). 
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Figure 6.28 Conformational changes at the peptide binding site. The overlay of pepMEK6-p38αK53R 
(in green, with peptide in purple) on p38αK53R structure (in light blue) show the conformational changes 
induced by entering of R-4. Residues involved in peptide binding are shown in sticks. Hydrogen bonds 
are in black dashed lines.  
 
 
However, whether Asp24 rotation is part of the activation mechanism is arguable. In the 
structures of the WT p38α, Asp124 is already interacting with Tyr107 and Gln128 and 
this interaction is also maintained upon docking interaction in the pepMEF2A-p38α and 
pepMEK3b-p38α structures.  
 
 
6.4.3.2 The peptide binding induces conformational changes at the P-Lip, DGF 
motif and Glycine-rich loop 
Macro conformational structural rearrangements are expected upon peptide binding, 
which should facilitate the phosphorylation of the P-Lip and promote nucleotide 
binding. The P-Lip, DFG motif and Glycine-rich loop are all involved in these steps. 
Since in apo-p38αK53R all these protein regions are ordered, it is now possible to 
investigate which are the preliminary conformational changes that occur when MEK6 
binds p38α. Initially, peptide binding brings the two lobes closer together. The             
N-terminal lobe rotates on the C-terminal lobe by approximately 5.2° and a 0.4 Å 
translation (calculate with Dyn dom; Poornam et al., 2009). During this process the 
hinge in the N-terminal lobe is broken (Figure 6.29). Residues 0-3 are not visible in the 
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N-terminal portion of p38α in the pepMEK6-p38αK53R structures. However, it is 
arguable whether this event is caused by lobe rearrangement. For example, it could be 
caused by the fact that the protein N-terminus no longer interacts with the hydrophobic 
binding groove of the adjacent symmetry related molecule, which can explain a loss in 
stability and the absence of electron density for residues 0-3 in pepMEK6-p38αK53R.  
 
 
Figure 6.29 Rearrangement of the lobes upon peptide binding. The overlay of pepMEK6-p38αK53R 
(N-terminal lobe in grey, C-terminal lobe in green) on the p38αK53R structure (in light blue) shows that 
peptide binding at the C-terminal lobe causes rotation of the N-terminal lobe. The panel magnifies the 
changes at the hinge terminal region. N- and C-terminus of p38αK53R in pepMEK6-p38αK53R structure 
are in black. Hydrogen bonds are in black dashed lines.  
 
 
Dramatic conformational changes are then observed (Figure 6.30). As expected, the 
phosphorylation lip in the C-terminal lobe is the site of the major conformational 
change (172-183). It becomes disordered upon peptide binding, from residue 171 to 
residue 183. The adjacent DFG motif (169-171) changes conformation, and the electron 
density surrounding the side chains, appears less clear. In the phosphate anchor region 
or Glycine-rich loop, Tyr35 rotates in a way that the hydroxyl group is coordinated by 
Ser32.  
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 216 
 
 Figure 6.30 Conformational changes induced by peptide binding. The overlay of pepMEK6-p38αK53R 
(N-terminal lobe in grey, C-terminal lobe in green) on the p38αK53R structure (in light blue) show the 
conformational changes induced by peptide binding in P-Lip (in red), the DFG motif (in magenta) and 
the Glycine-rich loop (in orange). In the P-Lip the only visible residues are 183-185. Tyr35, DFG and     
P-Lip residues from pepMEK6-p38αK53R and DFG residues, Thr180, Tyr182 from p38αK53R are shown 
as sticks. A) Electron density map (in grey) contoured at 1σ and difference electron density map (in 
green) contoured at 3σ from pepMEK6-p38αK53R structure are shown on DFG motif and P-Lip of 
p38αK53R. B) The rotation of Tyr35 and the position of residues involved in catalysis are shown. 
Hydrogen bonds are in black dashed lines.  
 
 
All these events promote the active conformation of p38. The disordered P-Lip will 
facilitate the rearrangement of the position of Arg67, Arg70, Arg149, Arg173, Arg186, 
and Arg189, which are supposed to form two basic grooves for accommodating            
P-Tyr182 and the P-Thr180 (Bellon et al., 1999) and allow the region to be 
accommodated in the active site of MEK6. 
The DFG motif is proposed to be involved in catalysis and binding of one catalytic 
magnesium ion. As it has been described for bis-phosphorylated p38γ when the 
nucleotide is inside the active site, the catalytic residues are positioned for starting the 
reaction. Nucleotide entry should then stabilise the flexibility of DFG motif observed, 
with Asp168 coordinating one of the magnesium ions. Furthermore, Lys53 and Gln74, 
which participate in catalysis, are expected to move. In the pepMKK3b-p38α structure 
conformational changes are also observed in His107 and Met109, where the nucleotide 
adenine is supposed to be accommodated. However, since p38α is mutated in Lys53, all 
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these possible changes are not observed, except for His107, which is present in two 
conformations.  
The most interesting conformational change, not previously observed, is the rotation of 
the sidechain of Tyr35 in the phosphate anchor region (Figure 6.30). The hydroxyl 
group of Tyr35 moves from coordinating the P-Lip to be hydrogen bonded by the 
Glycine-rich loop. The new conformation assumed is the same described in 
pepMEF2A-p38α and pepMEK3b-p38α structures, where it was not highlighted due to 
the lack of WT p38α with an ordered Glycine-rich loop.   
The rotation of Tyr35 could facilitate the entry of the nucleotide. The Glycine-rich loop 
is highly conserved among kinases and it is an integral part of the ATP-binding site. Its 
role is to anchor the ATP and to shield the bound nucleotide from solvent (Hemmer et 
al., 1997). Comparison of the p38αK53R structure with pepMek6-p38αK53R suggests 
that the movement of the tyrosine is like opening a gate. While in the inactive state the 
side chain and the interaction with P-Lip prevents the anchoring of the ATP due to 
steric clashes, the conformational change assumed upon MAPKK binding promotes the 
ATP recruitment and de-solvation by the glycine residues of the anchor region.
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6.5 Conclusions 
Two new structures have been presented in this chapter: p38αK53R and pepMEK6-
p38αK53R. Through the comparison of these structures with multiple crystal structures, 
several goals have been achieved in this project.  
First, the interaction between MEK6 docking peptide and p38α was described at the 
molecular level through the pepMEK6-p38αK53R structure. This structure lacks the 
mutation in the binding site described in the pepMEK6-p38αC162S structure (Garai et al., 
2012), which makes it a more realistic model.  
Second, in the pepMEK6-p38αK53R structure the peptide N-terminus is partially visible, 
which has allowed possible CD binding in crystallo to be discussed for the first time.  
Third, a new structure of p38α has been presented (p38αK53R), which provides for the 
first time a complete snapshot of the ordered un-phosphorylated p38α. Due to the 
unique opportunity, conformational changes in the Glycine-rich loop and the P-Lip 
caused by the docking interaction have been described for the first time. 
Two main questions will be addressed in this conclusion: 
• How can the described results be helpful in drug design against the D-motif 
binding site? 
• How do the described results improve the model of p38α activation? 
 
6.5.1 The R-4 binding pocket of p38α, a third element of the D-motif binding 
interaction 
As described in the introduction, the D-motif binding pocket is under investigation as a 
specific MAPK target. Through the comparison of pepMEK6-p38αK53R with the other 
peptide-p38α structures (pepMEK6- p38αC162S, pepMEF2A-p38α and pepMKK3b-p38α, 
overview in figure 6.31), it was highlighted that MEK6 adopts a unique way to bind 
Loop16.  
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Figure 6.31 Peptide binding in p38α. The peptide binding is shown in pepMEK6-p38αK53R, pepMEK6- 
p38αC162S, pepMEF2A-p38α and pepMKK3b-p38α structures (PDB code 1LEZ, 1LEW, 2Y8O; Chang et 
al., 2002; Garai et al., 2012) p38α residues involved in electrostatic interactions and peptide hydrophobic 
residues are highlighted. His126 does not interact with the peptide in pepMEK6-p38αK53R structure. 
Tyr311 and Asp125 are involved in peptide interaction both with MEK6 and MEF2A peptide. The 
disulphide bond is only present between Cys119 and MKK3b peptide.  
 
 
The R-4 side chain enters a hydrophobic groove where Phe129, Cys162 and His126 are 
present. The guanidinium group of R-4 is hydrogen bonded to the hydroxyl group of 
Tyr311, to the side chain of Gln310 and one of the alternative conformations of Asp125 
of helix αe. This pocket could represent a third element of the D-motif binding domain 
after the CD domain and the hydrophobic groove. Interactions with Tyr311 and Asp125 
have been also observed in pepMEF2A-p38α (Chang et al., 2002). A similar binding 
pocket is also present in ERK and JNK. In the alignment shown in figure 6.32, the 
residues belonging to this pocket for the three human proteins p38α, ERK2 and JNK1 
are highlighted. While the differences between ERK2 and p38α are minimal, 
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(Phe169p38α is substituted by tyrosine), the p38α residues are less conserved in JNK1 (4 
different residues). 
 
 
Figure 6.32 R-pocket residues in p38α, ERK2 and JNK1. The residues belong to the R-pocket are 
highlighted in yellow in the structure alignment of p38α, ERK2 and JNK1 MAPK. 
 
 
Thus, through the analysis of the pepMEK6-p38αK53R structure, a third binding element 
in the D-binding motif is proposed, which could be a possible determinant of D-motif 
binding site specificity. In this thesis the name R-pocket will be used to refer to it. 
 
 
6.5.1 MEK6 might adopt a “scanning process” for recruiting p38α  
In the pepMEK6-p38αK53R structure the backbone of 12 of the 16 residues of the peptide 
are visible in the electron density. The MEK6 peptide binds through hydrogen bonds, 
which involve S-9 and R-4 side chains in the N-terminus, and the ϕA and K backbone in 
the hydrophobic C-terminus. Further hydrophobic interactions stabilise the peptide. 
p38α MSQ--ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 58  
ERK2 MAA-AAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-P 58  
JNK1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60 
     *:            :    : *  ** **. :*.** * **:*:*     .**:**:* *   
p38α FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118  
ERK2 FEHQTYCQRTLREIKILLRFRHENIIGINDIIR-APTIEQMKDVYIVQDLMETDLYKLLK 117  
JNK1 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 120 
     *:   :.:*: **: ::  ..*:*:**: :::    ::*:::***:* .** ::* ::::   
p38α CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 177  
ERK2 TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177  
JNK1 M-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 
       .* .::: :::**:* *:*::*** ::********: ::  * *** ****** :      
p38α -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232  
ERK2 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237  
JNK1 ----FMMTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQW 234 
            :* **.**:*****::*    *.:.:*:******:.*::  : :*** .::**    
p38α KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA------------NPL 280  
ERK2 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA------------DSK 285  
JNK1 NKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 293 
     : ::  :*:*  * :: :   ..*.*: .  :     : .:*  .                  
p38α AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWK 338  
ERK2 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLK 344  
JNK1 ARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353 
     * ***.***.::  *** . :** * *:  ::**.:         . .::  :   :: *   
p38α SLTYDEVISFVPPP-----------LDQEEMES--------------------------- 360  
ERK2 ELIFEETARFQPGY-----------RS--------------------------------- 360  
JNK1 ELIYKEVMDLEERTKNGVIRGQPSPLGAAVINGSQHPSSSSSVNDVSSMSTDPTLASDTD 413 
     .* :.*.  :                                                     
p38α --------------  
ERK2 --------------  
JNK1 SSLEAAAGPLGCCR 427 
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Importantly, the electron density of the basic region (SKGKKR) is sufficient to exclude 
interactions with the CD domain and secondary structural rearrangement. However, this 
is in contrast with mutational analysis of the CD aspartate residues in p38α. Mutation of 
aspartates to alanines prevents the binding of the MKK3b peptide (Chang et al., 2002).  
Moreover, NMR studies have revealed that the MKK3b peptide binds Asp315, Asp316, 
and Glu317 in solution, all in or close to the CD domain (Akella et al., 2010). 
Two possible explanations can be proposed. First, the peptide could assume a different 
conformation in solution. In the crystal structure of pep-ERK2 the peptide has a 
secondary structure arrangement that allows interaction with the CD domain. It is 
possible that in different buffer conditions, or in the full length protein, the docking 
region has a similar conformation. However, as described in the introduction, ERK and 
p38 are activated in different ways, meaning that the docking interactions involved 
could be different.  
A second explanation is that the interactions at the CD domain and at the hydrophobic 
groove, occur sequentially, rather than simultaneously. The peptide-p38α structure 
presented in this work is the first in which the N-terminal peptide is defined showing 
that no interaction with the CD domain is present. However, the MEK6 docking peptide 
has a D-motif that is one of the most enriched in basic residues, leaving open the 
question whether they could assume a role in MAPK binding. B-factor analysis of the 
peptide reveals that the intra-Pro region has lower B factors (max 30 Å2) while they 
increase in the basic patch, up to 60 Å2. Individual occupancy refinement shows that the 
occupancy of the basic region is below 100%. Indeed, not all the Asp125 side chain 
population is coordinating the R-4 guanidinium group. Possibly, the basic N-terminal 
region is used by MEK6 as “search tool” for CD domain location, followed by the R-
pocket binding (formed by Asp125, Gln310 and Tyr311) and eventually the 
hydrophobic groove, where the interaction will be better stabilised by hydrophobic 
interactions. A “scanning process” is proposed, where MEK6 uses electrostatic 
interactions to find the hydrophobic groove. Possibly, crystallisation of p38α with the 
basic peptide region alone, will further elucidated this point.  
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6.5.3 How does the phosphorylation lip become disordered? 
It has been proposed that binding of MAPKK to MAPK, induces conformational 
changes in the active site at the interface of the two lobes. Both the P-Lip and the ATP 
binding site are involved. The structures solved here show that upon MEK6 peptide 
binding, the phosphorylation lip becomes disordered. The well ordered structure of 
mutant p38α provides a unique opportunity to investigate all the conformational 
changes occurring in the protein. Upon docking, three main events have been observed: 
• the N-terminal lobe gets closer to the C-terminal lobe; 
• in the Glycine-rich loop, the side chain of Tyr35 becomes coordinated by Ser32; 
• the P-Lip becomes disordered. 
How these events are connected to each other is an intriguing question. The K53R 
mutation has stabilised p38α in the ordered inactive conformation, in which the Tyr35 
side chain is coordinating the P-Lip. Upon binding at the C-terminal lobe, the MEK6 
peptide induces conformational changes in the N-terminal lobe, in particular to the 
Glycine-rich loop, where an evident shift in position is observed. The final result is the 
breaking of an H-bond between Tyr35 and Asp175. Tyr35 is then stabilised by an 
interaction with Ser32, and the phosphorylation lip becomes disordered. The order of 
these events cannot be determined and an alternative scenario is where the peptide 
induces disorder in the phosphorylation lip. This event causes conformational changes 
in the Glycine-rich loop of the N-terminal lobe. In both cases the intimate contact 
between the two lobes is broken which leads to disorder in the P-Lip.  
In the WT protein, where both the phosphorylation lip and Glycine-rich loop are 
unstable, an equilibrium between the two extremes (completely ordered to disordered 
loop) is expected. In this equilibrium, different Tyr35 conformations correspond to 
different grades of disorder in the phosphorylation lip. This explains why these residues 
are disordered (occupancy zero for both Tyr35 side chain) or  have high B-factors in the 
WT p38α structures. The overlay of all the structures solved so far with and without 
peptide suggests that upon binding, the Tyr35 moves closer to the Ser32 backbone 
(Figure 6.33). Since nucleotide binding is expected, this conformational change is likely 
opening a gate, which then allows the phosphate anchor or Glycine-rich loop to recruit 
and de-solvate the nucleotide molecule. Mutation analysis of Tyr35 could allow further 
investigation of the dynamics occurring in the active site. 
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Figure 6.33 Conformational changes of Tyr35. The conformational changes of Tyr35 is shown through 
the overlay of human p38α (in green), murine p38α (in cyan), p38αK53R ( in pink), pepMEK6-p38αK53R 
(in grey), pepMEK6-p38αC162S (in purple), pepMEF2A-p38α (in magenta)and  pepMKK3b-p38α (in 
yellow) . Residues with occupancy zero are shown in lines.  
 
 
The results shown in this chapter describe at molecular level the effects of MEK6 
docking interaction of MEK6 on p38α. Three are the new proposals: 
• the R-pocket is a third binding element in the D-motif binding groove of MAPK, 
which can be a determinant of D-motif binding groove specificity;  
• binding to the CD domain is relevant in p38α recruitment (scanning process), 
but not in p38α activation; 
• the docking interaction with p38α breaks any possible interaction between the  
P-Lip and the Glycine-rich loop by promoting the rotation of Tyr35 
hydroxybenzene group. 
While the first proposal refers to the entire MAPK family, the scanning process and the 
role of Tyr35 in MAPK activation are currently p38α exclusive. Indeed, this 
information could be used for a specific p38α drug design. A drug, which bound to the 
p38α CD domain, could hinder the scanning process, but since the MAPKK-CD domain 
interaction is a transient interaction, it would not completely prevent the interaction at 
the hydrophobic groove. Drugs, which target the hydrophobic groove, will be more 
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efficient, but less specific, due to the high similarity of this groove among MAPKs. 
Possibly, a drug binding both the hydrophobic groove and the R-pocket will increase 
the compound specificity. Finally a specific p38α drug could target the Glycine-rich 
loop and blocking the Tyr35 in the conformation described in p38αK53R structure.  
The structures described here, potentially provide several key information for a 
successful MAPK-specific drug design and increase the fundamental understanding of 
activation of p38α by MEK6. 
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Chapter 7 The non-canonical MEK6 phosphorylation pathway 
 
 
7.1 Introduction 
 
7.1.1 How does MAPKK double phosphorylate MAPK? 
In the previous chapter a docking interaction between MEK6 and p38α has been 
described. This interaction occurs at a location outside of the active site, and it is 
postulated to be followed by a transient enzyme-substrate interaction at the active site 
(Tanoue et al., 2001). The goal of the transient reaction is the activation of the MAPK 
by the double phosphorylation of the P-Lip, at residues Tyr182 and Thr180. How the 
double-phosphorylation reactions occur is still undefined. In particular, whether protein 
dissociation occurs between the two reactions is under discussion. Two possible 
mechanisms have been proposed: the processive and the distributive mechanism. Before 
discussing the aim of the project, the two mechanisms will be elucidated and open 
questions addressed. 
 
 
7.1.1.1 Processive vs distributive mechanisms 
The first phosphorylation mechanism proposed was the processive mechanism. In this 
mechanism the active MAPKK protein collides with and binds to the MAPK, 
phosphorylates it at one site, then in some way moves to align the second 
phosphorylation site for phosphorylation, phosphorylates MAPK a second time, and 
then dissociates, yielding a double phosphorylated, active MAPK protein. 
 
MAPKK + MAPK ⇄ MAPKK⋅MAPK →  MAPKK⋅MAPK-P ⇄ (MAPKK⋅MAPK-P)’ →MAPKK 
+ MAPK-PP 
 
The second mechanism is the distributive mechanism. In this mechanism, active 
MAPKK collides with and binds to MAPK, phosphorylates it once and then completely 
releases the mono-phosphorylated product. The monophosphorylated MAPK-P then 
collides with a second molecule of active MAPKK, becomes phosphorylated a second 
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time, and is released as MAPK-PP. 
 
MAPKK + MAPK ⇄  MAPKK⋅MAPK →  MAPKK⋅MAPK-P ⇄ MAPKK + MAPK-P    
 
MAPKK + MAPK-P ⇄ MAPKK⋅MAPK-P →  MAPKK⋅MAPK-PP ⇄ MAPKK + MAPK-PP 
  
 
While the first mechanism is MAPKK concentration independent, the second is 
concentration dependent. This generates a different stimulus/response curve. For a 
processive mechanism a hyperbolic curve would be expected, and for a distributive 
mechanism the stimulus/response curve would have a sigmoidal shape, due to initial 
accumulation of the mono-phosphorylated MAPK species. Several studies have 
suggested that the first phosphorylation event occurs on the tyrosine. Threonine 
phosphorylation of ERK2 MAPK by MAPKK-1 lags substantially behind the tyrosine 
in vitro (Haystead et al., 1992; Scott et al., 1995). Similar results have also been 
obtained in vivo for ERK1 (Robbins & Cobb, 1992). Mechanistic studies of MAPKK 
phosphorylation of MAPK have been carried out on Xenopus oocyte and rat ERK2, by 
human MEKK1 (Burack & Sturgill, 1997; Ferrell & Bhatt, 1997). It was shown that 
MAPKK carries out its dual phosphorylation of p42 MAPK by a distributive 
mechanism, where the amount of mono-phosphorylated MAPK becoming bis-
phosphorylated is depended on the MAPKK-1 concentration. Data indicated that the 
tyrosine is the first phosphorylation site. Similar data on the MAPK cascade has been 
obtained by Dalby and co-workers (Waas et al., 2001). They demonstrated that p38α 
phosphorylates the transcription factor ATF2 on Thr-69 and Thr-71 by a distributive 
mechanism, with the finding that mono-phosphorylated GST-ATF2 (residues 1–115 of 
full length ATF2) dissociates from p38α with a rate constant greater than, or equal to 
0.6 s-1 exactly the magnitude of GST-ATF21–115 turnover. 
 
 
7.1.1.2 In vitro vs in vivo 
However, the scenario proposed in vitro, could be different from what is occurring in 
vivo. The evidence that MAPKs interact with upstream and downstream proteins 
through docking-interactions suggests a processive mechanism could be favourable. In 
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this mechanism, the repositioning of the second phosphorylation site in the active site 
could be brought about through minimal reorganisation of the intermediate enzyme-
substrate complexes, while contact is maintained at the docking site. MAPKK and 
MAPK could carry on the reaction by simply “sliding” the active site from one 
phosphorylation site to the next. Moreover, experiments in vitro do not consider the 
participation of additional proteins. In these experiments substrates are freely diffusible 
with respect to activators and vice versa. This causes difficulties in achieving full 
phosphorylation of MAPK with MEK in vitro (Burack & Sturgill, 1997; Haystead et al., 
1992). It has been proposed that scaffold proteins could facilitate the interaction 
between MAPK protein cascades and possibly affect the type of mechanism adopted. A 
scaffold protein might stabilise a complex of active MEK and MAPK so that it has a 
lifetime longer than the kcat, causing activation to occur processively (Burack & 
Sturgill, 1997). 
Recently, Matsuda and co-workers have investigated the application of a distributive 
mechanism in vivo to activation of ERK2 by MEK1. Data on MAPK phosphorylation in 
HeLa cells after EGF activation reveal that the signal-response curve has a more linear 
gradient than the sigmoidal one proposed (Ferrell & Bhatt, 1997). This is due to the fact 
that the increase of pY-ERK2 did not precede, but rather accompanied, the increase in 
pTpY-ERK2.  The effect of molecular crowding has been proposed as the reason for the 
observation of a distributive nature of ERK phosphorylation (Ellis, 2001a; Ellis, 2001b; 
Minton, 2006). This is because molecular crowding is a critical difference between the 
environment in vitro and in vivo. Indeed, the re-analysis of the same phenomenon in 
diluted cytoplasmic cell extract revealed a distributive mechanism. The processive 
mechanism was recovered by simply adding 15% PEG (w/v) as crowding agent. In this 
scenario, scaffolding proteins could participate due to molecular crowding.  However, 
in contrast with the processive mechanism, dissociation between the first and the second 
phosphorylation has been observed. Eventually a “quasi-processive phosphorylation” 
was proposed, where the diffusion of both MEK and pY-ERK are considerably 
restricted by the molecular crowding effect. Therefore, MEK rebinds to and 
phosphorylates pY-ERK with higher probability, with regard to a distributive 
mechanism (Aoki et al., 2011). These data fit with a previous particle based simulation 
study, where it was suggested that fast rebinding of MAPK-P by MAPKK could revert 
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the distributive mechanism to a more processive-like one in vivo (Takahashi et al., 
2010). 
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7.2 Aim of this project 
The question of which mechanism is occurring in vivo is still open. In particular, it will 
be of interest to investigate whether a different mechanism can be related to the 
different conformational changes in the phosphorylation lip among MAPKs during the 
activation process (see Chapter 6). In the case of p38, a distributive mechanism implies 
a re-binding of the disordered P-Lip, while in a processive mechanism, MEK could bind 
and stabilise the phosphorylation lip once. However, in a fully processive mechanism, 
the exchange of the nucleotide will be a greater challenge than in the distributive.  The 
reactivation time of a kinase will depend on the order in which ADP and the modified 
substrate dissociate and ATP and substrate bind to it. A recent study on a protein kinase 
revealed that the modified substrate must dissociate from the enzyme before the ADP, 
and that the ADP/ATP exchange must take place before the enzyme can bind to the 
substrate again (Aoki et al., 2011). This is in agreement with the fact that kinases use 
ATP as phosphate donor, while the protein-ADP complex is the inactive state.  
In order to investigate these questions, it was decided to study the phosphorylation 
reaction catalysed by MEK6 using metallofluoride complexes. Published data show that 
an aluminium fluoride molecule was formed in solution when p38α was mixed with 
MEK6 and ADP (Xiaoxia et al., 2011). However, attempts to trap the p38α-ADP-ALF4-
-MEK6-TSA in the solid state failed. This is because it was found that the 
phosphorylation reaction was not completely inhibited. Thus, a series of qualitative and 
preliminary experiments were performed to investigate how ATP and ADP are involved 
in the reaction. Surprisingly, it was found that ADP can be used as phosphate donor.  
 230 
7.3 Experimental procedures 
 
7.3.1 Plasmid and protein expression-purification 
Constructs used and protocols for protein expression and purification has been 
described in the previous chapter, section 6.3.1. 
 
 
7.3.2 Native PAGE gels 
 
7.3.2.1 Native PAGE gel composition 
Native PAGE gels were always freshly prepared. The protein sample was mixed with 
loading buffer without heat denaturation. All gels were pre-run for at least 20 minutes, 
in order to remove possible impurities. Gels were run at 20-30 mA under constant 
current at 4°C, and stained in fresh Coomassie Blue stain solution then distained until 
the background was colourless (see Chapter 3 for stain and distain solutions 
composition).  
At the beginning of the project, 5% native PAGE gels were used (Figure 7.3). Later it 
was decided to use exclusively 7.5% gels. Gel compositions are shown in table 7.1: 
 
• Native gel composition table (Table 7.1): 
 
	  
1.5	  M	  
TrisHCl	  
pH8.8	  
0.5	  M	  
TrisHCl	  
pH6.8	  
10%	  
Ammonium	  
Persulfate	  
(APS)	  
30%	  Acrilammide,	  	  
0.8%	  Bis-­‐
Acrilammide	  
TEMED	   H2O	  
RUNNING	  GEL	  	  
(7.5%-­‐1	  gel)	   1.75	  ml	   -­‐	   0.025	  ml	   2.3	  ml	   0.060	  ml	   3.075	  ml	  
STACKING	  GEL	   -­‐	   1.25	  ml	   0.050	  ml	   0.5	  ml	   0.005	  ml	   3.2	  ml	  
 
• Running buffer 1X: 0.05 M Trizma , 0.38 M Glycine, adjust to pH8.8 
• Loading buffer 5X: 5 ml Glycerol 100%, H2O 2.7 ml, 2.13 ml of 0.5 M TriHCl 
pH6.8, Bromo Phenol Blue traces.  
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7.3.2.3 Sample preparation for Native PAGE gel  
Figures 7.3, 7.5 and 7.6, 7.7 show qualitative native PAGE gels. Each sample loaded 
contains proteins in equimolar amounts (1:1) with an excess of nucleotide (10 mM) 
(Table 7.2). Each sample was incubated for 20 minutes at RT before loading.  
Figures 7.4, 7.8, 7.9 and 7.10 report qualitative native PAGE gels, where in the amount 
of protein was defined based on the criteria of image quality. Activity buffer was further 
added (see section 7.3.4.1 for the solution composition).  
 
 
Table 7.2 Native PAGE gel sample composition 
 
Samples	   MEK6	  
(23μM)	  
p38α	  
(23μM)	  
MEK6	  
buffer	  
p38	  
buffer	  
ATP	  	  
(0.5	  μM)	  
ADP	  
	  (0.5	  μM)	  
ACTIVITY	  BUFFER	  
5X	  
MEK6	   8.7	  μl	  (7μM)	   -­‐	   -­‐	   8.7	  μl	   -­‐	   -­‐	   6	  μl	  
MEK6+ATP	   8.7	  μl	  (7μM)	   -­‐	   -­‐	   8.7	  μl	   0.6	  μl	  
(10mM)	  
-­‐	   6	  μl	  
MEK6+ADP	   8.7	  μl	  (7μM)	   -­‐	   -­‐	   8.7	  μl	   -­‐	   0.6	  μl	  
(10mM)	  
6	  μl	  
p38α	   -­‐	   8.7	  μl	  (7μM)	   8.7	  μl	   -­‐	   -­‐	   -­‐	   6	  μl	  
p38α+ATP	   -­‐	   8.7	  μl	  (7μM)	   8.7	  μl	   -­‐	   0.6	  μl	  
(10mM)	  
-­‐	   6	  μl	  
p38α+ADP	   -­‐	   8.7	  μl	  (7μM)	   8.7	  μl	   -­‐	   -­‐	   0.6	  μl	  
(10mM)	  
6	  μl	  
MEK6+p38α	   8.7	  μl	  (7μM)	   8.7	  μl	  (7μM)	   -­‐	   -­‐	   -­‐	   -­‐	   6	  μl	  
MEK6+p38α+ATP	   8.7	  μl	  (7μM)	   8.7	  μl	  (7μM)	   -­‐	   -­‐	   0.6	  μl	  
(10mM)	  
-­‐	   6	  μl	  
MEK6+p38α+ADP	   8.7	  μl	  (7μM)	   8.7	  μl	  (7μM)	   -­‐	   -­‐	   -­‐	   0.6	  μl	  
(10mM)	  
6	  μl	  
 
 
Reactions were stopped by the addition of 6 µl of loading buffer, containing 100mM 
EDTA. Only 10 µl of this final composition was loaded. 
EDTA was not present in the original loading buffer as it was discovered later that 
nucleotides were diffusing into the gel and activating the reaction, increasing 
background phosphorylation.  
 
 
7.3.3 Western blots of native PAGE gels  
Western blot experiments were performed using a polyclonal antibody, able to 
recognise both mono-phosphorylated and bis-phosphorylated p38α (Cell Signaling 
technology, Boston, MA, USA). As the secondary antibody, an IgG anti-rabbit was 
used, conjugated with alkaline phosphatase (Sigma, St.Louis, MO, USA). A SIGMA 
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premixed buffer was used for development (BCIP/NBT, B6O4-Sigma, St.Louis, MO, 
USA). The protocol is still in development; table 7.3 shows the major steps. 
Suggestions were taken from the Cell Signalling Technology website 
(www.cellsignal.com). 
 
 
Table 7.3 Western blot protocol 
 
STEPS	   METHODS	   SOLUTIONS	  
1. Native	  gels	  run	   All	   native	   gels	   were	   run	   in	  
duplicate.	  	  
	  
2. Protein	  Blotting	   One	   gel	   was	   used	   for	   Protein	  
Blotting.	   Electrotransfer	   was	  
performed	   with	   nitrocellulose	  
membrane,	   at	   250	   mM	   for	   45’	  
to	   1	   hour.	   The	   transfer	   was	  
checked	   with	   Red	   Ponceau	  
staining.	  
Transfer	   buffer=	   25	   mM	   Tris	  
base	   ,	   0.2	   M	   glycine,	   20%	  
ethanol	  	  (pH8.5)	  
3. Blocking	   The	   membrane	   was	   incubated	  
for	   one	   hour	   in	   the	   blocking	  
solution	  
Blocking/Ab	   solution=	   TBS	   1X,	  
5%	  BSA	  
TBS	   10X-­‐1L=	   24.2	   g	   Tris	   base,	  
80g	  NaCl	  (pH	  7.6)	  
4. Primary	  Antibody	  
incubation	  
The	   Ab	   was	   diluted	   1:10000	   in	  
the	  Blocking/Ab	  solution,	  ON,	  at	  
4°C,	  with	  gentle	  shaking.	  
Blocking/Ab	   solution=	   TBS	   1X,	  
5%	  BSA	  
	  
5. Washing	   Washing	   was	   performed	   three	  
times	   for	   5	   minutes,	   on	   gently	  
shaking,	   with	   the	   washing	  
solution.	  
Washing	   solution=	   TBS	   1X,	   5%	  
BSA,	  Tween	  0.1%	  
	  
6. Secondary	  Antibody	  
incubation	  
The	   Ab	   was	   diluted	   1:30000	   in	  
the	   Blocking/Ab	   solution,	   for	  
one	   hour,	   at	   RT,	   with	   gentle	  
shaking.	  
Blocking/Ab	   solution=	   TBS	   1X,	  
5%	  BSA	  
	  
7. Washing	   See	  step	  5.	   	  
8. Protein	  detection	   The	   membrane	   was	   incubated	  
with	   Tris	   pH	   9	   for	   one	   minute.	  
Then,	   incubated	   with	   the	  
developer	   solution	   (BCIP/NBT)	  
for	  1-­‐2’	  
100	  mM	  Tris	  pH9	  
 
 
 
 
 
 233 
7.3.4 Kinetic assays 
For kinetic assays, MEK6 and p38α buffers were exchanged to 50 mM HEPES pH 6.8, 
150 mM NaCl, 2 mM DTT, 10 mM MgCl2. The details of how the reactions were 
performed and the results analysed are below. 
 
 
7.3.4.1 Phosphorylation reactions 
The phosphorylation reaction mixture consisted of 1 µM MEK6 (or MEK6DD), 5 µM 
p38α, 10-10000 µM nucleotide, 50 mM HEPES pH 7.5, 100 mM NaCl, 10 mM MgCl2 
and 1 mM DTT. Reaction volumes were 100 µl. The concentrations of the proteins were 
chosen based on the finding of Ferrell and co-workers, which defined that MAPKK-1 
and p42 MAPK work in vivo at 1:5 ratio (Ferrell & Bhatt, 1997). The activity buffer, at 
5X concentration, was 250 mM HEPES pH 7.5, 50 mM MgCl2, 500 mM NaCl and 5 
mM DTT. Protein concentration was estimated using a thermo Scientific Nanodrop (see 
Chapter 2, Section 2.4.1). 
Reactions were initiated by the addition of nucleotide and terminated every 5 minutes 
for twenty minutes with 200 mM EDTA. Then samples were loaded on a native PAGE 
gel. For each time point, 18 µl of the reaction plus 6 µl of 1 M EDTA was loaded.  
Finally, in order to check the real endpoint of the kinetic experiments, each sample was 
left ON and run on a native gel the day after (the endpoint sample).  
 
 
7.3.4.2 Phosphorylation reaction analysis 
The bands obtained on native PAGE gels were quantified using ImageJ (Schneider et 
al., 2012). The procedure used is explained in detail in figure 7.1 for endpoint kinetic 
experiments. 
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Figure 7.1 Steps performed to quantify gel bands using ImageJ (Schneider et al., 2012). The 
rectangular selection was performed on maximum of 4 lanes at the same time. 
 
 
7.3.5 Nucleotide analogues  
Several nucleotide analogues were used during the experiments. The figure shows the 
relative structures (Figure 7.2). 
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Figure 7.2 Nucleotides and nucleotide analogues.                                                                                                                       
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7.4 Results and Discussion 
 
7.4.1 MEK6-p38α complex runs as a double band on native PAGE gel 
In order to characterise the mechanism of activation of p38α by MEK6 a crystal 
structure of the complex is necessary. In experiments to attempt to crystallise p38α in 
complex with MEK6-AMPPCP or MEK6-ADP-AlF4-, several techniques were used to 
test the formation of the complex in different conditions. As the first goal of the work 
was to trap in solid state the transition state analogue, initial experiments focussed on 
the MEK6-p38α-ADP-AlF4--TSA complex. Initially, MEK6DD, a mutated and 
constitutively active form of MEK6, and WT p38α were used.   
Classical size exclusion chromatography was not considered as a good candidate for 
testing complex formation. The two proteins have similar molecular weight and are both 
dimers in solution. Thus, homodimers and heterodimers were indistinguishable in the 
elution profile of the size exclusion chromatogram. 
Eventually native PAGE gels were revealed to be the most successful method for 
characterising the formation of the complex. The successful protocol was defined as: 
 
1. Prepare a TSA solution 3X (15 mM ADP, 6 mM AlCl3, 30 mM NH4F in protein 
buffer 3X) 
2. Mix the TSA solution with equimolar amounts of MEK6DD and p38α 
3. Incubate for one hour on ice (ter Haar et al., 2007) 
4. Run a 7.5% basic native PAGE gel in order to visualise complex formation 
Analysis by native PAGE gels showed the complex as two new bands, more positively 
charged with regard to the p38α band (Figure 7.3). As the p38α homodimer has the 
same size as the heterodimer, the difference between p38α and the complex mobility 
shift can be related only to the difference in charge.  
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Figure 7.3 Complex detection on a native PAGE gel. On the 5% native PAGE gel shown three samples 
were loaded: MEK6DD alone plus TSA solution (ADP+AlCl3+NH4F), p38α alone plus TSA solution and 
the mix of MKK6DD+p38α+TSA. 
 
 
The crystallisation trials of this complex at 10 mg/ml did not produce crystals. As the 
efficiency of complex formation is around 95-100% and the nature of the bands is 
unknown, the following hypotheses were tested: 
 
• the efficiency of the complex formation is not 100%; this means that monomers 
or homodimers remain in solution, decreasing the sample homogeneity; 
• as there are two bands and p38α has two phosphorylation sites both exposed to 
solvent (Wang et al., 1997), the two bands could be related to two different 
complexes in which MEK6 interacts with each of the phosphorylation sites. 
 
The complex was prepared with an excess of MEK6DD (1:1.2 as p38α:MEK6), using 
the construct with an uncleavable His6-tag. In order to separate the complex from excess 
MEK6DD, a Ni-NTA column was used. Then an anion exchange column was run with 
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a NaCl gradient in order to separate the two bands. The results were analysed using 
native and SDS PAGE. The data showed that the double bands were not separated after 
anion exchange. Moreover, the SDS PAGE data indicated a small increase in the p38α 
mass. 
Since the presence of two bands was related to sample heterogeneity, and possibly to 
unsuccessful crystallisation, whether the nature of the two bands was related to the 
phosphorylation reaction was investigated.  
 
 
7.4.2 ADP is a secondary phosphate donor in MEK6 phosphorylation reaction 
In the next sections it will be shown that MEK6 can use ADP as second preference 
phosphate donor after ATP for activating p38α. Indeed, the protein shift observed in the 
native PAGE gel of figure 7.3, is caused by phosphorylation at the P-Lip. In the 
classical phosphorylation pathway a kinase uses two ATP molecules as phosphate 
donors in order to double phosphorylate the substrate. Here, a non-canonical 
phosphorylation pathway is proposed, where ADP can remain trapped in the MEK6 
nucleotide binding site and be used to activate p38α.  
First, endpoint kinetic experiments of the phosphorylation reaction in the presence of 
both ATP and ADP were performed. Analysis of the results was performed on 7.5% 
native PAGE gels. The nature of each band obtained was defined by mass spectrometry 
analysis (CEA, Grenoble, France) and western blots, in which an antibody able to 
recognise both the mono-and bis-phosphorylated P-Lip was employed.  
Second, several controls were then performed. In order to eliminate the possibility that 
p38α auto-phosphorylation was in some way causing the observed results, the end-point 
kinetic experiments were repeated using the mutant p38αK53R. Furthermore, in order 
to eliminate the possibility of the presence of an extra-source of ATP caused by 
Adenylate kinase, the ADP phosphorylation experiments were run in the presence of an 
Adenylate kinase inhibitor. Third, a series of kinetic experiments where then performed 
to investigate the functional role of ADP phosphorylation. 
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7.4.2.1 Analysis of the native PAGE gels by mass spectrometry  
In the first endpoint kinetic experiments, the phosphorylation reaction performed by 
MEK6 on p38α was checked in the presence of both ATP and ADP. In these 
experiments, proteins are in equimolar ratio, (in the µM range), while nucleotides are in 
excess (in the mM range).  
Two MEK6 and three p38α constructs were used: 
 
• MEK6, which is the full length form of human MEK6. This construct was used 
in order to check the activity of WT MEK6. Moreover, it was used to verify if 
the protein was already active upon the expression-purification process;   
• MEK6DD, which is the full length and constitutively active form of human 
MEK6. This construct was used in order to check whether MEK6DD behaviour 
is similar to WT MEK6; 
• WT p38α;  
• p38αK53R, which is an inactive form of p38α. This construct was used in order 
to prevent any MEK6 phosphorylation-activation by p38α (as suggested in 
Ferrell & Bhatt, 1997) or possible p38α autophosphorylation;  
• p38αT180A, which is an inactive form of p38α. This construct was used for 
checking the ADP reaction when only one phosphorylation site (Tyr182) is 
available.  
 
The native PAGE gels obtained revealed a similar pattern (Figure 7.4-7.5). Both MEK6 
and MEK6DD bands are smeared, while p38α runs as more defined bands. When the 
MEK6-p38α or the MEK6DD-p38α sample is supplied with ATP, the p38α band shifts. 
This occurs for all three p38α constructs. In order to further characterise the native 
PAGE gels, the bands were analysed by mass spectrometry. Mass spectrometry 
experiments were carried out as a service at the CEA, Grenoble (France). The results 
obtained show that the p38α band shift or shift one is in accordance with 
phosphorylation at the P-Lip. Moreover, the mass spec data indicate that the first 
residue phosphorylated is Tyr182. 
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Figure 7.4 Native PAGE gels of MEK6-p38αK53R, MEK6DD-p38αK53R, MEK6DD-p38α in the 
presence of ATP or ADP. Details are written in the experimental procedures section. The 
phosphorylation states are indicated by red arrows. The blue arrow indicates the extra band MEK6DD is 
named as M-DD. p38αK53R is named as p38α*. 
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Figure 7.5 Native PAGE gels (7.5%) of MEK6DD-p38α and MEK6DD-p38αT180A. The 
phosphorylation states are indicated by red arrows. The phosphorylation legend is shown only for 
MEK6DD-p38αT180A for clarity. MEK6DD is named as M-DD. 
 
 
The native PAGE gels of figures 7.4-7.5 show similar band shifts for both MEK6 and 
MEK6DD native PAGE gels. This suggests that MEK6 is in an active form. 
Phosphorylation of MEK6 is carried out in vivo, by a specific MAPKKK. However, it is 
possible that MEK6 is phosphorylated during bacterial expression. To test this 
hypothesis, mass spectrometry analysis will be performed.  
When the MEK6DD construct is used, an extra third phosphorylation band is present 
(P3) in the native PAGE gels. Mass spectrometry results showed that this band is not 
linked to additional, non-specific phosphorylation. Two possible explanations are 
proposed. The first is that MEK6DD is able to phosphorylate p38α on other sites. The 
second, that the phosphorylation profile is also affected by the presence of MEK6DD, 
which means that while the two main bands are linked to a phosphorylation state in 
which p38α remains bound to MKK6DD, the band with highest mobility shift is linked 
to complex dissociation. This phenomenon occurs because the samples are not at 
chemical equilibrium during the electrophoresis step. Indeed, mass spectrometry 
analysis revealed that MKK6DD is present in the p38 bands, with a different ratio 
between the bands. Thus, the difference between the two lines is due to the complex’s 
electrophoretic properties.  
M"DD! "! M"DD! "! M"DD! M"DD!
"! p38α( p38α( p38α(T180A(
p38α(
T180A(
p38α(
T180A(
ATP! ATP! ATP! ATP! ATP! ADP!
p38α!
P"p38α((pTyr182)(
(
!
(
!
!
 242 
Despite this extra band, MEK6DD demonstrates similar behaviour to WT MEK6. Since 
MEK6DD has higher expression levels then MEK6, the experiments of the next 
sections were performed using MEK6DD.  
 
 
7.4.2.2 Analysis of the native PAGE gels by western blots  
As a complementary experiment to the mass spectrometry analysis, western blots (WB) 
were performed, using an antibody specific for the mono-phosphorylated or bis-
phosphorylated p38α. For these experiments, several phosphate donors or phosphate 
inhibitors were used (ATP, AMP-PNP, AMP-PCP, ADP, ApCp and AMP).  
The results obtained are in agreement with the mass spectrometry data (Figure 7.6). 
This is true also for the P3 line, which corresponds to the double phosphorylated p38α. 
The reaction is blocked only when AMP-PCP, non hydrolysable ADP (ApCp) or AMP 
are used (Figure 7.6). Surprisingly, the reaction was not blocked by AMP-PNP. This is 
probably due to the fact that the P-N-P bond is relatively liable to nucleophilic attack 
(Olesen et al., 2007). This information will be useful with the prospective of  
crystallising the ground state or transition state of the complex MEK6-p38α, using a 
nucleotide analogue able to block the phosphorylation reaction. 
 
 
 
Figure 7.6 Western blot results. MEK6DD and p38α were mixed with different nucleotides. 
Phosphorylation states are indicated by red and blue arrows. MEK6DD is named as M-DD. 
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7.4.2.3 Alternative explanations to the non-canonical phosphorylation pathway 
From these first experiments, MEK6DD appeared to be able to use ADP as a phosphate 
donor as well as ATP. Due to the novelty of this reaction, a thorough investigation into 
whether the data observed were caused by other factors was required. Extensive control 
experiments were performed to eliminate the possibility of extra ATP sources, different 
from those added, that could account for the effects observed. 
As shown in figure 7.4 the reaction was run with p38αK53R.  The mutant obtained is 
unable to bind nucleotide and is therefore unable to autophosphorylate or phosphorylate 
MEK6, eliminating the possibility that p38α itself is in some way causing the observed 
results. Moreover, this mutant cannot bind ATP, preventing p38α to be a ATP source 
for MEK6. The native page gel in figure 7.4, shows no difference between the use of 
p38αK53R or p38α, which excludes the possibility that the phosphorylation observed is 
dependent on p38α.  
As a second hypothesis, it was proposed that ATP could be generated from a 
contaminant, such as adenylate kinase. Adenylate kinase can produce ATP and AMP 
from ADP (2ADP ⇄  ATP+AMP) (Hanks et al., 1988). This enzyme can be efficiently 
inhibited by P1-(5’-Adenosyl)P5-(5’adenosyl) pentaphosphate (Ap5A), a nucleotide 
analogue that acts as competitive antagonist (Ki= 2±0.5×10-6 mM). Thus, MEK6DD 
and p38α were mixed as usual and Ap5A was added in µM-mM concentrations. As the 
results in figure 7.7 show, Ap5A does not affect the reaction.  
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Figure 7.7 Effects of µM or mM amount of Ap5A on p38α phosphorylation in presence of ADP. As 
controls the following samples were added: p38α+MEK6DD, p38α+ADP, p38α+MEK6DD+ADP. The 
red arrows indicates the mono- and bis-phosphorylated p38α. ADP is at a concentration of 5 mM in all 
samples. 
 
 
7.4.5 The Functional role of MEK6-ADP phosphorylation 
The use of ADP in phosphorylation reactions is quite unusual in biology. In this final 
section a sequence of preliminary experiments are described that try to investigate the 
functional meaning of the ADP phosphorylation.  
The data obtained so far showed that the phosphorylation reaction is more efficient in 
the presence of ATP than with ADP. Native PAGE gel results show that only when 
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ATP is used, could phosphorylation of all p38α in the sample be achieved. Thus, ADP 
can be an alternative phosphate donor when ATP is absent or the ATP-βP can be used 
as a second phosphate source after ATP-γP. The goal of these preliminary experiments 
was to check the relevance of γP and βP in the MEK6 reaction. Therefore, the reaction 
was analysed in vitro using three different nucleotides: ATP, ADP and ApCpp, in order 
to check the reaction efficiency when respectively γP-βP, βP and γP are present in 
solution. In the case where γP is only used, a similar efficiency is expected in the 
presence of ATP or ApCpp. In the case when γP-βP are both used, ADP and ApCpp 
should show a similar phosphorylation efficiency.  
The kinetic experiments were carried out as described in the methods section. 
MEK6DD and p38α were used as constructs. The results obtained, and the 
quantification analyses performed, suggest that ATP γP and βP are both relevant for the 
MEK6 phosphorylation reaction. The same experiment was repeated five times and as 
the endpoint kinetics show different results linked to the nature of the nucleotide, these 
native PAGE gels were quantified. However, the kinetic experiments provide 
information about the reaction rate. MEK6 is more efficient in the presence of ATP. 
The amount of the bis-phosphorylated form of p38α in the presence of ADP or ApCpp 
seems to be small and not relevant at physiological nucleotide concentrations (100 µM 
and 1 mM). Interestingly, in the presence of both nucleotides (ADP and ApCpp) a 
constant p38α amount remains un-phosphorylated (Figure 7.8). 
The endpoint kinetic experimental results were analysed and quantified. The ratio 
between the amount of bis-phosphorylated p38α in the presence of different nucleotides 
was calculated. The values indicate that MEK6 is more efficient in the presence of ATP 
and that there are no differences when ADP or ApCpp are used at physiological 
nucleotide concentrations (Figure 7.9). 
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Figure 7.8 Kinetic experiments in the presence of ATP, ADP or ApCpp. As expected, p38α is 
phosphorylated over the time course. Complete phosphorylation is not achieved in twenty minutes in any 
condition. The results could be dependent by an error in the experimental set up. Additional bands with 
lower electrophoretic mobility are also present. These bands correspond to aggregated p38α sample. 
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Thus, the data indicate that for MEK6DD activity both the γP and βP of ATP are 
relevant.  
As both γP and βP are playing a role, further experiments were proposed to test how 
each phosphate is involved. It can be proposed that the reaction can be carried out in a 
canonical way in which the nucleotide is rebound after p38α is released, or in a        
non-canonical way in which one ATP molecule is used to carry out both 
phosphorylation reactions: 
 
•  Canonical reaction (nucleotide rebinding):  
                                        MEK6ATP + p38α → MEK6 + P-p38α + ADP 
                                  MEK6ATP/ADP + P-p38α → MEK6 + P-P-p38α + ADP 
• Non-canonical reaction (one nucleotide binding):  
         MEK66ATP + p38α → MEK6ADP + P-p38α → MEK6 + P-P-p38α + AMP 
 
In the first mechanism either ATP or ADP could be bound by MEK6, in the second it is 
used exclusively as a phosphate source for Thr180 phosphorylation. 
 In order to investigate which reaction is occurring, kinetic experiments were repeated 
mixing ADP and ApCpp in a 1:1 ratio. In this way, in the solution both βP and γP are 
present and if the first reaction is correct it would be expected to see a similar pattern to 
the ATP efficient reaction. On examining the endpoint kinetic results, the efficiency 
obtained in the presence of both nucleotides is similar to when only ADP or ApCpp are 
used. These data suggest that the second mechanism (non-canonical reaction) is 
occurring. Indeed, these results suggest that the remaining nucleotide from the reaction 
performed with the ADP-ApCpp mix (AMP or ApCp) remains trapped in the complex, 
instead of being exchanged on a fast timescale as should be expected in a canonical 
phosphorylation reaction (Figure 7.10). 
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Figure 7.10 Endpoint kinetics for ADP-ApCpp. The endpoint kinetic experiment for ADP-ApCpp is 
shown in comparison with experiment of ATP/ADP/ApCp. 
 
 
While intriguing, these results are not conclusive. MEK6 could have a different affinity 
for each nucleotide. In particular, ApCpp affinity is usually lower than ATP affinity and 
in this case could affect the results obtained. Moreover differences in affinity for ApCpp 
and ADP could affect the interpretation of the results. Indeed, it will be essential to 
repeat the same experiments with radioactive nucleotides such as ATP-32γP and ATP-
32βP in order to confirm the transfer of the β-phosphate.  
 
 
7.4.6 Preliminary crystallographic results on ΔMEK6DD 
The possibility that MEK6 can use both ATP and ADP to phosphorylate its substrate 
raises the question of how the protein recognises the nucleotide in the active site in 
order to perform a second phoshorylation reaction. A proper answer to this question 
requires the structural characterisation of MEK6 in complex with both nucleotides. For 
this purpose, the truncated form of MEK6 (ΔMEK6DD) was used. ΔMEK6DD lacks 
the first 40 residues, which are the ones employed in the D-motif docking interaction 
and presumably are unstructured without substrate protein.  
The structure of a truncated form of MEK6DD has been solved by The Structural 
Genomics Consortium, Oxford (PDB code 3FME). In this structure, the protein is in 
complex with the kinase inhibitor staurosporin. From the overlay with other MAPKK 
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Lys137'
structures it is likely that the stautosporin binding site is the same as the nucleotide-
binding site. However, the interaction does not provide any information about 
nucleotide binding.  
Further investigations can be made using the structures of other human MAPKK similar 
to MEK6. MEK6 has high sequence similarity with MEK3 and MEK4 (80% and 50% 
identity respectively). While there are no MEK3 structures, the un-phosphorylated 
structure of MEK4 in complex with ANP has been solved (PDB code 3ALN; 
Matsumoto et al., 2010). Four molecules are present in the asymmetric unit and the 
nucleotide is bound differently in each one. Furthermore, it seems that only Lys137 is 
involved in sugar recognition in two of the molecules, while in the others the ribose is 
not co-ordinated by a lysine residue. If these observations are not affected by the fact 
that MEK4 is in an active form, it can be proposed that the MEK4 nucleotide binding 
site cannot specifically recognise the nucleotide selected, because there is no specific 
interaction with the sugar moiety or the phosphates (Figure 7.11) rather interactions 
primarily recognise the hydrophobic adenosine. 
 
 
Figure 7.11 Overlay of the four ANP molecules in the MEK4 structure. Each colour corresponds to 
one molecule in the asymmetric unit. Protein interactions with the sugar moiety are shown. Hydrogen 
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bonds are represented as dashed black lines. Lys137 is shown in sticks (PDB code 3ALN; Matsumoto et 
al., 2010). 
 
 
Therefore, in order to investigate nucleotide binding/recognition, the truncated form of 
MEK6DD in the presence of ADP or AMP-PCP was crystallised. The cloning was 
performed in Sheffield, purification and crystallisation was performed on site. 
Preliminary crystals were obtained at 4°C, at the HTX laboratory (Table 7.4). 
Optimisation is now on going. 
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ΔMEK6DD+AppCp+
Position:!Hampton_5,!H10!
Screen:!Mme!5000!
Condition:!0.1M!Hepes!pH7,!20%!
PEG!MME!5000!
Comments:!the!needles!are!
visible!since!the!second!week!
After!1!week! After!2!weeks!
ΔMEK6DD!
Position:!Hampton_2,!C08!
Screen:!Crystal!Screen!PEGIIon,!
11!
Condition:!0.2!M!potassium!
iodide!pH!6.8,!20!%w/vPEG!3350!!!
Comments:!the!needles!are!
visible!since!the!3th!day!After!1!day! After!3!days!
ΔMEK6DD++ADP+
Position:!Hampton_2,!C10!
Screen:!Crystal!Screen!PEGIIon,!
27!
Condition:!0.2!M!sodium!acetate!
trihydrate!pH!7.9,!20!%!PEG!3350!!!
Comments:!the!needles!are!
visible!since!the!1th!week!
After!3!days! After!1!week!
Table 7.4 Preliminary crystallisation results of ΔMEK6DD: 
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7.5 Conclusions 
A novel finding has been described in this chapter: the ability of MEK6 to use ADP as 
phosphate donor. Several preliminary experiments, which comprise a combination of 
different techniques (native PAGE gels, western blots and Mass spectrometry), led to 
this finding. Importantly, relevant controls have been performed, which have allowed 
the conclusion that the phosphorylation reaction is not dependent on possible p38α auto-
phosphorylation (p38K53R construct) or adenylate kinase contamination. Structural 
studies and radioactive experiments will hopefully provide a much more convincing 
proof of the reaction described.  
Through a series of kinetic experiments, the physiological meaning of the new finding 
was investigated. A new proposal was then formulated: MEK6 uses one ATP molecule 
to catalyse the double phosphorylation of p38α. After the tyrosine phosphorylation 
reaction, ADP remains in the active site of MEK6 and is used for the threonine 
phosphorylation. The ability of a kinase to use ADP as phosphate donor is not novel. So 
far ADP-dependent phosphorylation in kinases has been described for glucokinase and 
phosphofructokinase, which are archaeal enzymes (Guixe & Merino, 2009). However, 
these kinases cannot use ATP, which makes the MEK6 non-canonical phosphorylation 
different, in that both ADP and ATP can be used.  
The ability of MEK6 to use ATP β-phosphate for the second reaction, or in general the 
ability of using ADP as phosphate donor is a potential advantage: 
 
• in a processive or quasi-processive mechanism; in both mechanisms nucleotide 
exchange will be difficult, because protein dissociation is absent (processive 
mechanism) or very quick (quasi-processive mechanism). Moreover, it is known 
that nucleotide exchange can slow down the reaction (Aoki et al., 2011), which 
implies that an ADP molecule trapped in the MEK6 active site after the first 
reaction will improve reaction efficiency;  
• in the accommodation of phosphate groups during catalysis; after Tyr182 has 
been phosphorylated, the P-Lip remains disordered. This is due to the docking 
interaction between MEK6 and p38α. In fact, it has been demonstrated that also 
when p38α is double phosphorylated, but the N-terminal tail of MAPKK is 
bound, the P-Lip remains disordered (Akella et al., 2010). This implies that 
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during the second reaction the MEK6 active site has to accommodate several 
phosphate groups, which are P-Tyr82 and the nucleotide phosphate groups. The 
advantage of using ADP, instead of a second molecule of ATP, is that the 
number of phosphate groups will be the same in both phosphorylation reactions 
and a similar way of accommodating the negative charges can be employed. 
Structures of MEK6 in complex with different nucleotides will be helpful in 
elucidating this point. 
• when energy saving is required; the ability of MEK6 to use ADP as phosphate 
donor could be relevant in situations such as ischemia/hypoxia, where ATP 
saving is critical. This has been suggested for a homologue of ADP-dependent 
glucokinase that has been found in mus musculus (Ronimus & Morgan, 2004). 
Since in vivo the entire MAPK cascade is supposed to be bound to a unique 
scaffold protein, MAPK can use the ADP produced by the other reactions for 
activating p38α. 
 
Thus, the non-canonical MEK6 phosphorylation pathway is a really novel proposal, 
which, in the case that it will be confirmed, will lead to the discovery of a new 
mechanism for protein kinases to perform double-phosphorylation reactions. Structural 
studies will be important for investigating how the two transition states are 
accommodated and which are the main elements in catalysis. It is probable that MEK6 
uses the so called “minimal structural requirements”, that all protein kinases use to 
catalyse phosphorylation (Oruganty & Kannan, 2012).  
These catalytic requirements are: 
• the Glycine-rich loop; 
• a lysine/arginine in beta sheet 3 (sub-domain II) that binds ATP (as Lys56 in the 
double phosphorylated structure of p38γ, see Chapter6); 
• a glutamate in C-helix (sub-domain III) that coordinates with the beta sheet 3 
lysine/arginine, (as Glu74 in the double phosphorylated structure of p38γ, see 
Chapter 6); 
• two aspartates in the active site which belong to the HRD and the DFG motif 
(one is catalytic base, the other coordinates one of the two ATP magnesium 
ions).  
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All these elements are present in MEK6, except that the glutamate of the C-helix is 
substituted by an aspartate, a residue with similar charge. Thus, it is probable that 
MEK6 use the usual kinase machinery for catalysing the non-canonical phosphorylation 
reaction. This suggests the possibility that other kinases could work as MEK6. 
However, in the case of MEK6 there are particular determinants that promote the non-
canonical phosphorylation: the necessity of a double phosphorylation, the unstructured 
P-Lip and the fast rate of dissociation occuring in vivo for the complex. Possibly, 
similar systems will work in a similar way, such as MEK3, the other p38 activator, or 
JNK’s MAPKK which also has been proposed to induce disorder in the P-Lip upon the 
docking interaction (Garai et al., 2012; Heo et al., 2004). 
In conclusion, as the evolution theory defines, the MEK6 non-canonical 
phosphorylation pathway occurs not because “it can”, but because it is a great 
advantage in the system to which it belongs.  
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Chapter 8 Perspectives 
 
 
In this thesis a combination of 19F-NMR, X-ray crystallography and biochemical studies 
has been used to investigate enzyme catalysis, specifically in three different systems: 
 
• the bacterial mutase, β-Phosphoglucomutase from L. lactis (βPGM); 
• the human small G protein RhoA, with its GTPase activating protein 
(RhoGAP); 
• the human MAPK p38α, with one of its MAPKK activators (MEK6). 
The use of aluminium and magnesium fluoride as analogues of the “in flight” 
phosphorus of the transition state has furthered understanding of each system. The 
exception is the work on the p38α-MEK6 complex, where a TSA structure was not 
obtained. However, the experimental attempts for trapping the transition state has led to 
other relevant findings.  
Eventually for each subject novel relevant aspects of enzyme catalysis from substrate 
recognition to transition state formation have been defined.  
In this final chapter, the general issues that have been addressed in this thesis will be 
discussed, specifically:  
 
•  How the study of transition state complexes, which comprise fluoride 
analogues, can benefit from the combination of 19F-NMR and X-ray 
crystallography? 
• Is the charge balance hypothesis universal?  
• How substrate recognition is involved in catalysis?  
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8.1 How can the study of transition state complexes, which comprise fluoride 
analogues, benefit from the combination of 19F-NMR and X-ray crystallography? 
 
The combination of 19F-NMR and X-ray crystallography was crucial for the 
characterisation of the major and minor conformers in the βPGM-G6P-MgF3--TSA 
complex, the selection of the proper phosphonate analogue of βG1P and the 
investigation of charge balance in RhoA-GDP-AlF3 and RhoA-GDP- AlF4-/MgF3--
RhoGAPR85A transition states.  
The characterisation of the major/minor conformer in βPGM-G6P-MgF3--TSA, has 
shown how different conformers can exist through the combination of experiments in 
solution and the solid state. The successful combination of room temperature data 
collection and 19F-NMR overcame restrictions at 100 K, where only one single model 
could be defined. Further efforts that go in the same direction can be found in the 
scientific community, such as the software tool Ringer, which systematically samples 
electron density around the dihedral angles of protein side chains looking for alternative 
conformations (Lang et al., 2010). Magnesium fluoride was described for the first time 
in octahedral geometry rather than the classical TBP, opening the intriguing question of 
whether phosphorus could be similarly coordinated in the active site or if the 
rearrangements observed, such as the Ser114 backbone flipping, could be relevant in 
catalysis. For example, both phenomena could be involved in the releasing or binding of 
βG16BP. Indeed, the molecular mechanism by which βPGM releases and binds 
βG16BP in a different orientation is still under investigation. The structural changes that 
cause the observation of the major and minor conformers could be an explanation where 
the affinity of the active site changes.  
The combination of 19F-NMR and X-ray crystallography was also relevant in the 
selection of phosphonate analogues of βG1P. In this project, the most modern 
guidelines for designing and evaluation of a possible lead compound in academia 
environment were followed. First, the drug design was base on the structure of the 
natural enzyme substrate. This led to the design of phosphonate or fluorophosphonate 
compounds, which usually have the same or higher affinity as the natural substrate. 
Second, the most recent guidelines for the synthesis of phosphonates and 
fluorophosphonates compounds were followed. Third, 19F-NMR was used as a 
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screening tool for testing the potential of fluorine phosphonate and phosphonate 
candidates to form a trifluoromagnesate or a tetrafluoroaluminate complex. This use of 
19F-NMR has been already suggested (Vulpetti & Dalvit, 2012). Fourth, crystal 
structures were fundamental for interpreting the 19F-NMR and biochemical data. 
Indeed, the structures provided explanations for the inability of 1-α-hydroxyl 
phosphonates and the preference for the S-isomer to form βPGM-TSA complexes, 
which led to the conclusion that attempts to produce further fluorophosphonate 
molecules, such as βCF2G1P, would be useless. Importantly, from this work a possible 
new lead compound for combating bacterial infections (S)-βCHFG1P, has been 
proposed.  
19F-NMR and X-ray crystallography were also used for investigating how charge is 
balanced and catalysis is achieved in RhoA-GDP-AlF3 and RhoA-GDP-AlF4-/MgF3--
RhoGAPR85A complexes. Two main conclusions can be highlighted in this discussion. 
First, the solid and solution states can be different. Indeed, the crystallisation of RhoA-
GDP-AlF3 failed due to maintenance of a non-binding conformation in the crystal 
lattice, while 19F-NMR clearly demonstrated the formation of the complex in solution. 
Secondly, both crystal structures and 19F-NMR spectra of the RhoA-GDP-RhoGAPR85A-
TSA complexes revealed that AlF4- or MgF3- were present in the mutant metallofluoride 
complex rather than the expected AlF3 and MgF2. This is relevant because the 
interpretation of the moiety of transition state species in the electron density map can be 
ambiguous, in particular at resolutions lower than 2-2.5 Å. This implies that the 
recording of 19F-NMR spectra is good practice for unambiguously assigning the TSA 
species.  
 
 
8.2 Is the charge balance hypothesis universal? 
In the general introduction, the important consideration that charge balance, rather than 
the native geometry, for phosphoryl transfer enzymes is essential for TS stabilisation 
during catalysis was discussed. In this thesis, the study in solution and solid state of 
βPGMK145A-G6P-MgF2-TSA, RhoA-GDP-AlF3 and RhoA-GDP-AlF4-/MgF3--
RhoGAPR85A were primarily performed to investigate the charge balance hypothesis in a 
 260 
mutase and in a small G protein system. However, it resulted that charge balance 
interpretation in these mutated systems was more complicated than expected.  
Based on the charge balance hypothesis, the loss of a positive charge should bring the 
loss of a negative charge in the bound substrate in order to satisfy the zero charge 
required in the active site (Baxter et al., 2008; Cliff et al., 2010). In the case of 
PGKK219A, it has been found that one of the fluorine ions of ALF4- was substituted by a 
water molecule, without any change in the protein structure or in the metal fluoride 
features (Cliff et al., 2010). This occurs in βPGMK145A-G6P-MgF2-TSA too, where 
magnesium is coordinated by two fluorine atoms and one water molecule. However, a 
change in geometry was also observed, both in the magnesium fluoride geometry and 
the βPGM active site. In the case of the small G protein studied, both fluorine NMR and 
crystal structures confirm that the mutation R85A did not induce any change in the 
transition state analogue, but caused the substitution of the arginine finger with a 
tyrosine side chain.  
The complexity of these systems is probably related to specific features of the proteins 
studied, which prevent prediction with a simple rule of the consequences of charge 
mutation in the active site. In the case of the PGK-TSA, 19F-NMR spectra collected on 
both TSA of the WT and mutant show a clearly interpretable peak pattern; moreover, 
the mutant PGKK219A is a catalytically dead enzyme. The mutase and small G protein 
systems are less simple models: more than one conformer was present in the βPGM-
TSA spectra and the mutation performed in βPGM promotes one of them; in the case of 
RhoA and RhoAGAPR85A an intrinsic activity and residual activity is still present. Thus, 
how charge balance is achieved in these systems is still under investigation.  
Finally, it is an intriguing question how charge is balanced in MEK6 double 
phosphorylation of p38α. In this thesis, it has been proposed that MEK6 use one ATP 
molecule to catalyse both reactions. As discussed in section 7.5, this implies that the 
number of phosphorus groups inside the active site will be the same for both reactions. 
This scenario is a great advantage in term of charge balance, because the charge of the 
phosphorus groups could be accommodated in a similar way for both reactions. A 
different charge balance accommodation is indeed expected if for the second reaction 
where a second ATP molecule will be used, and, thus a fourth phosphorus would be 
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present in the active site. Indeed, charge balance is a further argument for the MEK6 
non-canonical phosphorylation reaction here proposed. 
 
8.3 How is substrate recognition involved in catalysis?  
Enzymes lower the activation energy through binding energy, which implies that the 
molecular characterisation of enzyme substrate recognition at both ground and 
transition state is a relevant goal in chemical biology, which leads to the comprehension 
of how an enzyme mechanism or enzyme region could become a possible 
pharmaceutical target. 
Substrate recognition has been studied in all the three systems described in this thesis. 
Firstly, it has been characterised for the first time how βPGM distinguishes between 
βG1P and G6P through the comparison of high resolution structures (1.1-1.3 Å). It was 
found that βPGM has probably evolved to recognise βG1P, which is the sugar that 
defines α/β anomer specificity.  
Secondly, the study on RhoA-GDP-AlF4-/MgF3--RhoGAPR85A provides a structural 
proof of the RhoGAP binding contribution in enhancing the RhoA GTP hydrolysis. 
RhoGAP binding promotes the corrected positioning and polarisation of the attacking 
water molecule, and occludes it in the active site.   
Thirdly, a structural characterisation of how MEK6 recognises p38α from the docking 
interaction has been provided for the first time. A dynamic model, the “the scanning 
process”, which requires further investigation, has been proposed, where MEK6 uses 
electrostatic interactions to find the hydrophobic groove on the p38α D-motif binding 
site. The electrostatic interactions are within two main elements of the D-motif binding 
site: the well known CD domain, and the R-pocket, which has been proposed in this 
thesis to be the third element of the D-motif binding site in MAPKs. 
 
Eventually, several new findings have been discussed, which could have a remarkable 
impact from the comprehension of phosphoryl transfer enzyme catalysis to drug design 
on one of the system analysed. Indeed it is hoped that the results obtained in this thesis, 
will be the basis for new and exciting research projects.  
The work done on βPGM has led to the finding of a possible lead compound. 
Experiments in vivo are now required to define where the compound could work as a 
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possible antibiotic, which is one of the most important goals of medical science in a 
world where bacteria start to be resistant to many antibiotics.  
The work done on p38α-MEK6 has led to several new proposals, among which the most 
novel is the MEK6 non-canonical phosphorylation pathway. The confirmation of this 
proposal is only the first step to a new field of investigation. The comprehension of how 
a protein that uses ATP as phosphate donor, could also use ADP, will indeed change the 
general way of thinking of the enzyme-ADP complex as the inactive complex or to the 
dissociation of enzyme-ADP complex as the reaction limiting step.  
Thus, the hope is that all the results reported in this thesis will have a positive impact on 
the efforts that both academia and the pharmaceutical industry are putting into the 
understanding of how phosphoryl transfer enzymes work and in the search for new 
targets and lead compounds in cancer, inflammatory diseases and infectious diseases, 
where all the systems described in this thesis are involved.  
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Appendix A Crystallographic theory 
 
 
A.1 Introduction 
Crystals have fascinated people since prehistoric times. With the discovery of X-ray 
diffraction in 1912 by Max von Laue, the possibility of investigating the internal 
structure of inorganic and organic crystals became possible.  
Today, protein crystal production has become one of the most relevant steps in 
biochemistry. Protein structures solved from X-ray diffraction provides information 
about protein folds and function. In this chapter, the principles  of determining a protein 
structure from a diffraction experiment will be discussed. As main reference the book 
“Principles of protein x-ray crystallography”, by Drenth J will be followed (Drenth, 
1999).  
First, the hardware required for the experiment will be described.  
 
 
A.2 Hardware 
The main pieces of hardware required for the collection of the X-ray diffraction data are 
an X-ray source and an X-ray detector. Since in this thesis most of the diffraction 
experiments were performed at the ESRF, the next paragraphs will refer to synchrotron 
radiation and, more specifically, the ESRF.  
 
 
A.2.1 Synchrotrons  
Synchrotrons are devices for circulating electrically charged particles at nearly the 
speed of light. Electrons or protons are first injected into an accelerator device, such as a 
linear accelerator or a booster synchrotron. Then the particle beam enters a vacuum tube 
in the storage ring, with a diameter from 10 to a few hundred meters.  The pseudo-
circular trajectory is then determined by the particle’s energy and by the magnetic field. 
The magnetic field acts through bending magnets, that are used to guide the particles in 
their orbit and causes changes in the direction followed. At each direction change the 
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particles lose energy. This phenomenon produces X-ray electromagnetic radiation 
(wavelength of 10-7-10-11 m). 
Synchrotrons are described by their energy of operation (E) and the magnetic strength 
of the bending magnets. The ESRF is an electron synchrotron that has a circumference 
of 8444.39 meters, is operated with energy of 6 GeV and has bending magnets with a 
0.86 -T field strength. In the storage-ring the beam is guided onto the pseudo-circular 
orbit by 64 bending magnets and is focused by 320 quadrupole magnets. A further 224 
sextupole magnets control the effect linked to the energy dispersion of the electrons 
(chromatic aberration). The storage-ring components are arranged in 16 super-period 
cells with the same magnet distribution, which is named the Chasman-Green structure 
(Lindley, 1999). Several devices, such as wavelength shifters and undulators are used in 
the super-period cell to increase locally synchrotron beam intensity. The wavelength 
shifter is similar to bending magnets, but with a sharper curvature and a stronger local 
magnetic field, which produces high-intensity X-rays and a shorter wavelength. 
Usually, a series of wavelength shifters or multiple wigglers are used, which is easily 
tuneable to the desired wavelength. Undulators are similar to the multiple wiggler, but 
with moderate magnetic fields and a large numbers of poles close together; moreover 
they produce radiation at more specific wavelength then wigglers (Figures A.1-A.2). 
Synchrotrons have several advantages with regard to home X-ray sources. The X-ray 
diffraction intensity is much higher (at least two orders of magnitude stronger) and the 
beam is less divergent. The higher intensity is relevant, because crystals of 
macromolecules tend to have a low scattering power, due to a low number of molecules 
inside the crystal and the high percentage of low diffracting elements. A less divergent 
beam results in sharper and better separated diffraction spots. 
Synchrotrons have also other relevant features, which are missing in the X-ray home 
source: 
 
• it is a multiple-wavelength source (essential for MAD experiments); 
• the tuneability can be regulated by selection of a specific spectral range with 
monochromators; 
•  the radiation is highly polarised, which can affect the anomalous X-ray 
scattering signal.  
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Figure A.1 The European Synchrotron Radiation facility (ESRF). The structure of the ESRF is 
shown with the main components. The injection system for the ESRF comprises a 200 MeV linear Pre-
Injector (LINAC) and a full energy fast cycling Booster synchrotron. One of the 16 super-period cells is 
shown. Each one contains two ondulators.  The synchrotron X-ray beam leaves the main storage ring at a 
point a few metres after the undulator. Upon leaving the storage ring, the X-rays enter one of 41 
beamlines, each an ensemble of laboratory blocks or “hutches” where the actual research takes place 
(www.esrf.eu). 
 
 
 
Figure A.2 The beamline experimental hutches. The schematic representation of an ESRF beamline 
shows that it is comprised of three main hutched or cabins: the optic cabin, which contains the mirror and 
monochromators which allow to focus and to tune the beam; the experimental cabin, which contains the 
hardware necessary for a specific experiment; the control cabin, from which the other hutches are 
controlled (www.esrf.eu). 
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A.2.2 Detectors 
For a crystal structure determination, the intensities of all (or a great many) reflections 
must be measured. This requires at least two more pieces of equipment: a mechanical 
tool, that will rotate the crystal in the X-ray beam to allow diffraction from all the 
lattices points and centre the crystal to the beam (see paragraphs A.2-A.3) and a 
detecting device for measuring the position and the intensity of the diffraction spots. 
At the ESRF, the following detectors were used: the CCD (charge coupled device 
detector) and PILATUS (Single photon counting pixel detector). 
 
 
A.2.2.1 CDD detector 
CCD detectors have extremely fast readout times, low background levels and a high 
maximum count rate (particularly useful with the intense beams produced by 
synchrotrons). A CCD is a two-dimensional surface that processes the signal 
immediately after photon detection.  
The three main components of the CCD detector are a phosphor screen, a fiber-optic 
taper, and a CCD chip. X-ray photons interact with the phosphor screen. In the ADSC 
Quantum detectors this is gallium arsenide doped with europium ions. The screen 
converts X-rays photons to light. Then the fiber-optic taper demagnifies the light image 
down to the size of the CCD chip. The CCD chip detects the light image as an electric 
charge.  
The CCD chip is made of silicon, which has a valence band and a conducting band 
available for the electrons. When subjected to photons the electrons acquire enough 
energy to go from the valence to the conducting band, leaving a hole behind. Electron-
hole pairs are formed in a pixel, which is gated by a local voltage. Once the exposure is 
over, the gate electrodes are changed to release the charge, which is read for each pixel 
sequentially and produces a charge, associated with each pixel. This charge is amplified 
and converted to an image that, after geometric and intensity correction, represents the 
number of X-ray photons incident on the detector surface (Figure A.3).  
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Figure A.3 CCD detector. The three main components of the CCD detector are shown as described in 
the main text.  
 
 
A.2.2.2 PILATUS detector 
The PILATUS detector is a recent type of X-ray detector, which has been developed at 
the Paul Scherrer Institut (PSI) for the Swiss Light Source (SLS).  
PILATUS detectors are two-dimensional hybrid pixel array detectors, which operate in 
single-photon counting mode. It comprises a preamplifier, a comparator and a counter. 
The preamplifier enforces the charge generated in the sensor by the incoming X-ray; the 
comparator produces a digital signal if the incoming charge exceeds a predefined 
threshold and thus, together with the counter, one obtains a complete digital storage and 
read-out of the number of detected X-rays per pixel without any readout noise, which is 
an advantage with regard to CDD detectors (Figure A.4). 
 
 
 
 
 
 268 
 
Figure A.4 The PILATUS detector detects X-rays without readout noise. A) X-rays of different 
energies are impinging on the detector. B) In the case of the integrating detectors such as CCD cameras, 
charge is accumulated and then converted. C) In the case of single photon counting an energy threshold is 
apply for each pixel and a comparator sends only those pulses to the counter which are higher than the 
energy threshold. Therefore, no readout noise is collected. 
 
 
Further advantages include: superior signal-to-noise ratio, readout time of 5 ms (instead 
of 1-120 s), a dynamic range of 20 bit, high detective quantum efficiency and the 
possibility to suppress fluorescence by an energy threshold that is set individually for 
each pixel. Practically, the PILATUS is a much faster data collection system, which 
provides a better background substraction. The short readout and fast framing time 
allow diffraction data to be collected in continuous mode without opening and closing 
the shutter for each frame.  
 
 
 
 
 
A	  
B	  
C	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A.3 Crystal properties 
A crystal is a three-dimensional periodical arrangement of molecules. When materials 
precipitate from a solution, the molecules attempt to reach the lowest free-energy state, 
which can lead to packing in a regular way. This phenomenon often leads to a 
symmetric relationship between the molecules.   
In crystal packing, three repeating vectors (a,b,c) with angles (α,β,γ) between them can 
be recognised. The three vectors define the unit cell in the crystal lattice. Thus, the 
crystal is a three dimensional repetition of the same unit cell. The edges of the unit cell 
form a grid, which is called crystal lattice. The crystal lattice is described by right hand 
coordinate system, in which the axis x, y, and z have the direction of a, b, c respectively 
(Figure A.5).  
 
 
 
Figure A.5 A unit cell within a crystal lattice. Angles and vectors defining the unit cell are in red. The 
crystal lattice system is in black. 
 
 
The repetition of the unit cell is called three-dimensional translational symmetry. Often, 
other symmetry operators can be found in the crystal. Protein crystals have rotation axes 
(2, 3, 4 and 6 fold axes) and rotation inversion axes which combine rotation with 
translation (screw axes). The combination of all the possible symmetry operators in a 
protein crystal leads to 32 possible point groups. The term point group refers to the fact 
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that all the symmetry operations pass through one point. The 32 point groups are 
assigned to a maximum of 7 crystallographic systems: Triclinic, Monoclinic, 
Orthorombic, Tetragonal, Trigonal, Hexagonal and Cubic (Table A.1). 
 
 
Table A.1 The seven crystal systems 
 
Crystal	  lattice	   Symmetry	  requirement	   Axes	   Angles	  and	  length	  
constrains	  
Triclinic	   None	   No	  constrains	   None	  
Monoclinic	   One	  2-­‐fold	  axes	   b	  parallel	  to	  2-­‐fold	  axis,	  
a	  and	  c	  perpendicular	  to	  
the	  2-­‐fold	  axis	  
α	  =	  γ	  =	  90°	  
Orthorombic	   Three	  perpendicular	  2-­‐
fold	  axes	  
a,	  b	  and	  c	  parallel	  to	  2-­‐
fold	  axis	  
α	  =	  β	  =	  γ	  =	  90°	  
Trigonal	   One	  3-­‐fold	  axes	   c	  parallel	  to	  3-­‐fold	  axis,	  
a	  and	  b	  perpendicular	  
to	  the	  3-­‐fold	  axis	  
α	  =	  β	  =	  90°	  
γ	  =	  120°	  
a	  =	  b	  
	  
Tetragonal	   One	  4-­‐fold	  axis	   c	  parallel	  to	  4-­‐fold	  axis,	  
a	  and	  b	  perpendicular	  
to	  the	  4-­‐fold	  axis	  
α	  =	  β	  =	  γ	  =	  90°	  
a	  =	  b	  
	  
Hexagonal	   One	  6-­‐fold	  axis	   c	  parallel	  to	  6-­‐fold	  axis,	  
a	  and	  b	  perpendicular	  
to	  the	  6-­‐fold	  axis	  
α	  =	  β	  =	  90°	  
γ	  =	  120°	  
a	  =	  b	  
	  
Cubic	   Four	  3-­‐fold	  axis	   a,	  b	  and	  c	  related	  by	  3-­‐
fold	  axis	  
α	  =	  β	  =	  γ	  =	  90°	  
a	  =	  b	  =	  c	  
 
 
If the lattice has a level of symmetry higher than triclinic (no symmetry), each particle 
in the cell will be repeated a number of times as a consequence of the symmetry 
operator. For example, if the space group is P212121, at least four equal particles are 
expected for the unit cell. In other words, the unit cell has four asymmetric units. The 
asymmetric unit is the smallest unit that can be rotated or translated to generate the unit 
cell, following the symmetry operators described by the space group. The number of 
molecules in the asymmetric unit can be higher than one. Since these molecules are not 
related by crystallographic symmetry, they can have different conformations. However, 
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they can be related by other symmetry operators, which is called non-crystallographic 
symmetry (NCS).   
Most crystals cannot be considered ideal single crystals because the regular repetition of 
the unit cells is interrupted by lattice defects (Figure A.6). The diffraction pattern of 
such crystals can be regarded as the sum of the diffraction patterns originating form 
mosaic blocks with slightly different orientations, this is called mosaicity or the mosaic 
spread of the crystal. The mosaic spread for a good quality protein crystals is between 
0.2-0.5°. Mosaicity can be increased during the cryocooling process and incorrect 
mosaicity estimation during data processing and reduction can decrease the quality of 
the statistical data.  
 
 
 
Figure A.6 Schematic of the mosaicity in the protein crystals. The image shows the difference 
between an ideal crystal and a real one, which can be thought of as a series of mosaic blocks with slightly 
different orientations. 
 
 
A.4 Diffraction from protein crystals 
The X-ray diffraction from a crystal derives from the structure of the molecule from 
which the crystal has grown. X-ray detectors collect this diffraction and a sequence of 
diffraction images is collected. The intensity of the spots depends on the electrons that 
scatter the X-rays, while the position of the spot arises from the positions of the 
molecules within the crystal lattice. Whether a spot will be observed or no is defined by 
Bragg’s law and visualised in the Ewald sphere construction.  
The diffraction of a crystal can be described as diffraction from its lattice planes, which 
are constructed through the lattice points. Parallel and equidistant planes, with 
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perpendicular distance d, form a set of planes. Each set is described by three indices, 
hkl, which are the Miller indices. Each index defines how many times the lattice plane 
cuts the axis a, b and c. Each set of planes reflects parallel X-rays in a way that the 
angle of incidence is equal to the angle of reflection and the beam is reflected by an 
angle of 2θ relative to each incident direction. Constructive interference will occur 
between reflected X-rays when the difference in the path length (the distance travelled 
by the X-rays), is an integral number of wavelengths. The difference in the distance 
travelled by reflected X-rays is 2dsinθ/λ and it can be applied to all reflected X-rays. 
This gives the Bragg’s Law: 
 2𝑑 sin 𝜃 = 𝑛𝜆 
 
where d is the distance between planes in the crystal, θ is the angle of incidence of the 
X- rays, n is an integer and λ is the wavelength of the X-rays (Figure A.7).  
 
 
 
Figure A.7 The Bragg’s law in the diffraction pattern. Two lattice planes are drawn separated by a 
distance d. Incident and reflected X-rays form an angle of θ with the lattice planes. The geometrical 
relationship between θ and d is shown.  
 
 
The X-ray diffraction pattern can be explained through the visual construction of the 
Ewald sphere and how the reciprocal lattice interacts with it (Figure A.8). The Ewald 
sphere is a sphere whose radius is reciprocal to the X-ray wavelength (1/λ) and whose 
centre is the crystal position. The reciprocal lattice, is an imaginary lattice formed by 
planes, which are perpendicular to the set of planes in the crystal lattice. Thus, the unit 
cell dimensions are reciprocally related to the unit cell dimension of the crystal lattice 
and the crystallographic system is the same. Specifically, there is an inverse 
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relationship. In the Ewald sphere construction, diffraction only occurs when the 
diffraction spots of the reciprocal lattice planes are on the sphere. Spots from different 
planes can be brought to diffraction by rotating the crystal, which implies the rotation of 
the reciprocal lattice. Thus, the direction of the diffracted beam depends on the X-ray 
wavelength, which determines the sphere radius, and by the unit cell distance of the real 
space, from which the unit cell distances of the reciprocal lattice are derived.  
Bragg’s law and the Ewald construction are related each other. As described in figure 
A.8, S is the distance between the diffracting spot and the reciprocal lattice with origin 
O. Based on the Ewald construction is length is 2sinθ/λ. When 2sinθ/λ is equal to 1/d, 
the Bragg’s law is satisfied. 
 
 
 
 
Figure A.8 A two-dimensional representation of the Ewald sphere. The sphere has a radius of 1/λ; so 
is the direction of the incident X-rays and s the direction of the scattered beam. The sphere has its origin 
at the crystal position. The origin of the reciprocal lattice is O, where the X-ray beam exits the Ewald 
sphere. The lattice point P is in contact with the sphere and will produce a reflection. OP is equal to S, 
whose amplitude is s-so , which in turn is 2sinθ/λ. 
 
 
Furthermore, as d is the distance between sets of planes in the lattice, S is perpendicular 
to these planes, which are the reflecting planes characterised by hkl indices.  
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Constructive scattering form the crystal can occur only when h/S, k/S, l/S are equal to 
cell dimensions a, b, c. These conditions are called the Laue conditions.  
 
 
A.5 Structure solution 
 
A.5.1 From Structure Factor to Electron Density 
The intensity of the diffracted beam is proportional to the square of the amplitude of the 
Structure Factor, F(S).  
The Structure Factor is a function of the electron density distribution in the unit cell: 
 𝐹 𝑠 = 𝑓!𝑒!!"!!∙!!  
 
where fj is the Structure Factor for a specific atom j and r is its position in respect of the 
unit cell with origin in O (r =ax+by+cz). Combining with the Laue conditions, the 
Structure Factor for each hkl is defined by: 
 𝐹!!" = 𝑓!𝑒!!"(!!!!!"!!!"!)!!  
 
Thus, the intensity of each of the spots in a diffraction pattern depends on the 
distribution of the electron density within the unit cell. The goal of the protein X-ray 
crystallography is to calculate the electron density ρ at every position x, y, z from the 
diffraction pattern collected.  
Since the Fhkl is a summation over all the atoms j in the unit cell, it can be also express 
as integration over all the electrons in the unit cell: 
 𝐹 ℎ𝑘𝑙 = 𝑉 𝜌(𝑥𝑦𝑧)𝑒!!"(!!!!"!!")𝑑𝑥𝑑𝑦𝑑𝑧!!!!!!!!!!!!  
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where ρ is the electron density and V the cell volume. Since ρ(xyz) is the Fourier 
transformation of F(hkl): 
 𝜌 𝑥𝑦𝑧 = 1𝑉 𝐹(ℎ𝑘𝑙)𝑒!!!" !!!!"!!"!!!  
  
where ρ(xyz) is expressed as summation because diffraction occurs only under Laue 
conditions.  
F can be represented as a vector F= 𝐹 𝑒!" (Figure A.9), which means that final the 
equation becomes: 
 𝜌 𝑥𝑦𝑧 = 1𝑉 𝐹(ℎ𝑘𝑙) 𝑒!!!" !!!!"!!" !!"(!!")!!!  
 
where ρ(xyz) is the variable while 𝐅(𝐡𝐤𝐥)  and the phase angle are the data which 
required to be defined experimentally. Although the module of F can be derived from 
the intensities, the phase angle cannot be derived straightforwardly from the diffraction 
pattern. This is the so called phase problem.  
 
 
 
Figure A.9 The Structure Factor. The Structure Factor can be represented as a vector F on the Argand 
diagram. The module of the vector is F amplitude, while the inclination is the phase.   
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A.5.2 The phase problem 
Different methods have been derived to overcome the phase problem. Isomorphus 
replacement, multiple and single anomalous diffraction method (MAD and SAD) are 
used when no information of the phases is known. Molecular replacement is used when 
phases can be calculated from a homologous model. 
All the methods used in protein crystallography for solving structures require the 
knowledge of the Patterson function. The Patterson function P(uvw) is a Fourier 
summation with intensities as coefficients and without phase angles or, rather, with all 
phase angles equal to zero: 
 𝑃 𝑢𝑣𝑤 = 1𝑉 𝐹(ℎ𝑘𝑙) ! cos 2𝜋(ℎ𝑢 + 𝑘𝑣 + 𝑙𝑤) 
 
where uvw are the relative coordinates to xyz in the unit cell. The dimensions of the real 
crystal lattice and the Patterson are the same. Since no phase knowledge is required, the 
Patterson map can be calculated from the intensities. If a real unit cell contains N atoms, 
the corresponding Patterson map will show N2 peaks, which correspond to the vectors 
used from going to one atom to all the others, including the one with length 0 that goes 
from an atom to the same atom (Figure A.10). This kind of representation is useful 
when a limited number of atoms are considered. 
 
 
 
Figure A.10 The Patterson map. The figure illustrates a Patterson map corresponding to a cell with one 
molecule. The N self-peak which correspond to the vector for going from one atom to the same one, 
overlap each other in the origin of the unit cell (self-Patterson map). The others are cross-vectors, which 
are the vectors for going from one atom to another. They are N(N-1) for a molecule with N atoms (cross-
Patterson map).  
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A.5.2.1 Isomorphus replacement and MAD/SAD 
Isomorphus Replacement and the MAD-SAD methods for phase calculation are used 
when no homologous structure is available. 
The first method developed was isomorphous replacement (Green, 1954). In this 
method, heavy metal atoms (such as mercury, platinum or gold) are introduced into the 
crystals that bind to specific residues (mercury binds to cysteine residues, platinum to 
methionine residues), naturally present or introduced into the protein, to create a heavy 
atom derivative (i.e. crystals with the same unit cell and orientation of protein). As 
heavy atoms are electron rich, the diffraction of the incident X-rays will differ from the 
diffraction from the native crystals. Thus, two F(S) will be measured: the one of the 
native crystal Fp, and the one of the derivative FPH. Referring to F vectoral 
representations, the different vector is FH, which amplitude depends on the heavy atoms 
position (Figure A.11).  
 
 
 
Figure A.11 Structure Factor of the heavy atom structure. FH is the difference vector between the 
Structure Factor of the native molecule and the Structure Factor of the derivative one. 
 
 
The heavy atom position is calculated using the Patterson map. The Patterson 
summation with the coefficients ( 𝐹!" − 𝐹! )! gives the Patterson map of the heavy 
atom arrangement in the unit cell. Since the Patterson unit cell and the real space unit 
cell are related each other, the coordinates of the heavy atom in the lattice can be 
calculated. FH amplitude is then estimated, including sign and phase angle.  
Now the protein phase angles can be determined. Since FH is known in amplitude and 
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phase, the phase problem is reduced to a phase ambiguity. The Harker construction 
provides an intuitive way of explaining how this phase solution is achieved (Figure 
A.12). A second derivative or more is required for solving the ambiguity. However, as 
errors are introduced in the F amplitude estimation and by poor isomorphism, the 
accuracy of the phase solution increases by increasing the number of derivatives used. 
For this reason the technique is better called Multiple Isomorphus Replacement (MIR).  
 
 
 
Figure A.12 The Harker construction. The Harker construction has been obtained by repeating the 
following instructions: 1) Draw a circle with radius 𝐹! . 2) From the centre of the circle vector the 
calculated -FH is drawn. 3) A second circle with module 𝐹!"  and centre in the end of the vector -FH is 
drawn. Two phase solutions are then obtained. 
 
 
Today, MIR is not the technique of choice as there are several difficulties in practice. A 
long trial and error procedure is followed to obtain derivatives and the binding of the 
heavy atoms could cause loss in resolution and non-isomorphism. It is preferable to use 
heavy atoms which are, or can be naturally included in the protein , such as Zn, Fe and 
Cu in metalloproteins. Moreover, if the construct used contain methionines, it is 
possible to genetically modify the protein to incorporate a heavy atom such as 
Selenium. Se-Met (selenium-methionine) is a modified residue, which is equivalent to a 
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methionine where the sulphur is replaced by a selenium atom. It is easily absorbed by 
cells and bacteria during protein expression, and used to replace methionine during 
protein synthesis in minimal media that lacks the natural resedue.  
To overcome the problem of the number of derivatives required, the anomalous 
scattering phenomenon is considered. The presence of a heavy atom breaks Friedel’s 
Law where Ihkl = I-h-k-l and leads to different intensities of Friedel pairs of reflections. 
Thus, for each heavy atom, two derivatives are obtained: Fhkl and F-h-k-l. The use of the 
anomalous scattering, is the principle of the SAD or MAD method (Hendrickson, 
1991). 
In a typical SAD or MAD experiment, a fluorescent scan of the heavy atom introduced 
in the crystal performed. The scan measures the photon emission of the heavy atom 
around the X-ray wavelength corresponding to its absorption edge. The plot of the 
absorption as a function of the X-ray energy, will show a typical curve with a sharp 
change at a specific λ, which is called the absorption edge. The change refers to ejection 
of an electron caused by a specific X-ray energy, which is different for each atom and 
can be affected by the experimental environment. In the diffraction pattern, Friedel’s 
law is broken and the maximum difference between the pairs hkl/-h-k-l is achieved at 
the peak of the absorption edge. Thus, in order to solve the phase problem, data 
collection is performed at the wavelength of the absorption peak. During the data 
processing and reduction two Structure Factors are then estimated: F(hkl) and F(-h-k-l). 
This experiment is called SAD, because only one wavelength is used. The experiment 
requires Synchrotron radiation, where the X-ray wavelength is tuneable.  
In a MAD experiment, up to four wavelengths are used, providing a much more 
accurate phase calculation. Four data sets can be collected, at the absorption peak (as in 
SAD), the point of inflection of the absorption curve, a remote wavelength and a high 
energy remote data set (Figure A.13). However, despite the accuracy that could be 
achieved, the experiment is time consuming and increase the probability of radiation 
damage in the crystal.  
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Figure A.13 The selenium k absorption edge. Anomalous scattering has two contributions: Δf and f”. 
The curves are shown respectively in purple and green (www.esrf.eu). The minimum achieved by Δf 
curve is the inflection point or λ1; the maximum achieved by f” curve is the absorption edge or λ2; λ3 is 
the remote wavelength, which is far from both λ1 and λ2. At λ=λ2 the anomalous difference is the largest. 
 
 
Thus, in SAD or MAD data are collected on a single crystal, without any problem of 
isomorphism. The scattering factors of the anomalously scattering atoms are different, 
and therefore, the intensities of reflections will be different for each wavelength at 
which a data set is taken.  
 
 
A.5.2.2 Molecular replacement 
If the structure of a homologous protein is known the model can be used to estimate the 
phases. This process is called molecular replacement (MR). The goal of the molecular 
replacement process is to transfer the known protein molecular structure from its 
crystalline arrangement to the crystal of the protein of unknown structure. The process 
is a two-step procedure, which comprises the calculation of a rotation and a translation 
function. In the rotation function, the orientation of the new molecule in the unit cell 
will be found. As first described by Rossman and Blow (Rossmann, 1990), the rotation 
function uses the Patterson maps to find the orientation, by looking for the function that 
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will overlap the self-Patterson map (see figure A.10). The two maps are expected to be 
very similar, apart from having a different orientation. The final result of the first step is 
a list of Eulerian angles or Polar angles, which described the rotation to apply to the 
Patterson function around an axis through its origin.  
Then the translation function is applied, which defines the translation required to 
overlap one molecule in real space. The simplest way for calculating this is by trial and 
error. The known molecule is moved through the asymmetric unit and the structure 
factors are calculated and compared to the observed ones, by calculating a correlation 
coefficient. Alternatively, the translation function can be calculated by comparing the 
cross-Patterson vectors map, which is made by vectors between atoms of two different 
molecules that are related each other in the model structure by crystallographic 
symmetry.  
 
 
A.5.3 Model building, Refinement and Validation 
After phases have been estimated and electron density maps calculated, the model can 
be built. The electron density is interpreted and a first molecular model is built to fit the 
density. The structure factors calculated on the basis of this model (Fcalc) are generally 
in poor agreement with the observed Structure Factors (Fobs). This is clearly shown by 
the difference Fourier map. The map shows positive electron density peaks at the site of 
atoms that were not present in the real structure and it shows negative peaks at the 
positions of the atoms present only in the model. The refinement is the process of 
adjusting the model to find a closer agreement between the calculated and the observed 
structure factors. The agreement index between the calculated and observed structure 
factors is usually represented by a Rfactor, defined by the equation: 
 𝑅 = 𝐹!"# − 𝑘 𝐹!"#!!!" 𝐹!"#!!"  
 
where k is the scale factor.  
It has been shown that Rfactor could reach very small values for a protein structure that 
later appear to be incorrect. This is due to the high model parameters that are 
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considered. To avoid this pitfall, the Free Rfactor is also used, which is unbiased from the 
refinement process. The reflection set is divided in two sets: the working-set (~95%) 
and the test-set (usually 5%). Refinement is run only on the working-set and the Free 
Rfactor is calculated only on the test set with exactly the same equation. If a structure is 
really improving during the refinement step both Rfactor will decrease. This process is 
called cross-validation. 
During refinement, both atomic coordinates and temperature factors or B-factors of the 
molecule are refined against the observed amplitudes. The refinement of the 
temperature factors considers the phenomenon that X-rays do not interact with identical 
atoms on exactly the same position in successive unit cells. This is due to the fact that 
atoms vibrate around their equilibrium position. Where the components of the vibration 
are the same in all directions, the vibration is called isotropic. At high resolution, 
differences can be measured and the temperature factor is refined as anisotropic. 
However, refinement of a full anisotropic model, which comprises six parameters, can 
be challenging. TLS refinement is a way of modelling anisotropic displacements using 
only a few parameters. The structure is divided in groups, which are supposed to move 
as rigid bodies; the rigid-body motion is described by translation (T), libration (L) and 
screw (S) tensors using a total of 20 parameters for each group. Then anisotropic 
parameters for each atom are derived (Murshudov et al., 2011). A correct refinement of 
the B-factors decreases the Rfactor values by providing a better model.  
The refinement process is usually run in a restrained way. This implies that limits for 
sterochemical parameters such as bond lengths, torsion angles and Van de Waals 
contacts, are introduced based on values determined from small molecules. Further NCS 
restrains can be added, which force same molecules related each other by non-
crystallographic symmetry to be equal.  
The function of minimising the difference between the Fcalc and the Fobs can be 
compared to a trajectory towards a minimum value. If the distance between the model 
and the real structure is too large, refinement can be trapped in a local minimum. In this 
situation simulating annealing can be applied in order to ‘push’ the model out of a local 
minimum and let it reach the real minimum. The basic idea of this method belongs to 
the molecular dynamic system, where the behaviour of a particle can be simulated at 
specific temperature and pressure. In the case of a molecular structure, the idea is to 
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raise the temperature sufficiently high for the atoms to overcome energy barriers. The 
increase in energy increases the freedom in the stereochemical restraints, which lets the 
structure achieve conformations that would not be allowed in a normal restrained 
refinement. Indeed, the system can jump the local energy minima and cool down to the 
real minimum.  
After the molecular model is refined, the structure needs to be validated. This is 
performed by checking the agreement between the structure stereochemistry and the 
conventional geometrical-chemical restrains. The stereochemistry of the main chain 
folding can be investigated with a Ramachandran plot, in which the dihedral angles φ 
and ψ allowed for each residue are plotted in a square matrix. Furthermore, unusual ω 
angles, eclipsed dihedral angles, unsatisfied high B-factors, unpaired charged residues 
should be checked carefully.  
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